DOI	Title	Authors	Abstract	Journal	Date
10.1016/S0140-6736(25)01635-6	the global , regional , and national burden of cancer , 1990-2023 , with forecast to 2050 : a systematic analysis for the global burden of disease study 2023 .		cancer be a lead cause of death globally . accurate cancer burden information be crucial for policy planning , but many country do not have up-to-date cancer surveillance data . to inform global cancer-control effort , we use the global burden of disease , injury , and risk factor study ( gbd ) 2023 framework to generate and analyse estimate of cancer burden for 47 cancer type or grouping by age , sex , and 204 country and territory from 1990 to 2023 , cancer burden attributable to select risk factor from 1990 to 2023 , and forecast cancer burden up to 2050. cancer estimation in gbd 2023 use data from population-based cancer registration system , vital registration system , and verbal autopsy . cancer mortality be estimate use ensemble model , with incidence inform by mortality estimate and mortality-to-incidence ratio ( mirs ) . prevalence estimate be generate from model survival estimate , then multiply by disability weight to estimate year live with disability ( ylds ) . year of life lose ( ylls ) be estimate by multiply age-specific cancer death by the gbd standard life expectancy at the age of death . disability-adjusted life-years ( dalys ) be calculate a the sum of ylls and ylds . we use the gbd 2023 comparative risk assessment framework to estimate cancer burden attributable to 44 behavioural , environmental and occupational , and metabolic risk factor . to forecast cancer burden from 2024 to 2050 , we use the gbd 2023 forecasting framework , which include forecast of relevant risk factor exposure and use socio-demographic index a a covariate for forecast the proportion of each cancer not affect by these risk factor . progress towards the un sustainable development goal ( sdg ) target 3.4 aim to reduce non-communicable disease mortality by a third between 2015 and 2030 be estimate for cancer . in 2023 , exclude non-melanoma skin cancer , there be 18·5 million ( 95 % uncertainty interval 16·4 to 20·7 ) incident case of cancer and 10·4 million ( 9·65 to 10·9 ) death , contribute to 271 million ( 255 to 285 ) dalys globally . of these , 57·9 % ( 56·1 to 59·8 ) of incident case and 65·8 % ( 64·3 to 67·6 ) of cancer death occur in low-income to upper-middle-income country base on world bank income group classification . cancer be the second leading cause of death globally in 2023 after cardiovascular disease . there be 4·33 million ( 3·85 to 4·78 ) risk-attributable cancer death globally in 2023 , comprise 41·7 % ( 37·8 to 45·4 ) of all cancer death . risk-attributable cancer death increase by 72·3 % ( 57·1 to 86·8 ) from 1990 to 2023 , whereas overall global cancer death increase by 74·3 % ( 62·2 to 86·2 ) over the same period . the reference forecast ( the most likely future ) estimate that in 2050 there will be 30·5 million ( 22·9 to 38·9 ) case and 18·6 million ( 15·6 to 21·5 ) death from cancer globally , 60·7 % ( 41·9 to 80·6 ) and 74·5 % ( 50·1 to 104·2 ) increase from 2024 , respectively . these forecasted increase in death be great in low-income and middle-income country ( 90·6 % [ 61·0 to 127·0 ] ) compare with high-income country ( 42·8 % [ 28·3 to 58·6 ] ) . most of these increase be likely due to demographic change , a age-standardised death rate be forecast to change by -5·6 % ( -12·8 to 4·6 ) between 2024 and 2050 globally . between 2015 and 2030 , the probability of die due to cancer between the age of 30 year and 70 year be forecast to have a relative decrease of 6·5 % ( 3·2 to 10·3 ) . cancer be a major contributor to global disease burden , with increase number of case and death forecast up to 2050 and a disproportionate growth in burden in country with scarce resource . the decline in age-standardised mortality rate from cancer be encourage but insufficient to meet the sdg target set for 2030. effectively and sustainably address cancer burden globally will require comprehensive national and international effort that consider health system and context in the development and implementation of cancer-control strategy across the continuum of prevention , diagnosis , and treatment . gate foundation , st jude child 's research hospital , and st baldrick 's foundation .	Lancet (London, England)	24/09/2025
10.4049/jimmunol.173.5.2995	a novel mutation in cd83 result in the development of a unique population of cd4+ t cell .	García-Martínez LF, Appleby MW, Staehling-Hampton K, Andrews DM, Chen Y, McEuen M, Tang P, Rhinehart RL, Proll S, Paeper B, Brunkow ME, Grandea AG 3rd, Howard ED, Walker DE, Charmley P, Jonas M, Shaw S, Latham JA, Ramsdell F	use a mouse mutagenesis screen , we have identify cd83 a be critical for the development of cd4 ( + ) t cell and for their function postactivation . cd11c ( + ) dendritic cell develop and function normally in mouse with a mutate cd83 gene but cd4 ( + ) t cell development be substantially reduce . additionally , we now show that those cd4 ( + ) cell that develop in a cd83 mutant animal fail to respond normally follow allogeneic stimulation . this be at least in part due to an altered cytokine expression pattern characterize by an increased production of il-4 and il-10 and diminished il-2 production . thus , in addition to it role in selection of cd4 ( + ) t cell , absence of cd83 result in the generation of cell with an altered activation and cytokine profile .	Journal of immunology (Baltimore, Md. : 1950)	01/09/2004
10.1038/s41586-025-09588-6	autoimmune response to c9orf72 protein in amyotrophic lateral sclerosis .	Michaelis T, Lindestam Arlehamn CS, Johansson E, Frazier A, Berry JD, Cudkowicz M, Goyal NA, Fournier C, Snyder A, Kwan JY, Crook J, Phillips EJ, Mallal SA, Ravits J, Marder KS, Sidney J, Sulzer D, Sette A	amyotrophic lateral sclerosis ( al ) be a neurodegenerative disease characterize by a progressive loss of motor neuron . neuroinflammation be apparent in affected tissue , include increase t cell infiltration and activation of microglia , particularly in the spinal cord ( 1,2 ) . autoimmune response be think to have a key role in al pathology , and it be hypothesize that t cell contribute to the rapid loss of neuron during disease progression ( 3,4 ) . however , until now there have be no reported target for such an autoimmune response . here we show that al be associate with recognition of the c9orf72 antigen , and we map the specific epitope that be recognize . we show that these response be mediate by cd4 ( + ) t cell that preferentially release il-5 and il-10 , and that il-10-mediated t cell response be significantly great in donor who have a longer predicted survival time . our result reinforce the previous hypothesis that neuroinflammation have an important role in al disease progression , possibly because of a disrupted balance of inflammatory and counter-inflammatory t cell response ( 4 ) . these finding highlight the potential of therapeutic strategy aim at enhance regulatory t cell ( 5 ) , and identify a key target for antigen-specific t cell response that could enable precision therapeutic in al .	Nature	01/10/2025
10.1038/s41573-025-01291-5	in vivo chimeric antigen receptor ( car ) -t cell therapy .	Bot A, Scharenberg A, Friedman K, Guey L, Hofmeister R, Andorko JI, Klichinsky M, Neumann F, Shah JV, Swayer AJ, Trudeau K, Weissman D, Stephan MT, Buchholz CJ, June CH	chimeric antigen receptor ( car ) -t cell therapy have transform the outcome of patient with haematological malignancy , yet it use be limit by labour-intensive manufacturing , constrain production capacity and variable clinical performance . in vivo car-t cell engineering , in which car-t cell be generate directly inside the patient 's body , seek to overcome these challenge by eliminate the need for ex vivo cell processing and complex logistics , as well a improve clinical performance . recent advance in virology , rna medicine and nanotechnology have catalyse a radical overhaul of this approach , which use targeted delivery system such a lentiviral vector and lipid nanoparticles to introduce car-encoding genetic material into endogenous t cell . early clinical study have show efficient transduction , sustain car expression and initial sign of antitumour activity , establish proof of concept . this review explore the underlie technology - include rna deliver by lipid nanoparticles and engineered viral vector - and discuss how they be be adapt to develop more broadly applicable , scalable , safe and effective car-t cell therapy . by remove the need for ex vivo manipulation and chemotherapeutic conditioning , this strategy could enable the wide application of car-t cell therapies not just to blood cancer but to autoimmune disease for which ex vivo car-t cell therapy have show strong promise , such a systemic lupus erythematosus .	Nature reviews. Drug discovery	30/09/2025
10.2147/NSS.S467531	effect of acute sleep deprivation on sport performance in athlete : a comprehensive systematic review and meta-analysis .	Gong M, Sun M, Sun Y, Jin L, Li S	use meta-analysis to comprehensively and quantitatively evaluate the impact of acute sleep deprivation on different sport performance of athlete , this study aim to provide scientific guidance for coach in optimize and adjust training and competition arrangement . establish literature inclusion and exclusion criterion , we conduct search in both chinese and english database . use stata 14.0 , we analyze 75 indicator from 27 included literature , focus on three aspect : the impact of acute sleep deprivation on overall athletic performance , the impact on sport performance across various athletic ability , and the disparity in athletic performance between morning and afternoon follow acute sleep deprivation . the effect size of acute sleep deprivation on overall athletic performance be -0.56 ( p < 0.05 ) . sub-analyses reveal effect size of -0.23 ( p < 0.05 ) for whole night sleep deprivation , -1.17 ( p < 0.05 ) for partial sleep deprivation at the end of the night , and -0.25 ( p > 0.05 ) for partial sleep deprivation in the beginning of the night . the effect size of acute sleep deprivation on high intensity intermittent exercise , skill control , speed , aerobic endurance , and explosive power indicator be -1.57 , -1.06 , -0.67 , -0.54 , and -0.39 respectively ( p < 0.05 ) . the effect size of acute sleep deprivation on the overall athletic performance in the morning and afternoon be -0.30 , and -1.11 , respectively ( p < 0.05 ) . acute sleep deprivation significantly impair the overall athletic performance of athlete , with a more pronounced negative impact observe with partial sleep deprivation at the end of the night . various type of exercise performance be adversely affect by acute sleep deprivation , with magnitude of impact rank high intensity intermittent , skill control , speed , aerobic endurance , and explosive power . follow acute sleep deprivation , athlete ' overall sport performance in the afternoon be inferior to that in the morning .	Nature and science of sleep	01/01/2024
10.1016/0022-2836(88)90482-2	selection of dna bind site by regulatory protein . ii . the bind specificity of cyclic amp receptor protein to recognition site .	Berg OG, von Hippel PH	the statistic of base-pair usage within know recognition site for a particular dna-binding protein can be use to estimate the relative protein bind affinity to these site , as well a to site contain any other combination of base-pairs . a have be describe elsewhere , the connection between base-pair statistic and bind free energy be make by an equal probability selection assumption ; i.e . that all base-pair sequence that provide appropriate binding strength be equally likely to have be choose a recognition site in the course of evolution . this be analogous to a statistical-mechanical system where all configuration with the same energy be equally likely to occur . in this communication , we apply the statistical-mechanical selection theory to analyze the base-pair statistic of the know recognition sequence for the cyclic amp receptor protein ( crp ) . the theoretical prediction be find to be in reasonable agreement with bind data for those sequence for which experimental binding information be available , thus lend support to the basic assumption of the selection theory . on the basis of this agreement , we can predict the affinity for crp binding to any base-pair sequence , albeit with a large statistical uncertainty . when the know recognition site for crp be rank accord to predict binding affinity , we find that the ranking be consistent with the hypothesis that the level of function of these site parallel their fractional saturation with crp-camp under in-vivo condition . when apply to the entire genome , the theory predict the existence of a large number of randomly occur `` pseudosites '' with strong binding affinity for crp . it appear that most crp molecule be engage in non-productive binding at non-specific or pseudospecific site under in-vivo condition . in this sense , the specificity of the crp bind site be very low . relative specificity requirement for polymerase , repressor and activator be compare in light of the result of this and the first paper in this series .	Journal of molecular biology	20/04/1988
10.1038/s41591-025-03978-z	a systematic review and meta-analysis of the efficacy and safety of pharmacological treatment for obesity in adult .	McGowan B, Ciudin A, Baker JL, Busetto L, Dicker D, Frühbeck G, Goossens GH, Monami M, Sbraccia P, Martinez-Tellez B, Woodward E, Yumuk V	this systematic review and network meta-analysis evaluate the efficacy and safety of obesity management medication ( omms ) in term of reduce body weight and impact on obesity-related complication . here a medline and embase search be perform up to 31 january 2025 for randomize controlled trial compare omms versus placebo/active comparators in adult . primary endpoint be percentage of total body weight loss ( tbwl % ) at the end of the study . secondary endpoint be tbwl % at 1 , 2 and ≥3 year , lipid profile , blood pressure , hemoglobin a1c , fast plasma glucose , mental health , serious adverse event , quality of life , cardiovascular morbidity and mortality , remission of obesity-related complication and all-cause mortality . fifty-six clinical trial be identified-orlistat ( 22 ) , semaglutide ( 14 ) , liraglutide ( 11 ) , tirzepatide ( 6 ) , naltrexone/bupropion ( 5 ) and phentermine/topiramate ( 2 ) -enrolling 60,307 patient ( 32,598 omm and 27,709 placebo ) . all omms show a significantly great tbwl % versus placebo ( p < 0.0001 ) , more than 10 % for semaglutide and tirzepatide . both tirzepatide and semaglutide show normoglycemia restoration , remission of type 2 diabetes and reduction in hospitalization due to heart failure . semaglutide be effective in reduce major adverse cardiovascular event and reduce pain in knee osteoarthritis . tirzepatide be effective in remission of obstructive sleep apnea syndrome and metabolic dysfunction-associated steatohepatitis . these result support the need to individualize the selection of omms .	Nature medicine	02/10/2025
10.1186/s13058-025-02123-5	hsa-mir-155-5p expression in primary breast tissue may have the potential for prediction of breast cancer brain recurrence : result from the multi-institutional exploratory cohort study .	Koyama Y, Muguruma M, Horimoto Y, Narui K, Yamada A, Yamada K, Yamamoto S, Orihara S, Kaise H, Kogure A, Yoshioka Y, Ochiya T, Ishikawa T	despite the known incidence of brain metastasis in breast cancer , no useful biomarker have be clinically establish for breast cancer brain metastasis ( bcbm ) . in the present study , we aim to examine the expression of micrornas ( mirnas ) relate to bcbm in formalin-fixed paraffin-embedded ( ffpe ) tissue to identify their usefulness a predictive biomarkers of breast cancer brain recurrence ( bcbr ) . pair of primary breast and metastatic site tissue sample be collect from 38 patient who experience the first recurrence of metastasis to a single distant organ ( brain/lungs/liver/bones = 11/12/9/6 patient ) between january 2007 and december 2021 at five institution in japan . we evaluate the expression of 15 mirnas in ffpe specimen of untreated breast and metastatic site from the same patient use quantitative polymerase chain reaction . analysis of the select 15 mirnas reveal that hsa-mir-155-5p exhibit significant bcbr-specific overexpression in untreated primary breast tissue ( p < 0.001 ) . two other mirnas , hsa-mir-150-5p and hsa-mir-20b-5p , exhibited moderate ( ρ = 0.587 ) and weak ( ρ = 0.350 ) positive correlation with hsa-mir-155-5p , respectively . the bcbr prediction model demonstrate a high discrimination ability for hsa-mir-155-5p ( auc = 0.960 ) . the localization of hsa-mir-155-5p in primary breast cancer tissue by in situ hybridization confirm that hsa-mir-155-5p be uniformly stain in the breast cancer cell . hsa-mir-155-5p expression in untreated primary breast tissue may be a valuable biomarker for predict bcbr . a personalized escalation strategy be expect to be helpful in conquer brain metastasis .	Breast cancer research : BCR	29/09/2025
10.1038/s41593-025-02062-6	muscle-derived mir-126 regulates tdp-43 axonal local synthesis and nmj integrity in al model .	Ionescu A, Ankol L, Ganapathy Subramaniam A, Altman T, Magen I, Cohen Y, Danino Y, Gradus-Pery T, Niv Y, Bar Avi O, Geller D, Ibraheem A, Cheng R, Steinberg N, Alfahel L, Duc P, Ergul-Ulger Z, Arslan D, Tan E, Rage F, Riva N, Quattrini A, Bekircan-Kurt CE, Israelson A, Dori A, Hornstein E, Perlson E	amyotrophic lateral sclerosis ( al ) be characterize by neuromuscular junction ( nmj ) disruption and neurodegeneration . recent finding highlight a pivotal role for tar dna-binding protein 43 ( tdp-43 ) in form axonal pathological condensate and facilitate nmj disruption through inhibition of local protein synthesis . however , the mechanism that drive local tdp-43 accumulation remain unknown . here we identify that the tdp-43 axonal accumulation in peripheral nerve of sod1 patient and mice stem from it aberrant local synthesis . this be a non-cell-autonomous process drive by muscle-derived mir-126a-5p extracellular vesicle ( ev ) . inhibit muscle secretion of mir-126a-5p prompt presynaptic tdp-43 synthesis and accumulation , which disrupt axonal translation and cause nmj degeneration . introduce mir-126 to sod1 ( g93a ) mouse , primary co-cultures and human induce pluripotent stem cell ( ipsc ) -derived co-cultures with al mutation exhibit neuroprotective effect and delay motor decline . these finding identify a transcellular communication axis between muscle and motor neuron that regulate axonal local synthesis and nmj maintenance , offer insight into al onset and progression .	Nature neuroscience	03/10/2025
10.1002/ajmg.10401	a 52-kb deletion in the sost-meox1 intergenic region on 17q12-q21 be associate with van buchem disease in the dutch population .	Staehling-Hampton K, Proll S, Paeper BW, Zhao L, Charmley P, Brown A, Gardner JC, Galas D, Schatzman RC, Beighton P, Papapoulos S, Hamersma H, Brunkow ME	van buchem disease be an autosomal recessive sclerosing bone dysplasia characterize by skeletal hyperostosis , overgrowth of the mandible , and a liability to entrapment of the seventh and eighth cranial nerve . the genetic determinant map to chromosome 17q12-q21 . we refine the critical interval to the < 1-mb region between d17s2250 and d17s2253 in 15 affected individual , all of whom share a common disease haplotype . furthermore , we report here the identification of a 52-kb deletion locate within the interval and encompass d17s1789 that be 100 % concordant with the disorder . although the deletion itself do not appear to disrupt the cod region of any know or novel gene ( s ) , the close flanking gene be meox1 on the proximal side , and sost on the distal side of the deletion . meox1 be know to be important for the development of the axial skeleton , whereas the sost gene be the determinant of sclerosteosis , a disorder that share many feature with van buchem disease , thus raise the possibility that van buchem disease result from dysregulation of the expression of one or both of these gene .	American journal of medical genetics	15/06/2002
10.1186/s12933-025-02939-7	joint effect of triglyceride glucose index and it obesity-related derivative with estimate glucose disposal rate on cardiometabolic multimorbidity in middle-aged and old chinese adult : a nationwide cohort study .	Ruan X, Ling Y, Chen J, Xiang Y, Ruan H, Zhang W, Jing L, Gao X, He Y, Lu X, Chang T, Xu J, Chen J	the triglyceride-glucose ( tyg ) index , tyg-body mass index ( tyg-bmi ) , tyg-waist circumference ( tyg-wc ) , tyg-waist-to-height ratio ( tyg-whtr ) , and estimate glucose disposal rate ( egdr ) serve a surrogate marker of insulin resistance ( ir ) and be associate with cardiometabolic disease ( cmds ) . however , the joint effect of tyg-related index and egdr on cardiometabolic multimorbidity ( cmm ) risk remain unclear . this study aim to assess both separate and combined effect of tyg-related index and egdr on cmm . the data of this study derive from the china health and retirement longitudinal study ( charls ) . tyg-related index and egdr be dichotomize at their median level for participant categorization . univariate and multivariate cox regression and restrict cubic spline ( rcs ) analyze effect of tyg-related index and egdr on cmm , while receiver operate characteristic ( roc ) curve , net reclassification improvement ( nri ) and integrated discrimination improvement ( idi ) assess their predictive performance . meanwhile , the mutual mediating effect and interaction effect be far assess . this study include 5,854 participant ( male : 47.5 % , median age : 57.0 year ) . compare to low tyg-related index plus high egdr , high tyg-related index plus low egdr have elevate cmm risk : tyg ( hr 3.59 , 95 % ci 2.28-5.65 ) , tyg-bmi ( hr 3.40 , 95 % ci 2.30-5.02 ) , tyg-wc ( hr 3.85 , 95 % ci 2.58-5.75 ) , and tyg-whtr ( hr 3.62 , 95 % ci 2.43-5.39 ) . furthermore , the addition of tyg-related index combine with egdr to the basic model significantly improve cmm risk prediction : tyg ( auc 0.713 , nri 0.363 , idi 0.008 , all p < 0.05 ) ; tyg-bmi ( auc 0.729 , nri 0.479 , idi 0.011 , all p < 0.05 ) ; tyg-wc ( auc 0.716 , nri 0.419 , idi 0.010 , all p < 0.05 ) ; and tyg-whtr ( auc 0.717 , nri 0.379 , idi 0.010 , all p < 0.05 ) . moreover , the mediation analysis demonstrate that egdr significantly mediate all tyg-related index ' association with cmm , with only obesity-related tyg index mediate the association between egdr and cmm . notably , no significant additive or multiplicative interaction be observe between any tyg-related index and egdr for cmm risk . high tyg-related index and low egdr be independently and jointly associate with high cmm risk . joint application of tyg-related index and egdr could improve early identification and prevention of cmm .	Cardiovascular diabetology	02/10/2025
10.1038/s41586-025-09539-1	proteotoxic stress response drive t cell exhaustion and immune evasion .	Wang Y, Ma A, Song NJ, Shannon AE, Amankwah YS, Chen X, Wu W, Wang Z, Saadey AA, Yousif A, Ghosh G, Mandula JK, Velegraki M, Xiao T, Wen H, Huang SC, Wang R, Beusch CM, Dawood AS, Gordon DE, Abdel-Hakeem MS, Ghoneim HE, Xin G, Searle BC, Li Z	chronic infection and cancer cause t cell dysfunction know a exhaustion . this cell state be cause by persistent antigen exposure , suboptimal co-stimulation and a plethora of hostile factor that dampen protective immunity and limit the efficacy of immunotherapy ( 1-4 ) . the mechanism that underlie t cell exhaustion remain poorly understood . here we analyse the proteome of cd8 ( + ) exhaust t ( t ( ex ) ) cell across multiple state of exhaustion in the context of both chronic viral infection and cancer . we show that there be a non-stochastic pathway-specific discordance between mrna and protein dynamic between t effector ( t ( eff ) ) and t ( ex ) cell . we identify a distinct proteotoxic stress response ( psr ) in t ( ex ) cell , which we term t ( ex ) -psr . contrary to canonical stress response that induce a reduction in protein synthesis ( 5,6 ) , t ( ex ) -psr involve an increase in global translation activity and an upregulation of specialized chaperone protein . t ( ex ) -psr be further characterize by the accumulation of protein aggregate and stress granule and an increase in autophagy-dominant protein catabolism . we establish that disruption of proteostasis alone can convert t ( eff ) cell to t ( ex ) cell , and we link t ( ex ) -psr mechanistically to persistent akt signalling . finally , disruption of t ( ex ) -psr-associated chaperone in cd8 ( + ) t cell improve cancer immunotherapy in preclinical model . moreover , a high t ( ex ) -psr in t cell from patient with cancer confers poor response to clinical immunotherapy . collectively , our finding indicate that t ( ex ) -psr be a hallmark and a mechanistic driver of t cell exhaustion , which raise the possibility of target proteostasis pathway a an approach for cancer immunotherapy .	Nature	01/10/2025
10.1056/NEJMoa2508170	sotatercept for pulmonary arterial hypertension within the first year after diagnosis .	McLaughlin VV, Hoeper MM, Badesch DB, Ghofrani HA, Gibbs JSR, Gomberg-Maitland M, Preston IR, Souza R, Waxman AB, Kopeć G, Meyer G, Olsson KM, Fu W, Shi Y, Miller B, Kim SS, Mackenzie HS, Brambatti M, Patel MJ, Koglin J, Cornell AG, Humbert M	sotatercept , an activin-signaling inhibitor , reduce morbidity and mortality among patient with long-standing pulmonary arterial hypertension . it effect in patient with pulmonary arterial hypertension within the first year after diagnosis be unclear . in this phase 3 trial , we enrol adult patient with world health organization functional class ii or iii pulmonary arterial hypertension who have receive the diagnosis less than 1 year earlier , have an intermediate or high risk of death , and be receive double or triple background therapy . patient be randomly assign to receive add-on therapy with subcutaneous sotatercept ( start dose , 0.3 mg per kilogram of body weight ; escalate to target dose , 0.7 mg per kilogram ) or placebo every 21 day . the primary end point be clinical worsening , a composite of death from any cause , unplanned hospitalization last at least 24 hour for worsen of pulmonary arterial hypertension , atrial septostomy , lung transplantation , or deterioration in performance in exercise test due to pulmonary arterial hypertension , assess in a time-to-first-event analysis . the trial be stop early owe to loss of clinical equipoise after the reporting of positive result from previous sotatercept trial . a total of 320 patient be include ( 160 each in the sotatercept and placebo group ) . the median duration of follow-up be 13.2 month . at least one primary end-point event occur in 17 patient ( 10.6 % ) in the sotatercept group and in 59 patient ( 36.9 % ) in the placebo group ( hazard ratio , 0.24 ; 95 % confidence interval , 0.14 to 0.41 ; p < 0.001 ) . deterioration in performance in exercise test due to pulmonary arterial hypertension occur in 8 patient ( 5.0 % ) in the sotatercept group and in 46 patient ( 28.8 % ) in the placebo group ; unplanned hospitalization for worsen of pulmonary arterial hypertension occur in 3 patient ( 1.9 % ) and 14 patient ( 8.8 % ) , respectively ; and death from any cause occur in 7 patient ( 4.4 % ) and 6 patient ( 3.8 % ) . no case of atrial septostomy or lung transplantation occur . the most common adverse event with sotatercept be epistaxis ( 31.9 % ) and telangiectasia ( 26.2 % ) . among adult with pulmonary arterial hypertension who have receive the diagnosis less than 1 year earlier , the addition of sotatercept to background therapy result in a low risk of clinical worsening than placebo . ( fund by merck sharp and dohme , a subsidiary of merck [ rahway , nj ] ; hyperion clinicaltrials.gov number , nct04811092 . ) .	The New England journal of medicine	30/09/2025
10.4049/jimmunol.167.11.6312	the amount of scurfin protein determine peripheral t cell number and responsiveness .	Khattri R, Kasprowicz D, Cox T, Mortrud M, Appleby MW, Brunkow ME, Ziegler SF, Ramsdell F	in the absence of the recently identify putative transcription factor scurfin , mouse develop a lymphoproliferative disorder result in death by 3 wk of age from a pathology that resemble tgf-beta or ctla-4 knockout mouse . in this report , we characterize mouse that overexpress the scurfin protein and demonstrate that these animal have a dramatically depress immune system . mouse transgenic for the foxp3 gene ( which encode the scurfin protein ) have few t cell than their littermate control , and those t cell that remain have poor proliferative and cytolytic response and make little il-2 after stimulation through the tcr . although thymic development appear normal in these mouse , peripheral lymphoid organ , particularly lymph node , be relatively acellular . in a separate transgenic line , force expression of the gene specifically in the thymus can alter thymic development ; however , this do not appear to affect peripheral t cell and be unable to prevent disease in mouse lack a functional foxp3 gene , indicate that the scurfin protein act on peripheral t cell . the data indicate a critical role for the foxp3 gene product in the function of the immune system , with both the number and functionality of peripheral t cell under the aegis of the scurfin protein .	Journal of immunology (Baltimore, Md. : 1950)	01/12/2001
10.1016/j.jns.2024.123303	multi-omic characterization of the effect of ocrelizumab in patient with relapsing-remitting multiple sclerosis .	Kornilov SA, Price ND, Gelinas R, Acosta J, Brunkow ME, Gervasi-Follmar T, Winger RC, Aldershoff D, Lausted C, Troisch P, Smith B, Heath JR, Repovic P, Cohan S, Magis AT	the study examine change in the plasma proteome , metabolome , and lipidome of n = 14 patient with relapsing-remitting multiple sclerosis ( rrms ) initiate treatment with ocrelizumab , assay at baseline , 6 month , and 12 month . analysis of > 4000 circulate biomarkers identify depletion of b-cell associated protein a the early effect observe follow ocrelizumab ( ocr ) initiation , accompany by the reduction in plasma abundance of cytokine and cytotoxic protein , marker of neuronaxonal damage , and biologically active lipid include ceramides and lysophospholipids , at 6 month . b-cell depletion be accompany by decrease in b-cell receptor and cytokine signaling but a pronounced increase in circulate plasma b-cell activate factor ( baff ) . this be follow by an upregulation of a number of signal and metabolic pathway at 12 month . patient with high baseline brain mri lesion load demonstrate both high level of cytotoxic and structural protein in plasma at baseline and more pronounced biomarker change trajectory over time . digital cytometry identify a putative increase in myeloid cell and a pro-inflammatory subset of t-cells . therapeutic effect of ocrelizumab extend beyond cd20-mediated b-cell lysis and implicate metabolic reprogramming , juxtapose the early normalization of immune activation , cytokine signaling and metabolite and lipid turnover in periphery with change in the dynamic of immune cell activation or composition . we identify baff increase follow cd20 depletion a a tentative compensatory mechanism that contribute to the reconstitution of targeted b-cells , necessitate further research .	Journal of the neurological sciences	15/12/2024
10.1126/science.adr7403	intercellular communication in the brain through a dendritic nanotubular network .	Chang M, Krüssel S, Parajuli LK, Kim J, Lee D, Merodio A, Kwon J, Okabe S, Kwon HB	intercellular nanotubular network mediate material exchange , but their existence in neuron remains to be explore in detail . we identify long , thin dendritic filopodia form direct dendrite-dendrite nanotube ( dnts ) in mammalian cortex . super-resolution microscopy in dissociated neuron reveal dnts ' actin-rich composition and dynamic , enable long-range calcium ion ( ca ( 2+ ) ) propagation . imaging and machine learning-based analysis validate in situ dnts a anatomically distinct from synaptic spine . dnts actively transport small molecule and human amyloid-β ( aβ ) ; dnt density increase before plaque formation in the medial prefrontal cortex of app/ps1 mouse ( app , aβ precursor protein ; ps1 , presenilin-1 ) , suggest that the dendrite-dnt network might play a role in alzheimer 's disease pathology . computational model of dnt-mediated aβ propagation recapitulate early amyloidosis , predict selective intracellular accumulation . these finding uncover a nanotubular connectivity layer in the brain , extend neuronal communication beyond classical synapsis .	Science (New York, N.Y.)	02/10/2025
10.1038/s41568-025-00869-w	unveil the molecular and immunological driver of antibody-drug conjugate in cancer treatment .	Zippelius A, Tolaney SM, Tarantino P, Balthasar JP, Thurber GM	after decade of investment , antibody-drug conjugate ( adcs ) be finally demonstrate their potential , mark by a grow number of clinical approval , application in early line of treatment and integration into drug combination , include immunotherapy . this progress have spur investment in develop new adcs and expand the use of approved adcs in clinical practice . the design of adcs be complex , involve multiple molecular component that interact with both tumour and host tissue microenvironments . in this review , we explore the molecular and immunological factor influence adc efficacy and toxicity . we describe how the molecular component of adcs determine their systemic , tissue and cellular distribution , which ultimately dictate therapeutic efficacy . these interaction also determine the toxicity profile and set limitation on maximum dosing . finally , we discuss the impact of adc treatment on immune cell , emphasize the distinct but interconnected role of immunogenic cell death , activation of immune cell such a dendritic cell and antibody-fc interaction . these mechanism be crucial for increase efficacy beyond the direct cytotoxic effect of the payload . by provide insight into the intricate interaction of adcs , this review aim to inform the rational design of combination therapy and guide the development of the next generation of clinically effective adcs .	Nature reviews. Cancer	02/10/2025
10.1126/science.adu4235	localize glutamine leakage drive the spatial structure of root microbial colonization .	Tsai HH, Tang Y, Jiang L, Xu X, Dénervaud Tendon V, Pang J, Jia Y, Wippel K, Vacheron J, Keel C, Andersen TG, Geldner N, Zhou F	plant root release exudate to encourage microbiome assembly , which influence the function and stress resilience of plant . how specific exudate drive spatial colonization pattern remain largely unknown . in this study , we demonstrate that endodermal casparian strips-forming the root 's extracellular diffusion barrier-restrict nutrient leakage into the rhizosphere , coincide with and control spatial colonization pattern of rhizobacteria . we find that vasculature-derived glutamine leakage be a major bacterial chemoattractant and enhancer of proliferation , define a previously unknown pathway for root exudate formation . bacteria defective in amino acid chemoperception display reduce attraction toward leakage site , and root with casparian strip defect display bacterial overproliferation , dependent on bacterial capacity for amino acid metabolization . associate chronic immune stimulation suggest that endodermal nutrient restriction be crucial for regulate microbial colonization and assembly , limit excessive proliferation that could compromise plant health .	Science (New York, N.Y.)	02/10/2025
10.1038/s41586-025-09391-3	monoclonal antibody protect against pandrug-resistant klebsiella pneumoniae .	Roscioli E, Zucconi Galli Fonseca V, Bosch SS, Paciello I, Maccari G, Cardinali G, Batani G, Stazzoni S, Tiseo G, Giordano C, Yuwei S, Capoccia L, Cardamone D, Ridelfi M, Troisi M, Manganaro N, Mugnaini C, De Santi C, Ciabattini A, Cerofolini L, Fragai M, Licastro D, Wyres K, Dortet L, Barnini S, Nicolau DP, Menichetti F, Falcone M, Abdelraouf K, Sala C, Kabanova A, Rappuoli R	the 'silent pandemic ' cause by antimicrobial resistance require innovative therapeutic approach . human monoclonal antibody ( mabs ) , which be among the most transformative and safe drug in oncology ( 1 ) and autoimmunity ( 2 ) , be rarely use for infectious disease and not yet use for antimicrobial resistance ( 3 ) . here we apply an antigen-agnostic strategy to isolate extremely potent human mabs against klebsiella pneumoniae sequence type 147 ( st147 ) , a hypervirulent and pandrug-resistant lineage that be spread globally . isolated mabs target the kl64 capsule and the o-antigen . however , although mabs displayed bactericidal activity in the picomolar range in vitro , only the capsule-specific mabs be protective against fulminant bloodstream infection by st147 and two geographically and genetically distant carbapenem-resistant kl64-bearing k. pneumoniae . protection observe in vivo correlate with in vitro bacterial uptake by macrophage and enchain bacterial growth . our study thus describe a mab that protect against pandrug-resistant k. pneumoniae and provide a strategy to isolate mabs and identify mabs that confer protection against bacteria with antimicrobial resistance .	Nature	01/10/2025
10.1016/j.neuron.2025.09.004	astrocyte-mediated central amygdala microcircuit gate comorbid anxiety symptom in chronic pain .	Zan GY, Yao SY, Deng YZ, Jiang YH, Ye RF, Chen Y, Long JD, Cheng YJ, Chai JR, Xu C, Zhao M, Liu ZQ, Liu JG, Wang YJ	comorbid anxiety symptom be prominent affective component of chronic pain , yet the central mechanism underlie these symptom remain elusive . the central amygdala ( cea ) regulate nociceptive processing and associate anxiety in chronic pain . however , the specific microcircuit and cell type within the cea that regulate pain-related anxiety have not be fully elucidate . in this study , we discover a microcircuit in the cea wherein dynorphinergic neuron of the lateral subdivision of the central amygdala ( cel ) project to the medial subdivision ( cem ) , activation of which gate anxiogenic effect associate with chronic pain . dynorphin-mediated activation of cem astroglial kappa opioid receptor ( kor ) , dependent upon corticotropin-releasing factor ( crf ) receptor 2 signaling , enhance cem neuron excitability by promote n-methyl-d-aspartate receptor ( nmdar ) activation , likely via release gliotransmitter d-serine . behaviorally , kor-mediated bidirectional communication between cea peptidergic neuron and astrocytes modulate the anxiogenic effect of chronic pain . our finding reveal a neuroglial microcircuit underlie pain-associated anxiety and suggest potential target for therapeutic intervention .	Neuron	02/10/2025
10.1038/s41586-025-09542-6	polygenic and developmental profile of autism differ by age at diagnosis .	Zhang X, Grove J, Gu Y, Buus CK, Nielsen LK, Neufeld SAS, Koko M, Malawsky DS, Wade EM, Verhoef E, Gui A, Hegemann L, Geschwind DH, Wray NR, Havdahl A, Ronald A, St Pourcain B, Robinson EB, Bourgeron T, Baron-Cohen S, Børglum AD, Martin HC, Warrier V	although autism have historically be conceptualize a a condition that emerge in early childhood ( 1,2 ) , many autistic people be diagnose later in life ( 3-5 ) . it be unknown whether earlier- and later-diagnosed autism have different developmental trajectory and genetic profile . use longitudinal data from four independent birth cohort , we demonstrate that two different socioemotional and behavioural trajectory be associate with age at diagnosis . in independent cohort of autistic individual , common genetic variant account for approximately 11 % of the variance in age at autism diagnosis , similar to the contribution of individual sociodemographic and clinical factor , which typically explain less than 15 % of this variance . we further demonstrate that the polygenic architecture of autism can be break down into two modestly genetically correlate ( r ( g ) = 0.38 , s.e . = 0.07 ) autism polygenic factor . one of these factor be associate with early autism diagnosis and low social and communication ability in early childhood , but be only moderately genetically correlate with attention deficit-hyperactivity disorder ( adhd ) and mental-health condition . conversely , the second factor be associate with late autism diagnosis and increase socioemotional and behavioural difficulty in adolescence , and have moderate to high positive genetic correlation with adhd and mental-health condition . these finding indicate that earlier- and later-diagnosed autism have different developmental trajectory and genetic profile . our finding have important implication for how we conceptualize autism and provide a model to explain some of the diversity find in autism .	Nature	01/10/2025
10.1038/s41577-025-01221-x	regulator of cd8 ( + ) t cell exhaustion .	Sun Q, Dong C	t cell exhaustion be an adaptive and distinct cell fate that emerge in response to persistent antigen stimulation , primarily in chronic infection and cancer . it be characterize by a progressive loss of effector function and sustained expression of multiple inhibitory receptor . progression to t cell exhaustion be drive by persistent antigen stimulation through the t cell receptor and be modulate by signal from co-stimulatory and inhibitory molecule as well a by microenvironmental factor such a cytokine , metabolite and neuronal factor . these extrinsic cellular factor reshape the t cell transcriptome , epigenome and metabolism towards a state of exhaustion through critical intrinsic cell regulator . in this review , we summarize our current understanding of the regulator involve in t cell exhaustion , highlight their role in direct the fate and functionality of distinct exhaust t cell subset and how they may be harness for the development of improved immunotherapy against cancer and chronic infection .	Nature reviews. Immunology	01/10/2025
10.1038/s41551-025-01513-6	enzyme-converted o kidney allow abo-incompatible transplantation without hyperacute rejection in a human decedent model .	Zeng J, Ma M, Tao Z, Rao Z, Wu C, Yin S, Jiang X, Chen G, Wang Z, Huang D, Zhu M, Liu L, Huo W, Yang H, Guo H, Chen G, Li F, Zheng C, Huang D, Rahfeld P, Kizhakkedathu JN, Withers SG, Lu X, Zhang K, Lin T, Song T	abo-incompatible kidney transplantation be widely use to meet the escalate need for organ . current recipient-centric desensitization protocol involve antibody depletion through plasmapheresis increase the risk of infection , perioperative bleeding event and cost . here we present a donor-centric desensitization protocol , convert type-a kidney into enzyme-converted o kidney during hypothermic perfusion to remove the a antigen from the kidney . an ex vivo model result in no antibody-mediated injury . encourage by this , an enzyme-converted o kidney be transplant into a type-o brain-dead recipient with a high titre of anti-a antibody , and no hyperacute rejection be observe . the graft be well tolerate with no evidence of antibody-mediated rejection for 2 day . antibody-mediated lesion and complement deposition be find start 3 day post-transplant , coincide with a-antigen regeneration , and later high banff score , suggest an immune-mediated response . single-cell sequencing confirm the elevated expression of accommodation-related gene , suggest the potential for longer-term tolerance . this study provide a donor-centric organ engineering strategy and have the potential to broaden the reach of abo-incompatible kidney transplantation , improve the fairness of and access to organ allocation .	Nature biomedical engineering	03/10/2025
10.1038/s41586-025-09589-5	dietary cysteine enhance intestinal stemness via cd8 ( + ) t cell-derived il-22 .	Chi F, Zhang Q, Shay JES, Han S, Ten Hoeve J, Yuan Y, Yang Z, Shin H, Block S, Solanki S, Shah YM, Vander Heiden MG, Agudo J, Yilmaz ÖH	a fundamental question in physiology be understand how tissues adapt and alter their cellular composition in response to dietary cue ( 1-8 ) . the mammalian small intestine be maintain by rapidly renew lgr5 ( + ) intestinal stem cell ( iscs ) that respond to macronutrient change such a fast regimen and obesogenic diet , yet how specific amino acid control isc function during homeostasis and injury remains unclear . here we demonstrate that dietary cysteine , a semi-essential amino acid , enhance isc-mediated intestinal regeneration follow injury . cysteine contribute to coenzyme a ( coa ) biosynthesis in intestinal epithelial cell , which promote expansion of intraepithelial cd8αβ ( + ) t cell and their production of interleukin-22 ( il-22 ) . this enhance il-22 signal directly augments isc reparative capacity after injury . the mechanistic involvement of the pathway in drive the effect of cysteine be demonstrate by several finding : coa supplementation recapitulate cysteine effect , epithelial-specific loss of the cystine transporter slc7a11 block the response , and mouse with cd8αβ ( + ) t cell lack il-22 or a depletion of cd8αβ ( + ) t cell fail to show enhanced regeneration despite cysteine treatment . these finding highlight how coupled cysteine metabolism between iscs and cd8 ( + ) t cell augment intestinal stemness , provide a dietary approach that exploit isc and immune cell crosstalk for ameliorate intestinal damage .	Nature	01/10/2025
10.1016/j.immuni.2025.09.011	obesity , diabetes , and inflammation : pathophysiology and clinical implication .	Donath MY, Drucker DJ	obesity and it related disorder , include type 2 diabetes and liver , kidney , and cardiovascular disease , be now recognize a chronic inflammatory condition . here , we review the mechanism underlie inflammation in these setting and how they may contribute to pathology . nutrient excess trigger immune activation through pattern recognition receptor and the nlrp3 inflammasome , lead to interleukin ( il ) -1β production and downstream cytokine cascade . initially adaptive , this inflammation promote tissue remodel and metabolic compensation , but chronic activation contributes to insulin resistance , β cell dysfunction , and end-organ damage . we discuss the current therapeutic option , with a focus on glucagon-like peptide-1 ( glp-1 ) receptor agonist , which , alone or combine with additional bioactive moiety , exert notable anti-inflammatory effect . some effect of glp-1 medicine be independent of glucose control or weight loss , and they be attribute to direct signal via the immune glp-1 receptor ( glp-1r ) and , indirectly , via central nervous system circuit . understand these mechanism may unlock far therapeutic potential in chronic inflammatory disease .	Immunity	03/10/2025
10.1126/science.adr5048	a comprehensive genetic catalog of human double-strand break repair .	de Alba EL, Salguero I, Giménez-Llorente D, Montes-Torres J, Fernández-Sanromán Á, Casajús-Pelegay E, Terrón-Bautista J, Barroso-González J, Bernal JA, Macintyre G, Fernández-Leiro R, Losada A, Cortés-Ledesma F	the analysis of dna sequence outcome provide molecular insight into double-strand break ( dsb ) repair mechanism . use parallel in-pool profiling of cas9-induced insertion and deletion ( indels ) within a genome-wide knockout library , we present a comprehensive catalog that assess the influence of nearly every human gene on dsb repair outcomes . this repairome resource uncovers uncharacterized mechanism , pathway , and factor involve in dsb repair , include oppose role for xlf and paxx , a molecular explanation for cas9-induced multinucleotide insertion , hltf function in cas9-induced dsb repair , the involvement of the saga complex in microhomology-mediated end joining , and an indel mutational signature link to vhl loss , renal carcinoma , and hypoxia . these result exemplify the potential of repairome to drive future discovery in dsb repair , crispr-cas gene editing and the etiology of cancer mutational signature .	Science (New York, N.Y.)	02/10/2025
10.1016/j.cell.2025.08.033	epithelial-mesenchymal transition .	Zhang CX, Huang RY, Sheng G, Thiery JP	epithelial-mesenchymal transition ( emt ) be a fundamental mechanism involve in the morphogenesis of metazoan . through this evolutionarily conserve multi-stage process , cell acquire quasi-epithelial to multiple intermediate morphology with epithelial and mesenchymal attribute , rarely reach a complete mesenchymal phenotype . complex evolutionary-conserved morphogenetic movement in gastrulation be describe extensively , a they exemplify the extent of epithelial cell plasticity in the animal kingdom . nonetheless , a single-gene knockout can modify the mode of gastrulation while achieve the same body plan . numerous interconnected mechanism drive different degree of emt , include surface receptor signal , metabolism , and epigenetics . emt be reactivate in adult tissue during repair and disease , particularly in cancer initiation , progression to metastasis , and refractoriness to treatment . emt also contribute to dormancy and drug tolerance , lead to minimal residual disease at the origin of recurrence . multiple emt state coexist in tumor , create a dynamic ecosystem for generate an inflammatory microenvironment , stemness , invasion , and metastasis . this review provide an in-depth description of these aspect along with recent controversy and offer new opportunity to far explore the multiple function of emt . examine the potential attribute of emt in tissue repair , fibrosis , and cancer progression can provide new opportunity for therapeutic intervention .	Cell	02/10/2025
10.1016/j.immuni.2025.09.007	notch3 destabilize regulatory t cell to drive autoimmune neuroinflammation in multiple sclerosis .	Benamar M, Contini P, Schmitz-Abe K, Lanzetta O, Getachew F, Bachelin C, Leyva Castillo JM, Wang M, Oktelik FB, Perrot O, Batamack Y, Arbag SN, Stephen-Victor E, Harb H, Agrawal PB, Louapre C, Ivaldi F, Uccelli A, Inglese M, Angelini C, Zujovic V, De Palma R, Chatila TA	the immune regulatory defect that promote neuroinflammation in multiple sclerosis ( m ) remain unclear . we show that a specific regulatory t ( treg ) cell subpopulation express notch3 be increase in individual with m and in mouse with experimental autoimmune encephalomyelitis ( eae ) . notch3 ( + ) treg cell be induce by the gut microbiota via toll-like receptor ( tlr ) -dependent mechanism . they then translocate to the central nervous system ( cns ) in eae where they promote disease severity . notch3 interacted with delta-like ligand 1 ( dll1 ) on microglia to subvert treg cell into t helper 17 ( th17 ) cell . notch3 deletion in treg cell prevent eae onset by stabilize treg cell and by simultaneously promote the expansion of a tissue-resident treg cell population that express neuropeptide y receptor 1 ( npy1r ) and which suppress pathogenic ifn-γ ( + ) and gm-csf ( + ) t cell . our study thus identify altered treg cell population dynamic a a fundamental pathogenic mechanism in autoimmune neuroinflammation .	Immunity	02/10/2025
10.1111/os.13380	relook into the risk factor of proximal junctional kyphosis in early onset scoliosis patient : do the location of upper instrument vertebra in relation to the sagittal apex matter ?	Yang B, Xu L, Zhou Q, Qian Z, Wang B, Zhu Z, Qiu Y, Sun X	grow rod surgery be the mainstay of treatment for early-onset scoliosis ( eos ) while proximal junctional kyphosis ( pjk ) be one of the most commonly report postoperative complication . we seek to investigate the impact of the location of upper instrument vertebra ( uiv ) in relation to the sagittal apex on proximal junctional kyphosis in eos after traditional grow rod ( grs ) treatment . a total of 102 eos patient who receive traditional grow rod treatment with a follow-up of at least 2 year between 2009 and 2020 be retrospectively review . radiographic measurement be perform before and after the index surgery and at the late follow-up . we investigate the coronal cobb angle and spinopelvic parameter of the whole spine . the location of the uiv , apex , low instrument vertebra ( liv ) , inflection vertebra ( iv ) , the number and distance of uiv-apex , liv-apex and iv-apex be also record . risk factor for pjk be analyze by logistic regression analysis . pjk be observe in 21 patient ( 20.6 % ) during the follow-up period . the pjk group show a young age at the index surgery ( 5.9 vs. 7.1 year , p = 0.042 ) , more lengthening procedure time ( 5.0 vs. 4.0 , p = 0.032 ) , large preoperative coronal cobb angle ( 82.0 vs. 75.6° , p = 0.038 ) , high correction rate ( 51.2 % vs. 44.4 % , p = 0.047 ) and large postoperative proximal junctional angle ( pja ) ( 13.9 vs. 5.5° , p < 0.001 ) than the non-pjk group . the ratio of the number and distance from uiv-apex to iv-apex also differ significantly between the two group . the logistic regression reveal that age at the index surgery ≤ 7 year , the ratio of the number from uiv- apex to iv- apex ≤ 0.6 and the ratio of the distance from uiv- apex to iv- apex ≤ 0.6 be independent risk factor for postoperative pjk . besides young age , a close location of uiv relative to the sagittal apex be identify to be an independent risk factor of postoperative pjk . selection of uiv at a relatively farther location away from the sagittal apex might help prevent occurrence of pjk .	Orthopaedic surgery	01/01/2009
10.1186/s12909-021-02946-8	familiarity and genetic literacy among medical student in indonesia .	Swandayani YM, Cayami FK, Winarni TI, Utari A	there be a lack of genetic knowledge among health care professional especially in some develop country such a indonesia . base on our experience , genetic disorder receive less attention in medical education and professional . this study aim to determine the familiarity and literacy of genetics among medical student in indonesia . a total of 1003 indonesian medical ( pre-clinical and clinical ) student complete the rapid estimate of adult literacy in genetics ( real-g ) questionnaire with a total score of seven for familiarity and eight for genetic literacy . the mann-whitney u test be use to compare the familiarity and genetic literacy score between pre-clinical and clinical student . the average score of familiarity and genetic literacy be 5.63 ± 0.96 and 6.37 ± 0.83 , respectively . genetic familiarity be high ( p = 0.043 ) among clinical student than pre-clinical student , while there be no significant difference in genetic literacy ( p = 0.362 ) between pre-clinical and clinical student . genetic familiarity do not impact the level of genetic literacy . however , medical student ' genetic literacy be influence by demographic characteristic , such a age , sex , university type , genetic learning experience , university accreditation , and university location . in general , indonesian medical student have relatively good familiarity and literacy in genetics although further study be necessary to accurately measure the genetic familiarity and literacy in medical student and general public .	BMC medical education	09/10/2021
10.1126/sciadv.adw7376	the pp2a-b55α phosphatase be a master regulator of mitochondrial degradation and biogenesis .	Cianfanelli V, Nanni M, Corrà S, Mauri S, Sumpton D, Lilla S, De Cegli R, Bordi M, Milletti G, Ferraina C, Hall A, Petraroia M, Clausi V, Giorda E, Scarsella M, Barbiera A, Cadeddu G, Colasanti M, Persichini T, Maeda K, Maya-Mendoza A, Bartek J, Di Malta C, Locatelli F, Zanivan S, Ismail S, Ziviani E, Cecconi F	mitochondrial homeostasis relies on a tight balance between mitochondrial biogenesis and degradation . although mitophagy be one of the main pathway involve in the clearance of damage or old mitochondrion , it coordination with mitochondrial biogenesis be poorly characterize . here , by unbiased approach include last-generation liquid chromatography couple to mass spectrometry and transcriptomics , we identify the protein phosphatase pp2a-b55α/ppp2r2a a a parkin-dependent regulator of mitochondrial number . upon mitochondrial damage , pp2a-b55α determines the amplitude of mitophagy induction and execution by regulate both early and late mitophagy event . a few minute after the insult , ulk1 be release from the inhibitory regulation of pp2a-b55α , whereas 2 to 4 hour later , pp2a-b55α promote the nuclear translocation of tfeb , the master regulator of autophagy and lysosome gene , to support mitophagy execution . moreover , pp2a-b55α control a transcriptional program of mitochondrial biogenesis by stabilize the parkin substrate and pgc-1α inhibitor paris . pp2a-b55α target rescue neurodegenerative phenotype in a fly model of parkinson 's disease , thus suggest potential therapeutic application .	Science advances	03/10/2025
10.1038/s41467-025-63880-7	mtch2 modulates cpt1 activity to regulate lipid metabolism of adipocytes .	Wu C, Wang T, Ghosh A, Long F, Sharma AK, Dahlby T, Noé F, Severi I, Colleluori G, Cinti S, Giordano A, Ding L, Khandelwal R, Kostidis S, Giera M, Balazova L, Gardeux V, Abu-Nawwas L, Deplancke B, Chourasia S, Kleiner S, Hamilton BS, Alcántara JMA, Ruiz JR, Blüher M, Pekcec A, Balaz M, Gross A, Neubauer H, Wolfrum C	metabolic disorder , include obesity and metabolic-associated steatohepatitis , arise from a chronic energy surplus . thus , enhance energy dissipation through increase respiration hold significant therapeutic potential for metabolic disorder . through a comprehensive analysis of human and murine adipose tissue , along with a functional screen , we identify mitochondrial carrier homolog 2 , a mitochondrial outer membrane protein , a a pivotal regulator of mitochondrial metabolism . intriguingly , it expression in adipose tissue be a strong determinant of obesity in human . adipocyte-specific ablation of mitochondrial carrier homolog 2 improve mitochondrial function and whole-body energy expenditure , independent of uncouple protein 1. furthermore , mitochondrial carrier homolog 2 regulate mitochondrial influx of free fatty acid by modulate the sensitivity of carnitine palmitoyltransferase 1 to malonyl-coa through direct physical interaction , lead to enhance energy expenditure in adipocytes/adipose tissue . here we show mitochondrial carrier homolog 2 function a a negative regulator of energy metabolism in adipocytes and represent a potential target for treat obesity and related metabolic disorder .	Nature communications	03/10/2025
10.1038/s41571-025-01077-z	the tumour microenvironment in pancreatic cancer - new clinical challenge , but more opportunity .	Kung HC, Zheng KW, Zimmerman JW, Zheng L	patient with advanced-stage pancreatic ductal adenocarcinoma ( pdac ) predominantly receive chemotherapy , and despite initial response in some patient , most will have disease progression and often dismal outcome . this lack of clinical effectiveness partly reflect not only cancer cell-intrinsic factor but also the presence of a tumour microenvironment ( tme ) that preclude access of both systemic therapy and circulate immune cell to the primary tumour , as well a support the growth of pdac cell . combine with improved preclinical model of pdac , advance in single-cell spatial multi-omics and machine learning-based model have provide novel method of untangle the complexity of the tme . in this review , we focus on the desmoplastic stroma and both the intratumoural and intertumoural heterogeneity of pdac , with an emphasis on cancer-associated fibroblast and their surrounding immune cell niche . we describe new approach in convert the immunologically 'cold ' pdac tme into a 'hot ' tme by prim t cell activation , overcome t cell exhaustion and unravelling myeloid cell-mediated immunosuppression . furthermore , we explore integrated target involve the tme , such a point of convergence among tumour , stromal and immune cell metabolism as well a oncogenic kras signal . finally , build on our experience with failed clinical trial in the past , we consider how this evolve comprehensive understanding of the tme will ensure future success in develop more effective therapy for patient with pdac .	Nature reviews. Clinical oncology	03/10/2025
10.1016/S0140-6736(25)01625-3	anti-cytokine biologics for asthma in adult .	Israel E, Wechsler ME, Jackson DJ, Moore WC	an estimate 3-10 % of patient with asthma be unable to reach full control with currently available inhaled therapy . in a large proportion of these patient , asthma can be drive in whole or in part by type 2 ( t2 ) inflammation , which be usually initiate by an immunological response to stimulation at mucosal surface . the introduction of monoclonal antibody , which target t2 inflammatory process , provide important option for this population . in the past decade , five anticytokine biologics ( acbs ) that block specific t2 inflammatory cytokine have be introduce . three biologics , mepolizumab , reslizumab , and benralizumab , inhibit the il-5 or il-5 receptor pathway ; dupilumab block il-4 and il-13 through it activity on the il-4 receptor-alpha ; and tezepelumab prevents activation of the thymic stromal lymphopoietin cytokine production cascade . these drug reduce exacerbation and improve lung function and patient-reported asthma quality of life in individual with a history of asthma exacerbation and evidence of t2 inflammation . some also allow oral corticosteroid reduction or elimination in patient dependent on these therapy for asthma control . the effect of acbs varies by the degree of t2 inflammation , which be most easily assess by blood eosinophil count and exhale nitric oxide . the use of acbs guide by these biomarkers and phenotypic characteristic of patient with severe asthma allow a personalised medicine approach that increase the likelihood of improvement .	Lancet (London, England)	29/09/2025
10.1186/s12943-025-02459-8	reprogramming cellular senescence and age clock for advanced cancer immunotherapy .	Yang H, Liu D, Qiu L, Wang R, Zhang C, Yu D, Zhong Q, Yuki N, Song Z, Zhu T, Ju H, Hong W, Zhu J	cellular senescence have gradually be recognize a a key process , which not only inhibit the occurrence of early tumor but also promote advanced malignant progression through secretory and immunomodulatory function . initially , cellular senescence manifest a irreversible cell cycle arrest , but now it encompass a broad phenotype regulate by the p53-p21cip1 and p16ink4a-rb pathway . although secretory phenotype relate to age can recruit immune effector to clear new tumor cell , persistent senescent cell population often trigger chronic inflammation , promote immune escape and fibrosis . in this review , we first discuss the molecular underpinnings of cellular senescence , highlight it induction pathway and diverse physiological or pathological role . we then examine the composition of the tumor microenvironment , where senescent cell accumulate and secrete pro-inflammatory cytokine , reshape immune surveillance and extracellular matrix architecture . against this backdrop , we explore how age clock refine our understanding of individual susceptibility to malignancy by distinguish biological from chronological age . we also present current therapeutic prospect , include senolytic agent target senescent stromal cell that promote tumor growth , and the utilization of age clock metric to tailor immunotherapy more effectively for old patient . finally , we consider the major challenge face clinical translation , from standardize multi-omics data pipeline to clarify the ethical implication of measure biological age . by bridge senescence biology with geroscience and cutting-edge oncology , we posit that age clock may catalyze a transformation in cancer care , enable more personalized , effective , and age-conscious treatment strategy .	Molecular cancer	02/10/2025
10.1016/j.immuni.2012.02.019	disruption of fnip1 reveals a metabolic checkpoint control b lymphocyte development .	Park H, Staehling K, Tsang M, Appleby MW, Brunkow ME, Margineantu D, Hockenbery DM, Habib T, Liggitt HD, Carlson G, Iritani BM	the coordination of nutrient and energy availability with cell growth and division be essential for proper immune cell development and function . by use a chemical mutagenesis strategy in mouse , we identify a pedigree that have a complete block in b cell development at the pre-b cell stage result from a deletion in the fnip1 gene . enforced expression of an immunoglobulin transgene fail to rescue b cell development . whereas essential pre-b cell signal molecule be activate normally in fnip1-null pre-b cell , the metabolic regulator ampk and mtor be dysregulated , result in excessive cell growth and enhanced sensitivity to apoptosis in response to metabolic stress ( pre-b cell receptor crosslinking , oncogene activation ) . these result indicate that folliculin-interacting protein 1 ( fnip1 ) be vital for b cell development and metabolic homeostasis and reveal a metabolic checkpoint that may ensure that pre-b cell have sufficient metabolic capacity to support division , while limit lymphomagenesis cause by deregulated growth .	Immunity	25/05/2012
10.1038/s41584-025-01305-x	novel approach to the stratified management of knee osteoarthritis .	Fuggle NR, Chapurlat R, Laslop A, Al-Daghri N, Alokail M, Thiyagarajan JA, Balkowiec-Iskra E, Berenbaum F, Bemden AB, Borg JJ, Bruyère O, Burlet N, Cavalier E, Rosa MM, Conaghan PG, Cooper C, Dennison EM, Englund M, Im GI, Haugen IK, Hiligsmann M, Kurth A, Lane N, Lories R, Marlovits S, Matijevic R, Mobasheri A, Ormarsdóttir S, Yerro MCP, Radermecker RP, Rannou F, Sepodes B, Silverman S, Torre C, Veronese N, Rizzoli R, Reginster JY, Harvey NC	knee osteoarthritis be a highly prevalent whole-joint disease that be associate with substantial morbidity . if step change be to be make in the management of knee osteoarthritis , novel patient stratification approach be need to identify the most effective treatment for individual patient . numerous method for stratify patient with knee osteoarthritis can be employ ; clinical presentation , include co-morbidity and pain phenotype , can influence treatment decision , and there be a rich history of image biomarker use , both from conventional radiograph and , since it development , via mri , in identify patient at risk of disease progression , and the latter facilitate the detection of synovitis . the development of novel biochemical biomarkers and the rapid growth of '-omics ' technology provide fresh opportunity to deploy these advance in the stratification of patient with knee osteoarthritis . the health economic landscape in this area be develop , and scoping work have highlight the need for further study .	Nature reviews. Rheumatology	03/10/2025
10.1038/s41593-025-02064-4	brain tumor induce widespread disruption of calvarial bone and alteration of skull marrow immune landscape .	Dubey A, Yamashita E, Stangeland B, Abbas I, Fooksman D, Harris RA, Palmer GM, Koba WR, Zhang J, Himes BT, Lu OR, Ho WS, Kuiper RV, Huffman D, Wu Z, Uchida Y, Ishii M, Welch RL, Fiedler AF, Reynolds D, Hosainey SAM, Dobrenis K, Ye Q, Fisher K, Killian N, Stanley ER, Eskandar E, Behnan J	the skull marrow niche have recently be identify a a reservoir that supply the brain with monocyte and neutrophil in the context of disease and injury , but it role in brain cancer remain unknown . here we show that glioblastoma , the most malignant type of brain tumor , induce calvarial bone abnormality in murine model and patient with glioblastoma , alter osteoclast activity and increase the number of skull channel in mouse . single-cell rna sequence reveal glioblastoma-mediated alteration in the immune landscape of skull marrow and femoral bone marrow , include expansion of neutrophil and deterioration of various b cell subset . in vivo inhibition of bone resorption reduce bone abnormality , but promote tumor progression in mesenchymal subtype tumor . this also abolish the survival benefit of the checkpoint inhibitor anti-pd-l1 , by reduce activate t cell and increase inflammatory neutrophil number . together , these data provide insight into how brain tumor affect skull bone and the immune environment .	Nature neuroscience	03/10/2025
10.1136/gutjnl-2025-334988	dpp-4 inhibitor alleviate gut-brain axis pathology in parkinson 's disease .	Jeong SH, Kim YJ, Shin JY, Oh KW, Lee JW, Lee PH	dipeptidyl peptidase-4 inhibitor ( dpp-4is ) have be report to exhibit therapeutic effect in parkinson 's disease ( pd ) , increase their potential for drug repurposing . one aspect of pd pathogenesis be think to be associate with the gut-brain axis , where α-synuclein from the gut be transmit to the brain via the vagus nerve ( vn ) . we explore whether sitagliptin , a dpp-4i , exhibit a protective effect in a low-dose rotenone-treated gut-brain axis-associated pd model . to explore the effect of sitagliptin , we use the oral rotenone-treated mouse model , which show spreading of pathological α-synuclein from the intestine in a stereotypic manner via the vn into the midbrain with motor deficit . sitagliptin mitigate rotenone-induced gut inflammation and toll-like receptor 2 ( tlr2 ) expression , reduce α-synuclein accumulation in the gut , vn and brain and lessen neuronal loss in the medulla and midbrain with recovery of motor performance . in addition , sitagliptin suppress inflammation in response to a tlr2 agonist and rotenone in macrophage , enteric glial cell and enteroendocrine cell line in vitro . in secretin tumour cell 1 , an enteroendocrine cell line , sitagliptin also decrease rotenone-induced endogenous α-synuclein level . the beneficial effect of sitagliptin be maintain even under glucagon-like peptide-1 receptor blockade . notably , sitagliptin significantly alter the gut microbiome , shift towards a profile that may counteract pd pathology . these finding demonstrate that sitagliptin alleviate α-synuclein deposition in the gut and brain through modulation of tlr2-mediated inflammation and alter the gut microbiome composition towards a more favourable profile , which indicate that dpp-4is can offer a novel therapeutic avenue for manage pd .	Gut	02/10/2025
10.1016/j.immuni.2025.09.004	eomesodermin ( + ) cd4 ( + ) t cell be critical for curative immunotherapy outcome .	Zhang P, Haeseleer F, Waltner OG, Gartlan KH, Bhise SS, Minnie SA, Adams RC, Yeh AC, Ensbey KS, Legg SRW, Sekiguchi T, Atilla E, Nemychenkov NS, Nelson EL, Joshi T, Liang EC, Hirayama AV, Abe K, Koyama M, Clouston AD, Gauthier J, Furlan SN, Hill GR	interleukin 10 ( il-10 ) -producing cd4 ( + ) type-1 regulatory t cell ( tr1 ) promote immune tolerance during chronic infection , autoimmunity , and transplantation . however , specific eomesodermin ( eomes ) -dependent stage of tr1 differentiation and function remain unclear . use preclinical model of bone marrow transplantation ( bmt ) , we demonstrate a tr1 differentiation trajectory in vivo from eomes ( + ) il-10 ( - ) to eomes ( + ) il-10 ( + ) subsets with the acquisition of cytokine , cytolytic , and exhaustion feature . the eomes ( + ) cd4 ( + ) fraction represent the dominant cytotoxic subset after bmt , mediate graft-versus-leukemia effect while limit inflammation . in cd19-targeted chimeric antigen receptor ( car ) t cell immunotherapy , eomes drive the same cd4 ( + ) tr1 phenotype that control cytolysis , while mitigate immune toxicity and promote persistence . in individual with high-grade b cell lymphoma that have long-term disease control after receive commercial cd19-targeted car t cell , eomes ( + ) tr1 cell represent a stable population comprise 40 % -80 % of the cd4 ( + ) car t cell population . hence , eomes control both regulatory and cytotoxic program in cd4 ( + ) t cell , essential for curative immunotherapy outcome .	Immunity	02/10/2025
10.1038/s41564-025-02114-4	a generative artificial intelligence approach for the discovery of antimicrobial peptide against multidrug-resistant bacteria .	Wang Y, Zhao L, Li Z, Xi Y, Pan Y, Zhao G, Zhang L	the discovery of novel antimicrobial peptide ( amp ) against clinical superbug be urgently need to address the ongoing antibiotic resistance crisis . amp be promise candidate due to their broad-spectrum activity , rapid bactericidal mechanism and reduced likelihood of induce resistance compare with conventional antibiotic . here , a pre-trained protein large language model ( llm ) , proteogpt , be establish and far develop into multiple specialized subllms to assemble a sequential pipeline . this pipeline enable rapid screen across hundred of million of peptide sequence , ensure potent antimicrobial activity and minimize cytotoxic risk . through transfer learning , we endow the llm with different domain-specific knowledge to achieve high-throughput mining and generation of amp within a unified methodological framework . notably , both mine and generate amp exhibit reduced susceptibility to resistance development in icu-derived carbapenem-resistant acinetobacter baumannii ( crab ) and methicillin-resistant staphylococcus aureus ( mrsa ) in vitro . the amp also show comparable or superior therapeutic efficacy in in vivo thigh infection mouse model compare with clinical antibiotic , without cause organ damage and disrupt gut microbiota . the mechanism of action of these amp involve disruption of the cytoplasmic membrane and membrane depolarization . overall , this study present a generative artificial intelligence approach for the discovery of novel antimicrobial against multidrug-resistant bacteria , enable efficient and extensive exploration of amp space .	Nature microbiology	03/10/2025
10.1016/j.ebiom.2025.105941	poor sleep health be associate with old brain age : the role of systemic inflammation .	Miao Y, Wang J, Li X, Guo J, Ekblom MM, Sindi S, Zhang Q, Dove A	poor-quality sleep have be link to increase dementia risk . we investigate the relationship between healthy sleep pattern and old brain age , and the extent to which this be mediate by systemic inflammation . the study include 27,500 adult from the uk biobank ( mean age 54.7 y , 54.0 % female ) . the presence of five self-reported healthy sleep characteristic ( early chronotype , 7-8 h daily sleep , no insomnia , no snoring , no excessive daytime sleepiness ) be sum into a healthy sleep score ( 0-5 pt ) and use to define three sleep pattern : healthy ( ≥4 pt ) , intermediate ( 2-3 pt ) , and poor ( ≤1 pt ) . low-grade inflammation be estimate use the infla-score , a composite index of inflammatory biomarkers . after a mean follow-up of 8.9 y , brain age be estimate use a machine learn model base on 1079 brain mri phenotype and use to calculate brain age gap ( bag ; i.e. , brain age minus chronological age ) . data be analyse use linear regression and generalised structural equation model . at baseline , 898 ( 3.3 % ) participant have poor sleep , 15,283 ( 55.6 % ) have intermediate sleep , and 11,319 ( 41.2 % ) have healthy sleep . compare to healthy sleep , intermediate ( β = 0.25 [ 0.11 , 0.40 ] , p = 0.010 ) and poor ( β = 0.46 [ 0.05 , 0.87 ] , p < 0.001 ) sleep be associate with significantly high bag . in mediation analysis , infla-score mediate 6.81 % and 10.42 % of the association between intermediate and poor sleep and high bag . poor sleep health may accelerate brain ageing . this may be drive by high level of systemic inflammation . alzheimerfonden ; demensfonden ; loo and han osterman foundation for medical research ; the knowledge foundation ; swedish research council .	EBioMedicine	30/09/2025
10.1016/j.ejvs.2025.09.045	international expert consensus on the management of acute aortic type b intramural haematoma and penetrate ulcer .	Squizzato F, D'Oria M, Antonello M, Trimarchi S, Mani K, Holden A, Kölbel T, Haulon S, Verhoeven E, Böckler D, Resch T, Azizzadeh A, Lombardi J, Piazza M	the aim of this study be to achieve an international expert consensus on manage acute type b penetrate aortic ulcer ( paus ) and intramural haematoma ( imhs ) . a modified delphi consensus process be employ to develop recommendation for the management of acute type b pau and imh . survey be send to international expert practice in high volume aortic centre worldwide . statement be vote on use a four point likert scale in a three round delphi process . statement achieve grade a ( full agreement 75 % ) or b ( overall agreement 80 % , full disagreement < 5 % ) be include a expert recommendation . consistency of response be measure use cohen 's κ and the intraclass correlation coefficient . eighty three expert be include in the final analysis : 25 statement achieve a consensus , 18 ( 72 % ) receive a grade b strength and 7 ( 28 % ) a grade a strength . most statement ( 97 % ) have a high consistency classify a grade i or ii . the expert panel agree on the indication for thoracic endovascular aortic repair ( tevar ) for complicate imh/pau , define by rupture or refractory pain/hypertension . uncomplicated imh/pau should be manage conservatively and follow up with serial compute tomography image during the acute phase . high risk uncomplicated imhs be identify by increased haematoma thickness , new onset or increased size of ulcer like projection , or transition to aortic dissection ; high risk uncomplicated paus be define by new associate haematoma , pau width/depth increase , or total aortic diameter increase . uncomplicated high risk imh/paus may be consider for tevar . in perform tevar , a proximal sealing length > 20 mm in a site free from haematoma should be achieve , eventually extend in zone 2 , with a 0 - 10 % oversize . patency of the left subclavian artery should be maintain . an agreement among international expert be achieve on assessment , management , and follow up of acute type b imhs and paus , address area of inconsistency or knowledge gap in exist guideline .	European journal of vascular and endovascular surgery : the official journal of	30/09/2025
10.1016/S1470-2045(25)00399-7	genetic modification of the ajcc classification of papillary thyroid cancer : an international , multicentre , retrospective cohort study .	Xing M, Lin S, Mathur A, Li Y, Bendlova B, Kuklikova V, Melo M, Jesus TT, Soares P, Colombo C, Fugazzola L, Mitsutake N, Matsuse M, Sako A, Estrada-Florez AP, Carvajal-Carmona LG, Bohórquez ME, Mian C, Vianello F, O'Neill CJ, Clifton-Bligh R, Czarniecka A, Jarzab B, Jung CK, Brahma B, Ladenson PW, Park YJ	the four-stage american joint committee on cancer ( ajcc ) staging system have be use for almost 50 year for assess the risk of multiple cancer ; the ajcc classification for papillary thyroid cancer be solely base on clinical parameter , and despite updated edition it accuracy remain suboptimal . we aim to evaluate whether the performance of the ajcc system could be improve by integrate tumour genetic status of braf and tert gene . this retrospective multicentre cohort study use patient medical record from 15 medical centre across ten country for patient ( of all age ) with papillary thyroid cancer who have be surgically treat with total thyroidectomy or hemithyroidectomy with or without neck dissection , follow by postoperative radioiodine ablation and appropriate thyroid-stimulating hormone level target . test for braf ( v600e ) and tert promotor ( tertp ) mutation be perform on genomic dna isolate from surgical or cytological specimen of primary papillary thyroid cancer tumour at each centre . data from all medical centre be pool for aggregated analysis of the relationship between the genetic status and papillary thyroid cancer-specific mortality for each of the four classical stage of the 7th and 8th edition of the ajcc system ( ajcc7e and ajcc8e ) . the primary endpoint be papillary thyroid cancer-specific mortality , characterise by mortality rate per 1000 person-years . use patient who be treat for papillary thyroid cancer between january 1979 , to july 2023 at the 15 centre , our cohort comprise of 4746 patient ( 3612 [ 76·1 % ] female and 1134 [ 23·9 % ] male ) , with median age of 48 year ( iqr 37-59 ; 89 [ 1·9 % ] patient age ≤18 year ) . for the 4400 patient with available ethnicity data , the majority be asian ( 2140 [ 48·6 % ] ) and 2096 ( 47·6 % ) be white . for ajcc7e , compare with the original stage , the genetic duet of braf ( v600e ) and tertp mutation be associate with increased mortality in all stage versus the corresponding original stage , although the hr for stage i do not reach statistical significance . those with wildtype braf ( v600e ) and tertp have flat survival curve for stage i-iii with ajcc7e and stag i-ii of ajcc8e . patient with dual mutation have reduction in survival across all stage for the ajcc7e ( stage i hr 5·96 [ 95 % ci 0·73-48·66 ] ; p=0·10 ; stage ii 5·94 [ 95 % ci 1·42-24·91 ] ; p=0·015 ; stage iii 4·04 [ 95 % ci 1·87-8·70 ] ; p=0·00037 ; and stage iv 1·79 [ 95 % ci 1·15-2·76 ] ; p=0·0092 ) . tertp mutation alone be also significantly associate with a significant increase in mortality for stage iv ( 3·57 [ 2·01-6·37 ] ; p < 0·0001 ) . for ajcc8e , we observe a similar pattern of increase mortality when both mutation be present compare to mortality in the original staging , with significant difference in hr for stage i and ii ( stage i adjust hr 10·30 [ 95 % ci 3·43-30·93 ] , p < 0·0001 ; stage ii hr 3·95 [ 95 % ci 1·92-8·15 ] ; p=0·00020 ) . stage iii also show increased mortality with dual mutation , but the increase be not statistically significant ( hr 1·77 [ 0·95-3·31 ] ; p=0·072 ) . in contrast to ajcc7e , the dual mutation do not increase mortality compare with the original stage iv ( hr 0·95 [ 0·47-1·92 ] , p=0·89 ) , but the tertp mutation do significantly increase mortality in stage iv papillary thyroid cancer ( hr 2·75 [ 1·36-5·58 ] , p=0·0049 ) . integrate the genetic status of braf and tertp into the ajcc system change the original risk stage of the ajcc system and significantly improve the accuracy of it mortality risk classification for papillary thyroid cancer . national institute on age , the auburn community cancer endow chair in basic research , the heart , breast , and brain health equity research program , national institute of health , and the american association for cancer research fellowship 21-40-69-estr ( usa ) ; ministry of health ( czech republic ) ; prémio francisco augusto da fonseca dia e maria josé melena da fonseca para jovens investigadores ( portugal ) ; italian ministry of health-ricerca corrente ( italy ) ; jsps kakenhi ( japan ) ; minciencias , l'oreal-unesco-icetex-colciencias , universidad del tolima ( colombia ) ; strategmed2/267398/4/ncbr/2015 , the national centre for research and development ( poland ) ; risbin iptekdok 2014 , ministry of health ( indonesia ) ; and the information and communication technology and future planning of the basic science research program via the national research foundation of korea ( nrf ) fund by the ministry of science ( korea ) .	The Lancet. Oncology	01/01/2045
10.1186/s12933-025-02932-0	association between metabolic score for insulin resistance and future stroke risk in patient with cardiovascular-kidney-metabolic syndrome stage 0-3 : a longitudinal analysis base on charls .	Wu H, Zhou Y, Lai X, Ma B, Ding L, Zhu X, Chen Z, Liu Z	metabolic disorder , cardiovascular disease , and chronic kidney disease be closely interrelate , and the proposal of cardiovascular-kidney-metabolic ( ckm ) syndrome concept have receive extensive attention.the disease burden of ckm be heavy , with stroke be a significant contributor , and ckm staging be bidirectional.a large body of evidence have demonstrate that insulin resistance be closely associate with disease such a stroke , obesity and chronic kidney disease . while the metabolic score for insulin resistance ( mets-ir ) serve a an important indicator for evaluate insulin resistance , the relationship between mets-ir and stroke incidence remains unclear in the population define by ckm syndrome stage 0-3. in this study , data on individual with ckm syndrome stage 0-3 without stroke at baseline be collect from china health and retirement longitudinal study ( charls ) .self-reported stroke be use a the primary outcome , with mets-ir at baseline a the exposure factor . logistic regression be perform to analyze the effect of mets-ir on the incidence of stroke among participant with ckm , and restrict cubic spline ( rcs ) regression be utilize to explore the potential nonlinear relationship between them . to evaluate the predictive value of mets-ir for stroke risk in individual with ckm syndrome stage 0-3 , we apply receiver operating characteristic ( roc ) analysis . a total of 5009 participant be include in this study , with a mean age of 60.48 ± 8.81 year . over a 5-year follow-up , 339 participant in this study develop incident stroke . participant be stratify into mets-ir quartile ( q1-q4 ) . in the fully adjust model , compare with q1 ( the low quartile ) , the odds ratio ( or ) for q3 be 1.88 ( 95 % 1.25-2.81 ; p = 0.002 ) , and the or for q4 be 1.72 ( 95 % 1.08-2.76 ; p = 0.02 ) . rcs analysis reveal a nonlinear relationship between mets-ir and stroke risk among participant with ckm syndrome stage 0-3 ( p-overall < 0.05 ; p-nonlinearity < 0.05 ) . roc analysis show an area under the curve ( auc ) of 0.726 ( 95 % 0.699-0.752 ) , with an optimal mets-ir cutoff value of 29.58. in individual with ckm syndrome stage 0-3 , elevate mets-ir level may be associate with an increase stroke risk . furthermore , mets-ir demonstrates moderate predictive value for stroke risk in this population . monitor mets-ir may therefore aid in their early identification .	Cardiovascular diabetology	01/10/2025
10.1186/s12916-025-04365-8	change in accelerated aging and risk of cardiovascular disease and mortality : three cohort study .	Zhang JJ, Yu HC, Geng TT, Chen SH, Wang YX, Guo H, Zhang XM, He MA, Gao JL, Liu G, Liao YF, Wu SL, Pan A	accelerate aging be a dynamic process , yet few study examine the association of change in accelerated age with cardiovascular disease ( cvd ) and mortality . this study aim to evaluate this association in three prospective cohort from china and the uk . data be draw from the kailuan cohort ( n = 107,830 ) , the dongfeng-tongji ( dftj ) cohort ( n = 14,032 ) , and the uk biobank ( n = 316,087 ) . accelerate aging be assess by phenoage and klemera-doubal method ( kdm ) age , measure at baseline ( kailuan cohort : 2006-2009 ; dftj cohort : 2008-2010 ; uk biobank : 2006-2010 ) and the first follow-up ( kailuan cohort : 2010-2013 ; dftj cohort : 2013 ; uk biobank : 2012-2013 ) . change in accelerated age be classify a persistent accelerate age , recovery from accelerate aging , delay accelerate age , and stable non-accelerated aging . cox proportional hazard model be use to estimate hazard ratio ( hr ) and 95 % confidence interval ( ci ) . meta-analysis be perform to summarize estimate across three cohort . median follow-up period be 10.3-15.9 year across three cohort . when define accelerate age by phenoage , baseline accelerate age be significantly associate with increased risk of cvd ( pooled 1.41 , 95 % 1.25 , 1.60 ) and mortality ( pooled 1.47 , 95 % 1.33 , 1.63 ) . compare to participant with persistent accelerated aging , participant recover from accelerate age ( pooled hr of 0.76 , 95 % 0.72 , 0.81 ; pool hr of mortality : 0.84 , 95 % 0.78 , 0.89 ) , delay accelerate age ( pooled hr of 0.75 , 95 % 0.70 , 0.79 ; pool hr of mortality : 0.77 , 95 % 0.72 , 0.83 ) or maintain non-accelerated aging ( pooled hr of 0.59 , 95 % 0.48 , 0.71 ; pool hr of mortality : 0.58 , 95 % 0.55 , 0.62 ) exhibit decreased risk of both cvd and mortality . when define accelerate age by kdm age , the result remain consistent with those of phenoage . accelerate aging be a significant risk factor for cvd and mortality . recover from or delay accelerated aging , or maintain non-accelerated aging , be associate with reduced risk of cvd and mortality .	BMC medicine	03/10/2025
10.1126/science.ady2167	engineer geminivirus replicons enable rapid in planta direct evolution .	Zhu H, Qin X, Wei L, Jiang D, Zhang Q, Wang W, Liang R, Zhang R, Zhang K, Liu G, Zhao KT, Chen K, Qiu JL, Gao C	direct evolution can rapidly generate genetic variant with new and enhanced property , yet efficient platform for perform such evolution directly in plant cell have be lack . we develop geminivirus replicon-assisted in planta direct evolution ( grape ) , a system that link gene function to geminivirus roll circle replication ( rcr ) to enable high-throughput selection for desired activity . grape support the screening of up to 10 ( 5 ) variant on a single nicotiana benthamiana leaf within four day . use grape , we evolve the immune receptor nrc3 to resist inhibition by the nematode effector sprysec15 and broaden the recognition spectrum of the rice immune receptor pikm-1 to recognize all six allele of the fungal effector avr-pik . grape provide a rapid , scalable , and generalizable platform for directed evolution of diverse gene in plant cellular context .	Science (New York, N.Y.)	02/10/2025
10.1016/S0140-6736(25)01039-6	effect of repurposed simvastatin on disability progression in secondary progressive multiple sclerosis ( ms-stat2 ) : a phase 3 , randomise , double-blind , placebo-controlled trial .	Chataway J, Williams T, Blackstone J, John N, Braisher M, De Angelis F, Bianchi A, Calvi A, Doshi A, Apap Mangion S, Wade C, Bordea E, Merry R, Barton G, Lyle D, Jarman E, Mahad D, Shehu A, Arun T, McDonnell G, Geraldes R, Craner M, Hillier C, Ganesalingam J, Fisniku L, Hobart J, Spilker C, Robertson NP, Kalra S, Pluchino S, Harikrishnan S, Mattoscio M, Harrower T, Young C, Lee M, Chhetri SK, Ahmed F, Rog D, Silber E, Gallagher P, Duddy M, Straukiene A, Nicholas R, Rice C, Tebbs S, Hawton A, Hunter R, Giovannoni G, Ciccarelli O, Beveridge J, Nixon S, Thompson AJ, Greenwood J, Pearson OR, Evangelou N, Sharrack B, Galea I, Gray E, Pavitt S, Chandran S, Ford HL, Frost C, Nicholas JM	despite the success of immune modulation in the treatment of relapse multiple sclerosis , disability progression be a major problem drive by multiple mechanism . comorbidities ( eg , vascular risk ) and age be think to augment these neurodegenerative pathology . in the phase 2b ms-stat trial of simvastatin ( 80 mg ) versus placebo in secondary progressive multiple sclerosis ( spms ) , the adjust difference in brain atrophy rate between group be -0·254 % per year : a 43 % reduction . in this phase 3 ms-stat2 trial , we aim to assess the efficacy of simvastatin versus placebo in slow the progression of disability in spms . this phase 3 , randomise , double-blind , parallel group , placebo-controlled clinical trial be conduct at 31 neuroscience centre and district general hospital in the uk . participant age 18-65 year with a diagnosis of spms and an expand disability status scale ( edss ) of between 4·0 and 6·5 be eligible and randomly assign ( 1:1 ) to oral simvastatin ( 80 mg ) or match placebo for up to 4·5 year , base on a minimisation algorithm within an independent and secure online randomisation service . all participant , site investigator , and the trial coordinate team be mask to treatment allocation . the primary outcome be time to 6-month eds confirm disability progression ( an increase of at least 1 point if edss score at baseline visit be less than 6·0 or an increase of 0·5 point if edss score at baseline visit be 6·0 or more ) assess in all randomly assign participant ( intention-to-treat analysis ) without imputation . this study be register with clinicaltrials.gov ( nct03387670 ) and be on the isrctn registry ( isrctn82598726 ) . the study be complete . between may 10 , 2018 , and july 26 , 2024 , 1079 patient be screen for eligibility and 964 participant be randomly assign , with 482 ( 50 % ) in the placebo group and 482 ( 50 % ) in the simvastatin group . of all 964 participant , 704 ( 73 % ) be female and 260 ( 27 % ) be male , with a mean age of 54 year ( sd 7 ) . 173 ( 36 % ) of 482 participant in the placebo group and 192 ( 40 % ) of 482 participant in the simvastatin group have 6-month confirm disability progression ( adjust hazard ratio 1·13 [ 95 % ci 0·91 to 1·39 ] , p=0·26 ) . although no emergent safety issue be see , there be one serious adverse reaction ( rhabdomyolysis ) in the simvastatin group . 12 ( 2 % ) of 482 participant in the placebo group and five ( 1 % ) of 482 participant in the simvastatin group have a cardiovascular serious adverse event . the ms-stat2 trial do not show a treatment effect of simvastatin in slow disability progression in spms . simvastatin use in multiple sclerosis should be confine to exist vascular indication . national institute for health and care research health technology assessment programme , uk multiple sclerosis society , and the u national multiple sclerosis society .	Lancet (London, England)	01/10/2025
10.1038/s41467-025-63454-7	induction of experimental cell division to generate cell with reduced chromosome ploidy .	Marti Gutierrez N, Mikhalchenko A, Shishimorova M, Frana D, Van Dyken C, Li Y, Ma H, Koski A, Liang D, Lee SG, Eyberg D, Safaei Z, Kang E, Lee Y, O'Leary T, Lee D, Krieg S, Wu D, Rubin E, Amato P, Mitalipov S	somatic cell nuclear transfer ( scnt ) enable the direct reprogramming of somatic cell into functional oocyte , albeit with a diploid genome . to address ploidy reduction , we investigate an experimental reductive cell division process , term mitomeiosis , wherein non-replicated ( 2n2c ) somatic genome be prematurely force to divide follow transplantation into the metaphase cytoplasm of enucleated human oocyte . however , despite fertilization with sperm , scnt oocyte remain arrest at the metaphase stage , indicate activation failure . artificial activation use a selective cyclin-dependent kinase inhibitor successfully bypass this arrest , induce the segregation of somatic chromosome into a zygotic pronucleus and a polar body . comprehensive chromosome trace via sequence reveal that homologous chromosome segregation occur randomly and without crossover recombination . nonetheless , an average of 23 somatic chromosome be retain within the zygote , demonstrate the feasibility of experimentally halve the diploid chromosome set . fertilized human scnt oocyte progress through normal embryonic cell division , ultimately develop into embryo with integrated somatic and sperm-derived chromosome . while our study demonstrate the potential of mitomeiosis for in vitro gametogenesis , at this stage it remain just a proof of concept and further research be require to ensure efficacy and safety before future clinical application .	Nature communications	30/09/2025
10.1016/S1470-2045(25)00429-2	long-term overall survival with dual ctla-4 and pd-l1 or pd-1 blockade and biomarker-based subgroup analysis in patient with advanced non-small-cell lung cancer : a systematic review and reconstruct individual patient data meta-analysis .	Di Federico A, Stumpo S, Mantuano F, De Giglio A, Lo Bianco F, Pecci F, Alessi JV, Wang X, Sperandi F, Melotti B, Gelsomino F, Skoulidis F, Garassino MC, Peters S, Awad MM, Ardizzoni A, Ricciuti B	immune checkpoint inhibitor target pd-l1 or pd-1 a monotherapy or combine with ctla-4 inhibitor or chemotherapy ( or both ) be the standard of care for patient with advanced non-small-cell lung cancer ( nsclc ) . however , it remain unclear which patient benefit from the addition of ctla-4 inhibitor . we aim to evaluate whether dual checkpoint blockade with ctla-4 and pd-l1 or pd-1 inhibitor provide similar efficacy to pd-l1 or pd-1 inhibitor monotherapy , or whether these strategy produce distinct outcome across nsclc subpopulation . we conduct a search of pubmed , medline , and embase for randomised phase 3 trial publish from database inception to nov 21 , 2024 , that investigate pd-l1 or pd-1 inhibitor , with or without ctla-4 inhibitor , in patient with advanced nsclc . we focus on study report kaplan-meier survival data at 5 year or biomarker analysis base on pd-l1 , kras , and stk11 mutational status . individual patient data be extract from kaplan-meier curve with webplotdigitizer version 5 and reconstruct with the ipdfromkm method . the primary endpoint of the study be 5-year overall survival in the overall population and in subpopulation base on pd-l1 tumour proportion score ( tps ) , tumour histology , and mutational status ( mutant v wild-type ) of kras and stk11 . this study be register with prospero , crd420251081707 . the initial search yield 1026 result , and six randomise clinical trial meet the eligibility criterion and be include . among the 2881 patient eligible for analysis ( 838 [ 29·1 % ] female and 2043 [ 70·9 % ] male ) , 1282 receive dual ctla-4 and pd-l1 or pd-1 blockade and 1599 receive single pd-l1 or pd-1 blockade . patient treat with dual ctla-4 and pd-l1 or pd-1 blockade have similar median overall survival compare with those treat with single pd-l1 or pd-1 inhibition ( 16·1 month [ 95 % ci 15·0-17·8 ] v 16·9 month [ 15·5-18·3 ] ; hr 0·95 [ 95 % ci 0·87-1·03 ] , p=0·19 ) . median overall survival be significantly longer with dual ctla-4 and pd-l1 or pd-1 blockade among patient with pd-l1 tps less than 1 % versus those treat with single pd-l1 or pd-1 inhibition ( 15·5 month [ 95 % ci 13·6-18·5 ] v 14·5 month [ 13·4-15·9 ] ; hr 0·85 [ 95 % ci 0·74-0·98 ] , p=0·021 ) , with 5-year overall survival rate of 16·6 % ( 95 % ci 13·4-20·6 ) versus 9·3 % ( 7·0-12·3 ) , respectively . median overall survival in patient with tumour harbour stk11 mutation be also significantly longer with dual ctla-4 and pd-l1 or pd-1 blockade compare with single pd-l1 or pd-1 inhibition ( 13·9 month [ 95 % ci 9·8-20·8 ] v 7·8 month [ 6·4-12·9 ] ; hr 0·67 [ 95 % ci 0·49-0·91 ] , p=0·012 ) . however , no significant difference in overall survival be find between treatment group by tumour histology ( squamous v non-squamous nsclc ) or by kras mutational status . compare with single pd-l1 or pd-1 inhibition , dual immune checkpoint blockade with ctla-4 and pd-l1 or pd-1 inhibitor be associate with improved overall survival in patient with advanced nsclc and pd-l1 tps less than 1 % and in those with stk11 mutation , but not in the overall population . prospective validation of these result in clinical trial be warrant . nextgenerationue .	The Lancet. Oncology	29/09/2025
10.1016/j.ccell.2025.09.004	neoadjuvant treatment of ibi310 plus sintilimab in locally advanced msi-h/dmmr colon cancer : a randomized phase 1b study .	Wang F, Chen G, Qiu M, Ma J, Mo X, Liu H, Li Y, Ding P, Wan X, Hu Y, Huang X, Jiang W, Wu X, Luo J, Zhou Y, Li L, Sun Y, Wang Q, Wang N, Jiang W, Yuan W, Li L, Liu L, Yuan X, Wang G, Song Z, Liu H, Ge J, Wang Y, Zhao P, Li T, You J, Tang J, Du X, Lin J, Zhang R, Fu Z, Xu J, Zhong H, Kang L, Deng Y, Lu X, Guo Q, Zhou H, Xu RH	although neoadjuvant immunotherapy show promising efficacy in locally advanced microsatellite instability-high or mismatch repair-deficient ( msi-h/dmmr ) colon cancer , whether dual immune checkpoint inhibition provide additional benefit over anti-pd-1 monotherapy remain unclear . this randomized phase 1b trial ( nct05890742 ) evaluate a neoadjuvant regimen of ibi310 ( anti-cytotoxic t lymphocyte-associated antigen 4 [ ctla-4 ] ) plus sintilimab ( n = 52 ) versus sintilimab monotherapy ( n = 49 ) . surgery be perform in 51 and 45 patient , respectively . the primary endpoint , pathological complete response ( pcr ) rate , be significantly high in the combination compare to the monotherapy arm within the modify intent-to-treat ( mitt ) population ( 78.4 % versus 46.7 % , p = 0.0015 ) , with consistent result in the intent-to-treat ( itt ) population ( 76.9 % versus 42.9 % ) . safety in both arm be comparable and manageable without new safety signal . after a median follow-up of 21.4 month , no disease recurrences occur . one death occur in each arm due to postoperative complication and adverse event . these finding demonstrate the added benefit of neoadjuvant ibi310 plus sintilimab over sintilimab monotherapy for locally advanced msi-h/dmmr colon cancer .	Cancer cell	02/10/2025
10.1016/S2213-2600(25)00287-5	dupilumab versus omalizumab in patient with chronic rhinosinusitis with nasal polyp and coexist asthma ( everest ) : a multicentre , randomise , double-blind , head-to-head phase 4 trial .	De Corso E, Canonica GW, Heffler E, Springer M, Grzegorzek T, Viana M, Horváth Z, Mullol J, Gevaert P, Michel J, Peters AT, Wagenmann M, Zaghloul S, Zhang M, Corbett M, Nash S, Angello JT, Radwan A, Deniz Y, Martin A, Hellings PW	chronic rhinosinusitis with nasal polyp ( crswnp ) be predominantly drive by type 2 inflammation . the biologics dupilumab and omalizumab , which target driver and mediator of type 2 inflammation ( interleukin [ il ] -4/il-13 signal and immunoglobulin e [ ige ] , respectively ) , be efficacious in treat crswnp but direct comparison be few . in everest ( evaluate treatment response of dupilumab versus omalizumab ) , the first head-to-head trial in respiratory biologics , we aim to compare the efficacy and safety of dupilumab and omalizumab in patient with severe crswnp who have mild , moderate , or severe asthma . everest be an international , randomise , double-blind , phase 4 trial , conduct at 100 hospital or clinical centre in 17 country . site be select with otolaryngology , pneumologist , allergist , and immunologist practice ; need to have previously conduct double-blind study ; and be require have nasal endoscopy and electrocardiogram machine . eligible patient age 18 year or old with severe uncontrolled crswnp ( with a nasal polyp score of 5 or more [ and ≥2 for each nostril ] ) , symptom of nasal congestion and loss of smell for at least 8 week before screening , and physician-diagnosed asthma . patient be randomly assign ( 1:1 ) to subcutaneous dupilumab 300 mg every 2 week or omalizumab weight-tiered and ige-tiered dosing every 2 week or 4 week for 24 week , with background mometasone furoate nasal spray . patient and investigator be mask to the study drug . primary endpoint be change from baseline in endoscopic nasal polyp score and university of pennsylvania smell identification test ( upsit ) at 24 week . efficacy be assess in the intention-to-treat population and safety be assess in patient who receive at least one dose of study medication . the trial be register at clinicaltrials.gov , nct04998604 . between sept 27 , 2021 , and dec 27 , 2024 , 819 individual be screen for study inclusion , 459 be exclude ( most common screen failure be : 167 do not meet nasal polyp score ≥5 or do not have ongoing symptom of nasal congestion and loss of smell , 114 do not meet pre-bronchodilator fev ( 1 ) ≤85 % predict normal , and 99 do not meet eligibility a per omalizumab drug-dosing ) , and 360 participant be randomly assign ( 181 assign to the dupilumab group and 179 assign to the omalizumab group ) . of the 360 participant , 198 ( 55 % ) participant be male , 162 ( 45 % ) be female , and the mean age of the total population sample be 52 year ( sd 13·1 ) . improvement be significantly great with dupilumab than omalizumab for all primary and secondary efficacy endpoint at week 24. least square mean difference in change from baseline dupilumab over omalizumab be : nasal polyp score -1·60 ( 95 % ci -1·96 to -1·25 ; p < 0·0001 ) and upsit 8·0 ( 6·3 to 9·7 ; p < 0·0001 ) . 115 ( 64 % ) of 179 participant in the dupilumab group and 116 ( 67 % ) of 173 participant in the omalizumab group report treatment-emergent adverse event , the most common of which be nasopharyngitis , accidental overdose , headache , upper respiratory tract infection , and cough . there be no death in the study . dupilumab be superior to omalizumab in patient with severe crswnp and coexist asthma . these finding support the efficacy of dupilumab in patient with type 2 respiratory disease versus an active biologic comparator , the know safety profile of dupilumab and omalizumab , and could enable good treatment target for patient with crswnp and asthma in clinical practice . sanofi and regeneron pharmaceutical .	The Lancet. Respiratory medicine	28/09/2025
10.1038/srep46971	retraction : murine hypothalamic destruction with vascular cell apoptosis subsequent to combine administration of human papilloma virus vaccine and pertussis toxin .	Aratani S, Fujita H, Kuroiwa Y, Usui C, Yokota S, Nakamura I, Nishioka K, Nakajima T	this correct the article 10.1038/srep36943 .	Scientific reports	11/05/2018
10.3171/2025.5.JNS25786	impact of glp-1 receptor agonist on stroke , subarachnoid hemorrhage , and intracerebral hemorrhage : a propensity-matched multi-institutional cohort study .	Costa M, O'Leary S, Price AM, Young CC, Srinivasan VM, Kan P	the author evaluate whether glucagon-like peptide-1 receptor agonist ( glp-1-ras ) improve outcome in patient with aneurysmal subarachnoid hemorrhage ( asah ) , spontaneous intracerebral hemorrhage ( sich ) , and acute ischemic stroke ( ai ) and reduce the overall incidence of these event . this retrospective study leverage trinetx data ( 2014-2024 ) to identify patient with asah , sich , or ai . individual receive exenatide , lixisenatide , semaglutide , dulaglutide , liraglutide , or tirzepatide within 8 week of diagnosis be propensity match to control . outcome ( e.g. , mortality , rebleeding/recurrence , seizure , hydrocephalus ) be assess at 6 and 12 month ; the incidence rate of stroke type be examine at 1 and 2 year . for asah patient , glp-1-ra use at 6 month reduce rebleeding ( or 0.73 , p = 0.003 ) and mortality ( or 0.41 , p < 0.001 ) and at 1 year lower cognitive deficit ( or 0.63 , p = 0.034 ) and mortality ( or 0.39 , p < 0.001 ) . in sich patient , glp-1-ras decrease hydrocephalus ( or 0.37 , p = 0.005 ) and seizures ( or 0.56 , p = 0.007 ) at 6 month , with persistent benefit at 1 year ( hydrocephalus , or 0.38 , p = 0.007 ; seizure , or 0.63 , p = 0.018 ) , alongside low mortality ( or 0.45-0.40 , both p < 0.001 ) and rebleeding ( or 0.70-0.69 , both p < 0.001 ) rate . in ais patient , mortality fell at 6 month ( or 0.27 , p < 0.001 ) and 1 year ( or 0.44 , p < 0.001 ) , with reduce recurrence ( or 0.60 , p < 0.001 ) and low hydrocephalus ( or 0.32 , p < 0.001 ) and seizure ( or 0.43 , p < 0.001 ) rate at 6 month . at 1 year , glp-1-ra user have low incidence rate of sah ( or 0.64 , p = 0.001 ) , ich ( or 0.62 , p < 0.001 ) , and ai ( or 0.82 , p = 0.003 ) , which be sustain at 2 year ( or 0.77-0.87 , all p < 0.05 ) . adverse event be similar . glp-1-ras be associate with improved survival and few complication across stroke subtypes , plus reduced hemorrhagic and ischemic stroke incidence . prospective trial be warrant to confirm these observation .	Journal of neurosurgery	03/10/2025
10.1016/j.anai.2025.09.014	basic mechanism of itch and advance in clinical management .	Coscarella G, Edwards E, Yosipovitch G	chronic pruritus require comprehensive assessment and management due to it profound impact on quality of life . the etiology of pruritus be diverse , encompass dermatologic , neuropathic , systemic , psychogenic , and mixed cause . pruritogens activate c and aδ fiber through histaminergic and non-histaminergic pathway . increase evidence highlight the role of th2 cytokine , particularly interleukin ( il ) -4 , il-13 , and il-31 , which directly stimulate sensory neuron and perpetuate the itch-scratch cycle . itch perception arises from dynamic interaction between the immune system and the peripheral and central nervous system . signal transmit by sensory fiber be process in the dorsal horn and relay to thalamic and cortical center , reinforce chronicity . diagnostic evaluation begin with detailed history and examination , complement by laboratory test such a complete blood count , kidney , liver , glucose , and thyroid function test to uncover systemic or neurologic contributor . for dermatologic condition , topical immunomodulators-including corticosteroid , calcineurin inhibitor , and pde4 inhibitors- be first-line option for localized itch . extensive itch may require systemic immunosuppressant or phototherapy . biologic agent target il-4/il-13 and il-31 pathway have revolutionize treatment for atopic dermatitis and prurigo nodularis , while jak-stat inhibitor also offer significant antipruritic effect in atopic dermatitis and beyond . neuropathic itch may respond to topical anesthetic : menthol , pramoxine , capsaicin , or compound ketamine-amitriptyline-lidocaine formulation , as well a systemic gabapentinoids and antidepressant . systemic or intractable pruritus may benefit from kappa opioid receptor agonist . new drug target the mast cell such a btk inhibitor , c-kit inhibitor , and mrgprx2 antagonist have robust anti-pruritic effect in mast cell-mediated disease . supportive measure , include psychosocial intervention , remain integral to long-term management .	Annals of allergy, asthma & immunology : official publication of the American	02/10/2025
10.1186/s12974-025-03546-9	microglial glycolytic reprogramming in alzheimer 's disease : association with impaired phagocytic function and alter vascular proximity .	Lu N, Jin Z, Liu N, Zhu C, Wei H, Xu Q	alzheimer 's disease ( ad ) be characterize by chronic neuroinflammation alongside amyloid-beta plaque and phosphorylated tau ( p-tau ) tangle accumulation . microglia , a resident immune cell , undergo glycolytic reprogramming that may exacerbate inflammation and impede toxic protein clearance . specifically , the glycolytic enzyme pyruvate kinase m2 ( pkm2 ) drive proinflammatory microglial phenotype link to neurodegeneration . this study investigate how pkm2-mediated microglial glycolytic reprogramming and inflammatory response alongside aβ/p-tau clearance in human ad brain . hippocampal-entorhinal cortex ( hp-ec ) tissue from 8 ad patient and 8 match control underwent multiplex immunohistochemistry and high-resolution spatial analysis . pkm2 ( + ) iba1 ( + ) microglia density significantly increase in ad versus control ( p < 0.001 ) , predominantly display a disease-associated microglial ( ham-like ) phenotype ( abca7 ( + ) ) with concurrent lipid-droplet accumulation ( plin3 ( + ) ; ldam phenotype ) . spatially , glycolytic pkm2 ( + ) iba1 ( + ) microglia accumulate near aβ plaque , p-tau tangle , and cerebral vasculature . notably , their distribution around plaques/tau show anomalous increase density with distance ( p < 0.001 ) , suggest impaired chemotaxis . perivascular localization lack clear chemotactic gradient . functionally , overall phagocytic activity ( cd68 ( + ) ) decrease significantly in ad ( p = 0.001 ) , primarily attribute to pkm2- subset , whereas pkm2 ( + ) iba1 ( + ) microglia exhibit pronounced phagocytic exhaustion ( plin2 ( + ) ; p < 0.001 ) , consistent around both aβ and p-tau lesion ( all p < 0.001 ) . our study establish that microglial glycolytic reprogramming via pkm2 promote a proinflammatory ham-like phenotype , phagocytic exhaustion , and peri-pathological accumulation with aggregate and cerebral vessel . target glycolytic pathway represent a viable therapeutic strategy for alleviate microglial dysfunction and neuroinflammation in ad .	Journal of neuroinflammation	02/10/2025
10.1186/s12943-025-02447-y	hsa_circ_0038737 promote parpi resistance in castration-resistant prostate cancer via igf2bp3-mediated dnph1 mrna stabilization .	Wang Z, Ge Q, Anwaier A, Liu S, Tian X, Zhang Z, Feng T, Hong Z, Ye D, Xu W, Qin X	resistance to poly ( adp-ribose ) polymerase inhibitor ( parpi ) pose a major challenge to therapeutic efficacy in castration-resistant prostate cancer ( crpc ) . although circular rna ( circrnas ) have emerge a critical regulator in cancer biology , their involvement in parpi resistance remain largely uncharacterized . this study aim to elucidate the molecular mechanism by which hsa_circ_0038737 modulate parpi resistance in crpc through post-transcriptional regulatory pathway . we employ a comprehensive set of in vitro and in vivo approach , include qrt-pcr , rna sequencing , rna-protein pull-down , rna immunoprecipitation , functional assay , and xenograft/organoid model , to investigate the biological function and mechanistic role of hsa_circ_0038737 in crpc progression and therapeutic response . we identify hsa_circ_0038737 a a nuclear-enriched circrna significantly upregulated in crpc , with expression level correlate with poor prognosis and aggressive clinical feature . mechanistically , hsa_circ_0038737 interacts with rna-binding protein ( rbp ) igf2bp3 , enhance the stability of dnph1 mrna , a nucleotide sanitizer critical for dna repair . the circrna-rbp-mrna regulatory axis promotes parpi resistance by facilitate dna damage repair capacity . moreover , we reveal that reverse-complementary alu element mediate circrna biogenesis , with hnrnpdl facilitate this process . pharmacologic inhibition of dnph1 effectively restore parpi sensitivity both in vitro and in vivo . our finding reveal a novel hsa_circ_0038737/igf2bp3/dnph1 axis drive parpi resistance in crpc , offer promise potential biomarkers and therapeutic target to overcome resistance and improve treatment outcome in advanced prostate cancer .	Molecular cancer	02/10/2025
10.1212/WNL.0000000000213904	longitudinal association of a polygenic risk score for plasma t-tau with incident alzheimer dementia and mild cognitive impairment .	Mourtzi N, Charisis S, Ntanasi E, Hatzimanolis A, Ramirez A, Sampatakakis SN, Yannakoulia M, Kosmidis MH, Dardiotis E, Hadjigeorgiou G, Sakka P, Mamalaki E, Papandreou C, Georgakis MK, Scarmeas N	elevated level of total tau ( t-tau ) be a key biomarker of neurodegeneration , often see in alzheimer disease ( ad ) . identify individual at increase risk of ad use minimally invasive biomarkers can enable early intervention . we develop a polygenic risk score ( pr ) for plasma t-tau and examine it association with the risk for develop clinical endophenotypes of ad pathology . this longitudinal cohort study use data from the hellenic longitudinal investigation of age and diet ( heliad ) study , involve individual age 65 year or old , free of ad , or amnestic mild cognitive impairment ( amci-an ad prodrome ) at baseline . our primary exposure be prstau , a pr base on common genetic variant link to plasma tau level . the primary outcome be amci or ad incidence . we assess the association between prstau level and amci/ad risk use cox regression model adjust for age , sex , education , apoe ε4 allele carriership , and population structure . we seek replication in a sample of uk biobank ( ukb ) participant age 60 year or old without prevalent dementia . in the heliad sample , among 618 cognitively healthy participant ( mean age 73.37 year , 58.4 % female ) , follow for 2.92 ± 0.80 year , 73 develop ad/amci . a 1 sd increase in prstau be link to a 29 % high ad/amci risk ( hazard ratio [ hr ] 1.290 , 95 % ci 1.006-1.654 ) . stratify analysis reveal great effect estimate in woman ( hr 1.451 , 95 % ci 1.023-2.058 ) and young participant ( hr 1.866 , 95 % ci 1.175-2.962 ) , whereas result in men and old participant do not reach statistical significance . in the ukb sample ( n = 142,637 , mean age 64.2 year , 52 % female ) , 2,737 participant develop ad over 12.9 ± 2.4 year of follow-up . high prstau be also link to increase ad risk ( hr 1.046 , 95 % ci 1.007-1.086 ) . these result support the potential utility of pr for plasma t-tau in predict ad/amci incidence . the relationship between genetic predisposition for elevated plasma t-tau level and ad pathology might be influence by sex and age , suggest that these factor should be consider in ad genetic risk modeling . pr could serve a an early indicator of genetic propensity for tau pathology , enhance exist ad diagnostic and risk stratification algorithm .	Neurology	11/11/2025
10.1212/WNL.0000000000214214	anti-inflammatory therapy for atherosclerotic stroke prevention .	Georgakis MK, Melton P, Živković L, Kopczak A, Katsanos AH	ischemic stroke cause by atherosclerosis be associate with the high risk of recurrence among stroke etiology , highlight a residual risk that current secondary prevention strategy fail to address . multiple line of research implicate inflammation in the pathogenesis of atherosclerosis , include recent large cardiovascular outcome trial demonstrate that anti-inflammatory therapy can lower residual vascular risk in patient with coronary artery disease . notably , low-dose colchicine , a long-used anti-inflammatory drug , have receive approval for cardiovascular risk reduction in patient with atherosclerosis . however , translation of anti-inflammatory treatment to patient with ischemic stroke have be challenge , with the first colchicine trial show neutral or conflict result . in this study , we review the preclinical , genetic , and epidemiologic literature link inflammation to atherosclerotic stroke ; examine key finding of cardiovascular outcome trial for stroke prevention ; and summarize complete and ongoing stroke-specific trial . we discuss the etiologic heterogeneity of ischemic stroke that may obscure anti-inflammatory treatment effect , highlight the need for precision medicine approach target patient with establish atherosclerosis and vascular inflammation . finally , we provide an overview of the emerge anti-inflammatory therapeutic that be under development for atheroprotection and outline a translational roadmap to accelerate clinical impact in stroke prevention .	Neurology	11/11/2025
10.1007/s11033-025-11081-2	unravel the multifactorial pathophysiology of polycystic ovary syndrome : exploring lifestyle , prenatal influence , neuroendocrine dysfunction , and post-translational modification .	Senthilkumar H, Chauhan SC, Arumugam M	polycystic ovary syndrome ( pcos ) be a complex , multifactorial metabolic and endocrine disorder in reproductive-age woman . this review discuss the interlinked role of lifestyle , metabolic dysregulation , insulin resistance , neuroendocrine impairment , genetic predisposition , and post-translational modification ( ptms ) in pcos pathogenesis . lifestyle component , especially those lead to obesity and insulin resistance , worsen the hyperandrogenism , ovulatory dysfunction , and inflammation . dietary treatment such a , dash diet and caloric restriction , particularly along with metformin , have be prove to improve metabolic and reproductive parameter . environmental toxin , such a endocrine-disrupting chemical ( edcs ) and advanced glycation end-products ( age ) , further compromise ovarian function and hormone regulation . oxidative stress and insulin resistance , drive by mitochondrial malfunction and chronic inflammation , create a self-perpetuating vicious cycle that compromise oocyte quality and worsen metabolic imbalance . neuroendocrine disruption , characterize by increased gnrh and lh pulsatility , be initiate by dysregulated kisspeptin , dynorphin , and neurokinin b signal in kndy neuron , modify gabaergic input , and increase amh and androgen . ptms such a phosphorylation , methylation , acetylation , and ubiquitination also play essential role in granulosa cell function , ar signaling , insulin sensitivity , and oocyte maturation . current and novel treatment option vary from lifestyle modification and pharmacological intervention ( e.g. , metformin , glp-1 receptor agonist , myoinositol , vitamin d , and statin ) to regenerative measure like mesenchymal stem cell and fecal microbiota transplantation . new therapy focus on ptms and neuroendocrine regulator remain the future hope . multidisciplinary individualized management be critical for successful pcos therapy and avert long-term complication .	Molecular biology reports	04/10/2025
10.1186/s12902-025-02043-7	efficacy and safety of variable-dose metformin a adjunctive therapy to insulin in adolescent with type 1 diabetes mellitus : a systematic review and network meta-analysis .	Li C, Qiao L, Li T	adolescent type 1 diabetes ( t1d ) be complicate by insulin resistance , dyslipidemia , and heighten cardiovascular risk . a adjunctive metformin therapy lack optimize dosing , we conduct a network meta-analysis ( nma ) to rigorously assess the dose-dependent efficacy and safety of metformin combine with insulin in this population . totally 764 adolescent ( age 10-19 year ) meet inclusion criterion be involve . we assess five metformin regimen : 1.0 g/day , 1.7 g/day , 2.0 g/day , weight-based ( ≤ 60 kg:1.0 g/day ; ≥60 kg:2.0 g/day ) , and multi-tiered weight-based ( < 50 kg:1.0 g ; 50-75 kg:1.5 g ; ≥75 kg:2.0 g ) . outcome include hba1c , bmi/bmi-z , insulin dose , lipid profile , and adverse event . a bayesian nma be perform use r 4.4.1 , with effect size report a mean difference ( md ) or relative risk ( rr ) with 95 % confidence interval ( ci ) . surface under the cumulative ranking curve ( sucra ) value ranked intervention . consequently , metformin 2.0 g/day significantly reduce bmi ( md=-0.6 kg/m² , 95 % -0.68 , -0.52 ) and ldl-c ( md=-12.78 mg/dl , 95 % -21.17 , -0.49 ) versus placebo . dos of 1.0 g/day , 2.0 g/day , and the 60 kg weight-based regimen significantly reduce daily insulin requirement . metformin 2.0 g/day and the 50 kg weight-based regimen reduce total cholesterol . no regimen significantly lower hba1c or triglyceride versus placebo . all dos demonstrate safety profile comparable to placebo regard gastrointestinal event , hypoglycemia , diabetic ketoacidosis ( dka ) , and transaminase elevation ( rrs not significant ) . to sum up , adjunctive metformin at 2.0 g/day offer significant benefit in weight management , insulin dose reduction , and lipid improvement ( ldl-c , total cholesterol ) for adolescent with t1d , with a favorable safety profile across all dos , which will represent a viable therapeutic option .	BMC endocrine disorders	03/10/2025
10.1126/science.ads8728	gcn1 couple gcn2 to ribosomal state to initiate amino acid response pathway signaling .	Zhou C, Zhang M, Murray J, Paulo J, Gygi S, Shao S, Whitman M, Keller T	during nutrient deprivation , activation of the protein kinase gcn2 regulate cell survival and metabolic homeostasis . in addition to amino acid stress , gcn2 be activate by a variety of cellular stress . gcn2 activation have be link to it association with uncharged trna , specific ribosomal protein , and condition of translational arrest , but their relative contribution to activation be unclear . here , we use in vitro translation to reconstitute gcn2 activation by amino acid stress and compare collide ribosome population induce by diverse translational stressor . initiation of gcn2 signaling require the di-ribosome sensor gcn1 , which recruit gcn2 to ribosomes in a collision-dependent manner , where gcn2 become activate by key ribosomal interaction and stably associate with collided ribosome . our finding define the molecular requirement and dynamic of gcn2 activation .	Science (New York, N.Y.)	02/10/2025
10.1016/j.neuron.2025.09.001	treg-microglia partnership in the injured spinal cord preserve treg cell function and regulate microglial cholesterol metabolism .	Qin T, Jiang T, Zhou Z, Wu M, Zhang Y, Yang Z, Zheng Z, Yi J, Wang X, Luo M, Gao P, Liu J, Huang Y, Liu H, Li Q, Zhou W, Zhang S, Guo X, He B, Wang Y, Fan J, Zhao S, Chen J, Yin G	the spatiotemporal dynamic and specific role of regulatory t ( treg ) cell in spinal cord injury ( sci ) remain unclear . use single-cell rna sequencing , flow cytometry , and immunofluorescence , we find that thymus-derived treg cell infiltrate the injured spinal cord via peripheral blood around 3 day post-sci . treg cell depletion worsen sci and impaired long-term recovery . transcriptomic profiling reveal strong anti-inflammatory function of treg cell and the potential to regulate cholesterol metabolism in neighbor microglia . further single-cell rna sequencing uncover the clonality of sci-associated treg cell . major histocompatibility complex class ii ( mhc ii ) expression on microglia , not macrophage , be crucial for sustain treg cell number and neuroprotective function , with myelin-phagocytosing microglia-activated treg cell show significant neuroprotective effect . treg cell mitigate microglial inflammation via ctla-4 and upregulated the atp-binding cassette transporter g1 ( abcg1 ) receptor in microglia , help to manage myelin load and reduce lipid droplet formation . our finding offer mechanistic insight into sci-associated treg cell and lay the groundwork for future treg-based therapy in sci treatment .	Neuron	29/09/2025
10.1038/s41551-025-01509-2	solid tumour car-t cell engineer with fusion protein target pd-l1 for localized il-12 delivery .	Murad JP, Christian L, Rosa R, Ren Y, Buckley AJ, Lee EHJ, Lopez LS, Park AK, Yang J, Yamaguchi Y, Trac C, Adkins LN, Chang WC, Martinez C, June CH, Forman SJ, Ishihara J, Lee JK, Stern LA, Priceman SJ	chimeric antigen receptor ( car ) -t cell efficacy in solid tumour be limited due in part to the immunosuppressive tumour microenvironment ( tme ) . to improve antitumour response , we hypothesize that enable car-t cell to secrete bifunctional fusion proteins consist of a cytokine modifier such a tgfβ ( trap ) , il-15 or il-12 , combine with an immune checkpoint inhibitor such a αpd-l1 , would provide tumour-localized immunomodulation to improve car-t cell functionality . here we engineer car-t cell to secrete tgfβ ( trap ) , il-15 or il-12 molecule fuse to αpd-l1 scfv and assess in vitro functionality and in vivo safety and efficacy in prostate and ovarian cancer model . car-t cell engineer with αpd-l1-il-12 be superior in safety and efficacy compare with car-t cell alone and those engineer with αpd-l1 fuse with tgfβ ( trap ) or il-15 . further , αpd-l1-il-12 engineer car-t cell improve t cell trafficking and tumour infiltration , and localize ifnγ production , tme modulation and antitumour response , with reduced systemic inflammation-associated toxicity . we believe our αpd-l1-il-12 engineering strategy present an opportunity to improve car-t cell clinical efficacy and safety across multiple solid tumour type .	Nature biomedical engineering	01/10/2025
10.1016/j.jacc.2025.07.061	fibrinolytic therapy for thromboembolic disease : approve indication and future direction .	Rashedi S, Leyva H, Hamade N, Pfeferman MB, Ortega-Paz L, Sadeghipour P, Talasaz AH, O'Donoghue ML, Jimenez D, Monrea M, Anderson CD, Elkind MSV, Lang IM, Weitz JI, Goldhaber SZ, De Caterina R, Konstantinides SV, Piazza G, Krumholz HM, Braunwald E, Bikdeli B	fibrinolytic therapy play a pivotal role in the management of thromboembolic disease by promote plasmin-mediated fibrin degradation and vessel recanalization , which frequently come at the cost of increase risk of hemorrhagic event , include intracranial bleeding . since the discovery of streptokinase in 1933 , several additional fibrinolytic agent have be develop . two plasminogen activators-urokinase and tissue plasminogen activator ( tpa ) -were identify in human sample . through recombinant dna technology , tpa be clone and modify to produce alteplase . subsequent effort to prolong it plasma half-life lead to the development of mutant derivative such a tenecteplase and reteplase . although fibrinolytic therapy in patient with st-segment elevation myocardial infarction be currently restrict to those who can not undergo primary percutaneous coronary intervention within 120 minute of presentation , it have be a mainstay treatment for acute ischemic stroke and pulmonary embolism ( pe ) with hemodynamic compromise . catheter-directed fibrinolysis have be evaluate in patient with intermediate-risk pe , deep vein thrombosis , acute limb ischemia , and after endovascular thrombectomy for ischemic stroke . fibrinolytic agent have also be use in other clinically important indication , such a central venous access device thrombosis , mechanical prosthetic valve thrombosis , leave ventricular assist device thrombosis , central retinal artery occlusion , cerebral venous sinus thrombosis , and leave ventricular thrombus . this paper provide a comprehensive overview of the current application , approve indication , evolve role , and future direction of fibrinolytic agent in thromboembolic disease .	Journal of the American College of Cardiology	07/10/2025
10.1016/j.drudis.2013.04.001	sclerostin : how human mutation have help reveal a new target for the treatment of osteoporosis .	Robinson MK, Caminis J, Brunkow ME	in the 1990s there be a tremendous mood of optimism among pharmaceutical scientist that identification of disease-associated variation in the human genome would result in a surge of new drug target ( the 'gene-to-drug ' mantra ) . to date the expected deluge of new drug have not arrive . however , a small number of drug arise directly from the study of rare human disorder show mendelian inheritance be now enter late stage clinical trial . here we describe the advantage of this approach and discuss the background and early clinical trial finding with antibody direct at a target identify in this way .	Drug discovery today	01/01/2013
10.1038/s41467-025-63750-2	platelet activation play a pro-inflammatory role in myasthenia gravis .	Wen Q, Zhang S, Wang Y, Liu H, Wang J, Su S, Xie N, Lu Y, Di L, Xu M, Wang M, Chen H, Wang S, Zhu W, Wen X, Han J, Wan D, Zhao S, Lu W, Tao Z, Duo J, Huang Y, Chai G, Duan R, Li X, Hao J, Da Y	myasthenia gravis ( mg ) be an autoimmune disorder that disrupt neuromuscular junction function through autoantibody . platelet be emerge a key player in the pathogenesis of mg , bridge innate and adaptive immunity . we analyze platelet transcriptome signature and their interaction with the immune system in achr+ immunotherapy-naïve mg ( nmg ) patient use bulk and single-cell rna sequence on peripheral blood mononuclear cell ( pbmc ) . nmg patient exhibit upregulation of gene relate to activation , inflammation , and cytoskeletal regulation . increase platelet count , activation , alter morphology , enhance cd62p expression , and elevate plasma cd40l level be observe in pbmcs , which diminish with minimal clinical status ( mm ) . functionally , platelet show heighten interaction with leukocyte , form aggregate that correlate with disease severity . these feature return to baseline after intravenous immunoglobulin or prolonged immunosuppressive therapy . this study underscore platelet activation 's critical role in mg and support platelet-targeted therapy .	Nature communications	02/10/2025
10.1038/s41586-025-09571-1	a human-specific regulatory mechanism reveal in a pre-implantation model .	Fueyo R, Wang S, Crocker OJ, Swigut T, Nakauchi H, Wysocka J	stem cell-based human embryo model offer a unique opportunity for functional study of the human-specific feature of development . here we genetically and epigenetically manipulate human blastoids , a 3d embryo model of the blastocyst ( 1 ) , to investigate the functional effect of hervk ltr5hs , a hominoid-specific endogenous retrovirus , on pre-implantation development . we uncover a pervasive cis-regulatory contribution of ltr5hs element to the hominoid-specific diversification of the epiblast transcriptome in blastoids . many of the ltr5hs genomic insertion in the human genome be unique to our own specie . we show that at least one such human-specific ltr5hs element be essential for the blastoid-forming potential via enhance expression of the primate-specific znf729 gene , encode a krab zinc-finger protein . znf729 bind to gc-rich sequence , abundant at gene promoter associate with basic cellular function , such a cell proliferation and metabolism . despite mediate recruitment of trim28 , at many of these promoter znf729 act a a transcriptional activator . together , our result illustrate how recently emerge transposable element and gene can confer developmentally essential function in human .	Nature	01/10/2025
10.1186/s11658-025-00789-5	program cell death in triple-negative breast cancer .	Liu Y, He J, Chen J, Chen T, Li W, Yang Z, Zeng F	triple-negative breast cancer ( tnbc ) be a particularly aggressive and therapeutically challenge subtype of breast cancer , define by the lack of estrogen receptor , progesterone receptor , and human epidermal growth factor receptor 2 expression . this absence of actionable molecular target contribute to it resistance to conventional treatment . this review provide an overview of the mechanistic function , interrelated process , and therapeutic implication of several program cell death ( pcd ) pathways-including apoptosis , pyroptosis , necroptosis , autophagy , and ferroptosis-in the context of tnbc pathogenesis and treatment . a conceptual framework be propose for leverage these interconnect cell death pathway a a basis for novel target intervention . give the complex interplay among various pcd form characterize by share feature such a inflammation , mitochondrial dysfunction , and overlap molecular mediator , this integrate network offer promise opportunity for combinatorial therapeutic strategy . modulation of one cell death pathway may influence others , potentially amplify therapeutic efficacy . furthermore , these pcd pathway be highly relevant to immunotherapy outcome , offer a foundation for synergistic treatment modality . this review provide an in-depth analysis of the crosstalk between immune-based therapy and pcd , along with a comprehensive discussion of derive therapeutic approach . however , tumor diversity , resistance mechanism , and discrepancy between preclinical model and human physiology pose major challenge in apply these finding clinically . the overarch goal be to present innovative insight and strategy to enhance the clinical management of tnbc and ultimately improve patient outcome .	Cellular & molecular biology letters	02/10/2025
10.1016/j.cell.2025.09.006	sequencing-free whole-genome spatial transcriptomics at single-molecule resolution .	Cheng Y, Dang S, Zhang Y, Chen Y, Yu R, Liu M, Jin S, Han A, Katz S, Wang S	recent breakthrough in spatial transcriptomics technology have enhance our understanding of diverse cellular identity , spatial organization , and function . yet exist spatial transcriptomics tool be still limit in either transcriptomic coverage or spatial resolution , hinder unbiased , hypothesis-free transcriptomic analysis at high spatial resolution . here , we develop reverse-padlock amplicon-encoding fluorescence in situ hybridization ( raefish ) , an image-based spatial transcriptomics method with whole-genome coverage and single-molecule resolution in intact tissue . we demonstrate the spatial profiling of transcript from 23,000 human or 22,000 mouse gene in single cell and tissue section . our analysis reveal transcript-specific subcellular localization , cell-type-specific and cell-type-invariant zonation-dependent transcriptomes , and gene program underlie preferential cell-cell interaction . finally , we further develop our technology for the direct spatial readout of guide rna ( grnas ) in an image-based , high-content crispr screen . overall , these development offer a broadly applicable technology that enable high-coverage , high-resolution spatial profiling of both long and short , native and engineered rna in many biomedical context .	Cell	01/10/2025
10.1016/j.molcel.2025.08.029	a needed nomenclature for nucleosomes .	Keogh MC, Almouzni G, Andrews AJ, Armache KJ, Arrowsmith CH, Baek SH, Bedford MT, Bernstein E, Côté J, David Y, Denu JM, Fierz B, Garcia BA, Glass KC, Gozani O, Helin K, Henikoff S, Jensen ON, Josefowicz SZ, Kelleher NL, Kutateladze TG, Lindner HH, Lu C, Luger K, Mallick P, Musselman CA, Muir TW, Paša-Tolić L, Schneider R, Shi X, Shi Y, Sidoli S, Smith LM, Tyler JK, Wolberger C, Workman JL, Strahl BD, Young NL	histone post-translational modification ( ptms ) be crucial to eukaryotic genome regulation , with a range of report function and mechanism of action . though often study individually , it have long be recognize that the modification function by combinatorial synergy or antagonism . interplay may involve ptms on the same histone , within the same nucleosome ( contain a histone octamer ) , or between nucleosomes in higher-order chromatin . give this , the field must distinguish ever great complexity , and the context in which it be study , with brevity and precision . the proteoform be introduce to define individual form of a protein by sequence and ptms , follow by the nucleoform to describe the particular gathering of histone within an individual nucleosome . there be now a need to define specific form of these entity in prose while provide space for experimental nuance . to this end , we introduce a nomenclature that can express discrete ptms , proteoforms , nucleoforms , or situation where define ptms exist in an uncertain context . though specifically design for the chromatin field , adaption of the framework could be use to describe-and thus dissect-how proteoforms be configure in functionally distinct complex across biology .	Molecular cell	02/10/2025
10.1186/s13062-016-0107-8	a paneukaryotic genomic analysis of the small gtpase rabl2 underscore the significance of recurrent gene loss in eukaryote evolution .	Eliáš M, Klimeš V, Derelle R, Petrželková R, Tachezy J	the cilium ( flagellum ) be a complex cellular structure inherit from the last eukaryotic common ancestor ( leca ) . a large number of ciliary protein have be characterize in a few model organism , but their evolutionary history often remain unexplored . one such protein be the small gtpase rabl2 , recently implicate in the assembly of the sperm tail in mammal . use the wealth of currently available genome and transcriptome sequence , include data from our on-going sequencing project , we systematically analyze the phylogenetic distribution and evolutionary history of rabl2 orthologs . our dense taxonomic sampling reveal the presence of rabl2 gene in nearly all major eukaryotic lineage , include small `` obscure '' taxon such a breviates , ancyromonads , malawimonads , jakobids , picozoans , or palpitomonads . the phyletic pattern of rabl2 gene indicate that it be present already in the leca . however , some organism lack rabl2 a a result of secondary loss and our present sampling predicts well over 30 such independent event during the eukaryote evolution . the distribution of rabl2 gene correlate with the presence/absence of cilium : not a single well-established cilium-lacking specie have retain a rabl2 ortholog . however , several ciliated taxon , most notably nematode , some arthropod and platyhelminth , diplomonads , and ciliated subgroup of apicomplexans and embryophytes , lack rabl2 as well , suggest some simplification in their cilium-associated function . on the other hand , several algae currently unknown to form cilium , e.g. , the `` prasinophytes '' of the genus prasinoderma or the ochrophytes pelagococcus subviridis and pinguiococcus pyrenoidosus , turn out to encode not only rabl2 , but also homologs of some hallmark ciliary protein , suggest the existence of a cryptic flagellated stage in their life cycle . we additionally obtain insight into the evolution of the rabl2 gene architecture , which seem to have ancestrally consist of eight exon subsequently modify not only by lineage-specific intron loss and gain , but also by recurrent loss of the terminal exon encode a poorly conserve c-terminal extension . our comparative analysis support the notion that rabl2 be an ancestral component of the eukaryotic cilium and underscore the still underappreciated magnitude of recurrent gene loss , or reductive evolution in general , in the history of eukaryotic genome and cell .	Biology direct	02/02/2016
10.1038/s41565-025-02017-9	spatiotemporal-adaptive nanotherapeutics promote post-injury regeneration in age through metabolic modulation .	Liang K, Zhao L, Zhang S, Zheng L, Zhang Z, Wang S, Chen J, Xu W, Wang W, Yang H, Song C, Qiu P, Zhao C, Fang W, Zhu J, Fan S, Liu Z, Tang R, Zhao Y, Fang X	in the elderly population , dysregulated cellular behaviour during the heal process impact tissue regeneration after injury . early in the regeneration process , pro-inflammatory macrophage contribute to immune imbalance , while in late stage , senescent stem cell reduce regenerative capacity . here we demonstrate that nicotinamide adenine dinucleotide ( nad ( + ) ) can reprogramme both type of dysfunctional cell . we develop a spatiotemporal-adaptive nanotherapeutic system for the delivery of nad ( + ) into select cell during different phase of tissue repair . by replenish intracellular nad ( + ) pool , this system reshape the multicellular regeneration niche , by metabolically rewire pro-inflammatory macrophage towards a pro-repair phenotype during the early phase , and enhance the differentiation capacity of senescent stem cell at late stage . this strategy effectively restore impaired bone regeneration in osteoporotic mouse and accelerate skin wound healing . our work present a spatiotemporal-adaptive nanomedicine platform that bridge cell metabolism , nanomedicine and regeneration therapy .	Nature nanotechnology	01/10/2025
10.1093/braincomms/fcaf337	systemic increase of ampa receptor associate with cognitive impairment of long covid .	Fujimoto Y, Abe H, Eiro T, Tsugawa S, Tanaka M, Hatano M, Nakajima W, Ichijo S, Arisawa T, Takada Y, Kimura K, Sano A, Hirahata K, Sasaki N, Kimura Y, Takahashi T	long covid primarily present with persistent cognitive impairment ( cog-lc ) , impose a substantial and lasting global burden . even after the pandemic , there remain a critical global need for diagnostic and therapeutic strategy target cog-lc . nevertheless , the underlying neural mechanism remain poorly understood . give the central role of synapsis in brain function , investigation of synaptic molecular change may provide vital insight into cog-lc pathophysiology . in this study , we use [ ( 11 ) c ] k-2 pet to characterize the density of ampa receptor ( ampars ) on the post-synaptic cell surface , which be crucial synaptic component in brain signalling . statistical parametrical mapping be use to spatially normalize and apply independent t-test for a voxel-based comparison . we select patient with cog-lc ( n = 30 ) base on repeatable battery for the assessment of neuropsychological status assess persistent cognitive impairment and healthy control ( n = 80 ) with no diagnosed neuropsychiatric disorder . the primary objective be to compare [ ( 11 ) c ] k-2 standardize uptake value ratio with white matter ( suvr ( wm ) ) a a reference region between patient with cog-lc and healthy control , and to define the regional extent of difference . the secondary objective be to examine association between [ ( 11 ) c ] k-2 suvr ( wm ) and plasma concentration of cytokine or chemokines . a an exploratory objective , we test whether [ ( 11 ) c ] k-2 pet data could distinguish cog-lc from healthy control use a partial least square base classification algorithm . a voxel-based comparison ( p < 0.05 , t > 1.66 , one-tailed , false discovery rate control ) and a volume of interest analysis ( p < 0.05 , bonferroni multiple comparison ) demonstrate that increase index of ampar density in large part of the brain of patient with cog-lc compare with that in healthy control . a voxel-based correlation analysis also show the brain region where [ ( 11 ) c ] k-2 suvr ( wm ) correlate positively with plasma tnfsf12 and negatively with plasma ccl2 concentration . a partial least square model train on the index of ampar density data demonstrate high diagnostic accuracy , achieve 100 % sensitivity and 91.2 % specificity . [ ( 11 ) c ] k-2 pet signal represent the index of ampar density on the post-synaptic neural cell surface , not on the glial cell surface . a systemic increase in synaptic ampars across the brain may drive abnormal information processing in cog-lc and , through excessive excitatory signalling , pose a risk of excitotoxic neuronal damage . we derive the hypothesis that [ ( 11 ) c ] k-2 pet would be helpful in establish a diagnostic framework for cog-lc and that antagonist for cell surface ampars , such a perampanel , would be a potential therapeutic target . these hypothesis should be investigate in future large-scale clinical study .	Brain communications	01/01/2025
10.1126/sciimmunol.ads0449	the immunology of brain tumor .	Bunse L, Bunse T, Kilian M, Quintana FJ, Platten M	brain tumor represent a unique challenge for cancer immunotherapy because of their location in an immune privilege site . however , the brain tumor immune microenvironment be dictate more by tumor type than the location within the brain per se . this feature be reflect by the high immunogenicity and response to immunotherapy of metastatic brain tumor compare with primary brain tumor . immunotherapy for brain tumor aim at inducing and boost tumor t cell response use vaccine , immune checkpoint inhibitor , or adoptive t cell therapy . a fundamental challenge in the field be how such brain tumor-targeting t cell gain access to brain tumor and maintain their function despite a hostile immunosuppressive microenvironment . here , we review current knowledge of the cellular and molecular determinant of the antigenicity of brain tumor and the immunosuppressive brain tumor microenvironment . expand and exploit this knowledge will provide the key for effective combinatorial therapy .	Science immunology	03/10/2025
10.1186/s12889-025-24746-1	association between sarcopenic obesity and risk of fall : a population-based cohort study among middle-aged and old adult use the charls .	Yu C, Meng Z, Wang X, Xiao J	although previous research have establish a strong link between sarcopenia and fall risk in middle-aged and old adult , the effect of sarcopenic obesity and possible sarcopenic obesity on fall risk remain underexplored in large-scale study . this longitudinal analysis aim to examine these association use nationally representative cohort data . we analyze data from the china health and retirement longitudinal study ( charls ) , include 9,996 participant age 45 and old with available body composition measurement . participant be categorize into four group base on asian work group for sarcopenia ( awgs ) criterion and median waist circumference ( wc ) : ( 1 ) normal wc without sarcopenia ( control group ) , ( 2 ) normal wc with sarcopenia , ( 3 ) obesity without sarcopenia , and ( 4 ) obesity with sarcopenia . cox proportional hazard model be use to estimate adjust hazard ratio ( hr ) , 95 % confidence interval ( ci ) , and p-values , with the control group a the reference . the model be sequentially adjust for demographic ( age , sex , residence ) , socioeconomic ( education ) , and behavioral ( smoking , alcohol ) variable . compare to participant with normal wc and no sarcopenia ( reference group ) , those with sarcopenic obesity have a significantly high risk of fall ( hr = 1.25 ; 95 % 1.00-1.56 ; p = 0.048 ) , even after adjust for demographic , socioeconomic , and behavioral factor . similarly , possible sarcopenic obesity be link to a modest but statistically significant increase in fall risk ( hr = 1.12 ; 95 % 1.02-1.24 ; p = 0.021 ) . subgroup analyse reveal that the fourth quartile show a trend toward high fall risk across all subgroup , especially among individual age ≥ 60 year and male . however , in most subgroup , the 95 % ci cross 1 , suggest limited statistical significance in some stratum . both sarcopenic obesity and possible sarcopenic obesity be associate with an elevated risk of fall . middle-aged and old adult should adopt preventive strategy , such a maintain regular physical activity , to preserve muscle mass and reduce the risk of fall .	BMC public health	03/10/2025
10.1016/S1470-2045(25)00280-3	safety and efficacy of a dexamethasone-sparing regimen with daratumumab and lenalidomide in patient with frailty and newly diagnose multiple myeloma ( ifm2017-03 ) : a phase 3 , open-label , multicentre , randomise , control trial .	Manier S, Lambert J, Hulin C, Macro M, Laribi K, Araujo C, Pica GM, Touzeau C, Godmer P, Slama B, Karlin L, Orsini Piocelle F, Dib M, Sanhes L, Morel P, El Yamani A, Tiab M, Tabrizi R, Richez V, Garderet L, Royer B, Bareau B, Mariette C, Fleck E, Robu D, Calmettes C, Rigaudeau S, Demarquette H, Frenzel L, Decaux O, Mohty M, Arnulf B, Bigot N, Perrot A, Corre J, Mary JY, Avet-Loiseau H, Moreau P, Leleu X, Facon T	patient with frailty and newly diagnose multiple myeloma have worse outcome due to high rate of adverse event ( aes ) and treatment discontinuation . this study evaluate a dexamethasone-sparing regimen of daratumumab plus lenalidomide versus lenalidomide plus dexamethasone in frail patient with newly diagnose multiple myeloma . in this prospective , randomised , open-label trial , conduct at 61 active intergroup francophone of myeloma centre , patient age 65 year or old with newly diagnose multiple myeloma and an eastern cooperative oncology group proxy frailty score of 2 or more be randomly assign 2:1 to receive daratumumab ( 1800 mg subcutaneously ) plus oral lenalidomide ( 25 mg daily for 21 day of a 28 day cycle ) and dexamethasone ( 20mg weekly ) for two cycle ( dexamethasone-sparing group ) or lenalidomide ( 25 mg daily ) and oral dexamethasone ( 20 mg weekly ; control group ) , with stratification by international staging system , age , and centre . the primary endpoint be progression-free survival . efficacy be assess in the intention-to-treat population and safety be assess in all patient expose to at least one dose of randomised intervention . this trial be register with clinicaltrials.gov , nct03993912 , and be complete . from oct 18 , 2019 to july 20 , 2021 , 335 patient be screen , of whom 295 patient be randomly assign ( 200 to lenalidomide plus daratumumab , 95 to lenalidomide plus dexamethasone ) . the median age be 81 year ( iqr 77-84 ) , with 180 ( 61 % ) age old than 80 year , and 151 ( 51 % ) patient be female and 144 ( 49 % ) be male . median follow-up be 46·3 month ( iqr 46·0-52·7 ) . median progression-free survival be 53·4 month ( 95 % ci 35·3-not reach ) in the dexamethasone-sparing group versus 22·5 month ( 16·5-39·0 ) in the control group ( hazard ratio [ hr ] 0·51 , 95 % ci 0·37-0·70 , p < 0·0001 ) . the most common grade 3-5 aes be neutropenia ( 110 [ 55 % ] of 200 patient in the dexamethasone-sparing group vs 23 [ 24 % ] of 95 patient in the control group ) , and infection ( 38 [ 19 % ] v 20 [ 21 % ] ) . serious adverse event occur in 126 patient ( 63 % ) in the dexamethasone-sparing group and 66 patient ( 69 % ) in the control group . aes lead to death occur in 23 patient ( 12 % ) in the dexamethasone-sparing group and 12 patient ( 13 % ) in the control group , with 4 ( 2 % ) and 2 ( 2 % ) grade 5 treatment-emergent adverse event , respectively . in the ifm2017-03 trial , use of lenalidomide plus daratumumab , with dexamethasone limit to the first 2 treatment cycle , reduce the risk of progression or death compare with lenalidomide plus dexamethasone , with no additional safety concern . lenalidomide plus daratumumab could therefore be consider a a treatment option for old patient with frailty and newly diagnose multiple myeloma . the study be fund by johnson & johnson .	The Lancet. Oncology	01/01/2045
10.1038/s41588-025-02336-6	target histone h2b acetylate enhanceosomes via p300/cbp degradation in prostate cancer .	Luo J, Chen Z, Qiao Y, Tien JC, Young E, Mannan R, Mahapatra S, Bhattacharyya R, Xiao L, He T, Eyunni S, Zhang Y, Zheng Y, Su F, Cao X, Wang R, Cheng Y, Seri R, George J, Shahine M, Miner SJ, Rees MG, Ronan MM, Roth JA, Vaishampayan U, Wang M, Wang S, Parolia A, Chinnaiyan AM	prostate cancer be drive by oncogenic transcription factor enhanceosomes comprise chromatin and epigenetic regulator . the lysine acetyltransferases p300 and creb-binding protein ( cbp ) be key cofactor that activate enhancer through histone acetylation . here we identify p300/cbp-mediated multisite histone h2b n-terminal acetylation ( h2bntac ) a a defining feature of oncogenic enhanceosomes in androgen receptor ( ar ) -positive prostate cancer . p300/cbp be essential for ar and ets transcription factor erg transcriptional activity , and their dual degradation eliminate h2bntac and histone h3 lysine 27 acetylation at hyperactive enhancer , lead to strong suppression of oncogenic transcription than target either paralog or bromodomain alone . cytotoxicity profile across > 900 cell line reveal that tumor with high h2bntac , include ar-positive prostate cancer , be selectively dependent on p300/cbp . in preclinical model , systemic p300/cbp degradation inhibit tumor growth , synergized with ar antagonist and show no evident toxicity . these finding position h2bntac a an epigenetic marker of enhancer addiction and establish dual p300/cbp degradation a a promising therapeutic strategy for enhancer-driven cancer .	Nature genetics	03/10/2025
10.1016/S2468-1253(25)00198-0	etrasimod a induction and maintenance treatment for patient with moderately to severely active ulcerative colitis in east asia ( enlight uc ) : a randomised , double-blind , placebo-controlled , multicentre , phase 3 study .	Wu K, Zheng C, Cao Q, Ding Y, Gao X, Zhong J, Chiu CT, Zhang H, Wang X, Wang B, Liang J, Liu X, Zhou Y, Xu B, Kim TO, Shen X, Chen D, Chen W, Liu Y, Shen J, Liu F, Ding X, Zhan Q, Chou JW, Zeng S, Lin Y, Ying L, Chen X	etrasimod be an oral , once-daily sphingosine 1-phosphate ( s1p ) receptor modulator for the treatment of active ulcerative colitis . in the randomised , placebo-controlled , double-blind phase 3 enlight uc study , also know a the es101002 study , we aim to evaluate the efficacy and safety of etrasimod in patient with moderately to severely active ulcerative colitis in east asia . use a central interactive web response system , in the 12-week induction period , adult ( age 18-75 year , inclusive ) with moderately to severely active ulcerative colitis ( modify mayo score [ mm ] 4-9 with an endoscopic subscore ≥2 and a rectal bleeding subscore ≥1 ) and an inadequate response , loss of response , or intolerance to at least one ulcerative colitis treatment be randomly assign ( 2:1 ) to once-daily oral etrasimod 2 mg or placebo . patient and study staff be mask to treatment assignment . patient be enrol from 52 hospital across china , taiwan , and souh korea . randomisation be stratify by previous treatment status and baseline disease activity . patient who have an mms clinical response at induction period week 12 be re-randomly assign ( 1:1 ) to once-daily oral etrasimod 2 mg or placebo for the 40-week maintenance period . randomisation be stratify by induction period treatment , previous exposure to biologicals or jak inhibitor , and concomitant use of oral corticosteroid at induction period baseline . the primary efficacy outcome be mms clinical remission ( stool frequency subscore=0 [ or stool frequency subscore=1 with a ≥1 point decrease from induction period baseline ] , rectal bleeding subscore=0 , and endoscopic subscore ≤1 [ exclude friability ] ) , assess in the induction and maintenance period separately ( at induction period week 12 and maintenance period week 40 ) . the primary efficacy analysis use the full analysis set ( fa ) , which include all patient who be randomly assign and receive at least one dose of study treatment for the induction period , and all re-randomly assigned patient who show clinical response at induction period week 12 and receive at least one dose of study treatment for the maintenance period . the safety analyse for each treatment period use the safety analysis set ( saf ) , which include all patient who receive any amount of study drug in the corresponding treatment period . enlight uc be register with clinicaltrials.gov ( nct04176588 ) and the study be complete . 606 patient be screen between sept 25 , 2019 , and april 27 , 2023 , and 340 be randomly assign for the induction period and treat ( 228 patient [ 88 female and 140 male ] assign to etrasimod and 112 patient [ 44 female and 68 male ] assign to placebo ) . 157 patient who show clinical response in the induction period be re-randomly assigned and treat in the maintenance period ( 77 patient [ 35 female and 42 male ] assign to etrasimod and 80 patient [ 32 female and 48 male ] assign to placebo ) . a significantly great proportion of patient treat with etrasimod than those treat with placebo , show clinical remission at induction week 12 ( 57 [ 25·0 % ] of 228 patient vs six [ 5·4 % ] of 112 patient ; adjust difference 20·4 % ; 95 % ci 13·4 % -27·4 % ; p < 0·0001 ) and maintenance period week 40 ( 37 [ 48·1 % ] of 77 patient vs 10 [ 12·5 % ] of 80 patient ; adjust difference 35·9 % ; 95 % ci 22·5 % -49·2 % ; p < 0·0001 ) . in the induction period , the most frequently report treatment-emergent adverse event ( teae ) be increase alt ( 22 [ 10 % ] in the etrasimod group vs one [ 1 % ] in the placebo group ) . in the maintenance period , the most frequently report teae be upper respiratory tract infection ( 14 [ 18 % ] in the etrasimod group vs 14 [ 17 % ] in the placebo group ) . across the induction and maintenance period , most teaes be mild to moderate in severity . five ( 2 % ) of 228 patient treat with etrasimod and four ( 4 % ) of 112 patient treat with placebo discontinue study treatment due to teaes during the induction period , and one ( 1 % ) of 77 patient treat with etrasimod and one ( 1 % ) of 81 patient treat with placebo discontinue study treatment due to teaes during the maintenance period . no grade 4 or high teae , malignancy , or death be report . etrasimod be effective and well tolerate a an oral induction and maintenance treatment in patient with moderately to severely active ulcerative colitis in east asia . everest medicine . for the chinese translation of the abstract see supplementary material section .	The lancet. Gastroenterology & hepatology	30/09/2025
10.1021/acs.jproteome.9b00569	measurement of organ-specific and acute-phase blood protein level in early lyme disease .	Zhou Y, Qin S, Sun M, Tang L, Yan X, Kim TK, Caballero J, Glusman G, Brunkow ME, Soloski MJ, Rebman AW, Scavarda C, Cooper D, Omenn GS, Moritz RL, Wormser GP, Price ND, Aucott JN, Hood L	lyme disease result from infection of human with the spirochete borrelia burgdorferi . the first and most common clinical manifestation be the circular , inflamed skin lesion refer to a erythema migrans ; later manifestation result from infection of other body site . laboratory diagnosis of lyme disease can be challenge in patient with erythema migrans because of the time delay in the development of specific diagnostic antibody against borrelia . reliable blood biomarkers for the early diagnosis of lyme disease in patient with erythema migrans be need . here , we perform select reaction monitoring , a targeted mass spectrometry-based approach , to measure select protein that ( 1 ) be know to be predominantly express in one organ ( i.e. , organ-specific blood protein ) and whose blood concentration may change a a result of lyme disease , or ( 2 ) be involve in acute immune response . in a longitudinal cohort of 40 lyme disease patient and 20 healthy control , we identify 10 protein with significantly alter serum level in patient at the time of diagnosis , and we also develop a 10-protein panel identify through multivariate analysis . in an independent cohort of patient with erythema migrans , six of these protein , apoa4 , c9 , crp , cst6 , pglyrp2 , and s100a9 , be confirm to show significantly alter serum level in patient at time of presentation . nine of the 10 protein from the multivariate panel be also verify in the second cohort . these protein , primarily innate immune response protein or protein specific to liver , skin , or white blood cell , may serve a candidate blood biomarkers require further validation to aid in the laboratory diagnosis of early lyme disease .	Journal of proteome research	03/01/2020
10.1248/bpb.b15-00842	mechanism underlie induction of hyperglycemia in rat by single administration of olanzapine .	Nagata M, Nakajima M, Ishiwata Y, Takahashi Y, Takahashi H, Negishi K, Yasuhara M	acute administration of olanzapine rapidly elevate blood glucose level . however , the mechanism underlie the rapid development of hyperglycemia with the administration of olanzapine remain unclear . the aim of the present study be to clarify the mechanism underlie olanzapine-induced acute hyperglycemia . male wistar rat receive an intravenous infusion of saline ( control ) or olanzapine 2.5 , 5 , or 10 mg/kg . blood sample be obtain periodically after olanzapine infusion to determine serum concentration of glucose , olanzapine , and several endogenous substance . in a separate experiment , rat receive an intravenous injection of propranolol ( 2 mg/kg ) 30 min before infusion of olanzapine ( 10 mg/kg ) . the intravenous infusion of olanzapine induce dose-dependent increase in the serum concentration of glucose , epinephrine , and insulin . pretreatment with propranolol suppress olanzapine-induced elevation in the serum concentration of glucose , but do not affect the serum concentration of olanzapine or olanzapine-induced increase in the serum concentration of epinephrine . although the serum concentration of corticosterone increase after administration of olanzapine , no significant difference be observe among the olanzapine dose group . furthermore , administration of olanzapine do not affect the serum concentration of glucagon or histamine . we develop a pharmacokinetic-pharmacodynamic model assume that the olanzapine-induced secretion of epinephrine lead to elevate serum glucose concentration . this model appear to satisfactorily characterize olanzapine-induced hyperglycemia . in conclusion , a single intravenous dose of olanzapine dose-dependently increase the serum concentration of glucose in rat , and epinephrine play a role in olanzapine-induced acute hyperglycemia .	Biological & pharmaceutical bulletin	01/01/2016
10.1016/S1470-2045(25)00409-7	first-line immunotherapy with or without chemotherapy versus braf plus mek inhibitor in braf ( v600e ) -mutated metastatic non-small-cell lung cancer ( front-braf ) : a multicentre , retrospective cohort study .	Di Federico A, Wang K, Chen MF, Barsouk AA, Pagliaro A, Chen LN, Ogliari FR, Stockhammer P, Thawani R, Raslan S, Gariazzo E, Fusco F, Hambelton GM, Citarella F, Meyer D, Aldea M, De Giglio A, Alessi JV, Pecci F, Gelsomino F, Corassa M, Vokes NI, Wang X, de Biase D, Abu Rous F, Areesawangkit P, Elghawy O, Cortellini A, Metro G, Ferrara R, Awad MM, Pabani A, Murray JC, Cappuzzo F, Garassino MC, Dagogo-Jack I, Riely G, Grant M, Herzberg BO, Ardizzoni A, Planchard D, Johnson BE, Langer CJ, Offin M, Negrao MV, Ricciuti B	patient with braf ( v600e ) ( ie , val600glu ) -mutated non-small-cell lung cancer ( nsclc ) can be treat with braf and mitogen-activated protein kinase ( mek ) inhibitor , or with immune checkpoint inhibitor ( icis ) with or without chemotherapy . we aim to investigate which initial systemic treatment should be prioritise in this population . in this retrospective cohort study conduct across 17 centre in the usa , italy , france , and brazil , clinicopathological data be collect from participant age 18 year and old with stage iv , treatment-naive , metastatic braf ( v600e ) -mutated nsclc and with an eastern cooperative oncology group performance status of 0-3 , who start first-line treatment with icis with or without chemotherapy ( pd-1 or pd-l1 inhibitor with or without platinum-based chemotherapy ) or braf and mek inhibitor ( dabrafenib and trametinib or encorafenib and binimetinib ) between jan 2 , 2015 , and july 11 , 2024. the primary endpoint be overall survival with first-line icis with or without chemotherapy versus with braf and mek inhibitor . 284 participant be identify for this study , of whom 88 ( 31 % ) receive icis with or without chemotherapy and 196 ( 69 % ) receive braf and mek inhibitor . the median age of participant be 68 year ( iqr 61-74 ) , and 148 ( 52 % ) participant be female and 136 ( 48 % ) male . participant in the icis with or without chemotherapy group have a high history of smoking ( 73 [ 83 % ] v 118 [ 60 % ] ; p=0·0002 ) and a high pd-l1 expression ( ≥50 % in 58 [ 66 % ] v 76 [ 39 % ] , 1-49 % in 16 [ 18 % ] v 67 [ 34 % ] , and < 1 % in eight [ 9 % ] v 31 [ 16 % ] ; p=0·0003 ) than those in the braf and mek inhibitor group . at a median follow-up time of 45·0 month ( 95 % ci 39·0-55·7 ) , icis with or without chemotherapy be associate with improved median overall survival compare with braf and mek inhibitor ( 40·9 month [ 95 % ci 33·3-not reach ] v 25·2 month [ 19·9-31·1 ] ; hazard ratio [ hr ] 0·69 [ 0·49-0·98 ] , p=0·039 ) . in subgroup analysis , icis with or without chemotherapy , compare with braf and mek inhibitor , be associate with long median overall survival in participant with a history of smoking ( hr 0·60 [ 0·40-0·90 ] , p=0·013 ) , with a pd-l1 tumour proportion score of ≥1 % or high ( hr 0·66 [ 0·45-0·98 ] , p=0·039 ) , age 70 year or old ( hr 0·54 [ 0·31-0·94 ] , p=0·029 ) , with tp53 co-mutations ( hr 0·46 [ 0·27-0·79 ] , p=0·0048 ) , and without brain metastasis ( hr 0·66 [ 0·45-0·99 ] , p=0·045 ) . with braf and mek inhibitor , frequency of adverse event of any grade and of grade 3 and high be similar whether administer a first-line therapy or a second-line therapy follow icis with or without chemotherapy . first-line icis with or without chemotherapy be associate with improved overall survival compare with braf and mek inhibitor in participant with metastatic braf ( v600e ) -mutated nsclc , particularly among specific subpopulation . these finding , although suggest potential clinical relevance , remain exploratory and require confirmation from prospective study . nextgenerationeu .	The Lancet. Oncology	01/01/2045
10.1186/s12943-025-02458-9	microbiome-metabolome interplay in pancreatic cancer progression : insight from multi-omics analysis .	Luo D, Chen Q, Li Y, Yang J, Tao Y, Ji L, Gong X	recent study suggest that intratumoral microbiome and alter metabolic network play crucial role in pancreatic cancer ( pc ) progression . however , the precise interplay between microbial community and tumor metabolism in pc remain poorly understood . this study aim to investigate the impact of the intratumoral microbiome , the metabolic landscape , and their interaction on pc development . 16 rdna sequencing and untargeted metabolomic profiling be perform on 47 paired pancreatic cancer and adjacent normal tissue to analyze their intratumoral microbiome and metabolic landscape . bioinformatics tool be use to conduct differential microbiome abundance analysis and pathway enrichment . a correlation analysis be perform to identify key microbiota-metabolite interaction . 16 rdna sequence reveal significant difference in the abundance and diversity ( α-diversity and β-diversity ) of the intratumoral microbiome in pc . the predominant specie in pancreatic cancer be pseudomonas . enrichment analysis show that amino acid metabolic pathway , include arginine and proline metabolism , arginine biosynthesis , be significantly enrich in pc . untargeted metabolomics identify 298 metabolite that be significantly alter in pc ( fold change > 1.5 , p-value < 0.05 ) . these include amino acid metabolite such a lys-leu , pro-leu , arg-leu , lys-val , his-lys , and others . functional enrichment analysis highlight several metabolic pathway that play important role in pancreatic cancer , include glycine , serine , and threonine metabolism , amino acid biosynthesis , metabolic pathway and cysteine and methionine metabolism . correlation analysis between microbiome and metabolic data reveal significant association between pseudomonas and several metabolite , include alpha-ketoisovaleric acid , 16-hydroxyhexadecanoic acid , myristic acid , nonanoic acid ( the spearman correlation coefficient r , 0.5 ≤|r|≤ 1 and p-value < 0.05 ) . this study suggest a relationship between the microbiome and metabolism in pancreatic cancer . we observe that pseudomonas contributes to alter amino acid metabolism , but whether this interaction be causal and the mechanism underlie it remain unclear . further experimental validation be require before consider microbiome-targeted metabolic intervention a viable therapeutic strategy .	Molecular cancer	02/10/2025
10.1093/eurheartj/ehaf766	taurochenodeoxycholic acid alleviate obesity-induced endothelial dysfunction .	Lu H, Wu Z, Wan M, Xiong S, Huang X, Liu T, Jiang X, He L, Ma C, Cui H, Yue X, Li J, Qin X, Wang Y, Zhang C, Yang J, Liu S, Zhang W	obesity be a global health challenge significantly increase cardiovascular disease ( cvd ) burden . effective prevention and treatment necessitate target early pathological change , particularly obesity-induced endothelial dysfunction ( ed ) . this study aim to characterize ed heterogeneity in non-hypertensive obese ( nho ) individual , investigate the association of serum metabolite with obesity-induced ed , and identify potentially predictive and therapeutic metabolite . utilize wire myograph , this study assess ed of ex vivo arteriole from omental adipose tissue of 213 nho patient , categorize into metabolically healthy obesity ( mho ) and metabolically unhealthy obesity ( muo ) . target metabolomic profiling identify association between serum metabolite and ed . obesity-induced ed in nho patient lack correlation with many traditional cardiovascular risk factor . the mho and muo individual exhibit similar ed and metabolomic profile characteristic . serum metabolomics identify bile acid ( ba ) , particularly chenodeoxycholic acid ( cdca ) , a negatively correlate with ed in nho patient . taurochenodeoxycholic acid ( tcdca ) , a taurine-conjugated derivative of cdca , protect against obesity-induced ed and hypertension . mechanistically , endothelial farnesoid x receptor ( fxr ) deletion aggravate obesity-induced ed and hypertension , negate the beneficial effect of bariatric surgery or tcdca treatment . the tcdca-fxr activation in endothelial cell upregulated atf4 transcription , which be suppress by phb1 , thereby enhance serine and one-carbon metabolism . this study suggest cdca a a promising biomarker for identification of obesity-induced ed . taurochenodeoxycholic acid demonstrate significant therapeutic potential for alleviate various form of obesity-induced ed . this effect be mediate by the endothelial tcdca-fxr-phb1-atf4 axis , which upregulates serine and one-carbon metabolism , thereby offer a novel strategy to delay the onset of hypertension and other cvds .	European heart journal	03/10/2025
10.1038/s41746-025-01976-6	current status and solution for ai ethic in ophthalmology : a bibliometric analysis .	Chen X, Yang Y, Yun D, Wang R, Lin Y, Luo M, Zhang W, Yu-Wai-Man P, Burton M, Liang L, Lin H	ophthalmology , an early adopter of medical artificial intelligence ( ai ) , have make significant advancement , but ethical discussion limit . this bibliometric analysis review 498 publication from web of science and scopus ( 2000-2023 ) to explore the evolution , status , thematic trend , data modality and their ethical focus , and solution in ophthalmic ai ethic . ophthalmology rank second in medical ai ethic , with major contributor from the united state ( u ) , china , the united kingdom ( uk ) , singapore and india . ethical concern focus on privacy , fairness , and transparency . ethical priority differ by modality with fundus imaging ( 59.4 % ) and optical coherence tomography ( oct ) ( 30.9 % ) a the most common . most study ( 78.3 % ) address ethic in diagnostic algorithm development , while only 11.5 % directly target ethical concern , though this focus be increase . this study highlight the need for ai technology and guideline to address ethical challenge in ophthalmology , offer a future direction for research and innovation in medical ai governance .	NPJ digital medicine	02/10/2025
10.1093/eurheartj/ehaf766	taurochenodeoxycholic acid alleviate obesity-induced endothelial dysfunction .	Lu H, Wu Z, Wan M, Xiong S, Huang X, Liu T, Jiang X, He L, Ma C, Cui H, Yue X, Li J, Qin X, Wang Y, Zhang C, Yang J, Liu S, Zhang W	obesity be a global health challenge significantly increase cardiovascular disease ( cvd ) burden . effective prevention and treatment necessitate target early pathological change , particularly obesity-induced endothelial dysfunction ( ed ) . this study aim to characterize ed heterogeneity in non-hypertensive obese ( nho ) individual , investigate the association of serum metabolite with obesity-induced ed , and identify potentially predictive and therapeutic metabolite . utilize wire myograph , this study assess ed of ex vivo arteriole from omental adipose tissue of 213 nho patient , categorize into metabolically healthy obesity ( mho ) and metabolically unhealthy obesity ( muo ) . target metabolomic profiling identify association between serum metabolite and ed . obesity-induced ed in nho patient lack correlation with many traditional cardiovascular risk factor . the mho and muo individual exhibit similar ed and metabolomic profile characteristic . serum metabolomics identify bile acid ( ba ) , particularly chenodeoxycholic acid ( cdca ) , a negatively correlate with ed in nho patient . taurochenodeoxycholic acid ( tcdca ) , a taurine-conjugated derivative of cdca , protect against obesity-induced ed and hypertension . mechanistically , endothelial farnesoid x receptor ( fxr ) deletion aggravate obesity-induced ed and hypertension , negate the beneficial effect of bariatric surgery or tcdca treatment . the tcdca-fxr activation in endothelial cell upregulated atf4 transcription , which be suppress by phb1 , thereby enhance serine and one-carbon metabolism . this study suggest cdca a a promising biomarker for identification of obesity-induced ed . taurochenodeoxycholic acid demonstrate significant therapeutic potential for alleviate various form of obesity-induced ed . this effect be mediate by the endothelial tcdca-fxr-phb1-atf4 axis , which upregulates serine and one-carbon metabolism , thereby offer a novel strategy to delay the onset of hypertension and other cvds .	European heart journal	03/10/2025
10.1038/s41746-025-01976-6	current status and solution for ai ethic in ophthalmology : a bibliometric analysis .	Chen X, Yang Y, Yun D, Wang R, Lin Y, Luo M, Zhang W, Yu-Wai-Man P, Burton M, Liang L, Lin H	ophthalmology , an early adopter of medical artificial intelligence ( ai ) , have make significant advancement , but ethical discussion limit . this bibliometric analysis review 498 publication from web of science and scopus ( 2000-2023 ) to explore the evolution , status , thematic trend , data modality and their ethical focus , and solution in ophthalmic ai ethic . ophthalmology rank second in medical ai ethic , with major contributor from the united state ( u ) , china , the united kingdom ( uk ) , singapore and india . ethical concern focus on privacy , fairness , and transparency . ethical priority differ by modality with fundus imaging ( 59.4 % ) and optical coherence tomography ( oct ) ( 30.9 % ) a the most common . most study ( 78.3 % ) address ethic in diagnostic algorithm development , while only 11.5 % directly target ethical concern , though this focus be increase . this study highlight the need for ai technology and guideline to address ethical challenge in ophthalmology , offer a future direction for research and innovation in medical ai governance .	NPJ digital medicine	02/10/2025
10.1016/j.redox.2025.103869	park7-driven igf2bp3-k76 lactylation mediates ferroptosis and haic resistance in hepatocellular carcinoma .	Zhu Z, Xia X, Lu Y, Li D, He X, Zhang B, Xiong G, Zhang W, Liang H, Zhu H	oxaliplatin/5-fluorouracil ( oxa/5-fu ) -based hepatic artery infusion chemotherapy ( haic ) represent a promising strategy against advanced hepatocellular carcinoma ( hcc ) , yet acquire resistance frequently impede it efficacy . here , we identify lactylation of igf2bp3 at lysine 76 ( igf2bp3-k76lac ) a a key driver of haic resistance . igf2bp3-k76lac overexpression enhances chemoresistance in vitro and in vivo . mechanistically , lactylation at igf2bp3 k76 strengthen it affinity for m6a-modified fsp1 mrna , upregulating fsp1 and confer ferroptosis resistance . blocking of igf2bp3-k76lac bolster oxa/5-fu-induced ferroptosis , disrupts antioxidant defense , and curbs tumor growth . moreover , park7 function a a lactyltransferase to facilitate igf2bp3-k76lac via increase the binding of lactate at igf2bp3-k76 site . finally , block antibody target igf2bp3-k76lac be show to work synergistically with oxa/5-fu to restore chemosensitivity . take together , our finding reveal a critical role for the park7-igf2bp3-k76lac-fsp1 axis in haic resistance , highlight igf2bp3-k76lac a a potential therapeutic target in hcc .	Redox biology	26/09/2025
10.1186/s12889-025-24558-3	association of social isolation and loneliness with incident cancer in a population-based cohort study .	Liu X, Chen P, Wang J, Li Z, Zhu Y, Yang J, Wang L, He S, Sun X, Li J, Yang H	social isolation and loneliness pose significant public health challenge globally . this study aim to examine the association of social isolation , loneliness and their combined effect with incident cancer . this study utilize data from the uk biobank ( ukb ) , which be a population-based prospective cohort . social isolation and loneliness be assess through self-reported questionnaire . cancer case be identify by link to cancer registry . a total of 430,376 participant be include , during a mean follow-up of 14.32 year , 45,131 participant be diagnose with cancer . compare to participant in least isolated group , those in most isolated group have significantly high risk of cancer of lip , oral cavity and pharynx ( hr 1.32 , 95 % ci 1.11-1.58 ) , cancer of digestive organ ( hr 1.10 , 95 % ci 1.03-1.16 ) , cancer of respiratory and intrathoracic organ ( hr 1.17 , 95 % ci 1.07-1.28 ) , breast cancer ( hr 1.11 , 95 % ci 1.04-1.18 ) , cancer of female genital organ ( hr 1.23 , 95 % ci 1.09-1.38 ) , and cancer of urinary tract ( hr 1.31 , 95 % ci 1.17-1.46 ) . however , the most isolated group have low risk of cancer of mesothelial and soft tissue ( hr 0.80 , 95 % ci 0.64-0.99 ) , prostate cancer ( hr 0.88 , 95 % ci 0.83-0.94 ) . individual with loneliness have a significantly increase risk of cancer of urinary tract ( hr 1.19 , 95 % ci 1.01-1.40 ) , but a reduced risk of cancer of skin ( hr 0.76 , 95 % ci 0.61-0.93 ) . social isolation and loneliness be independently associate with incident cancer , with implication for early effective cancer prevention .	BMC public health	01/10/2025
10.1038/s41586-025-09569-9	a miniature crispr-cas10 enzyme confers immunity by inhibitory signalling .	Doherty EE, Adler BA, Yoon PH, Hsieh K, Loi K, Armbruster EG, Lahiri A, Bolling CS, Wilcox XE, Akkati A, Iavarone AT, Pogliano J, Doudna JA	microbial and viral co-evolution have create immunity mechanism involve oligonucleotide signal that share mechanistic feature with human antiviral system ( 1 ) . in these pathway , include cyclic oligonucleotide-based antiphage signal system ( cbasss ) and type iii crispr system in bacteria and cyclic gmp-amp synthase-stimulator of interferon gene ( cgas-sting ) in human , oligonucleotide synthesis occur upon detection of virus or foreign genetic material in the cell , trigger the antiviral response ( 2-4 ) . here , in an unexpected inversion of this process , we show that the crispr-related enzyme mcpol synthesize cyclic oligonucleotides constitutively a part of an active mechanism that repress a toxic effector . cell-based experiment demonstrate that the absence or loss of mcpol-produced cyclic oligonucleotides trigger cell death , prevent the spread of virus that attempt immune evasion by deplete host cyclic nucleotide . structural and mechanistic investigation reveal mcpol to be a di-adenylate cyclase whose product , c-di-amp , prevents toxic oligomerization of the effector protein 2tmβ . analysis of cell by fluorescence microscopy show that lack of mcpol allow 2tmβ-mediated cell death due to inner membrane collapse . these finding unveil a powerful defence strategy against virus-mediated immune suppression , expand our understanding of the role of oligonucleotides in immunity .	Nature	01/10/2025
10.1002/ijgo.70577	paracetamol ( acetaminophen ) use during pregnancy and autism risk : evidence do not support causal association .	Louwen F, Deuster E, McAuliffe FM, Jacobsson B, Geary M, Fleischman S, Kihara AB	recent political statement link paracetamol ( acetaminophen ) use during pregnancy to autism spectrum disorder have create concern among patient and healthcare provider worldwide . this editorial critically examine the scientific evidence , highlight that the large and most methodologically rigorous population-based study employ sibling control analyse demonstrate no causal association between prenatal paracetamol exposure and neurodevelopmental disorder . while some observational study have suggest potential weak association , these finding likely reflect confound by indication and familial genetic factor rather than actual causal relationship . the most robust evidence come from a swedish population-based study of 2.48 million child , which find no increase risk when control for familial confounding . major international medical organization include acog , rcog , and figo , and regulatory agency include the european medicine agency continue to recommend paracetamol a the safe analgesic option during pregnancy when clinically indicate . the established risk of untreated pain and fever during pregnancy significantly outweigh theoretical concern base on methodologically limited study . healthcare provider should continue evidence-based counseling while avoid unnecessary anxiety about this essential medication in obstetric practice .	International journal of gynaecology and obstetrics: the official organ of the	30/09/2025
10.1038/s41467-025-64173-9	creative experience and brain clock .	Coronel-Oliveros C, Migeot J, Lehue F, Amoruso L, Kowalczyk-Grębska N, Jakubowska N, Mandke KN, Seabra JP, Orio P, Campbell D, Gonzalez-Gomez R, Prado P, Cuadros J, Tagliazucchi E, Cruzat J, Legaz A, Medel V, Hernandez H, Fittipaldi S, Altschuler F, Moguilner S, Baez S, Santamaria-Garcia H, González-Hernández A, Bonilla-Santos J, Güntekin B, Babiloni C, Abasolo D, Di Caterina G, Yener GG, Escudero J, Ochoa-Gómez JF, Soto-Añari M, Bruno MA, Valdes-Sosa PA, Anghinah R, Gonzalez-Montealegre RA, Clark RA, García AM, Kaltwasser L, Schürmann M, Meier JM, Brzezicka A, Whelan R, Lawlor B, Robertson IH, Bailey C, Melloni L, Sajnani N, Ibanez A	creative experience may enhance brain health , yet metric and mechanism remain elusive . we characterize brain health use brain clock , which capture deviation from chronological age ( i.e. , accelerate or delay brain age ) . we combine m/eeg functional connectivity ( n = 1,240 ) with machine learn support vector machine , whole-brain modeling , and neurosynth metanalyses . from this framework , we reanalyzed previously publish datasets of expert and match non-expert participant in dance , music , visual art , and video game , along with a pre/post-learning study ( n = 232 ) . we find delay brain age across all domain and scalable effect ( expertise > learning ) . the high the level of expertise and performance , the great the delay in brain age . age-vulnerable brain hub show increased connectivity link to creativity , particularly in area relate to expertise and creative experience . neurosynth analysis and computational modeling reveal plasticity-driven increase in brain efficiency and biophysical coupling , in creativity-specific delayed brain age . finding indicate a domain‑independent link between creativity and brain health .	Nature communications	03/10/2025
10.1001/jamanetworkopen.2025.33512	use of ai in identification of sexually transmit infection and anogenital dermatosis : a systematic review and meta-analysis .	Soe NN, Kusnandar II, Latt PM, Fairley CK, Chow EPF, Maatouk I, Johnson CC, Shah P, Peters RPH, Subissi L, Zhang L, Ong JJ	artificial intelligence ( ai ) excels in dermatology . however , it application to sexually transmitted infection ( stis ) remain unclear . to assess the performance of ai algorithm and their application in detect stis and anogenital dermatosis from clinical image in sexual health . six database ( ieee xplore , embase , scopus , medline , web of science , and cinahl ) be search for study publish from january 1 , 2010 , to april 12 , 2024 , use 3 main concept : artificial intelligence , diagnosis , and sexually transmitted infection . study that use ai to identify anogenital skin condition from clinical image be include . study that use non-ai approach or nonanogenital condition , as well a review and study lack performance metric , be exclude . follow the preferred reporting item for systematic review and meta-analyses ( prisma ) guideline , 2 reviewer independently assess full-text article and extract data use a standardized spreadsheet . another 2 reviewer resolve any disagreement . a modified quality assessment of diagnostic accuracy study ( quadas-2 ) critical appraisal tool and the checklist for evaluation of image-based ai report in dermatology ( clear derm ) be use for quality assessment . pool sensitivity and specificity of ai application for detect anogenital skin condition . a bivariate random-effects meta-analysis be conduct for condition with more than 3 study . of 5381 study screen and 258 full text select , 140 meet the inclusion criterion . most study report on mpox ( 110 [ 78.6 % ] ) , while other anogenital condition , include genital herpes ( 7 [ 5.0 % ] ) , genital wart ( 8 [ 5.7 % ] ) , scabies ( 8 [ 5.7 % ] ) , and molluscum contagiosum ( 6 [ 4.3 % ] ) , receive less attention . meta-analyses show high performance of ai for identification of mpox ( pooled sensitivity : 0.96 [ 95 % ci , 0.93-0.97 ] ; pool specificity : 0.98 [ 95 % ci , 0.97-0.99 ] ) , herpes simplex ( sensitivity : 0.91 [ 95 % ci , 0.71-0.98 ] ; specificity : 0.97 [ 95 % ci , 0.94-0.98 ] ) , genital wart ( sensitivity : 0.87 [ 95 % ci , 0.67-0.96 ] ; specificity : 0.98 [ 95 % ci , 0.95-0.99 ] ) , psoriasis ( sensitivity : 0.90 [ 95 % ci , 0.78-0.95 ] ; specificity : 0.98 [ 95 % ci , 0.96-0.99 ] ) , and scabies ( sensitivity : 0.89 [ 95 % ci , 0.84-0.93 ] ; specificity : 0.98 [ 95 % ci , 0.95-0.99 ] ) . study quality be variable , and the assessment identify high risk of bias across the population selection ( 76.1 % ) , reference standard ( 76.1 % ) , and index test ( 20.0 % ) . most study rely on open-source datasets ( 121 [ 86.4 % ] ) ; only 17 ( 12.1 % ) use external validation . all but 1 study ( 0.7 % ) remain at the proof-of-concept stage , and model be not publicly available for external evaluation . the finding suggest that ai show promise in identify stis and anogenital dermatosis but that significant research gap exist . future work should prioritize understudied stis and differential condition while improve data quality , conduct external validation , and validate finding in clinical setting .	JAMA network open	01/10/2025
10.1016/j.molcel.2025.09.006	parp1 auto-modification promotes faithful okazaki fragment processing and limit replication fork speed .	Elsborg JD, Munk SHN, Adelantado-Rubio A, Pék R, Fábian Z, Imburchia V, Zentout S, Hendriks IA, Buch-Larsen SC, Smith R, Bartek J, Duxin JP, Huet S, Maya-Mendoza A, Nielsen ML	poly ( adp-ribose ) polymerase ( parp ) inhibitor have prove their efficacy for treat tumor defective in homologous recombination via synthetic lethality . in response to dna break , parp1 be the primary adp-ribosylation writer , modify itself ( auto-modification ) and other protein to facilitate repair . however , enzymatic inhibition block both process , make it difficult to dissect their distinct functional role . use proteomics and site-directed mutagenesis , we identify a parp1 mutant deficient in auto-modification , yet it retain catalytic activity . this separation-of-function mutant reveal that parp1 auto-modification slows dna replication fork progression but be dispensable for repair factor recruitment . instead , auto-modification promote the timely release of parp1 at dna break site and prevent the formation of replication stress . simultaneous inhibition of fen1 and loss of parp1 auto-modification give rise to synthetic lethality , implicate auto-modification in okazaki fragment processing . our result demonstrate that trapping of parp at dna break impede repair factor accessibility , constitute an important dimension of parp-inhibitor-driven cytotoxicity .	Molecular cell	02/10/2025
10.1038/srep36943	murine hypothalamic destruction with vascular cell apoptosis subsequent to combine administration of human papilloma virus vaccine and pertussis toxin .	Aratani S, Fujita H, Kuroiwa Y, Usui C, Yokota S, Nakamura I, Nishioka K, Nakajima T	vaccination be the most powerful way to prevent human being from contract infectious disease include virus . in the case of the human papillomavirus ( hpv ) vaccine , an unexpectedly novel disease entity , hpv vaccination associate neuro-immunopathetic syndrome ( han ) , have be report and remain to be carefully verify . to elucidate the mechanism of han , we apply a strategy similar to the active experimental autoimmune encephalitis ( eae ) model - one of the most popular animal model use to induce maximum immunological change in the central nervous system . surprisingly , mouse vaccinate with pertussis toxin show neurological phenotype that include low responsiveness of the tail reflex and locomotive mobility . pathological analysis reveal the damage to the hypothalamus and circumventricular region around the third ventricle , and these region contain apoptotic vascular endothelial cell . these data suggest that hpv-vaccinated donners that be susceptible to the hpv vaccine might develop han under certain environmental factor . these result will give u the new insight into the murine pathological model of han and help u to find a way to treat of patient suffer from han .	Scientific reports	11/11/2016
10.1001/jamaoncol.2025.3760	the definition of cure in colon cancer : a pooled analysis of 15 randomized clinical trial .	Pastorino A, Liu H, Pederson L, Martelli V, Iveson T, de Gramont A, Alberts SR, George TJ, Yothers G, Harkin A, Labianca R, Taieb J, Schmoll HJ, Twelves C, Wolmark N, Saltz LB, Souglakos I, Goldberg RM, Kerr R, Lonardi S, Yoshino T, Puccini A, André T, Shi Q, Sobrero A	the definition of cure in stage ii to iii colon cancer ( cc ) remain unclear due to limitation in conventional end point , which include death and second primary tumor a event . these can complicate communication with patient regard long-term outcome . to distinguish relapse from compete health-related event to classify long-term outcome year after surgery and explore when the incidence of true relapse of the initial cc approach 0 % to define cure in this disease . design , set , this pooled analysis of individual patient-level data from 15 phase 3 randomized clinical trial assess time to cc-related relapse use kaplan-meier and aalen-johansen method , with death and second primary tumor treat a compete risk . cox regression model evaluate prognostic association , stratify by sex , stage , and tumor . patient with stage ii to iii cc who undergo adjuvant chemotherapy be include . all patient have undergone radical surgery for cc and receive adjuvant chemotherapy with a median follow-up of at least 6 year . the adjuvant colon cancer endpoint ( accent ) and the international duration evaluation of adjuvant chemotherapy ( idea ) databases included adjuvant study conduct between 1996 and 2015. data be analyze from february 2022 to june 2025. adjuvant chemotherapy regimen vary across trial , include fluoropyrimidines alone or in combination with oxaliplatin or biologic agent . the primary outcome be time to cc-related recurrence . the predefined threshold for cure be a recurrence risk below 0.5 % . of 35 213 include patient , 19 346 ( 54.9 % ) be male , and the mean ( sd ) age be 60.2 ( 10.8 ) year . the incidence rate of recurrence peak at 6.4 % ( 1993 of 31 373 ) between month 6 and month 12 and decrease continuously until year 10 of follow-up never exceed 0.5 % . recurrence rate appear to increase again after year 10 and peak at 2.0 % during year 12.5 to year 13 , a pattern observe exclusively in the mosaic trial . competing-event analysis reveal that death and second primary tumor inflate the apparent recurrence rate , especially for old patient . the overall cumulative incidence of relapse with death a compete risk be low among female patient ( hazard ratio , 0.58 ; 95 % ci , 0.45-0.76 ; p < .001 ) . in this pooled analysis of phase 3 randomized clinical trial , a recurrence rate less than 0.5 % occur after 6 year from surgery , support a practical definition of cure . recognize this milestone may improve patient communication , guide follow-up duration , and reduce unnecessary long-term surveillance .	JAMA oncology	02/10/2025
10.1038/s43587-025-00968-1	zdhhc11-mediated palmitoylation alleviate chondrocyte senescence and serve a a therapeutic target for osteoarthritis .	Wang K, He W, Gong Z, Gao J, Gao T, Pan N, Wu D, Yang Y, Li Z, Zhao X, Ji M, Shen S	osteoarthritis ( oa ) be a whole-joint disorder that interfere with the quality of life in old individual . here we report that zdhhc11 be highly express in articular chondrocytes but be downregulated in the degenerated cartilage of aged mouse and patient with oa . zdhhc11 prevents chondrocyte senescence and promote cartilage anabolism , culminate in an improved oa phenotype . the deletion of zdhhc11 in mouse ( zdhhc11 ( fl/fl ) ) exacerbate oa progression in a destabilized medial meniscus model . specifically , we identify zdhhc11 a a key palmitoyltransferase whose depletion lead to a gnb2-dependent e3 ubiquitin ligase-mediated proteasomal degradation of apod . mechanistically , zdhhc11-mediated palmitoylation alleviate oa progression by deactivate the gata4-p65 signaling pathway . we also propose an original lipid nanoparticle-based platform for zdhhc11 mrna delivery to rejuvenate impaired cartilage by specifically target chondrocytes in vivo . collectively , zdhhc11-dependent palmitoylation be essential for ameliorate oa , and the targeted delivery of zdhhc11 may serve a a promising strategy for future oa treatment .	Nature aging	30/09/2025
10.1155/2024/9526283	assessment of meat content and foreign object detection in cattle meatball use ultrasonography , radiography , and electrical impedance tomography imaging .	Ulum MF, Maryani, Rahminiwati M, Choridah L, Setyawan NH, Ain K, Mukhaiyar U, Pamungkas FA, Jakaria, Garnadi AD	meat content and physically hazardous contaminant in the internal section of meatball can not be detect by the naked eye or surface detector . this study be aim at analyze the meat content of cattle meatball and detect foreign object use ultrasonography ( usg ) , digital radiography ( dr ) , and electrical impedance tomography ( eit ) . meatball be produce use four different meat formulation ( 0 % , 25 % , 50 % , and 75 % meat ) and three treatment ( no preservative ( control ) , borax , and formalin preservative ) . cast iron and plastic bead be use a model of foreign object embed in the sample . the echogenicity , opacity , and resistivity value of each sample be evaluate and compare across group . the result show that the shelf life of the control meatballs be short than that of meatball with preservative . the echogenicity and opacity value for the different meat formulation be hypoechoic in usg and grey in dr. usg be able to distinguish between control and preservative-treated meatball but could not differentiate meat content and detect foreign object . conversely , dr effectively assessed meat content and detect iron-based foreign object , while eit show high resistivity value for iron and plastic bead compare to the meatball body .	International journal of food science	01/01/2024
10.1038/s41586-025-09580-0	track clonal evolution during treatment in ovarian cancer use cell-free dna .	Williams MJ, Vázquez-García I, Tam G, Wu M, Varice N, Havasov E, Shi H, Al-Rawi DH, Satas G, Lees HJ, Lee JJ, Myers MA, Zatzman M, Rusk N, Ali E, Shah RH, Berger MF, Mohibullah N, Lakhman Y, Chi DS, Abu-Rustum NR, Aghajanian C, McPherson A, Zamarin D, Loomis B, Weigelt B, Friedman CF, Shah SP	emergence of drug resistance be the main cause of therapeutic failure in patient with high-grade serous ovarian cancer ( hgsoc ) ( 1 ) . to study drug resistance in patient , we develop cloneseq-sv , which combine single-cell whole-genome sequencing ( 2 ) with targeted deep sequencing of clone-specific genomic structural variant in time-series cell-free dna . cloneseq-sv exploit tumour clone-specific structural variant a highly sensitive endogenous cell-free dna marker , enable the relative abundance measurement and evolutionary analysis of co-existing clonal population over the therapeutic time course . here , use this approach , we study 18 patient with hgsoc over a multi-year period from diagnosis to recurrence and show that drug resistance typically arise from selective expansion of a single or small subset of clone present at diagnosis . drug-resistant clone frequently show interpretable and distinctive genomic feature , include chromothripsis , whole-genome doubling , and high-level amplification of oncogene such a ccne1 , rab25 , myc and notch3 . phenotypic analysis of match single-cell rna sequence data ( 3 ) indicate pre-existing and clone-specific transcriptional state such a upregulation of epithelial-to-mesenchymal transition and vegf pathway , link to drug resistance . in one notable case , clone-specific erbb2 amplification affect the efficacy of a secondary targeted therapy with a positive patient outcome . together , our finding indicate that drug-resistant state in hgsoc pre-exist at diagnosis , lead to positive selection and reduced clonal complexity at relapse . we suggest these finding motivate investigation of evolution-informed adaptive treatment regimen to ablate drug resistance in future hgsoc study .	Nature	01/10/2025
10.1038/s41596-025-01259-0	report approval for transcranial electrical stimulation ( rate ) : expert recommendation base on a delphi consensus study .	Nejati V, Vaziri Z, Antal A, Antonenko D, Behroozmand R, Bestmann S, Brunelin J, Brunoni AR, Carvalho S, Davis NJ, Enticott PG, Fallgatter AJ, Ferrucci R, Fitzgerald PB, Hamada M, Hamilton RH, Hoy KE, Jaberzadeh S, Jamil A, Cohen Kadosh R, Krekelberg B, Laureys S, Romero Lauro LJ, Loo CK, Martin D, Martinotti G, Mondino M, Oliviero A, Pellicciari MC, Plewnia C, Pobric G, De Raedt R, Razza LB, Rocchi L, Salehinejad MA, Khorrami AS, Schecklmann M, Siebner HR, Taylor SF, Vanderhasselt MA, Vanneste S, Vicario CM, Woods AJ, Ziemann U, Nitsche MA	transcranial electrical stimulation ( te ) have gain substantial momentum a a research and therapeutic tool ; however , it suffer from challenge relate to reproducibility and quality assessment due to the absence of standardized reporting practice . here we aim to develop a comprehensive and consensus-based checklist for conduct and report te study to enhance the quality of research and report . in this consensus statement , we use a delphi approach conduct across three round and involve 38 expert to identify crucial element require to report in tes study . this consensus-driven approach include the evaluation of the interquartile deviation ( > 1.00 ) , the percentage of positive response ( above 60 % ) and mean importance rating ( < 3 ) , hence ensure the creation of a robust and well-balanced checklist . these metric be utilize to assess both the consensus reach and importance rating for each item . consensus be reach , lead to the retention of 66 out of the initial 70 item . these item be categorize into five group : participant ( 12 item ) , stimulation device ( 9 item ) , electrodes ( 12 item ) , current ( 12 item ) and procedure ( 25 item ) . we then distil a short version of the checklist , which include the 26 item deem essential . the report approval for transcranial electrical stimulation ( rate ) checklist be relevant to those carry out and assess te study , a it provide a structured framework for researcher to consider and report . for reviewer , it can serve a a tool to assess completeness , comprehensiveness and transparency of report . in addition , the rate checklist aim to promote a deep understanding of te and facilitates comparison between study within the field . overall , the rate checklist provide a shared reference point that may improve research quality , foster harmonization in reporting and , ultimately , enhance the interpretability and reproducibility of finding in both research and clinical context .	Nature protocols	03/10/2025
10.1186/s12943-025-02439-y	p23 act a a negative regulator of ferroptosis in nsclc by block gpx4 degradation via chaperone-mediated autophagy .	Chen J, Peng Y, Zhou M, Che Y, Zhao S, He C, Zhang W, Tian X, Zhang W, Liu Z, Zhou M, Liang G, Huo X, Wang Y, Yu Z, Ma X	ferroptosis have be identify a a tumor-inhibiting event in a variety of cancer ; however , it molecular basis in non-small cell lung cancer ( nsclc ) have not be completely elucidate . notably , glutathione peroxidase 4 ( gpx4 ) play a crucial role in ferroptosis . our previous research reveal that prostaglandin e synthase 3 ( p23 ) , a potential transcription factor , play a crucial role in promote cancer progression and metastasis through succinylation . our study reveal a previously unknown antiferroptotic function of p23 . mechanistically , p23 stabilizes gpx4 by competitively bind heat shock cognate 71 kda protein ( hsc70 ) to suppress chaperone-mediated autophagy ( cma ) activity , which subsequently inhibit ferroptosis and accelerate tumor growth . notably , impair p23 succinylation disrupt it interaction with hsc70 , restore cma-mediated gpx4 degradation . collectively , our finding suggest that target p23-regulated cma pathways represent a potentially viable strategy to modulate ferroptosis in nsclc .	Molecular cancer	02/10/2025
10.1158/2159-8290.CD-25-0947	epigenetic regulation of chromosomal instability by ezh2 methyltransferase .	Bai Y, Agustinus AS, Yomtoubian S, Meydan C, McNally DR, Yoffe L, Hubisz MJ, Tranquille M, Pramod S, Hong C, Plasilova ML, Kapoor AR, Singh A, Withers H, Dow LE, Laughney AM, Bhinder B, Elemento O, Melnick AM, Bakhoum SF, Mittal V	chromosomal instability ( cin ) and epigenetic reprogramming be central driver of breast cancer progression , yet the mechanism connect them remain elusive . we uncover a direct role of ezh2 histone methyltransferase in promote cin in triple-negative breast cancer ( tnbc ) . across breast cancer , ezh2 expression correlate with copy number alteration , and it catalytic activity be associate with increased cin in metastasis-initiating cell . pharmacological ezh2 inhibition suppress cin , reveal an unexpected vulnerability . integrate chromatin and transcriptome profiling identify tankyrase ( tnks ) , a poly ( adp-ribose ) polymerase , a a direct transcriptional target of ezh2 . mechanistically , ezh2-mediated tnks suppression disrupts cpap ( centrosomal p4.1-associated protein ) , drive centrosome overduplication , multipolar mitosis and exacerbate cin . in vivo , cin suppression be a critical mechanism underlie the anti-metastatic effect of ezh2 inhibition . these finding delineate a previously unrecognized epigenetic mechanism govern cin and establish ezh2 inhibitor a the first therapeutic agent capable of directly suppress cin , underscore the need for trial with metastasis-focused endpoint .	Cancer discovery	02/10/2025
10.1186/s12985-025-02928-y	human endogenous retrovirus ervk3-1 characterize a metabolically active and immunosuppressive subtype of liver cancer .	Wen X, Weng S, Chen M, Lin D, Xue W, Zeng D, Shen J	human endogenous retrovirus ( hervs ) , particularly the herv-k family , be increasingly recognize for their role in cancer biology , yet the function of ervk3-1 ( hervk_3p21.31 ) in liver hepatocellular carcinoma ( lihc ) remain largely unexplored . we analyze transcriptomic data from the tcga-lihc cohort to identify differentially express gene ( degs ) between high and low ervk3-1 expression group , follow by functional enrichment analysis ( go , kegg , gsea ) , protein-protein interaction ( ppi ) network construction , and hub gene identification . the immunological relevance of ervk3-1 be assess through tip immune cycle analysis , single-cell rna sequence datasets , and correlation with immune checkpoint expression . immunotherapy responsiveness be evaluate use tide and tcia database . high ervk3-1 expression be associate with enrichment in metabolic and oxidative stress-related pathway , while low expression correlate with cell cycle and dna replication . ppi analysis reveal mitosis-related hub gene ( e.g. , ccnb1 , cdk1 ) . ervk3-1 expression promote early immune cell recruitment but be inversely correlate with late stage of the cancer immunity cycle , include immune infiltration and t-cell killing . single-cell data show high ervk3-1 expression in immunosuppressive subset , alongside positive association with inhibitory immune checkpoint ( e.g. , pd-1 , ctla-4 , tim-3 ) . high ervk3-1 expression also correlate with great immune evasion and reduced immunotherapy responsiveness . ervk3-1 play a multifaceted role in lihc progression , contribute to metabolic reprogramming , immune suppression , and resistance to immunotherapy . these finding highlight ervk3-1 a a potential prognostic biomarker and therapeutic target in liver cancer .	Virology journal	01/10/2025
10.1016/S1470-2045(25)00345-6	assess pathological response to neoadjuvant therapy in renal cell carcinoma : a systematic review and guideline for sample and report standard from the international neoadjuvant kidney cancer consortium .	Blackmur JP, van der Mijn JCK, Warren AY, Browning L, Burgers F, Hirsch MS, Kapur P, Mehra R, Rao P, Signoretti S, Bex A, Stewart GD, van Montfoort ML, Jones JO	pathological response be a surrogate marker of efficacy of neoadjuvant therapy in various tumour type , but there be no consensus on report pathological response for renal cell carcinoma . we aim to assess the status of pathological response reporting in renal cell carcinoma and develop a recommendation on tissue preparation and response reporting for neoadjuvant treatment . we conduct a systematic review of publication on the pubmed and web of science database to identify manuscript report response to pre-surgical therapy in renal cell carcinoma . 119 eligible paper be identify . only five ( 4 % ) study include detail of how pathological response have be assess . qualitative statement on residual tumour be common ( 55 [ 46 % ] study ) , but only eight ( 7 % ) study use a quantitative assessment of pathological response . guideline for tissue preparation and pathological response reporting be review at an international workshop hold at the netherlands cancer institute in october , 2024 , and far develop through expert discussion . to assess neoadjuvant pathological response , nephrectomy specimen should be sample with the use of a standardised baseline approach with consideration for more extensive sampling . microscopic assessment should quantify the residual viable tumour in 10 % interval and great linear extent . clinical detail , include the neoadjuvant therapy receive , should accompany the pathological assessment . in this systematic review , we describe a standardised method for assessment and report pathological response , initially intend for use in clinical trial or research setting . these guideline will help investigator to assess whether the degree of pathological response be link to survival outcome and will inform future standard reporting practice .	The Lancet. Oncology	01/01/2045
10.1136/jitc-2025-012991	spatial transcriptomic profiling of metastatic renal cell carcinoma identify chemokine-driven macrophage and cd8+ t-cell interaction predictive of immunotherapy response .	Kalogirou C, Krebs M, Kunz AS, Hahn O, Kübler H, Schwinger M, Hartmann A, Schmieder A, Eckstein M	metastatic renal cell carcinoma ( mrcc ) still lack tissue-based biomarkers that predict benefit from first-line immune checkpoint inhibitor ( ici ) regimens . high-resolution spatial transcriptomics can dissect the tumor microenvironment ( tme ) and reveal prognostic niche invisible to bulk assay , offer a path toward precision immunotherapy . formalin-fixed , paraffin-embedded sample from 12 therapy-naïve patient with mrcc treat with ici-based combination be profile with 10x genomics visium and nanostring cosmx . six patient contribute matched metastatic lesion . cell-type deconvolution use robust cell type decomposition with a public single-cell rna-seq reference . clinical outcome ( mean follow-up 16.75 month ) be correlate with spatial feature . validation employ phase 2/3 javelin renal 101 as well a checkmate 010/025 transcriptomic data . spatial transcriptomics uncover pronounced divergence between primary tumor and metastasis in cellular composition and microarchitectural organization . canonical rcc molecular subtypes display marked intrapatient and interpatient spatial heterogeneity , underscoring limitation of bulk classification . five recurrent immune niche emerge across sample . one niche-rich in macrophage and cd8 ( + ) t cell and define by chemokine signaling-was closely associate with objective response in metastatic lesion yet absent or infrequent in matched primary . a gene signature reflect this niche stratify responder within the immuno-oncology ( io ) -treated arm of javelin 101 and checkmate 010/025 trial . on the other hand , signature derive from angiogenic tumor cell-rich niche define responder within the comparator arm ( tyrosine kinase inhibitor/everolimus ) in these trial . metastasis-specific immune niche , rather than primary-tumor characteristic , appear decisive for ici efficacy in mrcc . spatial transcriptomic profiling can identify these clinically relevant microenvironments and generate transferable gene signature , support biomarker-driven patient selection and trial design . integrate spatial tme analysis into future study may accelerate personalized immunotherapy strategy for mrcc .	Journal for immunotherapy of cancer	02/10/2025
10.1038/s41571-025-01075-1	optimize car t cell therapy for solid tumour : a clinical perspective .	Li J, Liu C, Zhang P, Shen L, Qi C	chimeric antigen receptor ( car ) t cell therapy be revolutionize the management of haematological malignancy but face particular hurdle in the treatment of solid tumour . in this review , we discuss important advance in refining car t cell therapy to provide practical clinical insight to address these challenge . we describe key strategy , include target antigen selection to enhance efficacy while minimize on-target , off-tumour toxicity ; early apheresis , rapid manufacturing and frontline application to preserve t cell fitness and ensure timely treatment ; lymphodepletion to augment car t cell expansion ; locoregional delivery to maximize local therapeutic concentration and reduce systemic toxicity ; and repeat infusion to prolong therapeutic effect . furthermore , we discuss advanced response evaluation frameworks that will be essential for accurate assessment of the efficacy of car t cell therapy , and we highlight the need for robust toxicity management approach to mitigate severe adverse event . by systematically address these multifaceted challenge , this review provide a comprehensive guide for the optimization of car t cell therapy for solid tumour to enhance both efficacy and safety .	Nature reviews. Clinical oncology	02/10/2025
10.1038/s41591-025-03918-x	genomically match therapy in advanced solid tumor : the randomized phase 2 rome trial .	Marchetti P, Curigliano G, Biffoni M, Lonardi S, Scagnoli S, Fornaro L, Guarneri V, De Giorgi U, Ascierto PA, Blandino G, D'Amati G, Aglietta M, Cremolini C, Conte P, Crimini E, Ceracchi M, Pisegna S, Verkhovskaia S, Bordonaro R, Bracarda S, Butturini G, Del Mastro L, DeCensi A, Fabbri A, Fenocchio E, Gori S, Metro G, Pessino A, Pozzessere D, Puglisi F, Tamberi S, Zambelli A, Marino D, Capoluongo E, Cappuzzo F, Cerbelli B, Giannini G, Malapelle U, Mazzuca F, Nuti M, Pruneri G, Simmaco M, Strigari L, Tonini G, Martini N, Botticelli A	despite recent advancement demonstrate the potential of tumor-agnostic biomarkers to guide effective therapy , randomize evidence support the clinical superiority of precision oncology approach compare to standard therapy remain limited . the rome trial be a multicenter , randomize , open-label phase 2 study compare tailor treatment ( tt ) to standard of care ( soc ) in patient with advanced solid tumor progress after one or two line of therapy . comprehensive genomic profiling on tissue and blood be perform to identify actionable alteration . overall response rate ( orr ) be the primary endpoint , and progression-free survival ( pfs ) , overall survival ( o ) , time to treatment failure ( ttf ) , time to next treatment ( ttnt ) and safety be the secondary endpoint . between november 2020 and august 2023 , 1,794 patient be screen , 897 be evaluate by the molecular tumor board ( mtb ) and 400 be randomize to tt or soc . tt achieve a significantly high orr ( 17.5 % versus 10 % ; p = 0.0294 ) and improve median pfs ( 3.5 month versus 2.8 month ; hazard ratio = 0.66 ( 0.53-0.82 ) , p = 0.0002 ) . tt also show superior 12-month pfs rate ( 22.0 % versus 8.3 % ) . median o be similar , with a 52 % crossover rate . grade 3/4 adverse event be also similar ( 40 % tt versus 52 % soc ) . these result highlight the potential of tt to improve outcome for patient with diverse actionable genomic alteration . these result also provide relevant evidence support a tumor-agnostic precision oncology strategy and highlight the potential of tt , guide by genomic profiling and mtb recommendation , to significantly improve outcome for patient with diverse actionable genomic alteration . clinicaltrials.gov identifier : nct04591431 .	Nature medicine	29/09/2025
10.1001/jamanetworkopen.2025.35343	cost-utility analysis of accelerate and standard strategy for renal replacement therapy initiation .	Round J, Akpinar I, Yan C, Patel N, van Katwyk S, Montgomery C, Wald R, Bagshaw SM	little be know about the long-term cost and outcomes related to strategy for timing of initiation of kidney replacement therapy ( krt ) in critically ill patient with severe acute kidney injury ( aki ) . to estimate the cost-utility and cost-effectiveness of accelerated krt initiation compare with standard krt initiation in critically ill patient with aki . design , set , in this economic evaluation , a state-transition model be develop use data from the standard v accelerate initiation of renal replacement therapy in aki ( starrt-aki ) trial , a multicenter , multinational randomize clinical trial of critically ill patient with severe aki conduct between october 2015 and september 2019. trial data be link to administrative health database in alberta , canada , to estimate cost and long-term clinical outcome . the model include 4 health state : no chronic kidney disease , severe chronic kidney disease , krt dependent , and dead . cost be report in 2024 canadian dollar . data be analyze from february 2022 to november 2024. initiation of krt . the primary outcome for the economic evaluation be cost per quality-adjusted life-year ( qaly ) gain . the qaly be a combined measure of patient quality of life and length of life . expect cost , qalys , incremental cost-effectiveness ratio ( icer ) , and incremental net monetary benefit ( inmb ) be estimate on the basis of 5000 monte carlo simulation . a total of 146 patient from the starrt-aki trial be include in the analysis , with 73 patient ( mean [ sd ] age , 59.67 [ 14.5 ] year ; 52 men [ 71.3 % ] ) randomize to receive accelerated initiation and 73 patient ( mean [ sd ] age , 61.88 [ 12.9 ] year ; 48 men [ 65.8 % ] ) randomize to receive standard initiation . standard initiation be more costly per patient than accelerate initiation ( mean [ sd ] , $ 251 370 [ $ 155 801 ] vs $ 231 518 [ $ 183 302 ] ) but generate more qalys ( mean [ sd ] 7.49 [ 2.03 ] qalys v 6.64 [ 1.76 ] qalys ) . the icer of standard initiation compare with accelerated initiation be $ 23 208 , with an inmb of $ 22 648 ( 95 % credible interval , $ 15 980- $ 29 316 ) when assume a willingness to pay per qaly of $ 50 000. the finding of this economic evaluation suggest that standard krt initiation may be cost-effective in a canadian setting , but this finding be sensitive to postdischarge cost trajectory and regional variation in krt dependence .	JAMA network open	01/10/2025
10.1038/s43587-025-00962-7	genome-wide analysis of brain age identify 59 associate locus and unveils relationship with mental and physical health .	Jawinski P, Forstbach H, Kirsten H, Beyer F, Villringer A, Witte AV, Scholz M, Ripke S, Markett S	neuroimaging and machine learning be advance research into the mechanism of biological age . in this field , 'brain age gap ' have emerge a a promising magnetic resonance imaging-based biomarker that quantify the deviation between an individual 's biological and chronological age of the brain . here we conduct an in-depth genomic analysis of the brain age gap and it relationship with over 1,000 health trait . genome-wide analysis in up to 56,348 individual unveil a heritability of 23-29 % attributable to common genetic variant and highlight 59 associate locus ( 39 novel ) . the lead locus encompasses mapt , encode the tau protein central to alzheimer 's disease . genetic correlation reveal relationship with mental health , physical health , lifestyle and socioeconomic trait , include depressed mood , diabetes , alcohol intake and income . mendelian randomization indicate a causal role of high blood pressure and type 2 diabetes in accelerated brain aging . our study highlight key gene and pathway relate to neurogenesis , immune-system-related process and small gtpase binding , lay the foundation for further mechanistic exploration .	Nature aging	03/10/2025
10.1093/jnci/djaf272	stratify lung adenocarcinoma risk with multi-ancestry polygenic risk score in east asian never-smokers .	Blechter B, Wang X, Dai J, Karsonaki C, Shi J, Shiraishi K, Choi J, Matsuo K, Chen TY, Hung RJ, Chen K, Shu XO, Kim YT, Choudhury PP, Williams J, Landi MT, Lin D, Zheng W, Yin Z, Zhou B, Wang J, Seow WJ, Song L, Chang IS, Hu W, Chien LH, Cai Q, Hong YC, Kim HN, Wu YL, Wong MP, Richardson BD, Li S, Zhang T, Breeze C, Wang Z, Bassig BA, Kim JH, Albanes D, Wong Sm JY, Shin MH, Chung LP, Yang Y, Zheng H, Dai H, Yatabe Y, Zhang XC, Kim YC, Caporaso NE, Chang J, Ho JCM, Daigo Y, Momozawa Y, Kamatani Y, Kobayashi M, Okubo K, Honda T, Hosgood HD, Kunitoh H, Watanabe SI, Miyagi Y, Matsumoto S, Horinouchi H, Tsuboi M, Hamamoto R, Goto K, Takahashi A, Goto A, Minamiya Y, Hara M, Nishida Y, Takeuchi K, Wakai K, Matsuda K, Murakami Y, Shimizu K, Suzuki H, Saito M, Ohtaki Y, Tanaka K, Wu T, Wei F, Machiela MJ, Kim YH, Oh IJ, Lee VHF, Chang GC, Chen KY, Su WC, Chen YM, Seow A, Park JY, Kweon SS, Gao YT, Liu J, Schwartz AG, Houlston R, Gorlov IP, Wu X, Yang P, Lam S, Tardon A, Chen C, Bojesen SE, Johansson M, Risch A, Bickeböller H, Ji BT, Wichmann HE, Christiani DC, Rennert G, Arnold SM, Brennan P, McKay J, Field JK, Davies MPA, Shete SS, Le Marchand L, Liu G, Andrew AS, Kiemeney LA, Zienolddiny-Narui S, Grankvist K, Cox A, Taylor F, Yuan JM, Lazarus P, Schabath MB, Aldrich MC, Jeon HS, Jiang SS, Chen CH, Hsiao CF, Hu Z, Burdett L, Yeager M, Hutchinson A, Hicks B, Liu J, Berndt SI, Wu W, Wang J, Li Y, Choi JE, Park KH, Sung SW, Kang CH, Wang WC, Xu J, Guan P, Tan W, Yu CJ, Yang G, Sihoe ADL, Choi YY, Park IK, Hung HH, Vermeulen RCH, Cheng I, Wu J, Tsai FY, Chan JKC, Li J, Lin HC, Liu J, Song B, Sawada N, Yamaji T, Wyatt K, Ma H, Zhu M, Wang Y, Qi T, Li X, Ren Y, Chao A, Iwasaki M, Zhu J, Wu G, Chen CY, ScD CC, Yang PC, Stevens VL, Fraumeni JF Jr, Lin K, Walters RG, Chen Z, Chatterjee N, Gorlova OY, Amos CI, Shen H, Hsiung CA, Chanock SJ, Rothman N, Kohno T, Lan Q, Zhang H	lung adenocarcinoma ( luad ) in never-smokers be a major public health burden , especially among east asian woman . polygenic risk score ( prss ) be promise for risk stratification but be primarily develop in european-ancestry population . we aim to develop and validate single- and multi-ancestry prss for east asian never-smokers to improve luad risk prediction . prss be develop use genome-wide association study summary statistic from east asian ( 8,002 case ; 20,782 control ) and european ( 2,058 case ; 5,575 control ) population . single-ancestry model include prs-25 , prs-ct , and ldpred2 ; multi-ancestry model include ldpred2+prs-eur128 , prs-csx , and ct-sleb . performance be evaluate in independent east asian data from the female lung cancer consortium ( flcca ) and externally validate in the nanjing lung cancer cohort ( njlcc ) . we assess predictive accuracy via auc , with 10-year and ( age 30-80 ) absolute risk estimate . the best multi-ancestry pr , use east asian and european data via ct-sleb ( clump and thresholding , super learning , empirical bayes ) , outperform the best east asian-only pr ( ldpred2 ; auc = 0.629 , 95 % 0.618,0.641 ) , achieve an auc of 0.640 ( 95 % ci : 0.629,0.653 ) and odds ratio of 1.71 ( 95 % ci : 1.61,1.82 ) per sd increase . njlcc validation confirm robust performance ( auc =0.649 , 95 % 0.623 , 0.676 ) . the top 20 % pr group have a 3.92-fold high luad risk than the bottom 20 % . far , the top 5 % pr group reach a 6.69 % lifetime absolute risk . notably , this group reach the average population 10-year luad risk at age 50 ( 0.42 % ) by age 41 , nine year earlier . multi-ancestry pr approach enhance luad risk stratification in east asian never-smokers , with consistent external validation , suggest future clinical utility .	Journal of the National Cancer Institute	01/10/2025
10.1080/09546634.2025.2563657	predictive factor for early super response to bimekizumab in 341 patient with psoriasis-a 24-week short-term multicenter real-life experience .	Çetinarslan T, Mergen MA, Türel Ermertcan A, Bülbül Başkan E, Yazıcı S, An İ, Gürel G, Adışen E, Demirbaş A, Dursun R, Aslancan B, Topkarcı Z, Esen M, Türkoğlu Z, Canat D, Kandiş S, Kılıç A, Ertam Sağduyu İ, Yazıcı EI, Gökyayla E, Demirel Öğüt N, Karstarlı Bakay ÖS, Temiz SA, Erdemir VA, Hapa FA, Aydin Ö, Hızlı P, Solak B, Bütüner M, Aytekin S, Albayrak H, Daye M, Türsen Ü, Sarıbaş Yıldırım AN, Cengiz Özyurt B	purpose/the efficacy of bimekizumab be show in moderate to severe plaque psoriasis . the aim of this study be to investigate the early super responder ( esr ) profile ( at week 4 ) to bimekizumab . we perform a multicenter retrospective study in 20 dermatology outpatient clinic in turkey . adult patient with moderate-to-severe psoriasis who be under bimekizumab for at least 12 week be enrol . a total of 341 adult patient be include . 136 have nail psoriasis ( 39.9 % ) , 148 have psoriatic arthritis ( psa ) ( 43.4 % ) , 223 ( 65.4 % ) have at least one difficult-to-treat area involvement , 155 ( 45.5 % ) be bio-naïve , 110 ( 32.5 % ) have ≥ 2 biologics history . at week 4 , pasi75 be achieve in 144 patient ( 49.8 % ) , pasi90 be achieve in 88 patient ( 30.4 % ) , pasi100 be achieve in 51 patient ( 17.6 % ) . family history ( p = 0.041 ) , palmoplantar involvement ( p = 0.008 ) , psa ( p = 0.097 ) , and bio-experienced status ( p = 0.060 ) be associate with low odds of be an esr , whereas each 1-point increase in baseline pasi be associate with significantly low odds of esr ( p < 0.001 ) . gender , age , disease duration , history of conventional systemic treatment , and presence of any comorbidity be not significantly associate with the likelihood of be an esr ( all p > 0.05 ) . bimekizumab be the effective treatment in both bio-naïve and bio-experienced patient ; however , it may have a more rapid onset of action in bionaive patient . further study be need on the long-term efficacy and safety data of bimekizumab .	The Journal of dermatological treatment	01/01/2025
10.1186/s12887-025-06161-y	a systematic review and meta-analysis of the treatment modality available for child afflict from cystic fibrosis .	Alruwaili TAM, Alanazi MF, Alruwaili BF, Fayed HK, Elsaeed M, Alnazi TD, Aljared A, Alanazi AMW, Alanazi AM, Alsharari SD, Alshammari A, Saad K	this study aim to evaluate the efficacy of different treatment modality in child with cystic fibrosis ( cf ) and determine the superiority of specific treatment modality . a comprehensive literature search be conduct use different search string across multiple database , include pubmed , cochrane library , embase , wos , scopus , cinahl , psycinfo , and google scholar , up to october 2024. randomized control trial ( rcts ) , case-control study and cohort study be include . the triple therapy indicate a significant reduction in cf-related complication , with an or of 0.29 and an rr of 0.54 , accompany by low heterogeneity ( i² = 0 % for both ) . physiotherapy and pulmonary exercise also yield a beneficial effect , with an or of 0.24 and an rr of 0.49 , without heterogeneity . in contrast , nutritional intervention reveal non-significant outcome ( or = 6.91 and rr = 2.63 ) , suggest the need to re-evaluate these strategy . ivacaftor alone do not achieve statistical significance ( or = 0.34 and rr = 0.58 ) , and the confidence interval be broad , indicate uncertainty in the effect estimate . azithromycin exhibit a positive effect on cf management , with an or of 2.37 and an rr of 1.54. the overall pool or across all treatment be 0.71 , with an rr not compute due to substantial heterogeneity ( i²=93 % ) . the study underscore the effectiveness of certain treatment , such a triple therapy and physiotherapy exercise , for cf while highlight the considerable variability in treatment outcome . notably , nutritional intervention need to be carefully reassess . the finding emphasize integrate physiotherapy and targeted pharmacological intervention into standard cf management tailor to individual need .	BMC pediatrics	03/10/2025
10.1016/j.jacc.2025.07.014	very high prevalence of nonoptimally control traditional risk factor at the onset of cardiovascular disease .	Lee H, Huang X, Khan SS, Son D, Lee HH, Kim EJ, Lloyd-Jones DM, Kim HC, Greenland P	recent study suggest that coronary heart disease ( chd ) may frequently occur in the absence of traditional cardiovascular disease ( cvd ) risk factor . however , it be unclear whether this could reflect missed clinical diagnosis or subthreshold nonoptimal risk factor exposure precede chd , and whether similar pattern be observe for heart failure ( hf ) or stroke . the purpose of this study be to determine the antecedent occurrence of nonoptimal level of 4 traditional risk factor ( blood pressure [ bp ] , cholesterol , glucose , and tobacco smoking ) before first chd , hf , or stroke . we analyze 2 population-based prospective cohort : knhis ( korean national health insurance service ) ( n = 9,341,100 ; baseline age ≥20 year ; follow-up , 2009-2022 ) and mesa ( multi-ethnic study of atherosclerosis ) ( n = 6,803 ; baseline age 45-84 year ; follow-up , 2000-2019 ) . among individual who develop incident chd , hf , or stroke during follow-up , we determine the prevalence of ≥1 traditional risk factor above optimal level-systolic bp ≥120 mm hg or diastolic bp ≥80 mm hg or bp-lowering treatment ; total cholesterol ≥200 mg/dl or lipid-lowering treatment ; fast glucose ≥100 mg/dl or diagnosis of diabetes or glucose-lowering treatment ; or past or current smoking-at any visit before cvd . analysis be base on 601,025 and 1,188 cvd event in knhis and mesa , respectively . prevalence of ≥1 nonoptimal risk factor be high ( 99.7 % and 99.6 % ) before chd , with similar pattern before hf ( 99.4 % and 99.5 % ) and stroke ( 99.3 % and 99.5 % ) in both knhis and mesa , respectively . prevalence of ≥1 risk factor before cvd be consistently high ( > 99 % ) across age group in both men and woman , with the low proportion observe for hf and stroke ( > 95 % ) when occur at age < 60 year in woman . prevalence of ≥2 risk factor be also common ( 93.2 % to 97.2 % ) before cvd event . in this binational study of 2 prospective cohort , the presence of nonoptimal level of ≥1 traditional risk factor be nearly universal before cvd . these result not only challenge claim that chd event frequently occur without antecedent major risk factor but also demonstrate that other cvd event , include hf or stroke , rarely occur in the absence of nonoptimal traditional risk factor , highlight the importance of primordial prevention effort .	Journal of the American College of Cardiology	07/10/2025
10.1038/s41467-025-63987-x	bacterial rna promotes proteostasis through inter-tissue communication in c. elegans .	Kyriakakis E, Medde C, Ritz D, Fucile G, Schmidt A, Spang A	life expectancy have be increase over the last decade , which be not match by an increase in healthspan . besides genetic composition , environmental and nutritional factor influence both health- and lifespan . diet be think to be a major factor for healthy ageing . here , we show that dietary rna specie improve proteostasis in c. elegans . inherent bacterial-derived double strand rna reduces protein aggregation in a c. elegans muscle proteostasis model . this beneficial effect depend on low level of systemic selective autophagy , the rnai machinery in the germline , even when the rna be deliver through ingestion in the intestine and the integrity of muscle cell . our data suggest a requirement of inter-organ communication between the intestine , the germline and muscle . our result demonstrate that bacterial-derived rna elicit a systemic response in c. elegans , which protect the animal from protein aggregation during ageing , which might extend healthspan .	Nature communications	01/10/2025
10.1016/j.ecoenv.2025.119155	decipher the carcinogenic role of benzo [ a ] pyrene in glioblastoma : insight from network toxicology , single-cell transcriptomics , and mendelian randomization .	Yi L, Wang W, Sun Z, Chen Y, Xiong Z, Ma L, Ye W, Li X	benzo [ a ] pyrene ( bap ) be a known environmental carcinogen link to multiple tumor , but it role in glioblastoma ( gbm ) remain poorly understood . this study aim to explore bap 's tumorigenic mechanism in gbm through an integrated approach combine network toxicology , single-cell transcriptomics , mendelian randomization , and bibliometric analysis . bap target gene be predict use chembl , sea , and pharmmapper , and gbm-related gene be retrieve from genecards , omim , and ttd . overlap gene be use to construct a protein-protein interaction network in cytoscape . molecular docking and molecular dynamic simulation be perform to assess bap-target interaction . single-cell rna-seq data ( gse131928 ) be analyze to profile gene expression in gbm subpopulation . mendelian randomization assess causal relationship between core gene and gbm risk , and finding be validate in vitro . bibliometric analysis track research trend on these gene . 31 overlap gene be identify . tp53 be highly express in mes-like and ac-like malignant cell as well a cd8⁺ tex cell . mr reveal a significant inverse association between tp53 expression and gbm risk ( or = 0.13 , 95 % 0.04-0.47 , p = 0.002 ) . dock and simulation show strong bap-tp53 binding , confirm by in vitro experiment . bibliometrics indicate that tp53 research in gbm have shift from basic mechanism to clinical translation . bap may drive gbm by target tp53 , offer insight for gbm prevention and therapy .	Ecotoxicology and environmental safety	01/10/2025
10.1200/JCO-25-01957	mosunetuzumab plus polatuzumab vedotin in transplant-ineligible refractory/relapsed large b-cell lymphoma : primary result of the phase 3 sunmo trial .	Budde LE, Zhang H, Kim WS, Maruyama D, Rego EM, Norasetthada L, Hong H, Ozcan M, Jeon YW, Cordeiro de Farias DL, Fogliatto LM, Pavlovsky A, Goto H, Olszewski AJ, Shah N, Hu B, Yin S, Wu H, To I, Ead WS, Ashby J, Janousek M, Pham S, Wang J, Kwan A, Batlevi CL, Wei MC, Westin J	prognosis for patient with refractory/relapsed large b-cell lymphoma ( lbcl ) consider ineligible for curative-intent therapy be poor . the combination of mosunetuzumab , a t-cell-engaging bispecific antibody , and polatuzumab vedotin , an antibody-drug conjugate , ( mosun-pola ) , represent a novel fixed-duration outpatient therapy . in the phase 3 sunmo trial , patient with refractory/relapsed lbcl who be ineligible for autologous stem cell transplant be randomize ( 2:1 ) to receive mosun-pola or rituximab , gemcitabine , and oxaliplatin ( r-gemox ) . dual primary endpoint be centrally-assessed overall response rate and progression-free survival . overall survival be a key secondary endpoint . a total of 208 patient be randomize to receive mosun-pola ( n=138 ) or r-gemox ( n=70 ) . at a median follow-up of 23.2 month , the primary analysis of sunmo demonstrate that the median progression-free survival be significantly longer with mosun-pola than with r-gemox ( 11.5 month [ 95 % confidence interval ( ci ) , 5.6-18 ] v 3.8 month [ 95 % ci , 2.9-4.1 ] ; hazard ratio for progression or death , 0.41 [ 95 % ci , 0.3-0.6 ] ; p < 0.0001 ) . overall response rate be significantly great with mosun-pola versus r-gemox ( 70 % vs 40 % ; p < 0.0001 ) , with a complete response rate of 51 % and 24 % , respectively . in the mosun-pola group , the rate of grade ≥2 cytokine release syndrome and usage of tocilizumab occur in less than 5 % of patient , and patient-reported outcome be improve compare with r-gemox . mosun-pola demonstrate superior efficacy verus r-gemox , with significant improvement in both overall response rate and progression-free survival , and infrequent cytokine release syndrome event with a manageable safety profile . ( fund by f. hoffmann-la roche ltd ; clinicaltrials.gov , nct05171647 ) .	Journal of clinical oncology : official journal of the American Society of	02/10/2025
10.2174/1874609809666151124233206	anesthesia issue in central nervous system disorder .	Mandal PK, Saharan S, Penna O, Fodale V	every year , million of people affect by disorder of the central nervous system ( cns ) undergo various diagnostic , therapeutic and surgical procedure require administration of anesthetic agent . anesthetic exert their anesthetic , amnesic and analgesic effect by act on multiple neuronal membrane protein in the cns . while some of the causal anesthetic target have be identify , a large number of anesthetic target remain unknown . the consequent longterm effect of anesthetic agent on expression of these various molecular target have be implicate in mediate potentially long-lasting adverse effect . recent work suggest that the effect of general anesthetic may not be entirely reversible , with animal study demonstrate persistent change in cns protein expression post recovery from anesthesia . age-associated or disease-induced alteration in the cns can profoundly alter multiple aspect of brain structure , biochemistry , and function . such maladaptive change in the brain can render it increasingly vulnerable to the effect of various anesthetic . the selection of appropriate anesthesia drug and protocol be mandatory , especially in individual with pre-existing cns disorder , so a to maximize anesthesia efficiency , avoid occurrence of adverse event , and ensure patient safety . this review aim to summarize and consider the effect and potential risk of commonly use anesthetic agent in patient with compromised cns function . we provide a comprehensive review of the establish as well a the implicated effect of anesthetic agent on the elderly as well a on the pathology and progression of common neurological condition .	Current aging science	01/01/2016
10.1016/j.cell.2025.08.038	multiscale proteomic modeling reveals protein network drive alzheimer 's disease pathogenesis .	Wang E, Yu K, Cao J, Wang M, Katsel P, Song WM, Wang Z, Li Y, Wang X, Wang Q, Xu P, Yu G, Zhu L, Geng J, Habibi P, Qian L, Tuck T, Li A, Tcw J, Roussos P, Brennand KJ, Haroutunian V, Johnson ECB, Seyfried NT, Levey AI, Bennett DA, Peng J, Cai D, Zhang B	the molecular mechanism underlie the pathogenesis of alzheimer 's disease ( ad ) , the most common form of dementia , remain poorly understood . proteomics offer a crucial approach to elucidate ad pathogenesis , a alteration in protein expression be more directly link to phenotypic outcome than change at the genetic or transcriptomic level . in this study , we develop multiscale proteomic network model for ad by integrate large-scale match proteomic and genetic data from brain region vulnerable to the disease . these model reveal detailed protein interaction structure and identify putative key driver protein ( kdps ) involve in ad progression . notably , the network analysis uncovers an ad-associated subnetwork that capture glia-neuron interaction . ahnak , a top kdp in this glia-neuron network , be experimentally validate in human induce pluripotent stem cell ( ipsc ) -based model of ad . this systematic identification of dysregulated protein regulatory network and kdps lay down a foundation for develop innovative therapeutic strategy for ad .	Cell	25/09/2025
10.1016/S2215-0366(25)00268-8	disease relapse , all-cause mortality , and adverse event associate with long-acting injectable antipsychotic versus oral antipsychotic in old people with schizophrenia in hong kong : a population-based within-subject analysis .	Wei Y, Yan VKC, Castle DJ, Huang C, Deng EK, Leung SM, Yiu HHE, Lee KJ, Lui SSY, Ng VWS, Hayes JF, Lai FTT, Wang H, Yan EWC, Chan EW	old individual ( age ≥65 year ) with schizophrenia be at increased risk of treatment non-adherence due to cognitive decline and complex polypharmacy . use of long-acting injectable ( lai ) antipsychotic in this population have not be systematically investigate . we aim to compare risk of disease relapse , all-cause mortality , and adverse event associate with lai versus oral antipsychotic among old people with schizophrenia . in this population-based within-subject analysis , we use territory-wide electronic health record from the clinical database analysis and report system of the hong kong hospital authority . individual diagnose with schizophrenia ( icd-9-cm code 295 ) in inpatient , outpatient , or emergency department setting between jan 1 , 1993 , and dec 31 , 2023 , be identify , and people age 65 year and old who be prescribe lai or oral antipsychotic between jan 1 , 2004 , and dec 31 , 2023 , be consider for inclusion . individual with incomplete demographic information be exclude . the primary outcome be disease relapse , define a hospital admission for schizophrenia . the secondary outcome comprise all-cause mortality and adverse event , include cardiovascular hospital admission , extrapyramidal symptom , acute liver injury , and acute kidney injury , which be identify use icd-9-cm code or laboratory test . a self-controlled case series study use poisson regression be conduct to compare the risk of disease relapse and adverse event between the treatment period of lai and oral antipsychotic . an individual-stratified cox regression be perform for all-cause mortality . time-varying confounders , include age , season , class of antipsychotic , covid-19 stringency index , and concomitant treatment with antidepressant , benzodiazepine or z-drugs , mood stabiliser , and antiparkinsonian drug , be adjust for . people with lived experience of schizophrenia be not involve in the design or conduct of the study . of 24 985 old individual with schizophrenia , 4696 ( 18·8 % ) be prescribe lai or oral antipsychotic . 10 655 ( 42·6 % ) of 24 985 individual be male and 14 330 ( 57·4 % ) be female . data on ethnicity be not available . compare with oral antipsychotic , lai antipsychotic be associate with statistically significantly low risk of hospital admission for schizophrenia ( incidence rate ratio [ irr ] 0·71 [ 95 % ci 0·64-0·78 ] , p < 0·0001 ) and all-cause mortality ( hazard ratio [ hr ] 0·23 [ 95 % ci 0·12-0·44 ] , p < 0·0001 ) . no statistically significant difference be find in cardiovascular hospital admission , acute liver injury , and acute kidney injury . lai antipsychotic be associate with increased risk of extrapyramidal symptom ( irr 2·17 [ 1·24-3·80 ] , p=0·0068 ) , but only with first-generation ( 2·86 [ 1·41-5·84 ] , p=0·0038 ) not second-generation lai antipsychotic . in old individual with schizophrenia , lai antipsychotic be associate with low risk of disease relapse and mortality , without increase risk of adverse event , than oral antipsychotic , except for elevated risk of extrapyramidal symptom specifically relate to first-generation lai antipsychotic . overall , lai antipsychotic , especially second-generation medication , could be more broadly consider for long-term use among this population , particularly at an early stage of disease . national natural science foundation of china .	The lancet. Psychiatry	30/09/2025
10.1016/j.cell.2025.08.037	decode alzheimer 's disease at the cellular level reveals promise combination therapy .	Coleman K, Tatonetti NP	alzheimer 's disease ( ad ) have long resist effective treatment due to it pathological heterogeneity and cell-type-specific regulatory change . in this issue of cell , li et al . leverage single-cell rna sequencing and drug repurposing to propose a promising combination therapy , validate through real-world evidence and mouse model , that target multiple ad-relevant cell type .	Cell	02/10/2025
10.1038/s41556-025-01773-z	microtubule architecture connect amot stability to yap/taz mechanotransduction and hippo signalling .	Vanni G, Citron A, Suli A, Contessotto P, Caire R, Gandin A, Mantovan G, Zanconato F, Brusatin G, Di Palma M, Peirano E, Pozzer LS, Albanese C Jr, Steiner RA, Cordenonsi M, Panciera T, Piccolo S	cellular mechanotransduction be a key informational system , yet it mechanism remain elusive . here we unveil the role of microtubule in mechanosignalling , operate downstream of subnuclear f-actin and nuclear envelope mechanic . upon mechanical activation , microtubule reorganize from a perinuclear cage into a radial array nucleate by centrosome . this structural rearrangement trigger degradation of amot protein , which we identify a key mechanical rheostat that sequester yap/taz in the cytoplasm . amot be stable in mechano-off but degrade in mechano-on cell state , where microtubule allow amot rapid transport to the pericentrosomal proteasome in complex with dynein/dynactin . this process ensure swift control of yap/taz function in response to change in cell mechanic , with experimental loss of amot protein render cell insensitive to mechanical modulation . ras/rtk oncogene promote yap/taz-dependent tumorigenesis by corrupt this amot-centred mechanical checkpoint . notably , the hippo pathway fine-tunes mechanotransduction : lats kinase phosphorylate amot , shield it from degradation , thereby indirectly restrain yap/taz . thus , amot protein stability serve a a hub link cytoskeletal reorganization and hippo signalling to yap/taz mechanosignalling .	Nature cell biology	01/10/2025
10.1186/s12974-025-03561-w	nlrp3 inflammasome and hearing loss : from mechanism to therapy .	Murillo-Cuesta S, Seoane E, Cervantes B, Zubeldia JM, Varela-Nieto I	the nlrp3 inflammasome , a key component of the innate immune system , have emerge a a central mediator of inflammation-driven sensorineural hearing loss ( snhl ) . this review synthesize current evidence on it involvement across a wide spectrum of auditory pathology , include genetic syndrome such a cap and autosomal dominant deafness ( dfna ) 34 , as well a noise-induced , age-related , drug-induced , and viral hearing loss . dysregulated activation of nlrp3 in the cochlea lead to the release of proinflammatory cytokine ( il-1b and il-18 ) and pyroptotic cell death , contribute to irreversible cochlear damage . experimental study have demonstrate that pharmacological inhibition of nlrp3 via agent such a mcc950 , oridonin and tranylcypromine can preserve auditory function . gain-of-function mutation in the nlrp3 gene be frequently associate with both syndromic and nonsyndromic hearing loss , and animal model express these mutation replicate cochlear inflammation and hearing deficit , validate their pathogenic role . clinically , il-1b signal blocker such a anakinra and canakinumab have show efficacy in caps patient , stabilize or improve hear outcome . emerge selective nlrp3 inhibitor , include dapansutrilo and mcc950 , be progress through early-phase clinical trial . additionally , natural compound such a piceatannol and oridonin have demonstrate otoprotective effect in preclinical model of noise- and drug-induced hearing loss . collectively , these finding position the nlrp3 inflammasome a a promising therapeutic target for snhl . future translational research should focus on validate nlrp3-targeting compound in human trial , identify biomarkers for early diagnosis , and explore combination therapy that integrate anti-inflammatory , antioxidant , and regenerative strategy . target nlrp3 may ultimately redefine treatment paradigm for prevent or halt progressive hearing loss .	Journal of neuroinflammation	04/10/2025
10.2196/jmir.6759	influence of pokémon go on physical activity : study and implication .	Althoff T, White RW, Horvitz E	physical activity help people maintain a healthy weight and reduce the risk for several chronic disease . although this knowledge be widely recognize , adult and child in many country around the world do not get recommended amount of physical activity . although many intervention be find to be ineffective at increase physical activity or reach inactive population , there have be anecdotal report of increased physical activity due to novel mobile game that embed game play in the physical world . the most recent and salient example of such a game be pokémon go , which have reportedly reach ten of million of user in the united state and worldwide . the objective of this study be to quantify the impact of pokémon go on physical activity . we study the effect of pokémon go on physical activity through a combination of signal from large-scale corpus of wearable sensor data and search engine log for 32,000 microsoft band user over a period of 3 month . pokémon go player be identify through search engine query and physical activity be measure through accelerometer . we find that pokémon go lead to significant increase in physical activity over a period of 30 day , with particularly engage user ( ie , those make multiple search query for detail about game usage ) increase their activity by 1473 step a day on average , a more than 25 % increase compare with their prior activity level ( p < .001 ) . in the short time span of the study , we estimate that pokémon go have add a total of 144 billion step to u physical activity . furthermore , pokémon go have be able to increase physical activity across men and woman of all age , weight status , and prior activity level show this form of game lead to increase in physical activity with significant implication for public health . in particular , we find that pokémon go be able to reach low activity population , whereas all 4 lead mobile health apps study in this work largely draw from an already very active population . mobile apps combine game play with physical activity lead to substantial short-term activity increase and , in contrast to many exist intervention and mobile health apps , have the potential to reach activity-poor population . future study be need to investigate potential long-term effect of these application .	Journal of medical Internet research	06/12/2016
10.1016/j.ccell.2025.09.003	sensory neuron drive pancreatic cancer progression through glutamatergic neuron-cancer pseudo-synapses .	Ren L, Liu C, Çifcibaşı K, Ballmann M, Rammes G, Mota Reyes C, Tokalov S, Klingl A, Grünert J, Goyal K, Neckel PH, Mattheus U, Schoeps B, Yıldızhan SE, Sezerman OU, Cevik NC, Sever EA, Karakas D, Safak O, Steiger K, Muckenhuber A, Görgülü K, Chen Z, Zhang J, Ye L, Maula Ali MI, Tiwari VK, Romanyuk N, Giesert F, Saur D, Rad R, Schmid RM, Algül H, Krüger A, Friess H, Ceyhan GO, Istvanffy R, Demir IE	cancer thrive on neuronal input . here , we demonstrate the presence of pseudo-synaptic connection between sensory nerve ending and cancer cell in an extracerebral cancer , i.e. , pancreatic ductal adenocarcinoma ( pdac ) . these synaptic site exhibit a selective enrichment of the glutamatergic n-methyl-d-aspartate receptor ( nmda ) receptor subunit nmdar2d ( grin2d ) on the cancer cell , which turn pdac cell responsive to neuron-derived glutamate and promotes tumor growth and spread . intriguingly , neuron transform a subset of co-cultured pdac cell into calcium-responsive cell via grin2d-type glutamate receptor at the neuron-cancer pseudo-synapses . we find that the expression of this subunit be due to the increase glutamate availability provide by sensory innervation in a neurotrophic feedforward loop . moreover , interference with the glutamate-grin2d signaling at these neuron-cancer pseudo-synapses markedly improve survival in vivo . this discovery of peripheral cancer-neuron pseudo-synapses may provide an opportunity for cancer-neuroscience-instructed oncological therapy .	Cancer cell	25/09/2025
10.1016/S2213-2600(25)00240-1	durvalumab , carboplatin , and etoposide in patient who be treatment-naive with extensive-stage small-cell lung cancer and poor performance status ( nej045a ) : a single-arm phase 2 trial .	Asao T, Saida Y, Watanabe S, Kisohara A, Kishi K, Morita R, Nakagawa T, Tsukita Y, Furuya N, Miyawaki T, Ishikawa N, Yamada T, Tanaka T, Morita S, Kikuchi T, Maemondo M, Kobayashi K	treat patient with extensive-stage small-cell lung cancer ( sclc ) with poor performance status pose considerable challenge . we aim to evaluate the combination of an immune checkpoint inhibitor with platinum-based therapy in this population . this open-label , single-arm phase 2 nej045a trial enrol untreated patient with extensive-stage sclc with performance status 2 or 3. participant receive four cycle of durvalumab , carboplatin , and etoposide , follow by durvalumab maintenance . a dose adjustment strategy be use , with initial reduction in carboplatin-etoposide dosage , subsequently adjust base on adverse event , allow for potential escalation . the primary endpoint be tolerability , assess by the proportion of patient complete induction therapy . a key secondary endpoint be 1-year survival rate . this trial be register at the japan registry of clinical trial ( jrcts031200319 ) and have be complete . between april 8 , 2021 , and oct 3 , 2023 , 57 patient ( performance status 2 n=43 and performance status 3 n=14 ) be enrol with a median age of 73·5 year ( iqr 69·0-77·5 ) , 44 ( 79 % ) of 56 be male . 26 ( 67 % ; 80 % ci 55·2-76·7 ; p < 0·0001 ) of 39 patient with performance status 2 and five ( 50 % ; 26·7-73·3 ; p=0·0088 ) of ten with performance status 3 complete induction therapy , exceed the pre-specified threshold . grade 3 or high adverse event occur in 52 ( 93 % ) of 56 patient , and 12 ( 21 % ) of 56 discontinued due to adverse event . the 1-year survival rate be 43·4 % ( 80 % ci 34·1-53·1 ) overall ( p < 0·0001 ) , 50·0 % ( 39·1-60·9 ) in performance status 2 ( p < 0·0001 ) , and 18·2 % ( 5·0-41·5 ) in performance status 3. durvalumab , carboplatin , and etoposide show tolerability and promise efficacy a a first-line treatment for patient with untreated extensive-stage sclc with poor performance status , support the integration of immune checkpoint inhibitor in this therapeutically challenging population . astrazeneca kk .	The Lancet. Respiratory medicine	28/09/2025
10.1016/j.chom.2025.09.009	immunometabolic reprogramming of macrophage by gut microbiota-derived cadaverine control colon inflammation .	de Oliveira Formiga R, Li Q, Zhao Y, Campos Ribeiro MA, Guarino-Vignon P, Fatouh R, Dubois L, Creusot L, Puchois V, Amouyal S, Alonso Salgueiro I, Bredon M, Chollet L, Ledent T, Scandola C, Auger JP, Danne C, Krönke G, Tkacz E, Emond P, Chevreux G, Pham HP, Pontoizeau C, Lamaziere A, Argüello RJ, Rolhion N, Michel ML, Wai T, Sokol H	cadaverine be a polyamine produce by the gut microbiota with link to health and disease , notably inflammatory bowel disease ( ibd ) . here , we show that cadaverine shape monocyte-macrophage immunometabolism in a context- and concentration-dependent fashion to impact macrophage functionality . at baseline , cadaverine be take up via l-lysine transporter and activate the thioredoxin system , while during inflammation , cadaverine signal through aconitate decarboxylase 1 ( acod1 ) -itaconate . both pathway induce activation of transcription factor , nuclear factor erythroid 2-related factor 2 ( nrf2 ) , which support mitochondrial respiration and promote immunoregulatory macrophage polarization . conversely , under high concentration , cadaverine act via histamine 4 receptor , lead to glycolysis-driven inflammation and pro-inflammatory function in macrophage . likewise , cadaverine exhibit paradoxical effect in experimental colitis , either protective or detrimental , evoke opposite fate on macrophage depend on level dictate by enterobacteriaceae . in ibd patient , elevate cadaverine correlate with high flare risk . our finding implicate cadaverine a a microbiota-derived metabolite manipulating macrophage energy metabolism with consequence in intestinal inflammation and implication for ibd pathogenesis .	Cell host & microbe	30/09/2025
10.3389/fimmu.2025.1666884	neutrophil-to-albumin ratio : a novel predictor of osteoporosis in rheumatoid arthritis .	Zhang Y, He Z, Li K, Wu Q, Wang S, Liu M, Liu Q, Xu Q, Kong X, Lin C	osteoporosis ( op ) frequently coexist with rheumatoid arthritis ( ra ) , but validate predictor of early risk be not extensively study . this study seek to examine the relationship between the neutrophil percentage-to-albumin ratio ( npar ) and the likelihood of develop ra-related op ( ra-op ) . after investigate the relationship between the npar and ra-op in the clinical retrospective study , we far validate this association use data from the national health and nutrition examination survey ( nhanes ) database ( 2005-2020 cycle ) . this retrospective study enrol 718 ra patient from the rheumatology department of the first affiliated hospital of guangzhou university of chinese medicine between january 2020 and december 2024. patient be categorize into low-npar ( < 1.7598 ) and high-npar ( ≥1.7598 ) group base on the median npar . extracted clinical data encompass demographic characteristic , comorbidities , serological marker , and other laboratory parameter . preliminary univariate and multivariate logistic regression analysis assess potential association between npar and ra-op , multi-model adjust logistic regression be subsequently apply to evaluate the independent association , subgroup analysis examine consistency across demographic and clinical stratum , receiver operating characteristic ( roc ) curve analysis assess npar 's diagnostic performance , and then restrict cubic spline ( rcs ) visualize potential non-linear relationship . finally use the identical statistical framework , we validate finding within the nhanes cohort . the high-npar group exhibit significantly high op incidence than the low-npar group ( 39.0 % vs. 26.5 % ; p < 0.001 ) . after full adjustment ( model 4 ) , npar remain independently associate with increased ra-op risk a a categorical variable ( high vs. low adjust or = 1.70 ( 95 % 1.01~2.88 ) ; p = 0.049 ) . subgroup analyse demonstrate no significant interaction effect ( p-interaction > 0.05 ) except for disease duration . the roc curve show an area under the curve ( auc ) of 0.58 ( 95 % 0.53~0.63 ) and npar cut-off of 1.886. the covariate-adjusted rcs indicate a linear dose-response relationship ( p overall=0.033 ; p nonlinearity=0.168 ) . nhanes cohort analysis independently validate both the npar-ra-op association and it linear characteristic . npar , serve a a novel composite biomarker integrate neutrophil-mediated inflammation and nutritional status ( via albumin ) , independently predict op risk in ra . it derivation from routine clinical parameter render npar a readily deployable , cost-effective tool for op risk stratification in clinical practice .	Frontiers in immunology	01/01/2025
10.1038/s41551-025-01525-2	targeted clearance of extracellular tau use aptamer-armed monocyte alleviate neuroinflammation in mouse with alzheimer 's disease .	Zhuo Y, Lu Y, Zhu Y, Wen N, Zou G, Lu H, Pei X, Zhang Y, Zhang Q, Wang X, Zhang W, Zhang Q, Wang Z, Xie S, Li CQ, Tan W, Qiu L	extracellular tau determine the progression of alzheimer 's disease , yet therapeutic strategy target it be hinder by poor brain delivery and limited clearance . here we develop a tau-clearing cell therapy base on monocyte functionalized with a high-affinity tau-specific aptamer . the aptamer be covalently conjugate to the surface of monocyte ( derive from bone marrow leucocyte and culture under monocyte-inducing condition ) via bioorthogonal chemistry without affect their viability or function . upon intravenous administration in mice express mutant and disease-relevant human tau , the engineered monocyte actively cross the blood-brain barrier and accumulate in tau-rich brain region such a the hippocampus and striatum . they efficiently phagocytosed extracellular tau , lead to a significant reduction in tau burden . a a result , glial activation be suppress , neuroinflammation be alleviate , and neuronal and mitochondrial integrity be preserve . long-term treatment improved memory and spatial learning , without induce toxicity or behavioural side effect . these result demonstrate that aptamer-guided monocyte can achieve target delivery , effective clearance and sustained neuroprotection , offer a promising strategy for therapeutic intervention in alzheimer 's disease .	Nature biomedical engineering	01/10/2025
10.1002/oby.70058	reason for discontinuation of obesity pharmacotherapy with semaglutide or tirzepatide in clinical practice .	Gasoyan H, Butsch WS, Casacchia NJ, Schulte R, Criswell V, Fox J, Renner H, Le P, Alpert J, Rothberg MB	this study aim to characterize the reason for treatment discontinuation with injectable semaglutide or tirzepatide for obesity in regular clinical practice . this cross-sectional study use electronic health record data between january 2022 and december 2024 from a single integrate health system in ohio and florida . the primary reason for treatment discontinuation be examine in a randomly select sample of adult with overweight or obesity and without type 2 diabetes who initiate injectable semaglutide or tirzepatide and discontinue treatment within the first year . we randomly select 288 patient ; 145 receive semaglutide and 143 tirzepatide . overall , 137 patient ( 47.6 % ) discontinue their medication due to cost or insurance-related issue , 42 ( 14.6 % ) due to inability to tolerate the side effect , 34 ( 11.8 % ) a they be unable to fill the medication due to shortage , 7 ( 2.4 % ) a they switch to a compounded medication , and 5 ( 1.7 % ) due to unsatisfactory weight loss ; 31 ( 10.8 % ) discontinue for other reason , and for 32 ( 11.1 % ) patient the discontinuation reason be not specify in the electronic health record . high cost or insurance-related issue be the most common reason for treatment discontinuation with semaglutide or tirzepatide for obesity . our finding highlight the need for policy to address cost and could inform discussion between healthcare provider and patient concern cost and side effect .	Obesity (Silver Spring, Md.)	02/10/2025
10.1016/j.ajcnut.2025.06.019	ultraprocessed food consumption , inflammatory index level , and risk of suicide attempt : finding from a prospective cohort study .	Wu Y, Sun M, Yuan Y, Zhang S, Zhu L, Lou Z, Shi Y, Li J, Sun Z, Yang L, Li L, Shen Y	suicide attempt ( sa ) be a major public health issue , with many case be preventable . however , the impact of dietary pattern remain inadequately study . currently , the rise consumption of ultraprocessed food ( upfs ) have be link to various health issue , include mental health disorder that may increase risk of sa . this study aim to investigate the association between upf consumption and sa , and explore the mediating role of sa-related inflammatory index level . this study include 208,938 participant from the uk biobank cohort , recruit from 2006 to 2010. cox proportional hazard model be use to assess the association between the weight proportion of upf intake and incident sa . substitution analysis be conduct to evaluate risk of sa when replace upf with unprocessed or minimally process food ( unpfs ) . causal mediation analysis be far conduct to estimate the mediating effect of inflammatory index level in this association . over a median follow-up of 13.1 y , 545 sa event be identify . compare with participant in the low quintile of upf consumption , those in the high quintile have a 1.63 time high risk of develop sa [ hazard ratio ( hr ) : 1.63 , 95 % confidence interval ( ci ) : 1.23 , 2.15 ] . additionally , each sd increase in upf consumption be associate with a 20 % high risk of sa ( 1.20 , 95 % 1.11 , 1.29 ) . notably , replace 20 % of upf weight with unpf be link to a 23 % reduction in sa risk ( 0.77 , 95 % 0.69 , 0.85 ) . furthermore , in causal mediation analysis , inflammatory index level mediate 0.7 % -1.5 % of the association between upf consumption and sa . high upf consumption be associate with an increase risk of sa , partially mediate by inflammatory index level . replace upf with unpf significantly reduce sa incidence , highlight potential benefit of transition to a diet with high unpf consumption .	The American journal of clinical nutrition	01/01/2025
10.1016/j.devcel.2025.09.009	tmk-pin1 drive a short self-organizing circuit for auxin export and signal in arabidopsis .	Huang R, Wang J, Chang M, Tang W, Yu Y, Zhang Y, Peng Y, Wang Y, Guo Y, Lu T, Cao Y, Zhou Y, Zhang Q, Huang Y, Wu A, Ren L, Gallei M, Dong J, Chen H, He J, Wen M, Friml J, Sun L, Xiong Y, Yang Z, Xu T	the versatile and pivotal role of the phytohormone auxin in regulate plant growth and development be typically link to it directional transport , rely on the polarize pin-formed ( pin ) auxin exporter at the plasma membrane ( pm ) . for decade , auxin have be propose to promote pin polarization , generate self-regulatory feedback mediate much of plant development , but mechanistic insight into this regulation be lack . here , we uncover an auxin-induced protein complex at the pm , contain auxin co-receptors transmembrane kinase ( tmks ) and pin1 auxin exporter , a the core machinery that underlie this feedback regulation . auxin promote pin1 phosphorylation by tmks , modulate pin1 polarization and transport activity . we also provide evidence that pin1-exported extracellular auxin be crucial for tmk activation and cell elongation , thus form the simple two-element self-regulatory feedback circuit . thus , these finding offer direct mechanistic insight into a potential self-organizing circuit for auxin signaling and transport to ensure proper plant development in arabidopsis .	Developmental cell	02/10/2025
10.1101/gad.8.10.1174	the dcc gene product in cellular differentiation and colorectal tumorigenesis .	Hedrick L, Cho KR, Fearon ER, Wu TC, Kinzler KW, Vogelstein B	the analysis of human colorectal tumor have reveal frequent loss of heterozygosity ( loh ) of the long arm of chromosome 18. a novel gene , dcc ( delete in colorectal cancer ) , locate within the region of loh on chromosome 18q be identify and have be implicate a a tumor suppressor gene . we have now show that dcc encode a membrane-bound protein of the immunoglobulin-cam family , a demonstrate by cell-surface labeling , immunohistochemical analysis , and sequencing of cdna clone . the dcc protein be find in axon of the central and peripheral nervous system and in differentiate cell type of the intestine . colorectal tumor that lose their capacity to differentiate into mucus produce cell uniformly lack dcc expression and loss of a chromosome 18q allele be often accompany by loss of dcc expression in colon tumor . these result provide evidence that dcc encode a cell surface-localized protein and emphasize the inverse relationship between differentiation and tumorigenesis .	Genes & development	15/05/1994
10.1186/s12943-025-02442-3	a circrna promote esophageal squamous cell carcinoma progression by inhibit trim25-mediated degradation of igf2bp family member .	Tan S, Ming Y, Guo J, Liu W, Ma H, Liu Y, Xu Z, Gu-Ha AL, Dai L, Lin YD, Peng Y	esophageal squamous cell carcinoma ( escc ) be a highly aggressive malignancy with poor prognosis and limited treatment option . while circular rna ( circrnas ) be frequently dysregulated in escc , their functional role and molecular mechanism in tumor progression remain largely unexplored . we characterize circrna use rt-pcr , sanger sequencing , and fluorescent in situ hybridization . gain- and loss-of-function study in vitro and in vivo be perform to assess circrna function . molecular interaction be investigate via rna pull-down assay couple with mass spectrometry , electrophoretic mobility shift assay , co-immunoprecipitation , and immunoblot analysis . clinical relevance be evaluate by rt-qpcr and immunohistochemistry in patient specimen . we identify circlnf , a novel circrna derive from the long non-coding rna firre gene , which be significantly upregulated in escc . functional assay demonstrate that circlnf promotes proliferative and migratory capacity in cultured cell and accelerate tumor progression and metastasis in animal model . mechanistically , circlnf directly interacts with igf2bp family protein through their `` cauc '' motif , protect them from trim25-mediated ubiquitination and proteasomal degradation . importantly , circlnf expression positively correlate with igf2bp1 protein level in escc patient tissue , underscore the clinical relevance of the circlnf-igf2bp axis in escc progression . our finding reveal an oncogenic role of circlnf in escc by inhibit trim25-mediated proteasomal degradation of igf2bp protein and highlight circlnf a a potential therapeutic target for escc .	Molecular cancer	03/10/2025
10.1038/s41467-025-63842-z	cross-ancestral gwas identifies 29 variant across head and neck cancer subsites .	Ebrahimi E, Sangphukieo A, Park HA, Gaborieau V, Ferreiro-Iglesias A, Diergaarde B, Ahrens W, Alemany L, Arantes LM, Betka J, Bratman SV, Canova C, Conlon MS, Conway DI, Cuello M, Curado MP, de Carvalho AC, de Oliviera JC, Gormley M, Hadji M, Hargreaves S, Healy CM, Holcatova I, Hung RJ, Kowalski LP, Lagiou P, Lagiou A, Liu G, Macfarlane GJ, Olshan AF, Perdomo S, Pinto LFR, Podesta JRV, Polesel J, Pring M, Rashidian H, Gama RR, Richiardi L, Robinson M, Rodriguez-Urrego PA, Santi SA, Saunders DP, Soares-Lima SC, Timpson N, Vilensky M, von Zeidler SV, Waterboer T, Zendehdel K, Znaor A, Brennan P, McKay J, Virani S, Dudding T	head and neck squamous cell carcinoma ( hnscc ) include diverse cancer arise in the oral cavity , oropharynx , and larynx , with the main risk factor be environmental exposure such a tobacco , alcohol , and human papillomavirus ( hpv ) infection . the genetic factor contribute to susceptibility across different population and tumour subsites remain incompletely understood . here we show , through a genome-wide association and fine mapping study of over 19,000 hnscc case and 38,000 control from multiple ancestry , 18 genetic risk variant and 11 signal from fine mapping of the human leukocyte antigen ( hla ) region , all previously unreported . rs78378222 , a regulatory variant for tp53 be associate with a 40 % reduction in overall hnscc risk . we also identify gene-environment interaction , with brca2 and adh1b variant show effect modify by smoke and alcohol use . subsite-specific analysis of the hla region reveals distinct immune-related association across hpv-positive and hpv-negative tumour . these finding refine the genetic architecture of hnscc and highlight mechanism link inherited variation , immunity , and environmental exposure .	Nature communications	02/10/2025
10.1016/j.cell.2025.09.005	evolution of mycobacterium tuberculosis transcription regulation be associate with increased transmission and drug resistance .	Culviner PH, Frey AM, Liu Q, Ha DTM, Thai PVK, Thu DDA, Quang NL, Calderon R, Lecca L, Caws M, Dunstan SJ, Murray MB, Thuong NTT, Fortune SM	mycobacterium tuberculosis ( mtb ) have co-evolved with human for thousand of year and be characterize by variation in virulence , transmissibility , and disease phenotype . to identify bacterial contributor to phenotypic diversity , we develop new rna sequencing ( rna-seq ) and phylogenomic tool to capture hundred of mtb isolate transcriptomes , link transcriptional and genetic variation , and find association between variant and epidemiologic trait . across 274 mtb clinical isolates , we uncover unexpected diversity in virulence gene expression , which we link to know and unknown regulator . surprisingly , we find that many isolates harbor variant associate with decreased expression of esxa ( esat6 ) and esxb ( cfp10 ) , which be virulence effector , dominant t cell antigen , and immunodiagnostic target . across > 55,000 isolates , these variant associate with increased transmissibility , especially in drug-resistant mtb strain . our data suggest expression of mtb virulence gene be evolve in response to drug-linked pressure , raise concern about use of these target in immunodiagnostics and next-generation vaccine .	Cell	30/09/2025
10.1038/s41586-025-09557-z	the panoptes system use decoy cyclic nucleotide to defend against phage .	Sullivan AE, Nabhani A, Izrailevsky DS, Schinkel K, Hoffman CRK, Robbins LK, Nagy TA, Duncan ML, Ledvina HE, Erbse AH, Kibby EM, Tak U, Dinh DM, Ednacot EMQ, Nguyen CM, Burroughs AM, Aravind L, Whiteley AT, Morehouse BR	bacteria combat phage infection use antiphage system and many system generate nucleotide-derived second messenger upon infection that activate effector protein to mediate immunity ( 1 ) . phage respond with counter-defences that deplete these second messenger , lead to an escalating arm race with the host . here we outline an antiphage system we call panoptes that indirectly detect phage infection when phage proteins antagonize the nucleotide-derived second-messenger pool . panoptes be a two-gene operon , optse , wherein opts be predict to synthesize a nucleotide-derived second messenger and opte be predict to bind that signal and drive effector-mediated defence . crystal structure show that opts be a minimal crispr polymerase ( mcpol ) domain , a version of the polymerase domain find in type iii crispr system ( cas10 ) . opts orthologues from two distinct panoptes system generate cyclic dinucleotide product , include 2',3'-cyclic diadenosine monophosphate ( 2',3'-c-di-amp ) , which we show be able to bind the soluble domain of the opte transmembrane effector . panoptes potently restrict phage replication , but phages that have loss-of-function mutation in anti-cyclic oligonucleotide-based antiphage signal system ( cbass ) protein 2 ( acb2 ) escape defence . these finding be unexpected because acb2 be a nucleotide 'sponge ' that antagonize second-messenger signalling . our data support the idea that cyclic nucleotide sequestration by acb2 release opte toxicity , thereby initiate inner membrane disruption , lead to phage defence . these data demonstrate a sophisticated immune strategy that bacteria use to guard their second-messenger pool and turn immune evasion against the virus .	Nature	01/10/2025
10.1158/0008-5472.CAN-25-0349	flt3-itd induces cmtm6 and enhances immune escape in acute myeloid leukemia .	Zwick M, Zinkel B, Spohr C, Rückert T, Halbach S, Shoumariyeh K, Scheid J, Baur AS, Braun LM, Angel M, Michaeli E, Todkar A, Nelde A, Märklin M, Holzmayer SJ, Dicks S, Boerries M, Duquesne S, Schlaak AE, Otto-Mora P, Bengsch B, Schiff M, Kissel S, Selle M, Follo M, Altmann H, Kunadt D, Illert AL, Walz JS, Walz G, Duyster J, Schetelig J, Brummer T, Zeiser R, Köhler N	fms-like tyrosine kinase-3 internal tandem duplication ( flt3-itd ) mutation be frequent in acute myeloid leukemia ( aml ) and be associate with a high risk of relapse . cklf-like marvel transmembrane domain contain member 6 ( cmtm6 ) stabilize pd-l1 surface expression and modulates tumor immunity in solid cancer . in this study , we find a role for flt3-induced cmtm6 in hematological malignancy . flt3 drove cmtm6 and pd-l1 expression in aml cell , while flt3 inhibition reduce expression of cmtm6 and pd-l1 . in three distinct allogeneic hematopoietic cell transplantation mouse model , transplantation of cmtm6 deficient flt3-itd+ leukemia cell result in prolonged survival , reduce leukemia burden , enhance t cell effector function , and decreased expression of t cell exhaustion marker compare to cmtm6 proficient flt3-itd+ leukemia cell . furthermore , combination therapy with anti-pd-l1 and tandutinib significantly improve survival , suppress leukemia cell expansion , and augment the anti-leukemia t cell response in mice bear flt3-itd+ leukemia . mechanistically , protein-protein interaction of flt3 and cmtm6 within their transmembrane domain , which be not phosphorylation dependent , enhance cmtm6 stability in leukemia cell , while flt3-itd do not increase cmtm6 and pd-l1 expression at the rna level . furthermore , cmtm6 upregulation and protein interaction with flt3 be validate in primary leukemia cell from two independent cohort of patient with flt3-itd+ aml . collectively , these finding uncover flt3-mediated stabilization of cmtm6 in aml cell , which result in enhanced pd-l1 cell surface expression and leukemia immune escape .	Cancer research	03/10/2025
10.3892/ijmm.2025.5651	the gut‑skin axis : emerge insight in understand and treat skin disease through gut microbiome modulation ( review ) .	Zhao Y, Yu C, Zhang J, Yao Q, Zhu X, Zhou X	emerge evidence indicate a significant association between the composition and functionality of the gut microbiome and various skin disorder , include psoriasis , atopic dermatitis , acne and several dermatological condition . the gut‑skin axis theory describe a complex bidirectional communication network between the gut and the skin , provide mechanistic insight into the pathogenesis of certain cutaneous disease . specifically , the gut microbiome influence skin health through the regulation of systemic immunity , inflammatory response and metabolic pathway . advance in high‑throughput sequencing and bioinformatics technology have substantially enhance the understanding of the role of the gut microbiome in skin pathology . clinical and preclinical study have demonstrate that restore gut microbial homeostasis via intervention such a faecal microbiota transplantation , probiotic and prebiotics can ameliorate symptom of skin disease . furthermore , personalize microbiome‑based therapy , next‑generation probiotic and dietary modification hold promise for refine gut‑skin interaction and advance precision medicine in dermatology . therapeutic strategy target the gut‑skin axis offer novel avenue for innovative dermatological treatment , with future breakthrough potentially involve microbial community engineering , postbiotics and artificial intelligence in microbiome‑related diagnostics . this narrative review summarize recent advance in gut‑skin axis research , explore it potential in the prevention and management of select dermatosis and discuss future trend and scientific development in the field .	International journal of molecular medicine	01/01/2025
10.1172/JCI190017	target specific kinase substrates rescue increase colitis severity induce by the crohn 's disease-linked lrrk2-n2081d variant .	Heaton GR, Li X, Li X, Zhou X, Zhang Y, Vu DT, Oeller M, Karayel O, Hoang QQ, Kars ME, Kamath N, Wang M, Tarassishin L, Mann M, Peter I, Yue Z	lrrk2 contain a kinase domain where the n2081d crohn 's disease ( cd ) risk and the g2019s parkinson 's disease ( pd ) pathogenic variant be locate . it be not clear how the n2081d variant increase cd risk or how these adjacent mutation give rise to distinct disorder . to investigate the pathophysiology of the cd-linked lrrk2 n2081d variant , we generate a knock-in ( ki ) mouse model and compare it effect with those of the lrrk2-g2019s mutation . lrrk2n2081d ki mouse demonstrate heightened sensitivity to induce colitis , result in more severe intestinal damage than in lrrk2g2019s ki and wt mouse . analysis of colon tissue reveal distinct mutation-dependent lrrk2 rab substrate phosphorylation , with significantly elevate phosphorylated rab10 level in lrrk2n2081d mouse . in cell , we demonstrate that the n2081d mutation activates lrrk2 through a mechanism distinct from that of lrrk2-g2019s . we also find that proinflammatory stimulation enhances lrrk2 kinase activity , lead to mutation-dependent difference in rab phosphorylation and inflammatory response in dendritic cell ( dc ) . finally , we show that knockout of rab12 , but not pharmacological lrrk2 kinase inhibition , significantly reduce colitis severity in lrrk2n2081d mouse . our study characterize the pathogenic mechanism of lrrk2-linked cd , highlight structural and functional difference between disease-associated lrrk2 variant , and suggest rab protein a promising therapeutic target for modulate lrrk2 activity in cd treatment .	The Journal of clinical investigation	01/10/2025
10.1038/s41564-025-02142-0	discovery and artificial intelligence-guided mechanistic elucidation of a narrow-spectrum antibiotic .	Catacutan DB, Tran V, Arnold A, Alexander J, Corso G, Yousefi Y, Tu MM, McLellan S, Tertigas D, Magolan J, Surette MG, Brown ED, Coombes BK, Barzilay R, Stokes JM	current clinical antibiotic be largely broad-spectrum agent that can alter the gut microbiome and promote colonization by enterobacteriaceae , which be often drug resistant . this include adherent-invasive escherichia coli ( aiec ) , particularly in patient with inflammatory bowel disease , in which dysbiosis create a niche for this pathogen to colonize . there be an urgent and unmet need for novel narrow-spectrum and microbiome-sparing antibiotic . here we screen 10,747 bioactive small molecule for antibacterial activity against aiec and discover enterololin , an antibacterial compound with targeted activity against enterobacteriaceae specie . enterololin could overcome intrinsic and acquire resistance mechanism in clinical isolates when combine with a subinhibitory concentration of spr741 , a polymyxin b analogue use here to increase outer membrane permeability in gram-negative bacteria . molecular substructure- and deep learning-guided mechanism-of-action investigation reveal that enterololin perturbs lipoprotein traffic through a mechanism involve the lolcde complex , laboratory-evolved resistant mutant predominantly map to lolc and lole , with an in vitro frequency of resistance of ~10 ( -8 ) to 10 ( -7 ) . enterololin show low mammalian cytotoxicity ( hek293 half-maximal inhibitory concentration ~100 µg ml ( -1 ) ) and suppress aiec infection in mouse model when administer in combination with spr741 , while largely preserve the overall microbiome composition . this study highlight the utility of deep learning method for predict molecular interaction and identify a promising enterobacteriaceae-specific antibacterial candidate for further development .	Nature microbiology	03/10/2025
10.3389/fimmu.2025.1635757	efficacy and safety of immune checkpoint inhibitor for advanced squamous non-small cell lung cancer : a systematic review and network meta-analysis .	Liu N, Zhang B, He J, Li S	significant efficacy heterogeneity exist between first- and second-line immunotherapy regimen for advanced squamous non-small cell lung cancer ( sqnsclc ) , but most regimen lack directly comparable clinical trial evidence , result in unclear prioritization . this analysis identify optimal treatment strategy by evaluate difference in efficacy across immune checkpoint inhibitor ( icis ) . we search through comprehensive database , include pubmed , embase , the cochrane library and the clinical trial database . traditional meta-analysis be do use stata 15.0 , while bayesian-framework network meta-analysis be implement with r 's gemtc package via markov chain monte carlo simulation . subgroup analysis be perform for different pd-l1 expression level , number of treatment , ethnic group , and smoke history . we include 25 randomize control trial . immune-related therapy can provide significant benefit relative to chemotherapy alone in advanced sqnsclc . compare with chemotherapy , except for ipilimumab+chemo [ hr = 0.92,95 % ( 0.59-1.40 ) ] , atezolizumab+chemo [ hr = 0.88 , 95 % ( 0.56-1.40 ) ] , and durvalumab+chemo [ hr = 0.84 , 95 % ( 0.52-1.40 ) ] , durvalumab+ tremelimumab+chemo [ hr = 0 . 88 , 95 % ( 0.54-1.40 ) ] , which significantly improve overall survival ( o ) . cemiplimab [ hr = 0.48 , 95 % ( 0.34-0.67 ) ] show the best os benefit . compare with chemotherapy , all immunotherapy significantly improve progression-free survival ( pfs ) except for ipilimumab+chemo [ hr = 0.87 , 95 % ( 0.75-1.00 ) ] . sugemalimab+chemo provide the best survival benefit [ hr = 0.34 , 95 % ( 0.24-0.48 ) ] . for pd-l1≥50 % tumor , penpulimab show excellent o and pfs ; for pd-l1 1-49 % tumor , pembrolizumab+chemo and camrelizumab+chemo achieve the best o and pfs , respectively ; for pd-l1≥1 % tumor , the tislelizumab+chemo and camrelizumab+chemo show the best o and pfs result , while for tumor with pd-l1 < 1 % , both nivolumab and serplulimab+chemo provide significant survival benefit . in asian patient , patient treat with pembrolizumab or pembrolizumab + chemotherapy have favorable o and pfs benefit . in non-asian patient , there be also favorable o and pfs benefit with cemiplimab . for former/current smoker , pembrolizumab+chemotherapy and camrelizumab+chemotherapy have significant o and pfs benefit , but most immunotherapy do not improve o and pfs in never smoker . camrelizumab+chemo [ or = 3.5 , 95 % ( 2.3-5.3 ) ] have the best overall response rate ( orr ) benefit . ipilimumab+chemo have the high incidence of adverse event ( aes ) [ or = 2.0 , 95 % ( 1.5-2.7 ) ] . http : //www.crd.york.ac.uk/prospero/ , identifier crd420251027447 .	Frontiers in immunology	01/01/2025
10.1016/j.jchf.2025.102660	semaglutide and exercise function in obesity-related hfpef : insight from the step-hfpef program .	Borlaug BA, Kitzman DW, Patel S, Chinnakondepalli KM, Butler J, Davies MJ, Petrie MC, Shah SJ, Verma S, Núñez J, Einfeldt MN, Liisberg K, Salsali A, Kosiborod MN	exercise function quantify by 6-minute walk distance ( 6mwd ) be severely impaired in patient with heart failure with preserved ejection fraction ( hfpef ) . this prespecified secondary analysis of pool data from the step-hfpef program ( research study to investigate how well semaglutide work in people live with heart failure and obesity ) examine factor associate with impaired exercise function at baseline , detailed effect of semaglutide on 6mwd , and on other key trial endpoint accord to baseline 6mwd in patient with hfpef . associate of 6mwd be assess at baseline , and effect of semaglutide on 6mwd be evaluate at early ( 20 week ) and final ( 52 week ) time point , across subgroup , and accord to the magnitude of weight loss achieve . effect of semaglutide on the dual primary ( change in kansas city cardiomyopathy questionnaire-clinical summary score [ kccq-css ] and body weight ) and secondary/exploratory endpoint be contrast by tertiles of baseline 6mwd . the author randomize 1,145 patient to semaglutide or placebo . compare with patient who have obesity-related hfpef and high 6mwd , those with low 6mwd be old and have low kccq-css , high body mass index and waist circumference , great systemic inflammation ( high c-reactive protein ) , and more severe congestion ( high n-terminal pro-b-type natriuretic peptide , more diuretic use ) . treatment with semaglutide increase 6mwd compare with placebo , an effect apparent at 20 week ( treatment difference 14.6 m [ 95 % 8.6-20.7 m ; p < 0.0001 ] ) that be maintain at 52 week ( treatment difference 17.1 m [ 95 % 9.2-25.0 m ; p < 0.0001 ] ) . increase in 6mwd with semaglutide ( vs placebo ) be similar across all relevant subgroup , with no significant interaction . treatment with semaglutide increase kccq-css and reduced body weight , reduce c-reactive protein , improve the hierarchical composite ( death , heart failure event , change in kccq-css and 6mwd ) , and reduce n-terminal pro-b-type natriuretic peptide across the spectrum of baseline 6mwd ( all p ( interaction ) = n ) . each 1-unit decrease in body mass index on treatment with semaglutide be associate with a 4.1 m ( 95 % 2.4-5.7 m ) increase in 6mwd ( p < 0.0001 ) . in patient with obesity-related hfpef , impaired 6mwd be most strongly associate with excess adiposity , congestion , and inflammation . semaglutide-mediated improvement in hf-related symptom , physical limitation , and exercise function be consistent across the spectrum of baseline 6mwd , observe as early a 20 week after the initiation of treatment , precede maximal weight loss . the effect be consistent across subgroup . there be strong correlation between great magnitude of weight loss and great improvement in 6mwd . ( research study to investigate how well semaglutide work in people live with heart failure and obesity [ step-hfpef ] , nct04788511 ; research study to look at how well semaglutide work in people live with heart failure , obesity and type 2 diabetes [ step-hfpef dm ] , nct04916470 ) .	JACC. Heart failure	03/10/2025
10.1016/j.cell.2025.09.004	functional rna split drive the evolutionary emergence of type v crispr-cas system from transposon .	Jin S, Zhu Z, Li Y, Zhang S, Liu Y, Li D, Li Y, Luo Y, Cheng Z, Zhao KT, Gao Q, Yang G, Li H, Liang R, Zhang R, Qiu JL, Zhang YE, Liu JG, Gao C	transposon-encoded tnpb nuclease give rise to type v crispr-cas12 effector through multiple independent domestication event . these system use different rna molecule a guide for dna targeting : transposon-derived right-end rna ( rernas or omega rna ) for tnpb and crispr rna for type v crispr-cas system . however , the molecular mechanism bridge transposon activity and crispr immunity remain unclear . we identify trancs ( transposon-crispr intermediate ) derive from distinct is605- or is607-tnpb lineage . trancs utilize both crispr rna and rernas to direct dna cleavage . the cryoelectron microscopy ( cryo-em ) structure of latranc from lawsonibacter sp . closely resemble that of the isdra2 tnpb complex ; however , unlike a single-molecule rerna , the latranc guide rna be functionally split into a tracrrna and crrna . an engineered rna split of isdra2 tnpb enable activity with a crispr array . these finding indicate that functional rna splitting be the primary molecular event drive the emergence of diverse type v crispr-cas system from transposon .	Cell	29/09/2025
10.11477/mf.1416202125	[ a case of coexistent persistent trigeminal and hypoglossal artery manifest with neurovascular compression syndrome by hypertension ] .	Asayama K, Hayashi K, Kanai Y, Tahara N, Kato Y, Abe S, Mitaki S, Nagai A	a 70-year-old woman visit our hospital with hypertension , diplopia , and right orbital pain . neurological examination reveal right ophthalmoplegia . ct angiography and mri identify a right persistent trigeminal artery ( pta ) , right persistent hypoglossal artery , and bovine aortic arch . the right internal carotid artery ( ica ) be displace laterally in the cavernous sinus due to the bifurcation of the pta . compression of the right oculomotor nerve , right trochlear nerve , and first division of the right trigeminal nerve by the elongated right ica be note and consider a potential cause of the ophthalmoplegia and orbital pain . symptom improve with normalization of blood pressure . during embryonic development , the right posterior communicate artery and bilateral vertebral artery be aplastic or hypoplastic , which suggest that these carotid-basilar anastomosis may have remain a supply route to provide sufficient blood flow to the posterior cerebral circulation . this be an extremely rare case of embryological implication manifest with neurovascular compression syndrome . ( receive 6 january , 2022 ; accept 17 february , 2022 ; publish 1 june , 2022 ) .	Brain and nerve = Shinkei kenkyu no shinpo	01/01/2021
10.1016/j.lanhl.2025.100764	aspirin and healthy lifespan in old people : main outcome of the aspree-xt observational study .	Shah RC, Ryan J, Webb KL, Wolfe R, Chan A, Chong TT, Ernst ME, Espinoza SE, Flynn O, Lee SY, McNeil J, Nelson MR, Orchard SG, Reid CM, Sheets K, Stocks NP, Weerasinghe NS, Wilson ME, Woods RL, Murray AM	in the aspirin in reduce event in the elderly ( aspree ) clinical trial , low-dose aspirin be not associate with survival free of dementia and persistent physical disability ( a measure of a healthy lifespan ) ; however , there be a small increased risk of death . give the long pre-clinical phase of many age condition , we aim to examine the legacy effect ( post-trial ) and the longer-term effect of aspirin versus placebo through extend follow-up in the aspree-xt observational study . between march 10 , 2010 , and dec 24 , 2014 , 19 114 community-dwelling people in australia and the usa , age predominantly 70 year and old , be randomly assign to low-dose aspirin or placebo for a median of 4·7 year a part of the aspree trial . post-trial observational follow-up continue for a median of 4·3 year ( iqr 4·1-4·6 ) . all component of the primary endpoint ( ie , incident dementia , persistent physical disability , and death ) be adjudicate by masked expert panel . analysis use cox proportional hazard model with intention-to-treat . 15 633 participant ( 8836 [ 56·5 % ] be woman , 6797 [ 43·5 % ] be men ; 981 [ 6·3 % ] be not white ) be eligible for and agree to observational follow-up . there be no effect of randomisation to aspirin ( 34·37 event per 1000 person-years ) versus placebo ( 33·68 per 1000 person-years ) on the primary endpoint ( hazard ratio [ hr ] 1·02 ; 95 % ci 0·94-1·11 ; p=0·63 ) in the aspree-xt period . similarly , over the period of both aspree and aspree-xt , no long-term effect of aspirin versus placebo be observe on the composite outcome of death , dementia , or persistent physical disability over almost a decade of follow-up ( hr 1·01 ; 95 % ci 0·95-1·08 ; p=0·65 ) , include no long-term effect on death ( 1·06 ; 0·99-1·14 ; p=0·10 ) . no effect of aspirin on incident major haemorrhagic event a compare with placebo be find in aspree-xt ; however , aspirin be associate with an increase hazard for incident major haemorrhagic event across both aspree and aspree-xt ( 1·24 ; 1·10-1·39 ) . low-dose aspirin do not appear to be effective in promote a healthy lifespan in initially healthy , community-dwelling old people . national institute on age and the national cancer institute ( usa ) .	The lancet. Healthy longevity	27/08/2026
10.1038/s41586-025-09560-4	efferocytic remodelling of pancreatic islet macrophage by limited β-cell death .	Zakharov PN, Chowdhury CS, Peterson OJ, Barron B, Vomund AN, Gorvel L, Unanue ER, Klechevsky E, Wan X, Ravichandran KS	the primary driver of type i diabetes be the autoimmune t cell that destroy insulin-producing β-cells within the islet of langerhans in the pancreas ( 1 ) . pancreatic islet macrophage have also be variably link to disease onset and progression . a macrophage-mediated removal of die cell through efferocytosis regulates tissue homeostasis and immune response ( 2 ) , here we investigate how efferocytosis by intra-islet macrophage influence the immune environment of pancreatic islet . use a series of complementary omics-based and functional approach , we identify a subset of anti-inflammatory intra-islet efferocytic macrophage ( e-mac ) within the pancreas of mouse and human . when limited β-cell apoptosis be induce in vivo in wild-type c57bl/6 mouse and diabetic-prone nod mouse , islet macrophage adopt this e-mac phenotype without an apparent increase in the total number of intra-islet macrophage . such limited β-cell apoptosis and increase in e-mac number lead to long-term suppression of autoimmune diabetes in nod mouse . this e-mac phenotype could also be recapitulate ex vivo by co-culturing macrophage with apoptotic β-cells . mechanistically , the e-mac-enriched population impart an anergic-like state on cd4 ( + ) t cell ex vivo and promoted accumulation of such anergic-like cd4 ( + ) t cell in vivo within the islet . analyse macrophage-t cell interaction within pancreatic islet use nichenet and target experimental validation , we identify the igf-1-igf1r axis a a contributor to the anergic-like t cell phenotype in the islet . collectively , these data advance a concept that efferocytosis-associated reprogramming of the islet macrophage and the subsequent influence on the adaptive immune response could be beneficial in modulate diabetic autoimmunity .	Nature	01/10/2025
10.1016/S0140-6736(25)01148-1	oral iptacopan therapy in patient with c3 glomerulopathy : a randomised , double-blind , parallel group , multicentre , placebo-controlled , phase 3 study .	Kavanagh D, Bomback AS, Vivarelli M, Nester CM, Remuzzi G, Zhao MH, Wong EKS, Wang Y, Krishnan I, Schuhmann I, Trapani AJ, Webb NJA, Meier M, Israni RK, Smith RJH	c3 glomerulopathy be an ultra-rare , severe form of glomerulonephritis cause by overactivation of the alternative complement pathway . we aim to assess efficacy and safety of iptacopan ( lnp023 ) , an oral , proximal complement inhibitor that target factor b to selectively inhibit the alternative pathway of the complement cascade . appear-c3g be a multicentre , randomise , double-blind , placebo-controlled , phase 3 study of iptacopan versus placebo ( both in addition to supportive care [ renin-angiotensin-aldosterone system ( raas ) inhibitor ] and immunosuppression ) . adult participant ( age 18-60 year ) with biopsy-confirmed c3 glomerulopathy be enrol from 35 hospital or medical centre in 18 country . inclusion criterion include reduced serum c3 concentration ( ie , < 77 mg/dl [ define a < 0·85 × low limit of the central laboratory normal range ] ) at screening , urine protein-creatinine ratio ( upcr ) of 1·0 g/g or high at day -75 and day -15 before randomisation , estimate glomerular filtration rate ( egfr ) of 30 ml/min per 1·73 m ( 2 ) or high at screening and day -15 , and vaccination against neisseria meningitidis and streptococcus pneumoniae . all eligible participant be randomise 1:1 via interactive response technology to either the iptacopan or the placebo group , stratify by treatment with corticosteroid , mycophenolic acid , or both ( yes or no ) . during the 6-month double-blind period , participant orally receive either iptacopan 200 mg twice daily or placebo ; this be follow by a 6-month open-label period in which all participant receive iptacopan 200 mg twice daily . the primary endpoint be relative reduction in proteinuria ( measure by log-transformed ratio to baseline in upcr sample from a 24-h urine collection ) at 6 month . the primary analysis be do in the full analysis set ( ie , all participant to whom study treatment be assign by randomisation ) ; all participant who receive at least one dose of study treatment be include in the safety analysis . this trial be register with clinicaltrials.gov ( nct04817618 ) and the adult cohort have be complete . between july 28 , 2021 , and feb 15 , 2023 , 132 participant be screen , of whom 58 do not complete the screening period and 74 ( 64 % male ; 69 % white ) be randomise 1:1 to receive either iptacopan ( n=38 ) or placebo ( n=36 ) . one participant in the placebo group discontinue treatment during the open-label period . the 24-h upcr percentage change relative to baseline at 6 month be -30·2 % ( 95 % ci -42·8 to -14·8 ) in the iptacopan group and 7·6 % ( -11·9 to 31·3 ) in the placebo group . in the iptacopan group , the geometric mean of 24-h upcr be 3·33 g/g ( 95 % ci 2·79 to 3·97 ) at baseline and 2·17 g/g ( 1·62 to 2·91 ) at 6 month ; in the placebo group , this be 2·58 g/g ( 2·18 to 3·05 ) at baseline and 2·80 g/g ( 2·37 to 3·30 ) at 6 month . the primary endpoint be meet with a relative reduction in 24-h upcr at 6 month for iptacopan versus placebo of 35·1 % ( 13·8 to 51·1 ; p=0·0014 ) . 30 ( 79 % ) of 38 participant in the iptacopan group have treatment-emergent adverse event , compare with 24 ( 67 % ) of 36 participant in the placebo group ; most of these be of mild or moderate severity . there be no death , no treatment discontinuation due to treatment-emergent adverse event , and no meningococcal infection . serious adverse event be report in three ( 8 % ) participant in the iptacopan group and one ( 3 % ) participant in the placebo group . iptacopan show a statistically significant , clinically meaningful proteinuria reduction in addition to raas inhibitor and immunosuppression at 6 month . iptacopan be well tolerate with an acceptable safety profile in patient with c3 glomerulopathy . novartis pharma .	Lancet (London, England)	25/09/2025
10.1038/s41392-025-02415-4	multiple sclerosis : molecular pathogenesis and therapeutic intervention .	Boutitah-Benyaich I, Eixarch H, Villacieros-Álvarez J, Hervera A, Cobo-Calvo Á, Montalban X, Espejo C	multiple sclerosis be a chronic immune-mediated disorder of the central nervous system characterize by demyelination , axonal loss , and neuroinflammation , culminate in progressive neurological disability . despite significant advance in understand it immunopathogenesis , current immunotherapy remain limited in their ability to halt disease progression , make multiple sclerosis incurable and highlight the critical need for novel therapeutic strategy . antigen-specific immunotherapy represent a groundbreaking approach that aim to restore immune tolerance to myelin-derived antigen while preserve the protective function of the immune system . unlike broad immunosuppressive strategy , antigen-specific immunotherapy offer the potential for highly targeted modulation of pathogenic immune response , reduce off-target effect and enhance safety profile . over the last two decade , preclinical study and clinical trial have explore diverse antigen-specific immunotherapy modality , range from peptide-based vaccine to nanoparticle platform , each aim at achieve durable tolerance in multiple sclerosis . this review provide a comprehensive overview of multiple sclerosis , cover it etiology , clinical feature , pathogenesis , pathology , and current therapeutic approach . thus , it delve into the current state of antigen-specific immunotherapy research , critically examine it success and limitation while address the translational challenge that must be overcome to realize it therapeutic potential . by integrate insight from immunology , biotechnology , and translational medicine , we propose direction for advance antigen-specific approach in the quest for transformative multiple sclerosis therapy .	Signal transduction and targeted therapy	02/10/2025
10.1002/advs.202503691	single cell and spatial transcriptomics define a proinflammatory and profibrotic niche after kidney injury .	Li L, Liao J, Zhang Y, Yao Z, Huang J, Wu K, Li L, Peng Y, Zhu H, Hong X, Liu X, Zhou L, Hou FF, Fu H, Liu Y	kidney fibrosis be the common outcome of chronic kidney disease ( ckd ) . it often instigate in the focal site by form the fibrogenic niche after injury . in this study , use single-cell rna sequencing ( scrna-seq ) and a spatial transcriptomic ( st ) approach , the cellular heterogeneity , spatial organization , and molecular interaction be delineate in the fibrotic kidney . through analysis of the scrna-seq and st data from normal and fibrotic kidney in mouse subject to unilateral ischemia-reperfusion injury , a tenascin c ( tnc ) -enriched , proinflammatory , and profibrotic microenvironment be identify that facilitated macrophage activation and promote renal inflammation and fibrosis . both tnc-enriched decellularized kidney tissue scaffold and exogenous tnc protein promote bone marrow-derived macrophage activation though toll-like receptor 4 ( tlr4 ) /nf-κb signal . either pharmacological inhibition of tlr4 signal or genetic knockout of it gene alleviate renal inflammation and fibrosis by inhibit macrophage activation in vivo . finally , chimeric mouse that receive bone marrow transplantation from tlr4-deficient donor be protect against kidney inflammation and fibrosis . these result suggest that tnc play a crucial role in orchestrate the formation of a proinflammatory and profibrotic niche that promote renal inflammation and fibrosis by activate macrophage via tlr4/nf-κb signaling . the finding underscore the complex interplay among fibroblast , extracellular microenvironment , and macrophage that drive kidney fibrosis .	Advanced science (Weinheim, Baden-Wurttemberg, Germany)	03/10/2025
10.1186/s13063-025-09038-8	early implantation of a transjugular intrahepatic portosystemic shunt ( tip ) in patient with liver cirrhosis and ascites ( etips ) : a multicentre , randomise control trial .	Bettinger D, Janoschke M, Jenkner C, Kaufmann M, van Gessel J, Otter HH, Schultheiss M, Thimme R	portal hypertension be a major complication in patient with liver cirrhosis , lead to severe outcome such a variceal bleeding and ascites . transjugular intrahepatic portosystemic shunt ( tip ) have emerge a an effective interventional treatment of recurrent ascites and variceal bleeding . however , up to 30 % of patient with recurrent ascites show tips refractory ascites , and prior data have show that the frequency of paracenteses before tip implantation predict ascites clearance indicate that tip implantation may be too late in some patient . especially , patient with grade 2 ascites and a meld score ≥ 15 , or grade 3 ascites irrespective of meld score at first decompensation with ascites face a high risk of further decompensation and mortality . therefore , these patient may benefit from early tip implantation in order to improve post-tips mortality . we hypothesise that early tip implantation in these select patient at the time of the first decompensation may improve transplantation-free survival compare to standard medical treatment ( smt ) . the etips study be a prospective , randomise , open , multicenter interventional , superiority trial . patient will be randomise 1:1 in the intervention group with tip implantation and in the smt group . the primary endpoint be transplantation-free survival . secondary endpoint include the time to ascites with need for paracentesis and quality of life assess six and 12 month after randomisation . expand the concept of early tip implantation to ascites management may offer significant survival benefit and may significantly change the treatment algorithm of patient with ascites . german registry for clinical study drks00034545 . register on 20/02/2025 . clinical trial nct06576934 . register on 04/12/2024 .	Trials	02/10/2025
10.1001/jamanetworkopen.2025.35200	acute surgery vs conservative treatment for traumatic acute subdural hematoma .	Van Essen TA, Yue JK, Barber J, Lingsma HF, Pisica D, den Boogert HF, van Dijck JT, Moojen WA, Hutchinson P, Markowitz AJ, Steyerberg EW, Okonkwo DO, Bodien YG, Valadka AB, Diaz-Arrastia R, Robertson CS, Foreman B, Wang VY, McCrea MA, Giacino JT, Yuh EL, de Ruiter GCW, Temkin NR, Maas AIR, Peul WC, Manley GT	it be unclear whether perform surgery for most patient with an acute subdural hematoma ( asdh ) and traumatic brain injury ( tbi ) be superior to conservative treatment . to compare the effectiveness of a strategy prefer acute surgical asdh evacuation with one prefer initial conservative treatment . design , set , this comparative effectiveness study use data from february 1 , 2014 , to july 31 , 2018 , from the prospective observational transforming research and clinical knowledge in traumatic brain injury study , conduct at 18 level 1 trauma center in the u . the study include patient with nonpenetrating tbi present to the emergency department and admit within 24 hour after injury with asdh detect on acute head compute tomography scan . statistical analysis be perform from december 1 , 2022 , to december 20 , 2024. acute surgical hematoma evacuation vs initial conservative treatment , compare outcome between center accord to treatment preference , measure by the case mix-adjusted probability of undergo acute surgery ( vs conservative treatment ) per center . functional disability at 6 month be assess with the glasgow outcome scale-extended at 6 month , analyze with ordinal logistic regression adjust for prespecified confounders , quantify with a common odds ratio ( or ) . variation in center preference be quantify with a median or ( mor ) . of 2697 include patient , 711 ( mean [ sd ] age , 46.5 [ 19.4 ] year ; 539 men [ 76 % ] ) have an asdh , of whom 148 ( 21 % ) underwent acute cranial surgery and 563 ( 79 % ) underwent initial conservative treatment . the acute surgery cohort have low mean ( sd ) glasgow coma scale score ( 6.8 [ 4.4 ] v 11.4 [ 4.6 ] ) , more pupil abnormality ( both pupil unreacting : 43 of 133 [ 32 % ] vs 41 of 477 [ 9 % ] ) , and few isolate asdhs ( eg , more with concurrent intracranial lesion ; 92 of 133 [ 69 % ] vs 297 of 563 [ 53 % % ] ) compare with the conservative treatment cohort . in the surgical cohort , 129 of 148 patient ( 87 % ) underwent decompressive craniectomy ( dc ) , and 17 of 148 ( 11 % ) underwent craniotomy . in the conservative treatment cohort , 67 of 563 patient ( 12 % ) underwent delay cranial surgery ( dc or craniotomy ) . the proportion of patient undergo acute surgery range from 0 % to 86 % ( median , 17 % [ iqr , 5 % -27 % ] ) between center , with up to a 3-fold high probability of prognostically similar patient receive acute surgery in one center compare with another random center ( mor , 2.95 [ 95 % ci , 1.79-7.47 ] ; p = .06 ) . center preference for acute surgery over initial conservative treatment be not associate with a good outcome ( or , 1.05 [ 95 % ci , 0.88-1.26 ] per 22 % [ iqr , 5 % -27 % ] increase in acute surgery at a give trauma center ) . in this comparative effectiveness study , similar patient with traumatic asdh be treat differently due to center-specific treatment preference . outcome be similar in center prefer surgical evacuation and those preferring initial conservative treatment . this study suggest that , for a patient with asdh for whom a neurosurgeon experience clinical equipoise between acute surgery v ( initial ) conservative treatment , conservative treatment may be consider .	JAMA network open	01/10/2025
10.2337/db25-0215	regulatory role of igf2r in insulin secretion and adaptive β-cell proliferation .	Shirakawa J, De Jesus DF, Tsuno T, Basile G, Inoue R, Takatani T, Nishiyama A, Okawa ER, Tamura T, Terauchi Y, Kulkarni RN	insulin-like growth factor-2 receptor ( igf2r ) , also know a cation-independent mannose-6-phosphate receptor , be localize in cytosolic vesicle and be unique in it ability to transport enzyme to the lysosome and to clear igf2 from the cell surface by act a a scavenger receptor . to evaluate the direct role of igf2r in β-cell biology , we undertake complementary in vitro knockdown and in vivo knockout approach . a β-cell line with a stable knockdown of igf2r ( igf2rkd ) exhibit decreased glucose-induced insulin secretion and enhance cell proliferation . tamoxifen-inducible β-cell-specific igf2r knockout mouse exhibit impaired glucose tolerance and blunt insulin secretion after high-fat-diet loading that be likely secondary to reduce β-cell mass due to attenuated proliferation . β-cells with igf2rkd have few autophagosomes after starvation and reduced expression of p62 , lc3b , and ulk1 . age mouse also have impair autophagy in βigf2r-deficient β-cells . reduce igf2r function and n6-methyladenosine ( m6a ) mrna methylation be observe in islet from both mouse and human type 2 diabetes . take together , these data point to igf2r a an important regulator of insulin secretion , cell proliferation , and autophagy in mammalian β-cells . the significance of insulin-like growth factor-2 receptor ( igf2r ) in β-cells remains unclear . to assess the physiological role of igf2r in β-cells , the effect of igf2r deficiency in vivo and in vitro be investigate . igf2r modulates insulin secretion , cell proliferation , and autophagy in β-cells . igf2r play a role in the regulation of β-cell biology .	Diabetes	03/10/2025
10.1186/s12943-025-02449-w	brd9-p53-e2f1 circuit orchestrates cell growth and dna damage repair in gastric cancer .	Zhou Q, Wang Q, Duan Y, Zhang C, Liu T, Liu H, Zhao M, Hu Z	brd9 be involve in multiple physiological and pathological pathway , yet it functional role and molecular mechanism in gastric cancer ( gc ) remain largely unexplored . address this knowledge gap be critical give the persistent global mortality burden of gc and the limited efficacy of current therapeutic strategy . brd9 expression in gc patient be systematically analyze use immunohistochemical ( ihc ) assay and transcriptomic datasets . comprehensive functional validation , employ cellular and murine tumor model , elucidate brd9 's role in gc progression . molecular pathway underlie brd9-mediated gastric carcinogenesis be delineate through integrated approach , include rna sequencing , co-immunoprecipitation ( co-ip ) , subcellular fractionation , and luciferase reporter assay . brd9 be significantly overexpressed in gc and associate with poor patient prognosis . functionally , brd9 promote gc cell proliferation and enhance dna damage repair capacity . mechanistically , elevate brd9 expression inhibit p53 nuclear translocation via direct binding , subsequently activate the e2f transcription factor family . notably , we identify that e2f1 directly bind to and transactivated the brd9 promoter , establish a positive feedback loop that sustain brd9 expression . additionally , brd9 knockdown sensitized gc cell to cisplatin and oxaliplatin treatment . these finding highlight the critical role of brd9 in gc progression and it therapeutic potential . the brd9-p53-e2f1 axis act a a crucial regulator of gc cell proliferation and dna damage response . target brd9 pharmacologically could be a novel therapeutic approach to enhance chemotherapy efficacy and improve treatment outcome in gc patient .	Molecular cancer	02/10/2025
10.1038/s44161-025-00717-y	spatial multiomics of acute myocardial infarction reveals immune cell infiltration through the endocardium .	Wünnemann F, Sicklinger F, Bestak K, Nimo J, Thiemann T, Amrute JM, Nordbeck M, Hartmann N, Ibarra-Arellano MA, Tanevski J, Chazotte M, Heine C, Frey N, Lavine KJ, Coscia F, Saez-Rodriguez J, Leuschner F, Schapiro D	myocardial infarction ( mi ) continue to be a leading cause of death worldwide . even though it be well establish that the complex interplay between different cell type determine the overall healing response after mi , the precise change in the tissue architecture be still poorly understood . in this study , we generate an integrative cellular map of the acute phase after murine mi use a combination of imaging-based transcriptomics ( molecular cartography ) and antibody-based highly multiplexed imaging ( sequential immunofluorescence ) . this enable u to evaluate cell type composition and change at subcellular resolution over time . we observe the recruitment of leukocyte to the infarcted heart through the endocardium and perform unbiased spatial proteomic analysis use deep visual proteomics ( dvp ) to investigate the underlying mechanism . dvp identify von willebrand factor ( vwf ) a an upregulated mediator of inflammation 24 hour after mi , and functional blocking of vwf reduce the infiltration of c-c chemokine receptor 2 ( ccr2 ) -positive monocyte and worsen cardiac function after mi .	Nature cardiovascular research	03/10/2025
10.1186/s12933-025-02920-4	dual modulation of lipid and glucose metabolism by a nutraceutical combination in patient at cardiometabolic risk : result from a multicenter randomize control trial .	Pacella D, Lembo M, Trimarco V, Izzo A, Manzi MV, Jankauskas SS, Forzano I, Gallo P, Spinelli A, Morisco C, Cristiano S, Rozza PI, Esposito E, Rozza F, Esposito L, Bear SKB, Giugliano G, Santulli G	recent evidence suggest that inhibit 3-hydroxy-3-methylglutaryl coenzyme a reductase ( hmgcr ) , a key enzyme in cholesterol biosynthesis , have beneficial effect on lipid metabolism and blood pressure ( bp ) , but detrimental consequence on glycemia . nutraceuticals ( nut ) contain both monacolin k ( mk ) and morus alba have be show to be more effective in lower lipid compare to nut formulation contain only mk . however , the effect of these nut on glucose homeostasis have not be fully determine . to evaluate the association between ldl-c-lowering therapy and glycemia in patient receive nut combination with or without morus alba , we analyze data from a prospective , randomize , active-treatment control trial ( nct02898805 ) , which enrol 359 patient to compare the effect of a nut combination contain mk alone ( formulation 1 , f1 ; n = 170 ) versus one containing mk and morus alba ( formulation 1 , f2 ; n = 189 ) . participant in the two treatment arm ( f1 vs. f2 ) be comparable in term of sex , age , metabolic parameter , and bp . after 3 month , both group experience significant reduction in ldl-c , fast plasma glucose , hba1c , and homa index . f2 treatment lead to a significantly great reduction in glycemic level compare to f1 treatment ( b = - 16 , p < 0.001 ) . notably , a divergent trend emerge over time : an inverse relationship between ldl-c and glycemic level be observe in the f1 group , while a significant direct association between ldl-c and glycemic level be detect in the f2 group ( b = 0.06 , p = 0.002 ) . take together , our finding indicate that the treatment with a nut combination contain morus alba simultaneously reduce plasma level of ldl-c and glucose .	Cardiovascular diabetology	03/10/2025
10.1038/s41467-025-63865-6	pathogenic variant reveal candidate gene for prostate cancer germline test for men of african ancestry .	Gheybi K, Soh PXY, Jiang J, Mbeki TMN, Louw M, Burns D, Mundra P, Kiriy D, Hasan MM, Jaratlerdsiri W, Lebelo MT, Campbell RA, Radzuma MB, Nenzhelele M, Obida M, Obida M, Ombuki WM, Oyaro MO, Patrick SM, Loda M, Wedge DC, Bristow RG, Brewer DS, Cooper CS, Reimand J, Cancel-Tassin G, Cussenot O, Hovens CM, Cocoran NM, Stricker PD, Schlomm T, Prins GS, Sørensen KD, Weischenfeldt J, Mutambirwa SBA, Ngugi PM, Thomas DM, Kote-Jarai Z, Eeles RA, Bornman MSR, Hayes VM	prostate cancer ( pca ) germline test , while gain momentum , be ancestry restrictive and african exclusive . through whole genome sequencing for 217 african ancestral case ( 186 southern african , 31 pan representative ) , we identify 172 potentially pathogenic variant in 78 dna damage repair or pca relate gene . prevalence for report ( 13/217 , 5.99 % ) and cumulative predict ( 24/217 , 11.06 % ) variant of significance ( 11 gene ) fall below that report for non-africans . conversely , brca1 , hoxb13 , cdk12 , mlh1 , msh2 , and brip1 remain unimpacted . through pathogenic ranking base on variant frequency and functionality , clinical presentation and tumour-matched biallelic inactivation , top-ranked candidate include prex2 , pole , fat1 , brca2 , polq , lrp1b and atm . besides notable impact of dna polymerase , include polg , fanconi anaemia gene include fancd2 , fanca , fancg , ercc4 , fance and fanci , while dna mismatch repair gene msh3 and pms1 outrank know namesake msh6 and pms2 . this study provide insight into the spectrum of african-relevant potentially pathogenic pca variant , highlight much-needed gene candidate for ancestry-inclusive germline testing .	Nature communications	02/10/2025
10.1371/journal.pone.0048639	the neural correlate of identity faking and concealment : an fmri study .	Ding XP, Du X, Lei D, Hu CS, Fu G, Chen G	the neural basis of self and identity have receive extensive research . however , most of these exist study have focus on situation where the internal representation of the self be consistent with the external one . the present study use fmri methodology to examine the neural correlate of two different type of identity conflict : identity faking and concealment . participant be present with a sequence of name and ask to either conceal their own identity or fake another one . the result reveal that the right insular cortex and bilaterally inferior frontal gyrus be more active for identity concealment compare to the control condition , whereas identity fake elicit a significantly large percentage signal increase than the control condition in the right superior frontal gyrus , leave calcarine , and right caudate . these result suggest that different neural system associate with both identity processing and deception be involve in identity concealment and faking .	PloS one	01/01/2012
10.1038/s41598-025-17956-5	development of cognitive , motor , metabolic , and mutant huntingtin aggregation in the zq175 mouse model of huntington 's disease .	McLean FH, Monteiro O, Lelos MJ, Ekkunagul T, Spicer RM, Rybnicek J, Lambert JJ, Langston RF	huntington 's disease ( hd ) be an inherited neurodegenerative disease . in human , the clinical diagnosis be often dependent on the emergence of motor symptom . however , cognitive impairment and metabolic change can be early indicator . hd mouse model be a useful tool to understand disease progression , however , relatively few study have monitor the timeline for the emergence of cognitive index with motor and metabolic phenotype in parallel . in this study , cognitive , motor , and metabolic phenotype be investigate at different age in the zq175 knock-in mouse alongside immunohistochemical and long-term potentiation ( ltp ) study . we demonstrate that zq175 mouse develop impaired hippocampal ltp at 3-months and cognitive deficit in visuospatial attention be evident by 4-months . long-term and spatial memory impairment emerge by 12-months , alongside motor impairment . additionally , an anxiolytic-like phenotype emerge at 6-months . difference in body weight be also detect from 6-months onwards , primarily drive by a reduction in fat mass . additionally , reduce brain weight and the presence of huntingtin aggregate in the hippocampus , striatum and hypothalamus be observe at 12-months . these data support the zq175 mouse a a model of hd , which recapitulate many aspect of the disease progression in human and can be use to understand mechanism underlie the disease .	Scientific reports	03/10/2025
10.1016/j.stemcr.2025.102649	integrated profiling of ipsc-derived motor neuron carry c9orf72 , fus , tardbp , or sod1 mutation .	Ma GM, Xia CC, Lyu BY, Liu J, Luo F, Guan MF, Wang JY, Sun L, Zhang L, Chen Y, Mao YW, Yu GQ, Wang WY	here , we conduct temporal rna sequencing ( rna-seq ) profiling of human induce pluripotent stem cell ( hipscs ) and induced pluripotent stem cell ( ipsc ) -derived motor neuron ( imns ) carry c9orf72 , fus , tardbp , or sod1 mutation in both patient with amyotrophic lateral sclerosis ( al ) and healthy individual . we discover dysregulated gene expression and alternative splicing ( a ) throughout imn development and maturation , and imns with mutation in als-associated gene display enrichment of cytoskeletal defect and synaptic alteration from the premature stage to mature imns . our finding indicate that synaptic gene dysfunction be a common molecular hallmark of familial al , which may result in neuronal susceptibility and progressive motor neuron degeneration . analysis of upstream splice factor reveal that differentially express rna-binding protein ( rbps ) in imns from patient with al may cause abnormal a event . overall , our research provide a comprehensive and valuable resource for gain insight into the share mechanism of familial al pathogenesis during motor neuron development and maturation in imn model .	Stem cell reports	02/10/2025
10.1016/S2213-2600(25)00283-8	assessment of the role of small airway dysfunction in relation to exacerbation risk in patient with well control asthma ( atlantis ) : an observational study .	Galant SP, Kuks PJM, Kole TM, Kraft M, Siddiqui S, Fabbri LM, Beghé B, Rabe KF, Papi A, Brightling CE, Singh D, Kocks JWH, Franzini L, Vonk JM, Kerstjens HAM, Heijink IH, Pouwels SD, Slebos DJ, van den Berge M	recent survey suggest that asthma remain inadequately control in more than 50 % of adult with asthma despite guideline-based standard therapy . small airway be often under-recognised a major site of airway obstruction and inflammation . this might be relate to lack of assessment with current tool such a impulse oscillometry , and thus under-treatment might explain inadequate control . small airway dysfunction , which be common in adult with well control asthma , might represent an important biomarker of future risk of exacerbation . we aim to investigate whether small airway dysfunction be present in patient with well control asthma and , if so , whether it be a risk factor for future exacerbation in this population . the observational assessment of small airway involvement in asthma ( atlantis ) study include 773 extensively characterised patient with asthma age 18-65 year from 29 primary and specialty clinic in nine country from june 30 , 2014 , to march 3 , 2017. patient be require to be diagnose with asthma at least 6 month before inclusion base on evidence of airway hyper-responsiveness , bronchodilator reversibility , or peak expiratory flow variability . patient be require to have stable asthma , define a no asthma exacerbation and regular asthma treatment at a consistent dose for 8 week before baseline visit . the current analysis include patient with well control asthma , define a an asthma control questionnaire ( acq-6 ) score of less than 0·75 at baseline . small airway dysfunction be define , base on deviation from predict value of impulse oscillometry parameter , a a z score of more than 1·645 for r5-r20 ( resistance at 5 hz minus resistance at 20 hz ) and ax ( area of reactance ) and a z score of less than -1·645 for x5 ( reactance at 5 hz ) , with additional analysis explore severe small airway dysfunction ( z score of 3 or -3 ) . atlantis be register with clinicaltrials.gov , nct02123667 . of 773 patient , acq-6 assessment be available for 772 patient . among these patient , 384 ( 50 % ) be classify a have well control asthma , and small airway dysfunction be present in 108 ( 36 % [ 95 % ci 30-41 ] ) of 304 patient with impulse oscillometry data available for r5-r20 , 89 ( 34 % [ 28-42 ] ) of 261 patient with data for ax , and 79 ( 26 % [ 21-31 ] ) of 303 patient with data for x5 . in the multivariable analysis , we find that r5-r20-defined small airway dysfunction be associate with increased risk of future exacerbation , independent of age , sex , smoke status , global initiative for asthma step 4-5 , previous exacerbation , percentage of predict fev ( 1 ) , ratio of residual volume to total lung capacity , and peripheral blood eosinophil count ( hazard ratio [ hr ] 2·26 [ 95 % ci 1·05-4·85 ] ; p=0·038 ) , whereas ax ( 2·07 [ 0·91-4·70 ] ; p=0·082 ) and x5 ( 0·86 [ 0·33-2·21 ] ; p=0·75 ) be not associate with exacerbation . for severe small airway disease , both r5-r20 ( hr 2·80 [ 95 % ci 1·26-6·26 ] ; p=0·012 ) and ax ( 2·51 [ 1·04-6·04 ] ; p=0·041 ) become independent predictor of future exacerbation , whereas x5 remain non-significant ( 0·99 [ 0·29-3·32 ] ; p=0·98 ) . we have address an undervalued trait by show that small airway dysfunction be a common , sensitive , early independent risk biomarker for future exacerbation in adult with well control asthma . chiesi pharmaceutical and the dutch ministry of health .	The Lancet. Respiratory medicine	29/09/2025
10.1038/s41467-025-63718-2	engineer exosomes with kras ( g12d ) specific sirna in pancreatic cancer : a phase i study with immunological correlate .	Kalluri VS, Smaglo BG, Mahadevan KK, Kirtley ML, McAndrews KM, Mendt M, Yang S, Maldonado AS, Sugimoto H, Salvatierra ME, Solis Soto LM, Haymaker C, Finch R, Gagea M, Fluty AC, Ludtke SJ, Jack Lee J, Jain AK, Varadhachary G, Shroff RT, Maitra A, Shpall E, Pant S, Kalluri R	oncogenic kras be amongst the key genetic driver for initiation and maintenance of pancreatic ductal adenocarcinoma ( pdac ) . here , we show that engineer exosomes with kras ( g12d ) specific sirna ( iexokras ( g12d ) ) reveal a biodistribution in pancreas with negligible toxicity in preclinical study in mouse and rhesus macaque . clinical testing of iexokras ( g12d ) in the iexplore ( iexokras ( g12d ) in pancreatic cancer ) phase i study employ a non-randomized single-arm classical 3 + 3 dose escalation design ( phase ia ) , follow by an accelerated titration design ( phase ib ) ( nct03608631 ) . the primary outcome include safety , tolerability and target engagement , and the secondary outcome aim to assess disease control . patient with advanced metastatic disease be enrol after failure of multiple line of therapy . iexokras ( g12d ) therapy be well-tolerated : the primary outcome be meet with iexokras ( g12d ) show no dose-limiting toxicity . the maximum tolerate dose be not reach even at the high dose . in some case , iexokras ( g12d ) therapy be associate with stable disease response ( secondary outcome ) . downregulation of kras ( g12d ) dna and suppression of phospho-erk be document together with an increase in intratumoral cd8 ( + ) t cell follow treatment . the cd8 ( + ) t cell recruitment priming by iexokras ( g12d ) inform on potential efficacy of immune checkpoint therapy and lead to validation test in preclinical pdac model . combination therapy of iexokras ( g12d ) and anti-ctla-4 antibody , but not anti-pd1 , reveal robust pre-clinical anti-tumor efficacy via fa mediate cd8 ( + ) t cell anti-tumor activity . this first-in-human , precision medicine clinical trial and support preclinical functional study offer new insight into priming of immunotherapy by oncogenic kras inhibitor for future opportunistic combination therapy for pdac patient .	Nature communications	30/09/2025
10.1186/s12974-025-03552-x	cytokine expression profile in the human brain of old adult .	Godoy JB, Vialle RA, Dos Santos L, Raittz RT, Wang Y, Menon V, De Jager PL, Schneider JA, Tasaki S, Bennett DA, Guizelini D, de Paiva Lopes K	alzheimer 's disease ( ad ) be a complex neurodegenerative condition link to chronic neuroinflammation . this study investigate the cytokine gene expression profile in cortical tissue sample from elderly individual with and without ad to identify potential biomarkers and enhance our understanding of disease pathogenesis . utilizing high-depth rna sequence data , we identify a set of cytokine whose expression significantly associate with different aspect of the ad phenotype , include measure of neurofibrillary tangle , amyloid-β deposition , and a person-specific rate of cognitive decline . single-nucleus transcriptomics data facilitate the identification of specific cell type , such a microglia and astrocyte , that significantly contribute to the inflammatory response in ad . additionally , we observe a correlation between the expression of certain cytokine and genetic risk for the disease . our finding indicate that cytokine-mediated neuroinflammation may play an important role in neurodegeneration and that modulate the immune response may offer a promising strategy for develop new therapy .	Journal of neuroinflammation	03/10/2025
10.2337/db25-0282	trem2+ macrophage alleviate renal tubule lipid accumulation and ferroptosis in diabetic nephropathy by repress il-1β-mediated cd36 expression .	Wang X, Wan J, Wang C, Tong Y, Chen Y, Wang X, Liu J, Li Q, Dong Z, Hong Q, Sun X, Cai G, Ouyang Q, Chen X	the presence of macrophage surround lipotoxic tubular epithelial cell ( tec ) be a hallmark of diabetic nephropathy ( dn ) . nevertheless , the mechanism of communication between these cell type be not well understood . previous study have reveal a unique subset of macrophage that express trigger receptor express on myeloid cell 2 ( trem2 ) in kidney of human patient and mouse with dn . here , we explore the characteristic and the function of trem2+ macrophage in the progress of dn . rna-sequencing of macrophage in kidney of trem2 knockout ( ko ) mouse feed a high-fat diet plus streptozotocin ( hfd/stz ) reveal functional enrichment of metabolic process , cytokine production , positive regulation of extracellular signal-regulated kinase ( erk ) cascade , and the regulation of phagocytosis . in vivo study demonstrate that trem2+ macrophage reduce lipid accumulation and mitigate ferroptosis of tec in diabetic mouse . mechanistically , trem2-deficient macrophage amplify the production of interleukin-1β ( il-1β ) through activate the erk signal pathway . furthermore , il-1β trigger cd36 expression via the transcription factor nf-κb . bioinformatics and functional assay show nf-κb bind the cd36 promoter , which directly bound to the promoter of cd36 to facilitate it transcription . inhibition of nf-κb blocked il-1β-induced cd36 production . this mechanism be exacerbate in trem2-deficient macrophage , which release excess il-1β to activate nf-κb in tubular cell , promote cd36-dependent lipid uptake and ferroptosis . additionally , we find trem2 play a role in enhance the phagocytosis and clearance of ferroptotic cell by bone marrow-derived macrophage . altogether , our result suggest trem2+ macrophage maintain homeostasis of the renal microenvironment and exert a protective function in dn . level of trigger receptor express on myeloid cell 2 ( trem2 ) in macrophage be increase in human patient and in mouse with diabetic nephropathy . trem2 suppress the extracellular signal-regulated kinase signal pathway , thereby inhibit il-1β production in macrophage . macrophage trem2 deficiency exacerbate tubular cell lipid deposition and ferroptosis by increase cd36 expression in an il-1β-dependent manner .	Diabetes	03/10/2025
10.1016/0888-7543(95)80042-k	a 1.8-mb yac contig span three member of the receptor tyrosine kinase gene family ( pdgfra , kit , and flk1 ) on mouse chromosome 5 .	Brunkow ME, Nagle DL, Bernstein A, Bucan M	we construct a yeast artificial chromosome ( yac ) contig span the gene encode kit ( kit ) , the platelet-derived growth factor alpha receptor ( pdgfra ) , and fetal liver kinase 1 ( flk1 ) , three member of a receptor tyrosine kinase gene family locate in the central portion of mouse chromosome 5. the orientation of yac clone and the extent of their overlap be determine by `` probe content mapping , '' that be , hybridization analysis of yac clone use the available gene probe and yac end sequence . for four yac clone , which constitute a minimal set span 1.8 mb , a detailed restriction map be construct . this map , in conjunction with the previously publish long-range restriction map , indicate the order , the physical distance , and the relative transcriptional orientation of the pdgfra , kit , and flk1 gene . the yac clone and correspond yac end probe present here provide an important resource for the molecular analysis of a cluster of developmental mutation , namely dominant white spotting ( w ) , patch ( ph ) , recessive spotting ( r ) , and rump-white ( rw ) , associate with this chromosomal region .	Genomics	20/01/1995
10.1016/S1473-3099(25)00476-1	long covid associate with sars-cov-2 reinfection among child and adolescent in the omicron era ( recover-ehr ) : a retrospective cohort study .	Zhang B, Wu Q, Jhaveri R, Zhou T, Becich MJ, Bisyuk Y, Blanceró F, Chrischilles EA, Chuang CH, Cowell LG, Fort D, Horowitz CR, Kim S, Ladino N, Liebovitz DM, Liu M, Mosa ASM, Schwenk HT, Suresh S, Taylor BW, Williams DA, Morris JS, Forrest CB, Chen Y	post-acute sequela of sars-cov-2 infection ( pasc ) remain a major public health challenge . although previous study have focus on characterise pasc in child and adolescent after an initial infection , the risk of pasc after reinfection with the omicron variant remain unclear . we aim to assess the risk of pasc diagnosis ( u09.9 ) and symptom and condition potentially relate to pasc in child and adolescent after a sars-cov-2 reinfection during the omicron period . this retrospective cohort study use data from 40 child 's hospital and health institution in the usa participating in the researching covid to enhance recovery ( recover ) initiative . we include patient young than 21 year at the time of cohort entry ; with document sars-cov-2 infection after jan 1 , 2022 ; and who have at least one health-care visit within 24 month to 7 day before the first infection . the second sars-cov-2 infection be confirm by positive pcr , antigen test , or a diagnosis of covid-19 that occur at least 60 day after the first infection . the primary endpoint be a clinician-documented diagnosis of pasc ( u09.9 ) . secondary endpoint be 24 symptom and condition previously identify a be potentially relate to pasc . we use the modified poisson regression model to estimate the relative risk ( rr ) between the second and first infection episode , adjust for demographic , clinical , and health-care utilisation factor use exact and propensity-score matching . we identify 407 300 ( 87·5 % ) of 465 717 eligible child and adolescent with a first infection episode and 58 417 ( 12·5 % ) with a second infection episode from jan 1 , 2022 , to oct 13 , 2023 , in the recover database . 233 842 ( 50·2 % ) patient be male and 231 875 ( 49·8 % ) be female . the mean age be 8·17 year ( sd 6·58 ) . the incident rate of pasc diagnosis ( u09.9 ) per million people per 6 month be 903·7 ( 95 % ci 780·9-1026·5 ) in the first infection group and 1883·7 ( 1565·1-2202·3 ) in the second infection group . reinfection be associate with a significantly increase risk of an overall pasc diagnosis ( u09.9 ) ( rr 2·08 [ 1·68-2·59 ] ) and a range of symptom and condition potentially relate to pasc ( rr range 1·15-3·60 ) , include myocarditis , change in taste and smell , thrombophlebitis and thromboembolism , heart disease , acute kidney injury , fluid and electrolyte disturbance , generalise pain , arrhythmia , abnormal liver enzyme , chest pain , fatigue and malaise , headache , musculoskeletal pain , abdominal pain , mental ill health , pot or dysautonomia , cognitive impairment , skin condition , fever and chill , respiratory sign and symptom , and cardiovascular sign and symptom . child and adolescent face a significantly high risk of various pasc outcomes after reinfection with sars-cov-2 . these finding add to previous evidence link paediatric long covid to multisystem effect and highlight the need to promote vaccination in young population and support ongoing research to good understand pasc , identify high-risk subgroup , and improve prevention and care strategy . national institute of health .	The Lancet. Infectious diseases	30/09/2025
10.1126/sciimmunol.adu6730	vaccination-induced t cell response maintain polyclonality with high antigen receptor avidity .	Kocher K, Drost F, Tesfaye AM, Moosmann C, Schülein C, Grotz M, D'Ippolito E, Graw F, Spriewald B, Busch DH, Bogdan C, Tenbusch M, Schubert B, Schober K	clonal expansion be a hallmark of adaptive immunity and have be challenge to investigate in human in a standardized manner compare with animal model . we study a cohort of 29 healthy individual who receive three mrna vaccination against sars-cov-2 before a breakthrough infection . we characterize the magnitude , phenotype , and clonal composition of cd8 t cell response against 16 epitope specificity by elispot ; flow cytometry ; and single-cell rna , protein , and t cell receptor ( tcr ) sequencing . one hundred six tcrs from five epitope-specific repertoire be reexpressed and test for peptide sensitivity . whereas vaccination-recruited t cell repertoire be enrich for high-avidity tcrs , differential clonal expansion be not link to fine avidity difference . instead , maintenance of polyclonality ensure robustness in counteract viral mutational escape through altered epitope . decipher the functionality of human antigen-specific t cell repertoires instruct our understanding of human t cell biology and may guide the development of vaccine and other immunotherapy .	Science immunology	03/10/2025
10.1080/15502783.2025.2568048	a randomized , placebo-controlled , crossover clinical trial to evaluate the effect of a turmeric formulation on muscle soreness and function recovery in moderately active adult .	Schönenberger KA, Laval J, Woods T, Truillet R, Naranjo-Modad S, Mettler S, Fança-Berthon P	turmeric may alleviate exercise-induced muscle soreness ( delay onset muscle soreness ) and muscular function loss due to the strong anti-inflammatory and antioxidant activity of it active compound , the curcuminoids . the primary objective of this trial be to evaluate the effect of a highly bioavailable turmeric formulation on delayed onset muscle soreness in male adult . in a randomized , double-blind , placebo-controlled , crossover trial ( clinicaltrials.gov nct04946981 ) , 44 moderately active adult ( 34 male , 10 female , mean [ sd ] age = 33.7 [ 6.4 ] year ) ingest a turmeric formulation ( 300 mg/day , thereof 90 mg of active curcuminoids ) or placebo for five day . on the second day , muscle damage be induce with exercise ( 30 min downhill run at 70 % vo₂ max ) . immediately before and 0 , 24 , 48 , and 72 hour post-exercise , muscle soreness during squat on quadriceps ( visual analog scale ) , muscular function ( knee extension dynamometer ) , muscle power ( vertical jump test ) , muscle damage ( serum creatine kinase ) , range of motion ( knee flexion ) , and perceive wellness and wellbeing ( questionnaire ) be assess . during exercise , exhaustion be assess use the borg rating of perceived exertion . the primary trial population consist of the male participant , outcome in female be consider exploratory . adjust least square mean with standard error ( se ) be obtain from mixed model for repeated measure . there be no significant difference between the turmeric formulation and placebo in muscle soreness area under the curve from pre-exercise to 72 hour post-exercise and at all timepoints , except for a trend observe in male 72 hour after exercise ( adjust mean [ se ] for difference from placebo = -4.8 [ 2.7 ] mm , p = 0.0776 ) . muscle soreness recovery ( difference between soreness at 72 hour and maximal post-exercise soreness ) be significantly great with the turmeric formulation compare to placebo ( adjust mean [ se ] for difference from placebo = -10.7 % [ 4.3 % ] , p = 0.0184 for the male participant , and -7.9 % [ 3.6 % ] , p = 0.0346 for the total sample ) . furthermore , in male , the decrease from pre-exercise to 24 hour after exercise in isokinetic peak torque be significantly low with the turmeric formulation ( adjust mean [ se ] for difference from placebo = 11.0 [ 4.9 ] nm , p = 0.0275 ) , a be the decrease in isokinetic max rep work ( adjust mean [ se ] for difference from placebo = 11.6 [ 4.9 ] j , p = 0.0195 ) , while vertical jump peak power at 24 hour after exercise be high ( median [ interquartile range ] with the turmeric formulation vs. placebo = 931.1 [ 825.9 ; 1001.1 ] w vs. 916.5 [ 824.8 ; 989.5 ] w , p = 0.0445 ) . supplementation with the turmeric formulation can accelerate exercise-induced muscle soreness recovery and could attenuate muscular function loss and improve performance after unaccustomed exercise in young , moderately active , male adult .	Journal of the International Society of Sports Nutrition	01/01/2025
10.1002/advs.202509695	dcaf12 ubiquitin ligase promote lung cancer metastasis by modulate the tric/cct chaperonin complex .	Wang Z, Huang H, Huang K, Cui X, Wu L, Lin R, Zhao Z, Chen H, Zheng C, Jin W, Chen S, Chen J, Xu Y, Wei D	metastasis be the primary challenge in lung cancer treatment . although proteostasis support tumor growth , the mechanism by which ubiquitin ligases reprogram chaperone network to drive metastasis be poorly understood . in this study , it be reveal that ddb1-cul4-associated factor ( dcaf12 ) , a substrate receptor for cul4-ring ubiquitin ligases , regulate metastatic progression through ubiquitin-mediated proteostatic reprogramming . dcaf12 depletion suppresses tumor cell migration and stemness in vitro and reduces pulmonary/hepatic metastasis in vivo . mechanistically , dcaf12 catalyze the non-degradative ubiquitination of tric/cct subunit , enhance chaperonin assembly and folding of cytoskeletal effector ( β-actin/tubulin ) and oncogenic client ( stat3/raptor/mlst8 ) , thereby activate the yap , stat3 , and mtor pathway . both genetic knockdown and pharmacological blockade ( via hsf1a ) of this axis potently inhibit metastasis . clinically , dcaf12 overexpression be correlate with yap/stat3 activation , advanced metastasis , and poor survival . three key insight be reveal : 1 ) ubiquitination-mediated tric/cct regulation a a metastatic switch , 2 ) dcaf12 a an oncogenic proteostasis hub , and 3 ) therapeutic potential validate through multimodal targeting . these finding establish the dcaf12-tric/cct axis a a mechanistically novel target that simultaneously disrupt cytoskeletal dynamic and oncogenic signaling , make it a promising therapeutic strategy for metastatic lung cancer .	Advanced science (Weinheim, Baden-Wurttemberg, Germany)	05/10/2025
10.1016/S0140-6736(25)00861-X	budesonide-formoterol versus salbutamol a reliever therapy in child with mild asthma ( care ) : a 52-week , open-label , multicentre , superiority , randomise control trial .	Hatter L, Holliday M, Oldfield K, Kearns C, Barry T, Black M, Bruce P, Colman A, Dickinson E, Eathorne A, Harwood M, Hills T, Lamb R, Kerse K, Krishnamoorthy S, Martindale J, Semprini A, Shortt N, McNamara D, Byrnes CA, Dalziel SR, Bush A, Weatherall M, Beasley R	combination inhale corticosteroid-formoterol reliever monotherapy reduce the rate of asthma attack compare to short-acting β ( 2 ) -agonist ( saba ) reliever monotherapy in adult . it comparative efficacy in child have not be establish . care be a 52-week , open-label , parallel-group , multicentre , superiority , randomise control trial in child age 5-15 year with asthma use saba reliever monotherapy at 15 clinical trial site in new zealand . participant be randomly assign ( 1:1 ) to either budesonide 50 μg-formoterol 3 μg , two actuation a need , or salbutamol 100 μg , two actuation a need . the primary outcome be asthma attack a rate per participant per year . this trial be register with the australian new zealand clinical trial registry , actrn12620001091998 . from jan 28 , 2021 , to june 23 , 2023 , we assess 382 participant for eligibility . we randomly assign 360 ( 94 % ) participant to treatment ( 179 [ 50 % ] to the budesonide-formoterol group and 181 [ 50 % ] to the salbutamol group ) . the annualised rate of asthma attack be lower in the budesonide-formoterol group than in the salbutamol group-cluster-adjusted rate 0·23 versus 0·41 per participant per year ( relative rate 0·55 [ 95 % ci 0·35-0·86 ] ; p=0·012 ) . the number of participant with at least one adverse event be 162 ( 91 % ) in the budesonide-formoterol group and 167 ( 92 % ) in the salbutamol group ( odds ratio 0·79 [ 95 % ci 0·35-1·79 ] ) . in child age 5-15 year with mild asthma , budesonide-formoterol reliever monotherapy be superior to salbutamol for prevent asthma attack , with a similar safety profile . health research council of new zealand , cure kid new zealand , and the barbara basham medical charitable trust ( manage by perpetual guardian ) .	Lancet (London, England)	04/10/2025
10.1186/s12916-025-04311-8	investigate the relationship of plasma micrornas and colorectal cancer risk use genetic evidence .	Bouras E, Papagiannopoulos CK, Mustafa R, Sobieski D, Schmit SL, Wu AH, Brenner H, Li CI, Chan AT, Pellatt AJ, Zheng W, Keku TO, Moreno V, Um CY, Van Guelpen B, Phipps AI, Pai RK, Lewis SJ, Martin RM, Gunter MJ, Peters U, Dehghan A, Tsilidis KK	micrornas ( mirnas ) be short , single-stranded rna that function a post-transcriptional regulator of gene expression . although circulate mirnas have be link to carcinogenesis , they have not yet be systematically investigate in relation to risk of colorectal cancer ( crc ) . we use mendelian randomization ( mr ) and colocalization analysis to investigate the association of genetically predict plasma mirna concentration ( 2083 mirnas in 710 individual ) with risk of crc ( 58,221 case and 67,694 control ) . for mirnas associate with crc risk , we also investigate their association with circulate plasma protein ( 4907 protein in 35,559 participant ) , bidirectionally , use mr. we perform pathway enrichment analysis ( pea ) to explore downstream molecular pathway . association of five mirnas with crc be find in mr and support in colocalization analysis . specifically , mir-146a-5p , mir-21-5p , and mir-4707-3p be positively , and mir-1908-5p and mir-6810-3p be inversely associate with crc risk . several protein association be find for these mirnas ( range of protein with p < 0.05 : 78-796 ; 211 with fdr < 5 % ) , and 11 pathway be identify in pea , include regulation of erb-b2 receptor tyrosine kinase 4 ( mir-6810-3p ) and insulin-like growth factor pathway ( mir-1908-5p ) . our result support a potential implication of mir-146a-5p , mir-21-5p , mir-4707-3p , mir-1908-5p , and mir-6810-3p to crc risk . however , their downstream effect should be elucidate before they can be utilize a preventive target .	BMC medicine	02/10/2025
10.1038/s41593-025-02068-0	single-dose psilocybin rapidly and sustainably relief allodynia and anxiodepressive-like behavior in mouse model of chronic pain .	Hammo A, Wisser S, Cichon J	chronic pain and mood disorder co-occur , exacerbate one another and share neurobiological mechanism , but whether a single intervention could promptly alleviate both condition remain unclear . here , in two chronic pain model , we show that a single dose of psilocybin induces a rapid and sustain reversal of both mechanical allodynia and anxiodepression-like state in adult male and female mouse . use local psilocin injection , the key active metabolite of psilocybin , we show that the engagement of prefrontal cortical circuit be critical for the concurrent alleviation of both condition . two-photon calcium imaging reveals that psilocin rapidly normalizes chronic pain-associated hyperactivity in anterior cingulate cortex layer 2/3 pyramidal neuron . pharmacologic manipulation with full agonist of 5-ht ( 2a ) and 5-ht ( 1a ) receptor replicate some , but not all , of psilocin 's cellular and behavioral effect , suggest that psilocin 's action arise from partial agonism at these receptor within share circuit govern pain and mood processing .	Nature neuroscience	02/10/2025
10.1038/s43018-025-01054-6	aberrant expression of slamf6 constitute a targetable immune escape mechanism in acute myeloid leukemia .	Sandén C, Landberg N, Peña-Martínez P, Thorsson H, Daga S, Puente-Moncada N, Rodriguez-Zabala M, von Palffy S, Rissler M, Lazarevic V, Juliusson G, Ohlin M, Hyrenius-Wittsten A, Orsmark-Pietras C, Lilljebjörn H, Ågerstam H, Fioretos T	immunotherapy have show limited success in acute myeloid leukemia ( aml ) , indicate an incomplete understanding of the underlying immunoregulatory mechanism . here we identify an immune evasion mechanism present in 60 % of aml case , wherein primitive aml cell aberrantly express the lymphoid surface protein slamf6 ( signal lymphocyte activation molecule family member 6 ) . knockout of slamf6 in aml cell enable t cell activation and highly efficient killing of leukemia cell in coculture system , demonstrate that slamf6 protects aml cell from recognition and elimination by the immune system in a mode analogous to the program cell death protein-ligand ( pdl1/pd1 ) axis . target slamf6 with an antibody against the slamf6 dimerization site inhibit the slamf6-slamf6 interaction and induces t cell activation and killing of aml cell both in vitro and in humanize in vivo model . in conclusion , we show that aberrant expression of slamf6 be a common and targetable immune escape mechanism that could pave the way for immunotherapy in aml .	Nature cancer	03/10/2025
10.1038/s41467-025-63885-2	sfpq-tfe3 reciprocally regulate mtorc1 and induces lineage plasticity in a mouse model of renal tumorigenesis .	Asrani K, Amaral A, Woo J, Abadchi SN, Vidotto T, Imada E, Skaist A, Feng K, Liu HB, Kasbe M, Satou Y, Baba M, Oike Y, Outeda P, Watnick T, Rosenberg AZ, Schmidt LS, Linehan WM, Argani P, Lotan TL	mit/tfe gene fusion like sfpq-tfe3 drive both epithelial ( translocation rcc ) and mesenchymal ( pecomas ) neoplasm . however , no mouse model for sfpq-tfe3-related tumor exist and the underlying mechanism of lineage plasticity remain unclear . here , we demonstrate that constitutive murine renal expression of sfpq-tfe3 disrupts kidney development with early neonatal renal failure and death , while post-natal induction induces infiltrative epithelioid tumor , that morphologically and transcriptionally resemble human pecomas , with strong activation of mtorc1 signal via increase v-atpase expression . remarkably , sfpq-tfe3 expression be sufficient to induce lineage plasticity , with down-regulation of the pax2/pax8 nephric lineage factor and tubular epithelial marker , and up-regulation of pecoma differentiation marker in transgenic mouse , cell line and human trcc . mtor inhibition downregulates sfpq-tfe3 expression and rescue pax8 expression and transcriptional activity in vitro . these data provide evidence of an epithelial cell-of-origin for tfe3-driven pecomas , highlight a reciprocal role for sfpq-tfe3 and mtor in drive lineage plasticity in the kidney .	Nature communications	03/10/2025
10.1038/s41467-025-63885-2	sfpq-tfe3 reciprocally regulate mtorc1 and induces lineage plasticity in a mouse model of renal tumorigenesis .	Asrani K, Amaral A, Woo J, Abadchi SN, Vidotto T, Imada E, Skaist A, Feng K, Liu HB, Kasbe M, Satou Y, Baba M, Oike Y, Outeda P, Watnick T, Rosenberg AZ, Schmidt LS, Linehan WM, Argani P, Lotan TL	mit/tfe gene fusion like sfpq-tfe3 drive both epithelial ( translocation rcc ) and mesenchymal ( pecomas ) neoplasm . however , no mouse model for sfpq-tfe3-related tumor exist and the underlying mechanism of lineage plasticity remain unclear . here , we demonstrate that constitutive murine renal expression of sfpq-tfe3 disrupts kidney development with early neonatal renal failure and death , while post-natal induction induces infiltrative epithelioid tumor , that morphologically and transcriptionally resemble human pecomas , with strong activation of mtorc1 signal via increase v-atpase expression . remarkably , sfpq-tfe3 expression be sufficient to induce lineage plasticity , with down-regulation of the pax2/pax8 nephric lineage factor and tubular epithelial marker , and up-regulation of pecoma differentiation marker in transgenic mouse , cell line and human trcc . mtor inhibition downregulates sfpq-tfe3 expression and rescue pax8 expression and transcriptional activity in vitro . these data provide evidence of an epithelial cell-of-origin for tfe3-driven pecomas , highlight a reciprocal role for sfpq-tfe3 and mtor in drive lineage plasticity in the kidney .	Nature communications	03/10/2025
10.7150/thno.117582	gpx1-driven selenium nanoplatform reprograms mams-mediated organelle crosstalk to reverse inflammatory adipose expansion in thyroid eye disease .	Tan Y, Zhang F, Cao J, Feng L, Xie B, Gao L, Chen X, Yan Z, Xiong W	background : thyroid eye disease ( ted ) be a multifactorial autoimmune disorder with limited therapeutic option due to the complexity of it oxidative , metabolic , and inflammatory network . this study aim to develop a selenium-based nanoplatform that target mitochondria-er interaction to reverse inflammatory adipose expansion in ted . method : we design a dual-responsive selenium nanoparticle ( se @ lnt ) modify with lentinan , capable of ros/ph-triggered release . human primary orbital fibroblast , bioinformatic analysis of public datasets , and ted mouse model be use to investigate the therapeutic mechanism . result : se @ lnt undergoes intracellular metabolic conversion into selenocysteine , which enhance gpx1 activity and promotes redox balance . it exert triple regulatory effect by stabilize mitochondrial membrane to reduce mtdna leakage , downregulating grp75 to normalize mam contact and calcium flux , and suppress perk-eif2α-atf4 signal to relieve er stress . transcriptomic profiling reveals multi-target modulation of immune-stromal interaction . in vivo , se @ lnt achieves orbital targeting , rapid hepatic-renal clearance , and significant reduction of adipose expansion with immune remodel . conclusion : se @ lnt offer the first mams-targeted nanotherapy for ted by reprogramming organelle crosstalk , restore metabolic-immune homeostasis , and modify disease progression at the subcellular level .	Theranostics	01/01/2025
10.1186/s12967-025-06818-3	vista express on tumor cell be regulate by m6a and influence immune microenvironment through stat3/ccl22 in nsclc .	Xu H, Shen K, Jiang B, Xu Q, Li B, Ke Z, Cheng Q, Zhu S, Wang D, Song Y, Lv T	immunotherapy be play an increasingly vital role in the treatment of non-small cell lung cancer ( nsclc ) , yet the challenge of immune evasion remain prevalent . therefore , investigate the regulatory mechanism of the tumor immune microenvironment could yield significant benefit . this study utilized differential expression analysis , wgcna , and lasso-cox to analyze the gse126044 dataset , identify n6-methyladenosine ( m6a ) -related molecule that play significant role in immunotherapy . the m6a modification of the molecule be validate through m6a dot blot , merip , rna pull-down and rna stability assay . their impact on the biological behavior of tumor cell ( tc ) be evaluate by cck-8 assay , wound heal assay , transwell assay , co-culture experiment and flow cytometry . furthermore , rna sequencing be conduct to uncover downstream pathway and cytokine , follow by subsequent validation . lastly , validation be carry out in vivo . through bioinformatics analysis , we identify that v-domain immunoglobulin suppressor of t cell activation ( vista ) serve a crucial role in immunotherapy and that it expression be regulate by m6a . it be subsequently confirm that mettl3 enhance the m6a modification level of vista mrna , which be recognize by ythdf1 . this interaction improve the stability of vista mrna , lead to increase expression of vista protein on the surface of tc . the elevated expression of vista boost the cytotoxic response of cd8 + t cell toward tc . rna sequence analysis indicate that the jak/stat pathway significantly contribute to this process . overexpression of vista on tc decrease the phosphorylation of stat3 , which in turn reduce the expression and release of ccl22 . this reduction alleviate immune suppression within the tumor microenvironment , result in increase enrichment and activity of cd8 + t cell and decreased enrichment of regulatory t cell ( tregs ) , ultimately enhance their cytotoxic effect against tc . we conduct a pioneering systematic study on the expression , function , and molecular mechanism of the vista molecule on nsclc tc . we propose that in the tumor immune microenvironment , vista function a both an immune checkpoint and a regulator of cd8 + t cell activation/recruitment and treg recruitment via it expression on tc .	Journal of translational medicine	02/10/2025
10.1001/jamaoncol.2025.3746	prostate-specific membrane antigen pet-guided intensification of salvage radiotherapy after radical prostatectomy : a phase 2 randomized clinical trial .	Belliveau C, Saad F, Duplan D, Petit C, Delouya G, Taussky D, Barkati M, Lambert C, Beauchemin MC, Clavel S, Mok G, Igidbashian L, Gauthier-Paré AS, Nguyen TV, McLaughlin PY, Keu KV, DaSilva JN, Juneau D, Ménard C	prostate-specific membrane antigen positron emission tomography ( psma-pet ) offer superior accuracy in detect prostate cancer lesion lead to intensify radiotherapy ( rt ) , but it impact on patient outcome be still undefined . to evaluate whether intensification of salvage rt ( srt ) after radical prostatectomy ( rp ) guide by psma-pet ( psmaisrt ) be associate with improved failure-free survival ( ffs ) . design , set , psmaisrt be a stratified cohort within a large psma-guided intensification of radiotherapy ( psmagrt ) trial , a phase 2 , two-center , registry-based randomized clinical trial . patient with biochemical recurrence follow rp who be eligible for standard-of-care ( soc ) srt from may 2018 to february 2021 , be eligible for randomization in the psmaisrt stratum . a total of 130 patient be randomize , with 2 who do not proceed to radiotherapy ( rt ) . the cutoff date for the primary analysis be october 26 , 2023. patient be randomize in a 1:1 ratio to receive either soc srt to the prostate bed , with or without elective pelvic rt , with or without adjuvant hormonal therapy ( ht ) , or psma-pet/ct-guided srt , intensify to detect site of disease . the primary end point be ffs , define a psa progression ( psa nadir > 0.2 ng/ml ) , radiological progression , next-line therapy initiation , or death . among 128 patient ( median [ iqr ] age , 71 [ 64-74 ] year ) , median ( range ) psa at enrollment be 0.3 ( 0.1-3.0 ) ng/ml . in the psmaisrt group , 33 of 64 patient ( 52 % ) receive intensified srt ; with addition of pelvic rt ( n = 16 [ 25 % ] ) , metastasis-directed rt ( n = 2 [ 3 % ] ) , lymph node boost ( n = 19 [ 30 % ] ) , or prostate bed boost ( n = 15 ) . adjuvant hormone therapy be equally prevalent in both arm ( 55 [ 86 % ] control vs 54 [ 84 % ] psmaisrt ) . at a median ( range ) follow-up of 37 ( 7-60 ) month , psmaisrt improve ffs ( hazard ratio [ hr ] , 0.50 ; 95 % ci , 0.27-0.94 ; p = .04 ) and eugonadal ffs ( hr , 0.45 ; 95 % ci , 0.21-0.96 ; p = .03 ) , with it great benefit in the subgroup with psa of 0.3 ng/ml or more ( hr , 0.17 ; 95 % ci , 0.04-0.79 ; p = .01 ) . few next-line treatment event occur in the psmaisrt arm ( 4 vs 12 ; hr , 0.32 ; 95 % ci , 0.11-1.02 ; p = .04 ) . there be no significant difference in toxic effect or quality of life between arm . this phase 2 trial demonstrate an isotoxic improvement in cancer control with psma-pet-guided intensification of srt after rp . confirmatory evidence be await from a subsequently accrue phase 3 trial . clinicaltrials.gov nct03525288 .	JAMA oncology	02/10/2025
10.1186/1471-2407-8-221	esophageal cancer risk by type of alcohol drinking and smoking : a case-control study in spain .	Vioque J, Barber X, Bolumar F, Porta M, Santibáñez M, de la Hera MG, Moreno-Osset E	the effect of tobacco smoking and alcohol drinking on esophageal cancer ( ec ) have never be explore in spain where black tobacco and wine consumption be quite prevalent . we estimate the independent effect of different alcoholic beverage and type of tobacco smoking on the risk of ec and it main histological cell type ( squamous cell carcinoma ) in a hospital-based case-control study in a mediterranean area of spain . we only include incident case with histologically confirm ec ( n = 202 ) . control be frequency-matched to case by age , sex and province ( n = 455 ) . information on risk factor be elicit by trained interviewer use structured questionnaire . multiple logistic regression be use to estimate adjust odds ratio and 95 % confidence interval ( ci ) . alcohol drinking and tobacco smoking be strong and independent risk factor for esophageal cancer . alcohol be a potent risk factor with a clear dose-response relationship , particularly for esophageal squamous-cell cancer . compare to never-drinkers , the risk for heavy drinker ( > or = 75 g/day of pure ethanol ) be 7.65 ( 95 % ci , 3.16-18.49 ) ; and compare with never-smokers , the risk for heavy smoker ( > or = 30 cigarettes/day ) be 5.07 ( 95 % ci , 2.06-12.47 ) . a low consumption of only wine and/or beer ( 1-24 g/d ) do not increase the risk whereas a strong positive trend be observe for all type of alcoholic beverage that include any combination of hard liquor with beer and/or wine ( p-trend < 0.00001 ) . a significant increase in ec risk be only observed for black-tobacco smoking ( 2.5-fold increase ) , not for blond tobacco . the effect for alcohol drinking be much strong when the analysis be limit to the esophageal squamous cell carcinoma ( n = 160 ) , whereas a lack of effect for adenocarcinoma be evidence . smoke cessation show a beneficial effect within ten year whereas drinking cessation do not . our study show that the risk of ec , and particularly the squamous cell type , be strongly associate with alcohol drinking . the consumption of any combination of hard liquor seem to be harmful whereas a low consumption of only wine may not . this may relate to the presence of certain antioxidant compound find in wine but practically lack in liquor . tobacco smoking be also a clear risk factor , black more than blond .	BMC cancer	01/08/2008
10.3389/fimmu.2025.1614702	integrate bioinformatics and experimental validation to reveal a novel vrk score a a prognostic and therapeutic biomarker in hepatocellular carcinoma .	Fu Z, Liu D, Chen M, Zhong G, Zhao Z, Gong J, Dai X, Hu J, Jia D, Cheng L, Cai D, Gong J	vaccinia-related kinase ( vrk ) family gene play a multifunctional role in tumor development . however , the role of vrk family gene in hepatocellular carcinoma ( hcc ) require further research . moreover , the clinical potential of the vrk-related model remain unclear . the aim of this study be to construct a vrk-related model to predict hcc prognosis and therapeutic efficacy . the data of hcc patient be extract from the cancer genome atlas ( tcga ) , international cancer genome consortium ( icgc ) , and gene expression omnibus ( geo ) databases . the single-sample gene set enrichment analysis ( ssgsea ) algorithm be use to calculate the vrk score of each sample . tumor immune estimation resource 2.0 ( timer 2.0 ) and tumor immune dysfunction and exclusion ( tide ) be use to evaluate immune cell infiltration and the immune checkpoint response . prrophetic be use for predict drug sensitivity . cck-8 , colony formation , wound healing , transwell and xenograft assay be use to experimentally validate the biofunction of vrk2 in hcc . we find that all vrk family gene be highly express in hcc . compare with patient with low vrk score , patient with high vrk1 or vrk2 expression in the tcga , icgc , and gse14520 cohort have poorer outcomes . moreover , patient with a high vrk score in the tcga , icgc , and gse14520 cohort also have poorer outcomes . importantly , cox analysis reveal that the vrk score be a potential independent risk factor for hcc . notably , timer2.0 and tide suggest that patient with high vrk score have high immune checkpoint response rate . similarly , drug sensitivity analyse suggest that patient with high vrk score be more resistant to sorafenib , paclitaxel , cisplatin , and gemcitabine . finally , experimental validation reveal that vrk2 knockdown inhibit hcc development in vitro and in vivo . the vrk score be find to be a reliable indicator for predict hcc prognosis and therapeutic efficacy . vrk2 be a potential therapeutic target for hcc .	Frontiers in immunology	01/01/2025
10.1016/j.neuron.2025.09.006	segregate supramammillary-dentate gyrus circuit modulate cognitive and affective function in healthy and alzheimer 's disease model mouse .	Luo YJ, Li L, Chen ZK, Dong P, Xie L, Farmer WT, Yu QS, Jiang LX, Su WK, Liu HS, Wang HZ, Jiao ZL, Melville DJ, Penel E, Sheehy RN, Landry T, Wang J, Jiang H, Xu XH, Chen X, Xu NJ, Xue T, Xu TL, Li YD, Song J	while progressive cognitive decline be the define feature of alzheimer 's disease ( ad ) , many patient also develop prominent neuropsychiatric symptom , include anxiety and depression . the circuit-level mechanism underlie these distinct symptom domain remain poorly understood , and treatment that address both cognitive and noncognitive aspect of ad be limit . here , we identify anatomically , molecularly , and functionally distinct subpopulation of supramammillary ( sum ) neuron that project to either the dorsal or ventral dentate gyrus ( ddg or vdg ) . these distinct sum neuron and their sum-dg subcircuits selectively regulate memory and emotion , respectively . in ad model mouse , sum neuron target ddg or vdg display aberrant activity during memory or emotional processing , and importantly , target optogenetic activation of sum-ddg or sum-vdg pathway selectively restore cognitive or affective function . these finding reveal sum-dg subcircuits a parallel modulators of cognitive and emotional state and highlight their potential a therapeutic target for address the multifaceted symptomatology of ad .	Neuron	03/10/2025
10.1016/j.ajpath.2020.01.007	identification of lacrimal gland postganglionic innervation and it regulation of tear secretion .	Jin K, Imada T, Hisamura R, Ito M, Toriumi H, Tanaka KF, Nakamura S, Tsubota K	tear fluid secrete from the exocrine lacrimal gland ( lg ) have an essential role in maintain a homeostatic environment for a healthy ocular surface . tear secretion be regulate by the sympathetic and parasympathetic component of the autonomic nervous system , although the contribution of each component be not fully understood . to investigate lg innervation , we identify sympathetic and parasympathetic postganglionic nerve , specifically innervate the mouse lg , by inject a retrograde neuronal tracer into the lg . interruption of neural stimulus to the lg by the denervation of these postganglionic nerve immediately and chronically decrease tear secretion , lead to lg atrophy along with destruction of the lobular structure . this investigation also find that parasympathetic , but not sympathetic , innervation be involve in these alteration .	The American journal of pathology	01/01/2020
10.1038/s41590-025-02289-2	chemotherapy-induced ca-repeat dna fragment in breast cancer trigger antitumor immune response .	Zhang X, Huang P, Chen H, Yang C, Yang X, Liu Y, Wu B, Zeng W, Saw PE, Ye S, Li J, Wang J, Wu Z, Wang J, Li H, Huang JD, Zeng M, Li M, Liu Q, Su S, Song E, Chen J	damage-associated molecular pattern generate by cancer treatment can modulate antitumor immunity , but the underlying mechanism of this effect be unclear . here we show that ca-enriched dna fragment result from dna-damaging chemotherapy in msh2-low tumor preferentially bind cgas with strong affinity and form biomolecular condensate by phase separation in the cytoplasm , result in antitumor immunity . however , classical ca-poor dna release from msh2-high tumor cell engage aim2 , result in immunosuppression by upregulating pd-l1 and ido . intratumoral administration of ca-rich dna fragment enhance antitumor immunity in syngrafted pymt tumor . clinically , ca-rich dna abundance in breast cancer follow chemotherapy be associate with increased tumor-antigen-reactive t cell and good chemotherapeutic response . therefore , different tumor dna fragment can trigger oppose immune response depend on their preference for differential sensor . this study highlight another mechanistic link between genome instability and immune modulation and the therapeutic potential of ca-rich dna to enhance antitumor immunity .	Nature immunology	29/09/2025
10.1016/j.ccell.2025.09.002	ketogenic diet inhibits glioma progression by promote gut microbiota-derived butyrate production .	Chen ML, He Y, Dong XH, Liu HF, Yan ZX, Lu XL, Miao QQ, Zhao QN, Zhang H, Luo L, Wang S, Li JY, Xiang DF, Lin Y, Li TR, Zhou XY, Zhou YY, Mao M, Zhang X, Wei H, Shi Y, Liu XD, Ping YF, Bian XW	the ketogenic diet ( kd ) be a potential therapeutic strategy for glioma ; however , the underlying mechanism remain unclear . herein , we first identify that glioma patient exhibit a distinct gut microbial profile characterize by reduced butyrate-producing bacteria abundance , particularly r. faecis , along with decreased butyrate level . notably , kd reshape the gut microbiota especially enrich a. muciniphila in a mucin-2-dependent manner , elevate butyrate production , and activate caspase-3 in microglia . these change promote an anti-tumor microglial phenotype , ultimately suppress glioma progression in mouse . crucially , kd 's anti-glioma effect be notably abolish by antibiotic treatment ; germ-free condition ; or specific depletion of mucin-2 , microglia , or microglial caspase-3 . furthermore , butyrate , a. muciniphila , r. faecis , or a. muciniphila plus r. faecis restores kd-induced microglial caspase-3 activation and the anti-tumor phenotype of microglia in antibiotics-treated or germ-free mouse . these finding highlight that target the gut microbiota by kd or supplement with butyrate could be an effective strategy for glioma therapy .	Cancer cell	25/09/2025
10.1148/radiol.233057	amplify research : the potential for podcasts to boost radiology journal article exposure .	Wang M, Le T, Leswick DA	background podcasts have become an increasingly popular method of communicate information in medicine , include in radiology . however , the effect of podcasts on the reach of journal article remain unclear . purpose to evaluate the influence of radiology podcasts on the performance metric , include downloads , citation , and altmetric attention score ( aa ) , of radiology article . material and method this be a retrospective study . all article publish in the print version of radiology from january 2021 to december 2022 be review ; editorial and case report be exclude . article feature on radiology podcasts be include in the podcast group . article publish within the same journal issue and category be the nonpodcast group . downloads , google scholar citation , dimension citation , and aas metric be record . the mann-whitney u test be use to compare median and evaluate difference between old and more recently publish article . result the podcast group , compose of 88 article , exhibit significantly high median value for downloads ( pg , 4521.0 ; nonpodcast group , 2123.0 ; p < .001 ) , google scholar citation ( podcast group , 14.5 ; nonpodcast group , 10.0 ; p = .01 ) , dimension citation ( podcast group , 12.0 ; nonpodcast group , 9.0 ; p = .01 ) , and aa ( podcast group , 43.0 ; nonpodcast group , 10.0 ; p < .001 ) compare with the nonpodcast group of 378 article . within both group , article publish in the early nonpodcast group ( january to june 2021 ) have high downloads ( podcast group , p = .08 ; nonpodcast group , p < .001 ) , google scholar citation ( podcast group and nonpodcast group , p < .001 ) , and dimension citation ( podcast group and nonpodcast group , p < .001 ) than article from the late period ( july to december 2022 ) . aas markedly increase in recent podcast article ( p = .03 ) , but aa for nonpodcast article significantly decrease over time ( p = .01 ) . conclusion radiology article feature on the radiology podcast have great median metric , include downloads , google scholar citation , dimension citation , and aas , compare with nonpodcast article , suggest that podcasts can be an effective method of disseminate and amplify research within the field of radiology . © rsna , 2024 see also the editorial by chu and nicola in this issue .	Radiology	01/01/2021
10.1038/s41584-025-01302-0	glucagon-like peptide-1 receptor agonist in arthritis : current insight and future direction .	Karacabeyli D, Lacaille D	obesity affect nearly one in six adult worldwide . excess adiposity be a pro-inflammatory state associate with increased risk of several type of arthritis , increase arthritis disease activity and/or severity , and poor response to certain treatment . obesity be a major risk factor for cardiovascular disease , the lead cause of death in people with common arthritides such a osteoarthritis ( oa ) , gout , rheumatoid arthritis , psoriatic arthritis and axial spondyloarthritis . glucagon-like peptide-1 receptor agonist ( glp-1ras ) be a promising therapeutic option for people with arthritis and obesity or type 2 diabetes mellitus owe to their pleiotropic effect , include weight loss , improve survival and reduced risk of major cardiovascular and renal event . in vitro and preclinical in vivo experiment in arthritis have uncover weight-loss-independent anti-inflammatory and chondroprotective property of glp-1ras . in knee oa , clinical data suggest that glp-1ras improve pain and function and reduce the risk of surgical intervention ; however , their effect on oa incidence remain incompletely understood . evidence suggest that glp-1ras do not directly prevent gout attack , but be effective in manage cardiometabolic condition commonly associate with gout and other arthritides . more research be need to clarify the effect of glp-1ras on incidence , disease activity , and progression of rheumatoid arthritis , psoriatic arthritis and axial spondyloarthritis .	Nature reviews. Rheumatology	01/10/2025
10.1016/j.lanmic.2025.101174	rapid pan-microbial metagenomics for pathogen detection and personalised therapy in the intensive care unit : a single-centre prospective observational study .	Alcolea-Medina A, Snell LB, Humayun G, Al-Yaakoubi N, Ward D, Alder C, Patel V, Vivian F, Meadows CIS, Wyncoll D, Paul R, Barratt N, Batra R, Edgeworth J, Nebbia G, Whitehorn J	most clinical metagenomic study do not provide rapid result , detect pathogen from all microbial kingdom , or measure clinical impact . we aim to evaluate the feasibility , performance , and clinical impact of a rapid pan-microbial respiratory metagenomic service for patient admit to intensive care unit ( icu ) . this be a single-centre observational study of a rapid metagenomics service that test respiratory sample from icu patient at guy 's and st thomas ' hospital , london , uk , between dec 5 , 2023 , and april 12 , 2024. test use a previously publish pan-microbial metagenomics workflow , which simultaneously detect bacteria , fungi , and dna and rna virus ; provide same-day preliminary result after 2 h ; and provide final result after 24 h. patient be include if they be age 18 year or old , admit to the icu , have confirm respiratory failure require supplemental oxygen or advance airway support , and have at least one of the following : ( 1 ) clinical suspicion of low respiratory tract infection base on clinical , biochemical , or radiological finding , ( 2 ) sepsis of unknown origin , and ( 3 ) concern from an intensive care physician regard inflammatory pathology . patient with a suspected or confirmed containment level three organism be exclude . the outcome be performance characteristic of the metagenomic test compare with routine diagnostic testing , detection of additional pathogen by metagenomics , change in antimicrobial prescribing within 24 h of test , and initiation of immunomodulation . we process 114 sample ( 1-5 per day ) from 74 patient ( 39 [ 53 % ] female and 35 [ 47 % ] male ) . 107 ( 94 % ) of 114 sample pass quality control , of which 101 ( 94 % ) provide same-day preliminary result . bacteria be detect in 45 ( 43 % ) of 104 tested specimen , fungal organism in 17 ( 16 % ) of 104 tested specimen , and virus in 28 ( 34 % ) of 83 tested specimen . sensitivity in low respiratory tract sample after 24 h be 97 % ( 95 % ci 87-100 ) for bacteria , 89 % ( 65-99 ) for fungi , and 89 % ( 71-98 ) for virus , with only one false positive for bacteria . metagenomics identify 42 pathogen not detect by other test in 32 ( 30 % ) of 107 sample . antimicrobial therapy be change after metagenomic result from 30 ( 28 % ) of 107 sample : 22 ( 21 % ) be de-escalated and eight ( 7 % ) be escalate . metagenomics contribute to the initiation of immunomodulation in 15 ( 20 % ) of 74 patient for a range of inflammatory condition . pathogen with clinical significance to local infection control or national public health be find in ten ( 14 % ) of 74 patient , include three invasive group a streptococci , two parvovirus b19 , and one each of hiv-1 , measles virus , mycobacterium tuberculosis , neisseria meningitidis , and mycoplasma pneumoniae . respiratory metagenomics for icu patient show good performance and turnaround time , and diverse clinical and public health benefit . this ability to inform both personalised patient therapy and infectious disease surveillance need evaluation in multicentre study . none .	The Lancet. Microbe	01/10/2025
10.1155/crp/9292002	the relationship between the fibrinogen-to-albumin ratio and short-term mortality in chinese patient with chronic heart failure : a retrospective cohort analysis .	Guo LL, Liu P, Cai LN, Hu L, Zhou YS	background : recent study have identify an association between the fibrinogen-to-albumin ratio ( far ) and the prognosis of coronary heart disease ; however , evidence regard it significance in heart failure patient remain limited . this study aim to examine the relationship between the far and short-term mortality among individual with heart failure . method : in this retrospective cohort study , we conduct an analysis of clinical data from patient with heart failure who be hospitalize at zigong fourth people 's hospital from december 2016 to june 2019. the primary exposure variable be the far , while the outcome of interest be mortality rate at 28 day and 3 month . multivariate logistic regression evaluate far 's independent association with short-term mortality , with predictive accuracy assess via roc curve and subgroup consistency through stratified analysis . furthermore , smooth curve fitting be utilize to investigate the linear relationship , and a series of sensitivity analysis be conduct to validate the robustness of the finding . result : the analysis include 1880 participant , of whom 58.1 % be female and 54.1 % be age 60-80 year . our study show that a one standard deviation rise in the far be link to a 45 % increase in 28-day mortality ( or = 1.45 , 95 % ci = 1.02-2.06 , p=0.04 ) after adjust for potential confounding factor . the 28-day mortality rate be markedly elevate in the high far group ( far > 0.126 ) compare to the low far group ( or = 4.01 , 95 % ci = 1.17-13.82 , p=0.028 ) . comparable finding be note at the 3-month mark . there be no significant interaction find in the subgroup analysis . a linear association be identify between far and short-term mortality . the optimal far cutoff value for predict 28-day mortality be 0.156 ( sensitivity 68.0 % , specificity 59.4 % , auc = 0.654 ) , while for 3-month mortality , it be 0.156 ( sensitivity 68.0 % , specificity 58.3 % , auc = 0.647 ) . sensitivity analyse corroborate the robustness of our finding . conclusion : a positive correlation exist between the far and short-term mortality among chinese patient with heart failure . these finding underscore the necessity for further investigation into the underlying pathophysiological mechanism and potential therapeutic intervention associate with far in the context of heart failure .	Cardiology research and practice	01/01/2025
10.1038/s41569-025-01211-5	takotsubo syndrome : pathophysiological insight and innovation in patient care .	Omerovic E, Redfors B	takotsubo syndrome , also know a broken heart syndrome , be first describe in japan in the 1990s and present a acute heart failure cause by transient contractile dysfunction that mimic acute coronary syndrome but be not cause by acute coronary obstruction . takotsubo syndrome account for as much a 2-3 % of suspected coronary syndrome and be considerably more common in woman than in men . in this review , we discuss the historical background and clinical feature of takotsubo syndrome and our evolve understanding of it pathophysiology . the hallmark feature of takotsubo syndrome be transient left ventricular dysfunction link to emotional or physical stressor . despite advance in our understanding of the clinical presentation and possible pathophysiological mechanism of takotsubo syndrome , this condition continue to challenge our fundamental understanding of human anatomy and physiology , particularly regard how acute emotional and physical stressor can trigger such profound cardiovascular dysfunction . although the definitive mechanism remain elusive , current hypothesis largely centre on catecholamine surge and sympathetic nervous system hyperactivation . diagnostic criterion have be develop by the mayo clinic and european society of cardiology work group but , in the absence of randomize controlled clinical trial , no specific treatment for takotsubo syndrome be available . in this review , we highlight the complex pathophysiology of takotsubo syndrome , with an emphasis on the interplay between emotional stress and cardiac health , and call for the development of evidence-based management protocol .	Nature reviews. Cardiology	02/10/2025
10.1038/s41380-025-03292-7	transcranial temporal interference stimulation for treat bipolar disorder with depressive episode : a feasibility study .	Zhou H, Wang M, Qi S, Chen Q, Lai J, Wu Z, Liu R, Wang L, Zhou H, Zhang S, Hu S	bipolar depression ( bd-d ) be a significant clinical challenge associate with high disease burden . transcranial temporal interference stimulation ( ttis ) , a novel and noninvasive approach for target deep brain structure , be investigate for it efficacy and safety in bd-d patient in this trial . thirty-six patient be recruit for a single-arm , open-label trial , and 25 complete the 5-day intervention consisting of 10 ttis session target the left nucleus accumbens . each session last 20 min , with a maximum current intensity of 2 ma and an envelope stimulation frequency of 40 hz . significant symptom reduction be observe follow treatment , with mean hamd-17 score decrease from 23.36 to 16.16 ( p < 0.0001 ) , madrs score from 39.12 to 31.28 ( p < 0.01 ) , hama score from 19.68 to 15.44 ( p < 0.05 ) , and qids score from 13.52to 9.68 ( p < 0.001 ) . eleven participant ( 44.0 % ) meet improvement criterion and seven ( 28.0 % ) achieve response . cognitive assessment indicate improvement in memory and executive function , and change in reward-related brain activity correlate positively with symptom reduction . adverse event be mild , mainly transient scalp discomfort . these finding provide preliminary evidence support the efficacy and safety of ttis for alleviate depressive symptom and cognitive impairment in bd-d .	Molecular psychiatry	02/10/2025
10.7326/ANNALS-24-01863	association between body composition and cardiometabolic outcome : a prospective cohort study .	Jung M, Reisert M, Rieder H, Rospleszcz S, Lu MT, Bamberg F, Raghu VK, Weiss J	current measure of adiposity have limitation . artificial intelligence ( ai ) model may accurately and efficiently estimate body composition ( bc ) from routine imaging . to assess the association of ai-derived bc compartment from magnetic resonance imaging ( mri ) with cardiometabolic outcome . prospective cohort study . uk biobank ( ukb ) observational cohort study . 33 432 ukb participant with no history of diabetes , myocardial infarction , or ischemic stroke ( mean age , 65.0 year [ sd , 7.8 ] ; mean body mass index [ bmi ] , 25.8 kg/m ( 2 ) [ sd , 4.2 ] ; 52.8 % female ) who underwent whole-body mri . an ai tool be apply to mri to derive 3-dimensional ( 3d ) bc measure , include subcutaneous adipose tissue ( sat ) , visceral adipose tissue ( vat ) , skeletal muscle ( sm ) , and sm fat fraction ( smff ) , and then calculate their relative distribution . sex-stratified association of these relative compartment with incident diabetes mellitus ( dm ) and major adverse cardiovascular event ( mace ) be assess use restrict cubic spline . adipose tissue compartment and smff increase and sm decrease with age . after adjustment for age , smoking , and hypertension , great adiposity and low sm proportion be associate with high incidence of dm and mace after a median follow-up of 4.2 year in sex-stratified analysis ; however , after additional adjustment for bmi and waist circumference ( wc ) , only elevate vat proportion and high smff ( top fifth percentile in the cohort for each ) be associate with increase risk for dm ( respective adjust hazard ratio [ ahrs ] , 2.16 [ 95 % ci , 1.59 to 2.94 ] and 1.27 [ ci , 0.89 to 1.80 ] in female and 1.84 [ ci , 1.48 to 2.27 ] and 1.84 [ ci , 1.43 to 2.37 ] in male ) and mace ( 1.37 [ ci , 1.00 to 1.88 ] and 1.72 [ ci , 1.23 to 2.41 ] in female and 1.22 [ ci , 0.99 to 1.50 ] and 1.25 [ ci , 0.98 to 1.60 ] in male ) . in addition , in male only , those in the bottom fifth percentile of sm proportion have increase risk for dm ( ahr for the bottom fifth percentile of the cohort , 1.96 [ ci , 1.45 to 2.65 ] ) and mace ( ahr , 1.55 [ ci , 1.15 to 2.09 ] ) . result may not be generalizable to non-whites or people outside the united kingdom . artificial intelligence-derived bc proportion be strongly associate with cardiometabolic risk , but after bmi and wc be account for , only vat proportion and smff ( both sex ) and sm proportion ( male only ) add prognostic information . none .	Annals of internal medicine	30/09/2025
10.1002/jmv.1890420413	acute sporadic hepatitis e in kuwait .	Koshy A, Richards AL, al-Mufti S, Grover S, Shabrawy MA, Pacsa A, al-Anezi H, al-Nakib B, Burans J, Carl M, et al.	fifty-seven adult patient with acute hepatitis and 34 comparison patient without liver disease be evaluate use a newly develop western blot assay for igm antibody to hepatitis e virus . the mean age of patient with hepatitis be 32 year ( range , 18-55 year ) ; 88 % be male . among patient with acute hepatitis , hepatitis a ( anti-hav igm positive ) be diagnose in two ( 4 % ) , hepatitis b ( anti-hbc igm positive ) in three ( 5 % ) , and hepatitis e ( anti-hev igm positive ) in 34 ( 60 % ) . one hepatitis patient have cmv igm , another have ebv igm , and 16 others ( 28 % ) be negative for all serologic marker of acute viral hepatitis . no patient with acute hepatitis a or b and none of the comparison patient without acute hepatitis have anti-hev igm . all but one case of acute hepatitis e be find among expatriate of asian origin , and acute hepatitis e be associate significantly with recent travel to the indian subcontinent . these data suggest that acute hepatitis e be common among foreign worker in kuwait but that little hev transmission be occur directly in kuwait .	Journal of medical virology	01/01/2041
10.1038/s41591-025-03933-y	clinical validation of an ai-based blood test device for diagnosis and prognosis of acute infection and sepsis .	Liesenfeld O, Arora S, Aufderheide TP, Clements CM, DeVos E, Fischer M, Giamarellos-Bourboulis EJ, House S, Humphries RL, Gill JK, Liu E, Mace SE, May L, Michelson E, Osborn TM, Panacek E, Rothman RE, Self WH, Smithline HA, Steingrub J, Van Heukelom P, Weissman A, Wilson M, Wolk DM, Wright DW, Buturovic L, Hasin-Brumshtein Y, Damaraju N, Lu C, Shak JR, Whitfield NN, Khatri P, Sweeney TE, Shapiro NI	lack of reliable diagnostics for the presence , type and severity of infection in patient present to emergency department with non-specific symptom pose considerable challenge . we develop triverity , which use isothermal amplification of 29 mrna and machine learn algorithm on the myrna instrument to determine likelihood of bacterial infection , viral infection and need for critical care intervention within 7 day . to validate triverity , the sepsis-shield study enrol 1,222 patient with clinically adjudicate infection status and need for critical care intervention within 7 day a endpoint . the triverity bacterial and viral score have high accuracy than c-reactive protein , procalcitonin or white blood cell count for the diagnosis of bacterial infection with area under the receiver operate characteristic ( auroc ) of 0.83 , and viral infection ( auroc = 0.91 ) . the triverity severity score have an auroc of 0.78 for predict illness severity and allow reclassification of risk for critical care intervention compare to clinical assessment ( quick sequential organ failure assessment ) alone . each of the three score have rule-in specificity > 92 % and rule-out sensitivity > 95 % . comparison of antibiotic administration at presentation with post-follow-up adjudication find that triverity could potentially reduce false positive and false negative for inappropriate antibiotic use by 60-70 % . further clinical testing in an interventional setting be need to prove actionability and clinical benefit of triverity .	Nature medicine	30/09/2025
10.1038/s41551-025-01496-4	large-scale visualization of α-synuclein oligomers in parkinson 's disease brain tissue .	Andrews R, Fu B, Toomey CE, Breiter JC, Lachica J, Beckwith JS, Tian R, Brock EE, Needham LM, Chant GJ, Loiseau C, Deconfin A, Baspin K, Popovic R, Evans J, Goh Y, Kurt B, Senicar L, Edmonds M, Bartels T, Bengoa-Vergniory N, Magill PJ, Jaunmuktane Z, Freeman OJ, Taylor BJM, Hardy J, Lashley T, Ryten M, Vendruscolo M, Wood NW, Weiss LE, Gandhi S, Lee SF	parkinson 's disease ( pd ) be a neurodegenerative condition characterize by the presence of intraneuronal aggregate contain fibrillar ɑ-synuclein know a lewy body . these large end-stage specie be form by small soluble protein nanoscale assembly , often term oligomers , which be propose a early driver of pathogenesis . until now , this hypothesis have remain controversial , at least in part because it have not be possible to directly visualize nanoscale assembly in human brain tissue . here we present advanced sensing of aggregates-parkinson 's disease , an image method to generate large-scale α-synuclein aggregate map in post-mortem human brain tissue . we combine autofluorescence suppression with single-molecule fluorescence microscopy , which together enable the detection of nanoscale α-synuclein aggregate . to demonstrate the use of this platform , we analyse ~1.2 million nanoscale aggregate from the anterior cingulate cortex in human post-mortem brain sample from patient with pd and healthy control . our data reveal a disease-specific shift in a subpopulation of nanoscale assembly that represent an early feature of the proteinopathy that underlie pd . we anticipate that quantitative information about this distribution provide by advanced sensing of aggregates-parkinson 's disease will enable mechanistic study to reveal the pathological process cause by α-synuclein aggregation .	Nature biomedical engineering	01/10/2025
10.1183/13993003.01126-2025	european respiratory society clinical practice guideline for the management of adult bronchiectasis .	Chalmers JD, Haworth CS, Flume P, Long MB, Burgel PR, Dimakou K, Blasi F, Herrero-Cortina B, Dhar R, Chotirmall SH, Ringshausen FC, Altenburg J, Morgan L, Nigro M, Crichton ML, Van Meel C, Sibila O, Timothy A, Kompatsiari E, Hedberg T, Vandendriessche T, McShane PJ, Tonia T, Winthrop K, Loebinger MR, Lorent N, Goeminne P, Shteinberg M, Polverino E, Aliberti S	bronchiectasis be a common lung condition associate with wide range of infectious , immunological , autoimmune , allergic and genetic condition . exacerbation and daily symptom have the large impact on patient and healthcare system , and they be the key focus of treatment . current practice be heterogeneous globally , and bronchiectasis have historically be a neglected disease . here , we present evidence-based international guideline for the management of adult with bronchiectasis . a european respiratory society ( er ) task force , comprise global expert , a methodologist , and patient representative , develop clinical practice guideline in accordance with er methodology and the grade ( grade of recommendation , assessment , development and evaluation ) approach . systematic literature search , data extraction , and meta-analysis be perform to generate evidence table , and recommendation be formulate use the evidence-to-decision framework . a total of 8 pico ( patient , intervention , comparator , outcomes ) question and 3 narrative question be develop . the task force recommendation include strong recommendation in favour of airway clearance technique for most patient with bronchiectasis and pulmonary rehabilitation for those with impaired exercise capacity . we issue a strong recommendation for the use of long-term macrolide treatment for patient at high risk of exacerbation and a strong recommendation in favour of long-term inhaled antibiotic in patient with chronic pseudomonas aeruginosa infection at high risk of exacerbation . conditional recommendation support the use of eradication treatment or mucoactive drug in specific circumstance . we suggest not to routinely use long term oral , non-macrolide antibiotic treatment or inhaled corticosteroid . additional guidance be also provide on test for underlying cause , manage exacerbation , and manage the deteriorating patient . the er bronchiectasis guideline provide an evidence-based framework for optimal management of adult with bronchiectasis and serve a a benchmark for evaluate the quality of care . the european respiratory society ( er ) guideline for the management of bronchiectasis in adult provide evidence-based recommendation for the care of people with clinically significant bronchiectasis , define by the presence of permanent dilatation of the bronchi evident on chest ct scan , along with characteristic clinical symptom . [ 1 ] these guideline be intend for all healthcare professional involve in the care of adult with bronchiectasis , as well a for policymakers , regulatory authority , and pharmaceutical company . bronchiectasis be a complex and heterogeneous disease ; therefore , no guideline can be entirely comprehensive or replace clinical judgement . all guideline recommendation must be interpret within the specific clinical context in which they be apply . separate er guideline for the management of bronchiectasis in child exist [ 2 ] . bronchiectasis due to cystic fibrosis ( cf ) have a distinct evidence base ; therefore , guidance for the management of cf be provide elsewhere . [ 3 ] some bronchiectasis-associated condition also have distinct guideline for investigation and management , such a primary ciliary dyskinesia ( pcd ) [ 4 ] , allergic bronchopulmonary aspergillosis ( abpa ) [ 5 ] and non-tuberculous mycobacterial ( ntm ) pulmonary disease [ 6 ] . while the present guideline apply for these condition , they should be interpret in conjunction with the relevant syndrome-specific recommendation .	The European respiratory journal	28/09/2025
10.1016/j.phymed.2025.157312	zhenqi fuzheng granule target the scfas-gpr109a axis to enhance pd-1 antibody efficacy via immunometabolic remodel in colorectal cancer .	Guo L, Yi J, Zhang A, Zheng X, Wang M, Yang F, Kong X, Meng J	immune checkpoint inhibitor ( icis ) , particularly pd-1 antibody , represent a breakthrough in colorectal cancer ( crc ) treatment . however , their clinical efficacy remain limited by tumour-induced immunosuppression . traditional chinese medicine ( tcm ) have attract grow interest a a potential adjuvant to immunotherapy . zhenqi fuzheng granule ( zqfz ) be a clinically approve herbal prescription widely use a an adjuvant therapy for crc , yet it mechanistic underpinnings remain elusive . to investigate how zqfz improve the efficacy in crc , with emphasis on gut microbiota modulation , scfas production , and downstream immunometabolic pathway involve gpr109a , and confirm that butyrate play an important role in colorectal cancer inhibition . phytochemical analysis of zqfz be conduct use lc-ms/ms and uplc-ms/ms , identify and quantify seven major compound . in vivo experiment , aom/dss-induced crc mouse model be treat with zqfz , pd-1 antibody , or their combination . tumour progression , body weight , and survival be monitor . gut microbial composition and colonic scfas level be assess via 16 rrna sequence and gas chromatography . rt-qpcr be employ to validate the expression of key gene associate with the gpr109a/akt/mtor/hif-1α signaling pathway . molecular change in the gpr109a/akt/mtor/hif-1α pathway be evaluate through western blotting , transcriptomic , and proteomic analysis . immune cell infiltration and phenotype be analyze by flow cytometry . molecular docking and molecular dynamic simulation be conduct to predict the binding affinity and structural stability between gpr109a and akt1 . the interaction between gpr109a and akt1 , as well a between butyrate and gpr109a , be far validate in vitro use microscale thermophoresis ( mst ) assay . to evaluate the microbial basis of zqfz activity , antibiotic-pretreated mouse receive zqfz-derived fecal microbiota transplantation ( fmt ) . in vitro experiment , to investigate the mechanism by which sodium butyrate ( nab ) , the major gut microbial metabolite of zqfz , inhibit glycolysis in colorectal cancer under hypoxic condition , cck-8 assay , flow cytometry , lactate measurement , and western blotting be perform to assess cell viability , apoptosis , lactate production , and the expression of akt/mtor/hif-1α and glycolysis-related protein . lc-ms/ms profiling identify multiple bioactive constituent in zqfz . target uplc-ms/ms quantification reveal that the formulation contain adenosine ( 0.87mg/g ) , salidroside ( 0.11 mg/g ) , astragaloside iv ( 0.07 mg/g ) , calycosin ( 0.03 mg/g ) , formononetin ( 6.7 μg /g ) , chlorogenic acid ( 1.4 μg/g ) , apigenin ( 0.5 μg/g ) . in vivo study , both zqfz and pd-1 antibody inhibit tumour growth , with the combination treatment exert the most pronounced antitumour effect . zqfz reshape the gut microbiota , increase the level of short-chain fatty acid ( scfas ) , particularly butyrate , and activate the gpr109a pathway , lead to downregulation of the akt/mtor/hif-1α signaling axis , suppression of hk2 expression and lactate production , and consequent inhibition of glycolysis . immune remodeling be also observe , include reduce infiltration of myeloid-derived suppressor cell ( mdscs ) , polarization of macrophage toward the m1 phenotype , restoration of the cd4⁺/cd8⁺ t cell ratio , and modulation of serum cytokine include upregulation of il-2 , il-12 , and ifn-γ , along with downregulation of il-4 and il-10 . zqfz-derived fmt significantly inhibit tumour growth , suppress glycolysis-related marker ( pkm2 , glut1 , hif-1α , ldha ) , and remodel the immune microenvironment by reduce mdscs and enhance m1 macrophage and cd8⁺ t cell infiltration . in hypoxia-mimicking in vitro experiment , sodium butyrate ( nab ) , the principal gut microbial metabolite of zqfz , suppress colorectal cancer cell viability and induced apoptosis . through activation of gpr109a , nab inhibit the akt/mtor/hif-1α pathway and glycolysis-related enzyme , reduced lactate production , and far suppress glycolysis . molecular docking and dynamic simulation suggest a stable interaction between gpr109a and akt1 , which be confirm in vitro by mst show high-affinity binding ( kd=74.5 ± 20.8 nm ) ; mst also verify moderate-affinity binding between gpr109a and sodium butyrate ( kd=43.3 ± 6.5 μm ) , support a dual interaction model wherein butyrate activates gpr109a , which in turn directly bind akt1 to inhibit downstream glycolytic signaling . this study uncover a novel integrate mechanism whereby zqfz enhance pd-1 antibody efficacy via the gut microbiota-scfas-gpr109a axis , and nab-mediated glycolysis inhibition under hypoxia far confirm it immunometabolic mechanism against crc .	Phytomedicine : international journal of phytotherapy and phytopharmacology	26/09/2025
10.1093/ndt/gfaf203	teneligliptin and empagliflozin attenuate ferroptosis-mediated acute tubular injury .	Ema C, Iwakura T, Tsuji N, Nakayama Y, Tsuchida M, Kitamura A, Katahashi N, Ishigaki S, Isobe S, Fujikura T, Ohashi N, Kato A, Sugimoto K, Yasuda H	ferroptosis be a key mechanism of tubular cell death in acute kidney injury ( aki ) , particularly in folic acid- and glycerol-induced model . dipeptidyl peptidase 4 ( dpp4 ) and sodium-glucose cotransporter 2 ( sglt2 ) inhibitor exhibit renoprotective effect beyond glucose lowering , and emerge evidence suggest both may suppress ferroptosis . we hypothesize that teneligliptin ( tg ) and empagliflozin ( empa ) protect tubular cell from ferroptosis-mediated injury by reduce lipid peroxidation . hk-2 cell be pretreated with inhibitor of apoptosis ( z-vad-fmk ) , necroptosis ( necrostatin-1s ) , or ferroptosis ( ferrostatin-1 ) , and then expose to folic acid or myoglobin . the effect of tg on erastin- , folic acid- , and myoglobin-induced injury , and of empa on erastin- and myoglobin-induced injury , be evaluate use cell viability and lipid peroxidation assay . in vivo , tg be test in folic acid- and glycerol-induced aki model , and empa in the glycerol-induced aki model . renal function , tubular injury , inflammation , and glutathione peroxidase 4 ( gpx4 ) expression be assess . localization of dpp4 , nadph oxidase 1 ( nox1 ) , nox4 , and megalin in the kidney be analyze by immunostaining . ferrostatin-1 , but not z-vad-fmk or necrostatin-1s , prevented folic acid- and myoglobin-induced cell death in vitro . both tg and empa significantly reduce erastin-induced cell death and lipid peroxidation . tg also attenuate cell death and lipid peroxidation in folic acid- and myoglobin-induced injury . empa improved viability and reduced lipid peroxidation in the myoglobin model . in vivo , tg improve renal function , reduce tubular damage and inflammation , and preserve gpx4 expression . empa show similar protective effect in rhabdomyolysis-associated aki . dpp4 co-localized with nox4 , but show no co-localization with nox1 . tg treatment disrupt the co-localization of nox4 with dpp4 . tg and empa attenuate tubular cell death and kidney injury in ferroptosis-mediated aki model , potentially through the reduction of lipid peroxidation . these finding highlight ferroptosis suppression a a potential mechanism underlie their renoprotective effect in aki prevention .	Nephrology, dialysis, transplantation : official publication of the European	03/10/2025
10.3389/fendo.2025.1625973	global , regional , and national burden of type 2 diabetes-related diabetic kidney disease attributable to low physical activity from 1990 to 2021 : a systematic analysis of the global burden of disease study 2021 with prediction to 2050 .	Wang M, Yan R, Xia W, Gao Y, Liu Y, Bao L, Luo H, E J, Wang H, Li B, Zheng Y	low physical activity ( lpa ) significantly heighten the susceptibility of both type 2 diabetes mellitus ( t2dm ) and chronic renal disease . nearly half of population diagnose with t2dm globally worsen into diabetic kidney disease ( dkd ) . focus on physically inactive population , we aim to comprehensively evaluate the trend over time and regional change in t2dm-associated dkd attributable to lpa burden . we utilize data of the 2021 global burden of disease ( gbd ) study to initially assess the worldwide effect of t2dm-associated dkd attributable to lpa by compute the number and age-standardized rate ( asrs ) of death , disability-adjusted life year ( dalys ) , year of life lose ( ylls ) , and year live with disability ( ylds ) , categorize by subtypes in 2021. linear regression model be apply to analyze the illness burden from 1990 to 2021. furthermore , cluster analysis be perform to assess the regional difference in disease burden across gbd region . lastly , to forecast the illness burden for the next 25 year , we utilize the autoregressive integrated move average ( arima ) and excess risk ( er ) model . in 2021 , the fatality attribute to t2dm-related dkd attributable to lpa amount to 30835 ( 95 % 12346-51646 ) case , with 698484 ( 95 % 275039-1158032 ) dalys . the asrs of death and dalys be 0.38 ( 95 % 0.15-0.63 ) and 8.19 ( 95 % 3.21-13.6 ) per 100000 individual , respectively . between 1990 and 2021 , there be a notable escalation in death , dalys , ylds , and ylls , as well a their asrs . the high burden be observe among male , old adult ( age 70 year and above ) , and middle socio-demographic index ( sdi ) . significant difference be note in the disease burden among various region and country a define by the gbd study . predictive analysis indicate a continued escalation of this burden by the year 2050. the global impact of dkd attributable to lpa remains considerable , with significant disparity note across different gender , age , and region . to mitigate this burden , it be crucial to implement effective intervention aim at address physical inactivity , specifically design for targeted demographic group .	Frontiers in endocrinology	01/01/2025
10.3389/fmicb.2015.00625	host-pathogen interaction between the human innate immune system and candida albicans-understanding and modeling defense and evasion strategy .	Dühring S, Germerodt S, Skerka C, Zipfel PF, Dandekar T, Schuster S	the diploid , polymorphic yeast candida albicans be one of the most important human pathogenic fungi . c. albicans can grow , proliferate and coexist a a commensal on or within the human host for a long time . however , alteration in the host environment can render c. albicans virulent . in this review , we describe the immunological cross-talk between c. albicans and the human innate immune system . we give an overview in form of pair of human defense strategy include immunological mechanism as well a general stressor such a nutrient limitation , ph , fever etc . and the corresponding fungal response and evasion mechanism . furthermore , computational system biology approach to model and investigate these complex interaction be highlight with a special focus on game-theoretical method and agent-based model . an outlook on interesting question to be tackle by system biology regard entangle defense and evasion mechanism be give .	Frontiers in microbiology	01/01/2015
10.1186/s13024-025-00892-3	molecular hallmark of excitatory and inhibitory neuronal resilience to alzheimer 's disease .	Castanho I, Naderi Yeganeh P, Boix CA, Morgan SL, Mathys H, Prokopenko D, White B, Soto LM, Pegoraro G, Shah S, Ploumakis A, Kalavros N, Bennett DA, Lange C, Kim DY, Bertram L, Tsai LH, Kellis M, Tanzi RE, Hide W	a significant proportion of individual maintain cognition despite extensive alzheimer 's disease ( ad ) pathology , know a cognitive resilience . understand the molecular mechanism that protect these individual could reveal therapeutic target for ad . this study define molecular and cellular signature of cognitive resilience by integrate bulk rna and single-cell transcriptomic data with genetics across multiple brain region . we analyze data from the religious order study and the rush memory and age project ( rosmap ) , include bulk rna sequencing ( n = 631 individual ) and multiregional single-nucleus rna sequencing ( n = 48 individual ) . subject be categorize into ad , resilient , and control base on β-amyloid and tau pathology , and cognitive status . we identify and prioritize protect cell population use whole-genome sequencing-derived genetic variant , transcriptomic profiling , and cellular composition . transcriptomics and polygenic risk analysis position resilience a an intermediate ad state . only gfap and klf4 expression distinguish resilience from control at tissue level , whereas differential expression of gene involve in nucleic acid metabolism and signal differentiate ad and resilient brain . at the cellular level , resilience be characterize by broad downregulation of lingo1 expression and reorganization of chaperone pathway , specifically downregulation of hsp90 and upregulation of hsp40 , hsp70 , and hsp110 family in excitatory neuron . mef2c , atp8b1 , and reln emerge a key marker of resilient neuron . excitatory neuronal subtypes in the entorhinal cortex ( atp8b+ and mef2c ( high ) ) exhibit unique resilience signal through activation of neurotrophin ( bdnf-ntrk2 , modulate by lingo1 ) and angiopoietin ( angpt2-tek ) pathway . mef2c+ inhibitory neuron be over-represented in resilient brain , and the expression of gene associate with rare genetic variant reveal vulnerable somatostatin ( sst ) cortical interneurons that survive in ad resilience . the maintenance of excitatory-inhibitory balance emerge a a key characteristic of resilience . we have define molecular and cellular hallmark of cognitive resilience , an intermediate state in the ad continuum . resilience mechanism include preserve neuronal function , balance network activity , and activation of neurotrophic survival signal . specific excitatory neuronal population appear to play a central role in mediate cognitive resilience , while a subset of vulnerable interneurons likely provide compensation against ad-associated hyperexcitability . this study offer a framework to leverage natural protective mechanism to mitigate neurodegeneration and preserve cognition in ad .	Molecular neurodegeneration	01/10/2025
10.1084/jem.20080340	a point mutation in the murine hem1 gene reveals an essential role for hematopoietic protein 1 in lymphopoiesis and innate immunity .	Park H, Staehling-Hampton K, Appleby MW, Brunkow ME, Habib T, Zhang Y, Ramsdell F, Liggitt HD, Freie B, Tsang M, Carlson G, Friend S, Frevert C, Iritani BM	hem1 ( hematopoietic protein 1 ) be a hematopoietic cell-specific member of the hem family of cytoplasmic adaptor protein . orthologues of hem1 in dictyostelium discoideum , drosophila melanogaster , and caenorhabditis elegans be essential for cytoskeletal reorganization , embryonic cell migration , and morphogenesis . however , the in vivo function of mammalian hem1 be not know . use a chemical mutagenesis strategy in mouse to identify novel gene involve in immune cell function , we positionally clone a nonsense mutation in the hem1 gene . hem1 deficiency result in defective f-actin polymerization and actin capping in lymphocyte and neutrophil cause by loss of the rac-controlled actin-regulatory wave protein complex . t cell development be disrupt in hem1-deficient mouse at the cd4 ( - ) cd8 ( - ) ( double negative ) to cd4 ( + ) cd8 ( + ) ( double positive ) cell stage , whereas t cell activation and adhesion be impair . hem1-deficient neutrophil fail to migrate in response to chemotactic agent and be deficient in their ability to phagocytose bacteria . remarkably , some rac-dependent function , such a th1 differentiation and nuclear factor kappab ( nf-kappab ) -dependent transcription of proinflammatory cytokine proceed normally in hem1-deficient mouse , whereas the production of th17 cell be enhance . these result demonstrate that hem1 be essential for hematopoietic cell development , function , and homeostasis by control a distinct pathway lead to cytoskeletal reorganization , whereas nf-kappab-dependent transcription proceeds independently of hem1 and f-actin polymerization .	The Journal of experimental medicine	24/11/2008
10.1016/j.jhep.2025.08.020	multicenter phase ii trial of lenvatinib in patient with advanced hepatocellular carcinoma after progression on first-line atezolizumab plus bevacizumab .	Kim HD, Sym SJ, Chon HJ, Kim M, Kang JH, Ryoo BY, Lee CK, Hong J, Ryu H, Bae WK, Kim H, Kim H, Kim JW, Kim TY, Yoo C	background & atezolizumab plus bevacizumab ( atezo-bev ) be the global standard first-line therapy for unresectable hepatocellular carcinoma ( uhcc ) . however , most patient eventually experience disease progression and optimal second-line strategy after atezo-bev failure remain unclear . prospective evidence support multikinase inhibitor in this context be limit . this investigator-initiated , multicenter , single-arm study ( kcsg hb23-04 ) enrol 50 patient with uhcc who progress after first-line atezo-bev across 13 site between august 2023 and may 2024. patient receive second-line lenvatinib at 12 mg or 8 mg daily , depend on body weight , until disease progression or unacceptable toxicity . the primary endpoint be progression-free survival . secondary endpoint be overall survival , objective response rate , disease control rate , duration of response , and safety . of the 50 patient enrol , the median age be 66 year , and 72 % have a viral etiology . the median time to progression with atezo-bev be 6.5 month . during a median follow-up of 12.6 month , the median progression-free survival be 5.4 month ( 95 % ci 4.2-7.1 ) ( > 4.5 month ) , meet the prespecified primary endpoint . median overall survival be 9.8 month ( 95 % ci 8.1-nr ) . the objective response rate be 14.0 % , and the disease control rate be 82.0 % . the median duration of response be 9.4 month . survival outcome be different accord to the objective response with lenvatinib , but not by time to progression on atezo-bev or hcc etiology . the most common adverse event be diarrhea ( 42.0 % ) , hypothyroidism ( 32.0 % ) , and anorexia ( 30.0 % ) . grade ≥3 adverse event occur in 46.0 % of patient . lenvatinib demonstrate promising efficacy and a manageable safety profile a a second-line treatment for patient with hcc progress on atezo-bev . these finding offer prospective evidence support lenvatinib a a viable treatment option in the post-atezo-bev context . this study provide the first prospective evidence for the use of lenvatinib a a second-line therapy for patient with unresectable hepatocellular carcinoma who have progress after first-line atezo-bev treatment . the finding highlight the potential of lenvatinib a a viable therapeutic option in a clinical setting where few alternative be available . the result be particularly important for healthcare professional manage unresectable hepatocellular carcinoma , a they provide a robust framework for consider lenvatinib in second-line treatment protocol . give the manageable safety profile , these finding could be translate into practical recommendation for clinical practice , offer physician a treatment strategy to improve patient outcomes follow atezo-bev failure while guide future research into combination therapy and broad patient population . nct06138769 .	Journal of hepatology	04/09/2025
10.1038/s41598-025-16917-2	systematic review and meta-analysis of antioxidant with or without exercise training improve muscle condition in old adult .	Wang Y, He Z, Long C, Li Y, Yuan Y, Huang T	oxidative stress and physical inactivity be regard a important mechanism contribute to muscle loss . however , the efficacy of antioxidant and their potential synergy with exercise training remain controversial for old population . the study aim to evaluate the effect of antioxidant , either combine with or without exercise , on improve muscle strength , mass , and physical performance in old adult . we conduct a comprehensive search of the pubmed , medline , and embase database to identify randomize controlled trial ( rcts ) on muscle condition in subject age 55 year or old . the search period cover from the inception of each database until june 10 , 2024. a total of 39 rcts involve 1714 participant be include . the meta-analysis present that antioxidant alone could enhance muscle strength in 1 repetition maximum ( rm ) in leg press and physical function in the old population . exercise alone could increase the walk distance of 6 min walk more than antioxidant alone . the combination of antioxidant and exercise far improve 1rm in leg press , usual walk speed and walk distance of 6 min walk compare to antioxidant alone . additionally , this combination enhance handgrip strength , 1rm in leg press and walk distance of 6 min walk more than exercise alone . this meta-analysis demonstrate that antioxidant alone have positive effect on muscle condition in old individual . however , the combination of antioxidant and exercise be more effective than either intervention alone in improve muscle strength and physical function among the old adult .	Scientific reports	02/10/2025
10.1186/s12884-025-08169-9	comprehensive identification of immune-related biomarkers and therapeutic target in preeclampsia : integrative bioinformatics and experimental validation .	Wu X, Li X, Wu Y, Yang H, Wu J, He L	preeclampsia ( pe ) be a serious hypertensive complication during pregnancy characterize by immune dysregulation and vascular dysfunction , however , the precise molecular mechanism and effective therapeutic strategy remain unclear . this study focus on identify immune-related differentially express gene ( irdegs ) in pe , investigate their biological significance and regulatory network , and establish robust diagnostic model through integrated bioinformatics and experimental analysis . gene expression data from the gse75010 dataset be analyze utilize the r-based `` limma '' package to determine differentially express gene ( degs ) , which be intersect with immune-related gene ( irgs ) to obtain irdegs . functional enrichment be assess use gene ontology ( go ) , kyoto encyclopedia of gene and genome ( kegg ) , and disease ontology ( do ) analyse . hub gene be identify via random forest ( rf ) and lasso regression algorithm , and their diagnostic performance be assess via receiver operate characteristic ( roc ) curve evaluation in both training ( gse75010 ) and validation ( gse44711 ) cohort . immune cell composition and it association with hub gene be explore use cibersort . regulatory network , include protein-protein interaction ( ppi ) , mrna-mirna and mrna-tf interaction , be construct use encori and chipbase database . analysis of potential pharmaceutical-gene interaction be perform via dgidb platform interrogation , follow by experimental validation in placental tissue and trophoblast cell . we identify 354 degs , include 49 irdegs ( 25 upregulated and 24 downregulated ) . enrichment evaluation demonstrate that irdegs be associate with pi3k-akt signaling , chemokine signaling , and cytokine-cytokine receptor interaction . do analysis link irdegs to pe , cardiovascular disease , and reproductive disorder . four hub gene ( flt1 , pik3cb , klrd1 , and apln ) be identify a pe biomarkers base on their connectivity in the ppi network and performance in machine learning model . the rf-based diagnostic model demonstrate excellent discrimination ability with auc of 0.9468 ( train cohort ) and 0.9844 ( validation cohort ) . immune infiltration analysis reveal high level of eosinophil , plasma cell , and cd8 + t cell in pe , while monocyte and m2 macrophage be reduce . notably , hub gene show distinct correlation with immune cell subtypes , such a the positive association observe between flt1 and plasma cell , contrast with the inverse relationship document between apln and cd8 + t cell . network analysis identify 128 mrna-mirna and 31 mrna-tf interaction pair . drug-gene interaction analysis show cyclooxygenase inhibitor , such a aspirin , target apln , while tnf-α inhibitor , such a etanercept , target klrd1 . experimental validation confirm consistent expression trend across clinical specimen and in vitro model : flt1 and pik3cb be significantly upregulated while klrd1 and apln be significantly downregulated in both preeclamptic placental tissue and hypoxia-exposed trophoblast cell . our study identify four hub irdegs that may serve a potential diagnostic indicator and therapeutic target for pe . these finding suggest an important role of immune dysregulation in pe pathogenesis and offer new perspective for treatment strategy . by integrate computational prediction with experimental evidence , our work contribute to the foundation for future clinical application , though further research include early-stage pe be need to validate these observation .	BMC pregnancy and childbirth	03/10/2025
10.1002/advs.202503277	discovery of a potent and selective tead degrader with durable degradation activity .	Cao L, Yang J, Liu Y, Chen X, Shi Y, Zhao Y, Zhang Y, Chen J, Li B, Wen W, Chen L, Peng B, Huang L, Sun Y, Zhou L, Rees MG, Ronan MM, Roth JA, Guo Z, Xing J, Zhu G, Wang Y, Jiang B, Lu J, Zhao K, Lu W	the tea/atss ( tead ) family of transcription factor be key effector of the hippo pathway , exert their function through interaction with the coactivators yap and taz . over the past five year , the development of yap-tead disruptors have emerge a a central focus of both academic and industrial effort aim at target the hippo pathway for cancer therapy . in this study , the discovery and comprehensive characterization of kg-fp-003 , a potent , selective , and durable tead degrader be report . kg-fp-003 exhibit superior activity compare to the lipid-binding pocket ( lbp ) inhibitor myf-03-176 and the tead-yap protein-protein interaction ( ppi ) inhibitor iag933 , efficiently degrade all tead isoforms at low nanomolar concentration in a ubiquitin-proteasome system ( ups ) -dependent manner . this degradation translate into more robust and sustain therapeutic response both in vitro and in vivo . furthermore , barcoded cell line screen reveal elevated sensitivity in several cancer type , include endometrial carcinoma , glioblastoma , ovarian epithelial tumor , and osteosarcoma . these finding position kg-fp-003 a a compelling lead candidate for tead isoform-selective therapy and underscore it potential utility beyond hippo-dysregulated mesothelioma .	Advanced science (Weinheim, Baden-Wurttemberg, Germany)	05/10/2025
10.1016/j.jacc.2025.08.047	inflammation and cardiovascular disease : 2025 acc scientific statement : a report of the american college of cardiology .	Mensah GA, Arnold N, Prabhu SD, Ridker PM, Welty FK	the crucial role of inflammation in the pathogenesis and clinical outcome of cardiovascular disease ( cvd ) have recently gain increased attention . in particular , residual inflammation , measure with high-sensitivity c-reactive protein ( hscrp ) remain strongly predictive of recurrent event , even in statin-treated patient . similarly , elevate hscrp in apparently healthy individual identify a higher-risk group in whom statin therapy significantly reduce the risk of first major cvd event even if ldl-cholesterol be normal . this report provide an updated understanding of the role of chronic , low-grade inflammation in cvd and highlight new seminal research finding , especially in atherosclerosis , myocardial infarction , heart failure , and pericarditis . consensus recommendation be summarize for screening , evaluation , and cvd risk assessment ; inflammatory biomarkers in cardiovascular imaging ; inflammation inhibition in behavioral and lifestyle risk ; and anti-inflammatory approach in primary and secondary prevention as well a in heart failure and other cvds . this report also address current challenge and future opportunity . for example , it caution that not all trial of anti-inflammatory therapy in secondary prevention have be successful and such trial evidence be need before broad recommendation for other agent can be make . additionally , in successful trial , the interplay between inflammation and key physiological system often remain incompletely examine . another promising area of research be the role that novel special pro-resolving bioactive lipid molecule play in promote the resolution of inflammation and cvd risk reduction . in aggregate , the evidence link inflammation with atherosclerotic cvd be no longer exploratory but be compelling and clinically actionable . the time for take action have now arrive .	Journal of the American College of Cardiology	29/09/2025
10.3389/fneur.2025.1673321	determine the efficacy and safety of acupuncture for the treatment of menstrual migraine : an updated systematic review and meta-analysis .	Wu Q, Fan L, Wu D, Gao H, Han D, Hu H, Qian L	menstrual migraine ( mm ) be a common type of headache link to hormonal fluctuation during the menstrual cycle , remain challenge to treat due to the limited efficacy of current therapy . while acupuncture show potential a a therapeutic option for mm , the exist evidence do not clearly support it routine clinical use . this protocol for a systematic review ( sr ) and meta-analysis seek to gather and evaluate recent clinical evidence regard the effectiveness and safety of acupuncture in treat mm . a comprehensive search be conduct across multiple database from their inception to april 2025 , include pubmed , medline , ovid , embase , sciencedirect , the chinese national knowledge infrastructure ( cnki ) , wanfang , the chinese biomedical literature ( cbm ) database , and the vip database . this be complement by regular update from trial registry such a the cochrane central register of controlled trial ( central ) and the who international clinical trial registry platform ( ictrp ) , which target unpublished and ongoing randomize control trial ( rcts ) . eligible study be rcts compare acupuncture with western medicine , herbal remedy , sham acupuncture , or no intervention for the management of mm . primary outcome include the pain intensity [ visual analog scale ( va ) ] , the frequency of migraine attack ( fm ) , and duration of migraine ( dm ) . secondary outcome encompass response rate , headache impact test-6 ( hit-6 ) , the menstrual headache index ( mhi ) , the serum level of 5-hydroxytryptamine ( 5-ht ) , and adverse event . analysis involve meta-analysis , subgroup comparison , publication bias detection , sensitivity testing , risk-of-bias evaluation , and profiling of adverse event . the quality of evidence be judge accord to the grading of recommendation assessment , development , and evaluation ( grade ) criterion . a total of 39 rcts comprise 2,584 participant be include . compare with control intervention , acupuncture significantly reduce va score , decrease the frequency and duration of migraine attack , and improved response rate , as well a hit-6 and mhi score . additionally , acupuncture be associate with increased serum 5-ht level . meta-analytic finding indicate that acupuncture demonstrate a favorable safety profile in the treatment of mm . finding suggest that acupuncture for mm produce the most notable reduction in migraine severity . nevertheless , the grade assessment indicate low overall certainty of the evidence , with considerable heterogeneity present in multiple pooled analysis . therefore , well-designed , large-scale rcts be urgently require to strengthen the evidence base . http : //www.crd.york.ac.uk/prospero/view/crd42022367446 .	Frontiers in neurology	01/01/2025
10.1186/s11658-025-00785-9	rsl3 promote parp1 apoptotic function by distinct mechanism during ferroptosis .	Chen D, Xie F, Mo Y, Qin D, Zheng B, Chen L	the classical ferroptosis activator rsl3 target enzymes with nucleophilic active site , primarily act on glutathione peroxidase 4 ( gpx4 ) to trigger ferroptosis . recent study identify rsl3 a a potential pro-apoptotic agent . however , the mechanism by which rsl3 induces apoptosis during ferroptosis remain elusive . poly ( adp-ribose ) polymerase ( parp1 ) determine cell fate in response to dna damage , where it loss or cleavage by activated caspase-3 induces apoptosis to attenuate tumor progression . we elucidate a novel mechanism underlie parp1 regulation , encompass both it caspase-dependent cleavage and full-length depletion during rsl3-mediated ferroptosis-apoptosis crosstalk . to investigate the role of rsl3 during ferroptosis , we treat several cancer cell of different histological type with vary dos of rsl3 to induce apoptosis . the regulatory protein of parp1 be analyze use real-time quantitative polymerase chain reaction ( rt-qpcr ) and western blot analysis . the n ( 6 ) -methyladenosine ( m ( 6 ) a ) modification level of parp1 be determine by m ( 6 ) a rna immunoprecipitation ( merip ) -qpcr analysis . additionally , an rna immunoprecipitation ( rip ) -qpcr assay be perform to identify the target protein of the m ( 6 ) a site of parp1 . furthermore , we establish a mouse xenograft model of parp inhibitor ( parpi ) -resistant cell to analyze the effect of rsl3 on parpi-resistant tumor growth . rsl3 trigger two parallel apoptotic pathway via increase reactive oxygen specie ( ro ) production during ferroptosis : ( 1 ) caspase-dependent parp1 cleavage and ( 2 ) dna damage-dependent apoptosis result from reduce full-length parp1 . the latter occurs through inhibition of mettl3-mediated m ( 6 ) a modification and subsequent suppression of parp1 translation . moreover , we find that rsl3 retain pro-apoptotic function in parpi-resistant cell and effectively inhibit parpi-resistant xenograft tumor growth in vivo . rsl3 orchestrate ferroptosis-apoptosis crosstalk via parp1 , demonstrate therapeutic potential against tumorigenesis , particularly in parpi-resistant malignancy .	Cellular & molecular biology letters	02/10/2025
10.3390/nursrep13040116	aggression against nursing personnel during the first wave of covid-19 pandemic : an internet-based survey .	Cruz JPS, Genis-Mendoza AD, López-Narváez ML, González-Castro TB, Juárez-Rojop IE, Tovilla-Zárate CA, Nicolini H	( 1 ) background : health care worker , particularly nurse , have be regularly assault during the covid-19 pandemic . purpose : to evaluate the prevalence and location of assault against nursing personnel in latin america , and to determine predictor factor for aggression against nurse . ( 2 ) method : a cross-sectional online survey be answer by 374 nurse work in health care during the covid-19 pandemic . the aggression against nurse be estimate use the victimization scale . ( 3 ) result : a total of 288 nurse be include in this study . the victimization scale show that 52.1 % of nurse have suffer aggression by the general population during the covid-19 pandemic . male be more likely to be attack than female ( p < 0.05 ) . additionally , male be attack more frequently on public transport ( x ( 2 ) = 6.72 , p = 0.01 ) . the home neighborhood and market be other location with a high risk of be assault ( 3.39 , 1.53-7.50 ) . ( 4 ) conclusion : our result indicate that nurse in latin america who work during the covid-19 pandemic and social isolation have be frequently assault by the general public . male be more frequently attack than female and the main place of aggression be public transportation , their home neighborhood and supermarket . implication for nursing practice : it be necessary to create and implement protocol and guideline to support nursing personnel during the covid-19 pandemic . this study be retrospectively register at the juarez autonomous university of tabasco ( 103/cipdacs/2020 ) on the ( 08/2020 ) .	Nursing reports (Pavia, Italy)	07/10/2023
10.1038/s41579-025-01242-2	clostridioides difficile pathogenesis and control .	Chilton CH, Viprey V, Normington C, Moura IB, Buckley AM, Freeman J, Davies K, Wilcox MH	clostridioides difficile infection ( cdi ) continue to be a notable burden worldwide , both in term of patient mortality and morbidity , and the economic cost associate with treatment , diagnosis and management . the epidemiology of c. difficile have change markedly over the decade , with high cdi rate drive by clinical pressure exacerbate by the severe acute respiratory syndrome coronavirus 2 pandemic , antibiotic resistance and selective pressure cause by antimicrobial use . c. difficile be challenge to diagnose and treat a it form spore and can persist asymptomatically within the gut . some strain express multiple virulence factor , include adhesins and toxin . the gut microbiota be crucially important in cdi , a a healthy microbiota be resistant to colonization with c. difficile . dysbiosis , often cause by antimicrobial exposure , enable c. difficile spore to germinate and produce toxin , cause symptom that can range from mild diarrhoea to fulminant colitis and death . this review describe change in epidemiology and effect on diagnosis , discuss recent breakthrough in the understanding of pathogenesis and antibiotic resistance and explore the role of microbiota dysbiosis in cdi and novel microbiota therapy in cdi treatment .	Nature reviews. Microbiology	02/10/2025
10.1038/s41572-025-00654-x	listeriosis .	Disson O, Charlier C, Pérot P, Leclercq A, Paz RN, Kathariou S, Tsai YH, Lecuit M	listeriosis be a serious food-borne bacterial infection cause by listeria monocytogenes . l. monocytogenes be a facultative intracellular bacterial specie that can replicate inside human cell , as well a thrive in a variety of environment , include soil , decay vegetation , animal intestine and food such a unpasteurized dairy product , soft cheese , raw meat , fish , seafood , vegetable and fruit . clinically , l. monocytogenes can cause gastroenteritis in healthy individual or serious invasive infection in at-risk population . for example , maternal-fetal infection during pregnancy can lead to adverse pregnancy outcome . in the elderly and immunosuppressed , listeriosis can cause septicaemia and central nervous system infection ( also know a neurolisteriosis ) with high mortality and risk of long-term sequela . genomic study have identify four lineage of l. monocytogenes , with lineage i comprise the most virulent strain . the pathogenicity of l. monocytogenes reflect it ability to resist gastric and bile acid , colonize the intestinal lumen , cross the intestinal barrier , survive intracellularly in the bloodstream , evade immune response , and cross the placental and blood-brain barrier . diagnosis of listeriosis ( septicaemia , neurolisteriosis , maternal-neonatal listeriosis or focal listeriosis ) involve clinical observation and microbiological testing base on bacterial culture or dna detection in individual with prior antimicrobial therapy . treatment typically involve aminopenicillins and aminoglycosides , with no evidence of clinically meaningful acquire antimicrobial resistance . although listeriosis be a well-studied infection , a clear picture of it global burden , it pathophysiology , the dynamic of the l. monocytogenes population and transmission route be need . on the host side , new risk factor , include genetics , and new treatment regimens to improve patient outcome need to be identify .	Nature reviews. Disease primers	02/10/2025
10.1016/j.molmed.2025.09.002	endometriosis and comorbidities : molecular mechanism and clinical implication .	Petraglia F, Vannuccini S, Donati C, Jeljeli M, Bourdon M, Chapron C	endometriosis , traditionally view a a gynecological condition , be increasingly recognize a a systemic disease due to it frequent association with inflammatory and autoimmune comorbidities . recent molecular and genetic insight reveal dysregulated hormone receptor signaling , heighten inflammatory response , and immune dysfunction a central driver of disease progression . these discovery offer compelling explanation for extra-pelvic symptom and open up avenue for targeted diagnostics and therapy . this review integrate emerge evidence to highlight endometriosis a a multisystem disorder , underscore the need for multidisciplinary care . by redefine endometriosis beyond reproductive health , this perspective encourage a broad , systemic view of woman 's health and foster innovation in precision medicine .	Trends in molecular medicine	01/10/2025
10.1016/j.immuni.2025.09.012	inflammation in atherosclerosis : lesson and therapeutic implication .	Libby P, Soehnlein O	inflammatory pathway operate at all stage of atherosclerosis . these process be drive by risk factor and other stimulus that can spark inflammation by elicit misdirected response of intrinsic vascular cell and leukocyte , culminate in lesion initiation , progression , and complication . continue dissection of the key underlying inflammatory mechanism with increasingly sophisticated tool have inspire successful clinical trial and enabled translation to the clinic . here , we review the mechanistic understanding of the etiology and progression of atherosclerosis . we discuss how cardiovascular risk factor converge at the level of the bone marrow to perturb hematopoiesis , yield output with a pro-inflammatory slant . we further consider how circulating myeloid cell enter , propagate , and persist in atherosclerotic lesion and how intimal macrophage take center stage in regulate the inflammatory milieu . in this context , we delineate emerge therapeutic strategy aim at mitigate inflammation in atherosclerosis and how these add to exist measure toward reduce the global cardiovascular disease burden .	Immunity	03/10/2025
10.1038/s41380-025-03273-w	classification of major depressive disorder use vertex-wise brain sulcal depth , curvature , and thickness with a deep and a shallow learning model .	Goya-Maldonado R, Erwin-Grabner T, Zeng LL, Ching CRK, Aleman A, Amod AR, Basgoze Z, Benedetti F, Besteher B, Brosch K, Bülow R, Colle R, Connolly CG, Corruble E, Couvy-Duchesne B, Cullen K, Dannlowski U, Davey CG, Dols A, Ernsting J, Evans JW, Fisch L, Fuentes-Claramonte P, Gonul AS, Gotlib IH, Grabe HJ, Groenewold NA, Grotegerd D, Hahn T, Hamilton JP, Han LKM, Harrison BJ, Ho TC, Jahanshad N, Jamieson AJ, Karuk A, Kircher T, Klimes-Dougan B, Koopowitz SM, Lancaster T, Leenings R, Li M, Linden DEJ, MacMaster FP, Mehler DMA, Meinert S, Melloni E, Mueller BA, Mwangi B, Nenadić I, Ojha A, Okamoto Y, Oudega ML, Penninx BWJH, Poletti S, Pomarol-Clotet E, Portella MJ, Radua J, Rodríguez-Cano E, Sacchet MD, Salvador R, Schrantee A, Sim K, Soares JC, Solanes A, Stein DJ, Stein F, Stolicyn A, Thomopoulos SI, Toenders YJ, Uyar-Demir A, Vieta E, Vives-Gilabert Y, Völzke H, Walter M, Whalley HC, Whittle S, Winter N, Wittfeld K, Wright MJ, Wu MJ, Yang TT, Zarate C, Veltman DJ, Schmaal L, Thompson PM	major depressive disorder ( mdd ) be a complex psychiatric disorder that affect the life of hundred of million of individual around the globe . even today , researcher debate if morphological alteration in the brain be link to mdd , likely due to the heterogeneity of this disorder . the application of deep learning tool to neuroimaging data , capable of capture complex non-linear pattern , have the potential to provide diagnostic and predictive biomarkers for mdd . however , previous attempt to demarcate mdd patient and healthy control ( hc ) base on segmented cortical feature via linear machine learn approach have report low accuracy . in this study , we use globally representative data from the enigma-mdd work group contain 7012 participant from 31 site ( n = 2772 mdd and n = 4240 hc ) , which allow a comprehensive analysis with generalizable result . base on the hypothesis that integration of vertex-wise cortical feature can improve classification performance , we evaluate the classification of a densenet and a support vector machine ( svm ) , with the expectation that the former would outperform the latter . a we analyze a multi-site sample , we additionally apply the combat harmonization tool to remove potential nuisance effect of site . we find that both classifier exhibit close to chance performance ( balance accuracy densenet : 51 % ; 53 % ) , when estimate on unseen site . slightly high classification performance ( balance accuracy densenet : 58 % ; 55 % ) be find when the cross-validation fold contain subject from all site , indicate site effect . in conclusion , the integration of vertex-wise morphometric feature and the use of the non-linear classifier do not lead to the differentiability between mdd and hc . our result support the notion that mdd classification on this combination of feature and classifier be unfeasible . future study be need to determine whether more sophisticated integration of information from other mri modality such a fmri and dwi will lead to a high performance in this diagnostic task .	Molecular psychiatry	03/10/2025
10.1016/j.tibs.2025.09.001	mitochondrial dynamic and pore formation in regulated cell death pathway .	Hohorst L, Ros U, Garcia-Saez AJ	mitochondrion act a central hub for cell death signal . during apoptosis and regulate necrosis ( pyroptosis , necroptosis , and ferroptosis ) , mitochondrion undergo drastic change include membrane permeabilization , fragmentation , and loss of membrane potential . however , dissection of the mechanism underlie these process be challenge because they involve remodel of mitochondrial membrane couple to the assembly of protein complex whose dynamic be difficult to capture . we discuss progress in our understanding of mitochondrial alteration in cell death and highlight state-of-the-art experimental approach to study them . we focus on advanced single-molecule and correlative microscopy method which have recently provide unprecedented detail about the dynamic and structure of protein complex in mitochondrion and their impact on membrane organization .	Trends in biochemical sciences	02/10/2025
10.1136/openhrt-2025-003636	postmarketing analysis of sotatercept : identifying serious unlabelled event .	Cao Z, Xiao Q, Li X, Zhang H, Zhang M	sotatercept , an activin signal inhibitor approve in march 2024 for pulmonary arterial hypertension ( pah ) , demonstrate efficacy in clinical trial . this pharmacovigilance study evaluate it real-world safety profile use the u food and drug administration ( fda ) adverse event reporting system ( faers ) to identify postmarketing risk . faers report from 2024 be analyse , focus on case where sotatercept be designate a the primary suspect . duplicate entry be remove use standardised fda protocol . adverse event ( aes ) be categorise use the medical dictionary for regulatory activity ( meddra v.28.0 ) . disproportionality signal be assess via report or ( rors ; 95 % ci low limit > 1 with ≥3 case ) . severity be classify use the eudravigilance important medical event ( imes ) list . among 1 484 350 deduplicated report , 613 sotatercept-associated aes ( 1717 occurrence , 395 meddra term ) be identify . disproportionality analysis reveal 48 safety signal : 30 align with labelled risk ( eg , haemoglobin elevation ( ror=272.2 ) , telangiectasia ( ror=334.1 ) ) and 18 novel signal . the most frequent aes include headache ( n=78 ) , epistaxis ( n=57 ) and diarrhoea ( n=53 ) . two unlabelled events-cerebral haemorrhage and ascites-met criterion for critical imes . most report originate from the usa ( 98.5 % ) and involve female ( 73.6 % ) . this study confirm sotatercept 's labelled risk ( haematological and vascular effect ) and identifies novel safety concern , include cerebral haemorrhage and ascites , highlight the need for vigilant monitoring in pah management . real-world data underscore the value of postmarketing surveillance for detect rare or unanticipated aes . clinician should prioritise monitoring for haematological abnormality and bleed risk . longitudinal study be warrant to clarify long-term safety outcome .	Open heart	30/09/2025
10.1001/jamanetworkopen.2025.34491	electroacupuncture in patient with early urinary incontinence after radical prostatectomy : a randomized clinical trial .	Niu J, Wang Y, Wang Y, Shi J, Liang J, Zhao X, Xu T, Guo H, Qiu X	postprostatectomy urinary incontinence ( ui ) impair quality of life , yet effective noninvasive therapy remain limited . to investigate the efficacy and safety of electroacupuncture in patient with early ui after radical prostatectomy ( rp ) . design , set , this prospective , single-center , randomize , single-blinded clinical trial be conduct at nanjing drum tower hospital , affiliate hospital of medical school , nanjing university , from july 23 , 2021 , to november 1 , 2024 , with 20-week follow-up complete march 24 , 2025. men with localized prostate cancer who undergo robot-assisted rp and experienced ui ( define a use of ≥2 pad per day ) 4 to 6 week postoperatively be consecutively enrol and randomly assign 1:1 to the electroacupuncture or sham stimulation group . patient with any prior neoadjuvant hormonal therapy , any prior prostatic surgery , any history of pelvic surgery , and history of ui before rp be exclude . three participant withdraw before the intervention , and 101 ( 91.8 % ) complete follow-up . intention-to-treat analysis be use . patient in the electroacupuncture group receive electroacupuncture administer at bilateral ciliao , zhongliao , and xialiao acupoints , with sparse-dense wave electrostimulation ( alternate between 2 and 15 hz ) for 30 minute per session , 3 time per week for 6 week . the sham stimulation group underwent identical procedure with nonpuncturing flat-tip needle at offset point . the primary outcome be urinary continence ( uc ) , define a the use of 0 to 1 pad per day 6 week after the first electroacupuncture session . a total of 110 men ( median age , 69 [ iqr , 67-72 ] year ) be randomize . at week 6 , the intention-to-treat analysis show that the electroacupuncture group achieve a significantly high uc rate than the sham stimulation group ( 24 of 55 [ 43.6 % ] vs 12 of 55 [ 21.8 % ] ; relative risk , 2.00 ; 95 % ci , 1.12-3.59 ; p = .02 ) . the finding of this randomized clinical trial show that electroacupuncture significantly accelerate postprostatectomy uc recovery and may serve a a safe adjunct to standard care . these finding support integrate electroacupuncture into multimodal rehabilitation protocol to reduce early ui burden . clinicaltrials.gov identifier : nct04972669 .	JAMA network open	02/09/2025
10.1038/s41467-025-63707-5	contribution of leukocyte telomere length to cardiovascular disease onset from genome-wide cross-trait analysis .	Qiao J, Wang Q, Zhao Y, Chang M, Sun S, Zhang P, Yao K, Chen M, Zheng L, Xing X, Cai L, Jegga AG, Jiang L, Pauklin S, Zou R, Yang Y, Feng Y	telomere shorten be a well-established marker of cellular aging and genomic instability . while the relationship between leukocyte telomere length and cardiovascular disease have long be of interest , their genetic interplay remain incompletely understood . in this study , we observe substantial genetic overlap beyond genome-wide correlation and identify a potential causal relationship between leukocyte telomere length and coronary artery disease . specifically , we discover 248 pleiotropic locus , 22 of which show strong evidence of colocalization . some share loci implicate multiple pleiotropic gene across different trait pair , include aldh2 , acad10 , tmem116 , sh2b3 ( all at 12q24.12 ) , tmed6 ( 16q22.1 ) , serpinf1 ( 17p13.3 ) , and xpo7 ( 8p21.3 ) . functional analysis highlight key pathway involve in dna biosynthesis and telomere maintenance . notably , sh2b3 be validate through proteome-wide mendelian randomization analysis , suggest it potential a a therapeutic target . here we report the share genetic basis between leukocyte telomere length and cardiovascular disease , provide valuable insight into future therapeutic development .	Nature communications	30/09/2025
10.1016/j.rmcr.2025.102286	a novel cystic fibrosis mutation `` dels1255 '' in a male diagnose at birth .	Gerges M, Sutherland S, Chiasson M	cystic fibrosis ( cf ) be an autosomal recessive disorder cause by pathogenic variant in the cftr gene . over 2000 cftr variant have be identify , and ongoing genetic characterization remain critical for guide eligibility for cftr modulator therapy and contribute to variant database that support diagnosis and research . we describe a 20-year-old caucasian male who be a compound heterozygous for the common f508del mutation and a novel variant , p.ser1255del ( c.3763_3765deltca ; dels1255 ) . he be diagnose with cf in the neonatal period follow meconium ileus , confirm by elevated sweat chloride test . his clinical course include pancreatic insufficiency , chronic staphylococcus aureus colonization , and sinus disease with nasal polyp , but no evidence of cf-related diabetes or liver disease . molecular diagnostic testing conduct at stanford clinical laboratory use pcr and bidirectional sanger sequence confirm the f508del mutation and identify the previously unreported dels1255 variant , an in-frame deletion of a serine residue at position 1255. this variant be absent from population database and a missense mutation at the same codon have previously be associate with severe cf phenotype , support it likely pathogenicity . the patient be initiate on elexacaftor-tezacaftor-ivacaftor ( eti ) therapy in 2021 , base on the presence of the f508del allele . since start eti , he have experience substantial clinical improvement , include improved spirometry , radiology , and a marked reduction in sweat chloride concentration . the response be presume to be drive by the f508del variant , while the effect of dels1255 on modulator responsiveness remain unknown . this case add to the grow spectrum of cftr variant with clinical relevance .	Respiratory medicine case reports	01/01/2025
10.1002/adma.202508072	engineer apoptotic extracellular vesicle for programmable regulation of neutrophil-macrophage-ros pathogenic axis to reconstruct rheumatoid arthritis microenvironment .	Kang Y, Han X, Zhou S, Wang X, Wang Y, Song P, Su X, Qin M, Qian D, Meng H, Yan J, Pu F, Zhang H	rheumatoid arthritis microenvironment ( ram ) contain complex pathogenic mediator that interact dynamically to drive the progression of rheumatoid arthritis ( ra ) . however , most current ra treatment be single-target intervention , exert limited impact on ram . herein , apoptotic extracellular vesicle ( apoev ) be construct for programmable regulation of the neutrophil-macrophage-ros pathogenic axis , aim to reconstruct ram and improve ra therapy . mesenchymal stem cell ( msc ) be pretreated with dexamethasone ( dex ) and induced apoptosis to produce dex-loaded and fasl-overexpressing apoev ( d @ apoev ( fasl ) ) , which be far modify with low-molecular-weight heparin ( lmwh ) through a ros-responsive cleavage linker to form d @ apoev ( fasl ) ∩l . after intravenous injection into ra mouse , d @ apoev ( fasl ) ∩l target the inflamed joint base on their msc-derived feature and block neutrophil recruitment through bind to p-selectin on vascular endothelial cell . in response to high ro , d @ apoev ( fasl ) ∩l shed lmwh and expose fasl , induce neutrophil apoptosis through the fas/fasl signal pathway . subsequently , the apoptotic neutrophil trigger macrophage reprogramming from m1 to m2 phenotype , and the release dex significantly reduce the oxidative damage . various in vitro and in vivo assessment have confirm that d @ apoev ( fasl ) ∩l can effectively regulate neutrophil , macrophage , and ro , trigger an immune cascade , and restore intra-articular immune homeostasis , exhibit an effective ram reconstruction ability and a promising therapeutic effect for ra .	Advanced materials (Deerfield Beach, Fla.)	03/10/2025
10.1186/s41043-025-01090-z	effect of ketogenic diet on muscle mass , strength , aerobic metabolic capacity , and endurance in adult : a systematic review and meta-analysis .	Wang Y, Xiao Q, Zhang Z, Yang Y	the ketogenic diet ( kd ) have gain popularity a an efficient approach to weight loss and body fat loss . concern about reduce muscle mass and performance have be rise during weight loss , a muscle mass and functionality be crucial for health . however , the effect of the kd on muscle not only for athlete or trainer but also for adult with less physical exercise be still controversial . we conduct a thorough search of database include embase , pubmed , cochrane library , and web of science up to july 19 , 2025. three aspect of muscle assessment be conduct , include muscle mass , power and strength , aerobic metabolic capacity , and endurance . we include randomize and non-randomized controlled study that compare the kd with other dietary intervention . study without control group be exclude . a random-effects model would be utilize when significant difference in population and intervention across study be of concern . the grade system be employ to assess evidence quality , while evidence reliability be gauge via sensitivity analysis . a total of 33 study be analyze , reveal no significant difference between the kd and other diet in muscle mass ( 0.06 , 95 % -1.97 to 2.09 , p = 0.95 ) , muscle power ( countermovement jump : -0.06 , 95 % -0.49 to 0.38 , p = 0.80 ) and strength ( squat : -0.19 , 95 % -0.53 to 0.15 , p = 0.27 ; bench press : -0.15 , 95 % -0.49 to 0.18 , p = 0.37 ) . however , a significant decrease in fat-free mass ( -0.48 , 95 % -0.73 to -0.23 , p < 0.001 ) and fat mass ( -1.31 , 95 % -2.06 to -0.57 , p < 0.001 ) be observe in the kd group compare with the control group . the kd also improve fat oxidation ( 0.13 , 95 % 0.08 to 0.17 , p < 0.001 ) and reduced respiratory exchange ratio ( -0.07 , 95 % -0.11 to -0.03 , p < 0.001 ) during an exercise test . the vo ( 2max ) and vo ( 2max ) relative to body weight , treadmill time to exhaustion , and rating of perceived exertion be not significantly affect by kd . among adult population , kd can increase fat oxidation to modify muscle metabolism , while no significant reduction in muscle mass or strength be observe . additional well-designed randomize control trial be warrant to definitively determine the effect of ketogenic diet on muscle parameter .	Journal of health, population, and nutrition	01/10/2025
10.1186/s12964-025-02403-9	the primary cilium a a multifunctional organelle : emerging role and unanswered question .	Corbeil D, Thamm K, Karbanová J, Fargeas CA, Jászai J	the primary cilium , a solitary membrane-bound , microtubule-based cellular organelle , have be consider an evolutionary relict for almost a century . over the past three decade , interest in this protruding , non-motile structure of the plasma membrane have be boost by the identification of ciliary dysfunction a the underlie cause of developmental abnormality and inherited disorder , commonly call ciliopathies . the primary cilium respond to environmental stimulus , such a mechanical , chemical , or light ( in the case of the modified cilium of photoreceptors ) signal . the membrane of primary cilium host specific sensory complex and/or receptor associate with various pathway , predispose them to transmit ( or convert ) spatiotemporal environmental information into cellular response . these dual mechanochemical aspect lead to the recognition that primary cilium be multifunctional sensory organelle that act a `` cellular antenna '' . beyond their establish role in signal transduction , primary cilium be newly recognize a important hub for short- and long-distance intercellular communication due to their ability to release and , perhaps , selectively take up extracellular vesicle , which be biological carrier exchange between cell . in addition , the physical contact of the primary cilium with other cilium , cytonemes or with nerve cell axon add another layer of complexity to the mechanism of sensory and/or intercellular communication between neighbor cell that need to be far explore . in this review , we focus on these new and less-explored ciliary property and process , which can affect cell communication and signaling and thus have a direct impact on development , tissue homeostasis , and pathological condition .	Cell communication and signaling : CCS	02/10/2025
10.1007/s00011-025-02105-5	integrative genomics and functional immunology reveal clostridia specie a modulators of neuroinflammation in amyotrophic lateral sclerosis .	Wang S, Jiang H, Yao T	this multiomics study investigate causal relationship between the gut microbiota ( gm ) , immune dysregulation , and amyotrophic lateral sclerosis ( al ) pathogenesis use mendelian randomization ( mr ) with experimental validation . analysis incorporate genome-wide data from 87,347 participant ( n = 7738 ; 20,806 patient , 59,804 control ; immune phenotype : n = 3757 ) , transcriptomic data from 71 subject ( 56 al patient , 15 control ) , and experimental validation in matched cohort ( n = 6 subject per group ) . two-sample bidirectional mr and mediation analysis be use to evaluate association . experimental validation employ flow cytometry for myeloid-derived suppressor cell quantification , enzyme-linked immunosorbent assay for cytokine , and real-time polymerase chain reaction for bacterial validation . statistical analysis include inverse variance weight method with cohen 's d calculation . sixteen bacterial taxon , include p_firmicutes.c_clostridia , display protective association with the risk of al , whereas sixteen show harmful association . mediation analysis suggest that p_firmicutes.c_clostridia may confer protection through cd33+hla-dr-myeloid-derived suppressor cell upregulation ( 23.8 % mediation effect ) . experimental validation confirm few myeloid-derived suppressor cell in al patient ( 4.0 ± 0.8 % vs. 7.5 ± 1.0 % , p < 0.001 , cohen 's d = 1.4 ) and low level of anti-inflammatory cytokine ( tgf-β1 : cohen 's d = 1.8 , p < 0.001 ) . these finding support causal association between gut microbial taxon and the al risk , which be mediate through immunoregulatory mechanism , highlight therapeutic target within the gut‒immune‒brain axis .	Inflammation research : official journal of the European Histamine Research	03/10/2025
10.1016/j.xcrm.2025.102396	update efficacy and predictive biomarkers of ql1706 , a bifunctional pd-1/ctla-4 dual blocker in advanced solid tumors-a phase 1/1b study .	Ma Y, Lin S, Chen Q, Xue J, Yang Y, Zang A, Cheng Y, Zhang Y, Wang X, Chen Z, Qu S, He J, Chen C, Jin C, Zhu D, Li Q, Liu X, Su W, Ba Y, Li W, Li Q, Zhu C, Huang Z, Kang X, Xue S, Li H, Wang C, Luo F, Huang Y, Zhang L, Zhao H	ql1706 have show promise efficacy in solid tumor in a phase 1/1b study . here , we report updated long-term survival outcome and biomarker analysis . among 468 patient treat with ql1706 ( 5 mg/kg ) , median progression-free survival ( mpfs ) and overall survival ( mo ) be 1.5 and 14.2 month for non-small cell lung cancer ( nsclc ) , 1.9 and 20.2 month for nasopharyngeal carcinoma ( npc ) , and 4.2 and 18.6 month for cervical cancer ( cc ) , respectively . liver metastasis be correlate with poor progression-free survival ( pfs ) and overall survival ( o ) in nsclc and poor o in cc , while elevate lactate dehydrogenase be link to short pfs and o in npc . cdk4/11q13 diploid or the expression of gzmk ( high ) & myc ( low ) distinguish npcs with the most favorable pfs . in nsclc , pd-l1 ( + ) /til ( + ) or a low cxcl13 ratio indicate well outcome . ql1706 offer long-term survival benefit in solid tumor , with identified molecular marker aid in select suitable candidate . this study have be register on clinicaltrials.gov ( nct04296994 and nct05171790 ) .	Cell reports. Medicine	03/10/2025
10.1016/j.jhep.2025.08.038	reversal of aclf and alf use whole blood extracorporeal system combine hla-depleted liver organoids with granulocyte-monocyte apheresis .	Yamaguchi H, Yoneyama Y, Ichimura K, Ohtsu K, Soen M, Moriya C, Kumagai M, Myers RP, Subramanian GM, Takebe T	background & acute-on-chronic liver failure ( aclf ) be characterize by catastrophic loss of liver function in patient with advanced chronic liver disease , with 28-day mortality rate reach up to 80 % . despite advance in intensive care , the high mortality primarily stem from the absence of a therapeutic modality that simultaneously address both the profound systemic inflammatory response and severe hepatic synthetic dysfunction . we design an integrate extracorporeal circuit , term the utopia system , which combine granulocyte and monocyte apheresis ( gma ) with human induce pluripotent stem cell-derived hepatocyte-like cell ( ihlc ) organoids engineer with hla-a , hla-b , and ciita triple knockout . the efficacy of utopia be test after direct whole blood exposure through venous flow in rat model of aclf and acute liver failure ( alf ) . utopia treatment significantly improve survival in both aclf and alf rat model , outperform gma or ihlc monotherapy and hepg2 cell-based device . improved survival be associate with reduced coma severity , improve liver biochemistry , and reduce hyperammonaemia , hyperbilirubinemia , and systemic inflammation . transcriptomic and histological analysis reveal restoration of hepatic metabolic gene expression and hepatocyte regeneration . mechanistically , ihlc-secreted α-fetoprotein suppress hepatocyte cell cycle arrest via p21 downregulation and enhanced regeneration , while utopia restore hnf4α activity and dampen pro-inflammatory cytokine , include il-6 and tnf-α . the tandem utopia circuit confers a significant survival benefit in preclinical rodent model of aclf and alf by provide anti-inflammatory , synthetic , and metabolic support . elucidate the regenerative signal that promote recovery of the injured liver may far expand the potential of this whole blood extracorporeal system a a novel , off-the-shelf liver support therapy . restore hepatic metabolism while control inflammation in acutely decompensated cirrhosis remain a major unmet clinical need . by combine hla-modified human induce pluripotent stem cell-derived liver organoids with granulocyte and monocyte apheresis , we develop a bioartificial liver system that manage inflammation , restore liver function , and promote regeneration in two rat model of severe liver failure . this therapy could offer an off-the-shelf treatment option for patient with life-threatening liver failure .	Journal of hepatology	02/10/2025
10.1016/S2213-2600(25)00299-1	reframing remission in severe asthma : a conceptual framework for distinguish disease activity versus damage .	Porsbjerg C, Rupani H, Brannan JD, Ueki S, Nawijn MC, Erjefält JS, Chanez P, Anderson GP, Pavord ID	remission be emerge a a feasible treatment goal in moderate-to-severe asthma , drive by the success of biologic therapy in control inflammation and reduce exacerbation . yet current definition of remission-focused on symptom control , lung function , and corticosteroid reduction-lack precision , can only be ascertain retrospectively , and do not reflect the underlying mechanism and pathology that drive disease progression . this gap limit the clinical applicability of these definition and might obscure opportunity for early , disease-modifying intervention . in this series paper , we propose a refined framework for understand and reach remission , centre on distinguish modifiable disease activity from irreversible remodelling and comorbidity-related factor that contribute to disease burden . we introduce the concept of at-risk asthma a a crucial phase characterise by high disease activity and immune dysregulation , in which timely intervention might prevent irreversible airway and extrapulmonary damage and support long-term disease modification . we examine how symptom , lung function impairment , and exacerbation can arise from distinct and overlap mechanism , underscore the need for careful attribution in clinical assessment . we also outline four key pathophysiological domains-airway hyper-responsiveness , immune hyper-responsiveness , immune remodelling , and structural remodelling-and describe their temporal evolution and implication for treatment responsiveness . finally , we present a domain-based strategy for assessment and intervention , link target therapy to underlie mechanism . this approach support more personalised treatment decision and redefines remission , not simply a the absence of symptom , but a stabilisation of disease biology . a the field advance towards early intervention and more tailored application of biologics in at-risk asthma , such a framework could be essential to improve long-term outcome and prevent overtreatment of irreversible disease .	The Lancet. Respiratory medicine	29/09/2025
10.1038/s41467-025-63696-5	tumor immune dynamic and long-term clinical outcome of stage iiia nsclc patient treat with neoadjuvant chemoimmunotherapy .	Schmid D, Sobottka B, Manzo M, Trüb M, Leonards K, Herzig P, Oyewole OR, Jermann P, Hayoz S, Savic Prince S, Tochtermann G, Natoli M, Pless M, Bettini A, Früh M, Mauti LA, Britschgi C, Peters S, Mark M, Ochsenbein AF, Janthur WD, Waibel C, Mach N, Froesch P, Buess M, Bohanes P, Gonzalez M, Alborelli I, Rothschild SI, Koelzer VH, Zippelius A	neoadjuvant chemoimmunotherapy offer promise to improve outcome for patient with resectable non-small cell lung cancer ( nsclc ) . yet not all patient derive treatment benefit , and reliable biomarkers of response be still lack . we here assess the long-term clinical outcome of neoadjuvant chemotherapy and perioperative anti-pd-l1 inhibition in resectable stage iiia nsclc in the sakk 16/14 trial and provide a comprehensive characterization of anti-tumor immune response for biomarker-based treatment personalization . we report secondary outcome of median event-free survival ( efs ) of 4.0 year and median overall survival not be reach after a median follow-up of 5.4 year . computer-aided spatial image analysis emphasize the importance of cd8 ( + ) t cell position in tumor , and large tertiary lymphoid structure in pre-treatment biopsy correlate with improved efs . genomic technique reveal the association of intratumoral tcr diversity with response . finally , circulate proliferate cd39 ( + ) pd-1 ( + ) cd8 ( + ) t cell and elevated level of ccl15 post-treatment be see in patient with sustained therapeutic benefit . nct02572843 .	Nature communications	30/09/2025
10.1038/s41397-025-00384-z	serine-arginine protein kinase 1 ( srpk1 ) be under-expressed in mucinous colorectal cancer , and may mediate resistance to oxaliplatin .	Duggan WP, Azimi M, Flanagan L, Sullivan GP, Reynolds IS, Fay J, Dussmann H, Ní Chonghaile T, Sheehan KM, Jirström K, Prehn JHM, Burke JP	5-15 % of all colorectal cancer ( crcs ) be mucinous . mucinous crcs be associate with an inhibited response to standard adjuvant and neoadjuvant therapy . serine-arginine protein kinase 1 ( srpk1 ) be an enzyme , which modulate the activity of multiple splice factor . srpk1 under-expression be associate with resistance to platinum-based chemotherapeutic agent in multiple tumor type . the objective of this study be to evaluate srpk1 expression in mucinous crc and to explore the potential relationship between differential srpk1 expression and oxaliplatin resistance in mucinous crc . rectal cancer and crc tissue microarrays ( tma ) be stain with srpk1 to compare expression between mucinous and non-mucinous tumor . srpk1 expression be analyze in mucinous and non-mucinous crc cell line . cell be treat with oxaliplatin to explore difference in treatment response . mucinous cell be transfected with an srpk1 crispr/cas9 lentiviral activation plasmid to investigate the relationship between srpk1 expression and oxaliplatin resistance . the tma cohort include 117 patient with mucinous and 441 patient with non-mucinous crc . srpk1 be find to be under-expressed in both the mucinous rectal cancer ( p < 0.001 ) and crc cohort ( p = 0.003 ) . on univariate analysis , srpk1 under-expression be find to be associate with bad 5-year o ( p = 0.001 ) . treatment of mucinous crc cell with oxaliplatin do not result in a significant increase in cell death ( p = 0.149 ) . however overexpression of srpk1 follow transfection with a crispr/cas9 activation plasmid result in a significant increase in sensitivity of these cell to oxaliplatin treatment ( p = 0.029 ) . srpk1 be under-expressed in mucinous crc , and under-expression be associate with bad o . this may be due to the positive effect of srpk1 on oxaliplatin sensitivity .	The pharmacogenomics journal	03/10/2025
10.1038/s41586-025-09532-8	a new paradigm for outer membrane protein biogenesis in the bacteroidota .	Liu X, Orenday Tapia L, Deme JC, Lea SM, Berks BC	in gram-negative bacteria , the outer membrane be the first line of defence against antimicrobial agent and immunological attack ( 1 ) . a key part of outer membrane biogenesis be the insertion of outer membrane protein by the β-barrel-assembly machinery ( bam ) ( 2-4 ) . here we report the cryo-electron microscopy structure of a bam complex isolate from flavobacterium johnsoniae , a member of the bacteroidota , a phylum that include key human commensal and major anaerobic pathogen . this bam complex be extensively modify from the canonical escherichia coli system and include an extracellular canopy that overhang the substrate folding site and a subunit that insert into the bam pore . the novel bamg and bamh subunit that be involve in form the extracellular canopy be require for bam function and be conserve across the bacteroidota , suggest that they form an essential extension to the canonical bam core in this phylum . for bamh , isolation of a suppressor mutation enable the separation of it essential and non-essential function . the need for a highly remodelled and enhance bam complex reflect the unusually complex membrane protein find in the outer membrane of the bacteroidota .	Nature	01/10/2025
10.1016/j.phrs.2025.107977	tdp-43 in alzheimer 's disease : pathophysiology and therapeutic strategy .	Zhou X, Lin X, He Y, Huang N, Luo Y	alzheimer 's disease ( ad ) be a complex neurodegenerative disorder characterize by the dysregulation of multiple molecular mechanism . in recent year , transactive response dna-binding protein 43 kda ( tdp-43 ) have increasingly be recognize a a critical pathological protein and have become a prominent focus in ad research . tdp-43 be involve not only in physiological process such a rna metabolism , protein quality control , and mitochondrial regulation but also in ad pathology through abnormal aggregation , dysregulated nucleocytoplasmic transport , and aberrant posttranslational modification , lead to neurotoxicity , mitochondrial dysfunction , and disrupt protein homeostasis . study have show that tdp-43 closely interact with two core pathological hallmark of ad , β-amyloid ( aβ ) and tau . by promote aβ oligomerization and tau hyperphosphorylation , tdp-43 accelerate the pathological progression of this disease . give the multifaceted role of tdp-43 in ad , therapeutic strategy target tdp-43 have show great potential . approach such a modulate it rna splicing activity , inhibit pathological aggregation , restore the balance of nucleocytoplasmic transport , and prevent it mitochondrial localization offer new avenue for ad treatment . this review systematically summarize the pathological mechanism of tdp-43 in ad and it interaction with aβ and tau and discuss the feasibility of target tdp-43 a a therapeutic strategy . future study should far elucidate the role of tdp-43 in the early stage of ad and develop specific therapeutic agent that target tdp-43 , with the aim of provide new insight for precision treatment of ad .	Pharmacological research	04/10/2025
10.1186/s13098-025-01947-7	c-reactive protein-triglyceride glucose index predict mortality in cardiovascular-kidney-metabolic syndrome stage 0-3 : a prospective cohort study .	Ying Q, He F, Wu L, Wei Q, Xu J	cardiovascular-kidney-metabolic ( ckm ) syndrome be define by the interplay of metabolic risk factor , chronic kidney disease , and cardiovascular disease . the c-reactive protein-triglyceride glucose index ( cti ) be a composite biomarker that reflect both inflammation and insulin resistance , but whether it be associate with mortality in person with early-stage ckm syndrome be unknown . we analyze data from the national health and nutrition examination survey from 1999 to 2010. we use multivariable cox proportional-hazards model to assess the association between the cti score and the risk of all-cause mortality and cardiovascular disease ( cvd ) mortality , with vital status ascertain through linkage to the national death index through december 31 , 2019. among 10,718 participant , a total of 1783 death ( 491 from cvd ) occur during a mean follow-up of 14.0 year . in fully adjust model , a high cti score be associate with a great risk of all-cause mortality ( hr per unit increase , 1.56 ; 95 % ci , 1.36 to 1.78 ) and of cvd mortality ( hr per unit increase , 2.03 ; 95 % ci , 1.49 to 2.77 ) . the association with all-cause mortality be strong among participant under the age of 60 than among those over 60 year old ( p < 0.001 for interaction ) . our study find that in patient with early-stage ckm syndrome , a high cti be independently associate with an increase risk of all-cause mortality and cvd mortality . this association be more significant in young participant .	Diabetology & metabolic syndrome	03/10/2025
10.1016/j.jare.2025.09.056	the significance of urine extracellular vesicle dna methylation detection in the diagnosis and classification of prostate cancer .	Ding T, Diao Y, Fu R, Gong C, He Q, He W, Zhang L, Yang X, Zeng X, Yu L, Liu J, Shi W, Zhang K, Hao X	a one of the most common malignant tumor in men , prostate cancer ( pca ) still lack convenient , non-invasive and highly specific diagnostic marker . the advantage of extracellular vesicle ( ev ) dna in tumor diagnosis have gradually attract the attention of researcher . however , methylation detection , which be more advantageous than mutation detection in tumor diagnosis , have not be widely practice in ev dna , and it value in pca diagnosis also remain underexplored . this study aim to establish and optimize an ev dna methylation detection system and evaluate it diagnostic and classification potential for pca . we characterize ev dna biological property , optimize pretreatment strategy , validate it correlation with genomic dna methylation , and explore urine ev dna methylation target in 86 benign prostatic hyperplasia ( bph ) and 109 pca patient across three cohort ( screen : 30 bph/33 pca ; training : 27 bph/30 pca ; validation : 29 bph/46 pca ) . heterogeneous biological characteristic be observe among dna from different subtypes of ev , but methylation profile remain consistent across subtypes and post-dnase i treatment . ev dna accurately reflect the methylation state of source cell genomic dna . by combine our screen result with data from the tcga database and previously report , we develop a panel consisting of 667 pca-specific methylation target for detection . among these , six methylation site ( macf1、linc01359-1、linc01359-2、adcy4、gaplinc、c19orf25 ) demonstrate high diagnostic value for pca , enable construction of pca and aggressive pca differential diagnosis model with auc up to 0.74 and 0.91 respectively . the diagnostic value of these six marker be far confirm use methylight pcr in the validation cohort which also display promising performance a a tool for diagnose pca . this study highlight the potential of urine ev dna methylation a a novel diagnostic marker for pca and lay a foundation for future ev dna research .	Journal of advanced research	01/10/2025
10.1186/s10195-025-00885-4	active and passive physical therapy in patient with chronic low-back pain : a level i bayesian network meta-analysis .	Baroncini A, Maffulli N, Manocchio N, Bossa M, Foti C, Schäfer L, Klimuch A, Migliorini F	chronic low back pain ( clbp ) be common . physiotherapy be frequently indicate a a non-pharmacological management of these patient . this bayesian network meta-analysis compare active versus passive physiotherapy versus their combination in term of pain and disability in patient with mechanical and/or aspecific clbp . in june 2025 , the following database be access : pubmed , web of science , google scholar and embase . all the randomise control trial ( rcts ) which evaluate the efficacy of a physiotherapy program in patient with lbp be access . data regard pain score , the roland-morris disability questionnaire ( rmq ) and the oswestry disability index ( odi ) be collect . the network meta-analyses be perform use the stata ( version 14 ; statacorp , college station , tx , usa ) routine for bayesian hierarchical random-effects model analysis , employ the inverse variance method . the standardised mean difference ( std ) be use for continuous data . data from 2768 patient ( mean age 46.9 ± 10.9 year , mean bmi 25.8 ± 2.9 kg/m ( 2 ) ) be collect . the mean length of follow-up be 6.2 ± 6.1 month . between group , comparability be find at baseline in term of mean age , proportion of woman , mean bmi , symptom duration and patient-reported outcome measure ( prom ) . by the end of the follow-up period , the active group evidence the low pain score ( smd 1.00 ; 95 % ci -3.28 to 5.28 ) . the active group evidence the low rmq score ( smd 0.94 ; 95 % ci -4.96 to 3.09 ) . the active group evidence the low odi score ( smd -1.23 ; 95 % ci -9.83 to 7.36 ) . active physiotherapy show good result than passive physiotherapy and a combination of both for the management of mechanical and/or non-specific clbp . level i , bayesian network meta-analysis of rcts .	Journal of orthopaedics and traumatology : official journal of the Italian	03/10/2025
10.1371/journal.pone.0127045	alternate hemiplegia of childhood : retrospective genetic study and genotype-phenotype correlation in 187 subject from the u ahcf registry .	Viollet L, Glusman G, Murphy KJ, Newcomb TM, Reyna SP, Sweney M, Nelson B, Andermann F, Andermann E, Acsadi G, Barbano RL, Brown C, Brunkow ME, Chugani HT, Cheyette SR, Collins A, DeBrosse SD, Galas D, Friedman J, Hood L, Huff C, Jorde LB, King MD, LaSalle B, Leventer RJ, Lewelt AJ, Massart MB, Mérida MR 2nd, Ptáček LJ, Roach JC, Rust RS, Renault F, Sanger TD, Sotero de Menezes MA, Tennyson R, Uldall P, Zhang Y, Zupanc M, Xin W, Silver K, Swoboda KJ	mutation in atp1a3 cause alternate hemiplegia of childhood ( ahc ) by disrupt function of the neuronal na+/k+ atpase . publish study to date indicate 2 recurrent mutation , d801n and e815k , and a more severe phenotype in the e815k cohort . we perform mutation analysis and retrospective genotype-phenotype correlation in all eligible patient with ahc enrol in the u ahc foundation registry from 1997-2012. clinical data be abstract from standardized caregiver ' questionnaire and medical record and confirm by expert clinician . we identify atp1a3 mutation by sanger and whole genome sequencing , and compare phenotype within and between 4 group of subject , those with d801n , e815k , other atp1a3 or no atp1a3 mutation . we identify heterozygous atp1a3 mutation in 154 of 187 ( 82 % ) ahc patient . of 34 unique mutation , 31 ( 91 % ) be missense , and 16 ( 47 % ) have not be previously report . concordant with prior study , more than 2/3 of all mutation be clusteredin exon 17 and 18. of 143 simplex occurrence , 58 have d801n ( 40 % ) , 38 have e815k ( 26 % ) and 11 have g947r ( 8 % ) mutation [ correct ] .patients with an e815k mutation demonstrate an early age of onset , more severe motor impairment and a high prevalence of status epilepticus . this study far expand the number and spectrum of atp1a3 mutation associate with ahc and confirm a more deleterious effect of the e815k mutation on select neurologic outcome . however , the complexity of the disorder and the extensive phenotypic variability among subgroups merit caution and emphasize the need for further study .	PloS one	01/01/2015
10.1186/s13054-025-05573-7	the effect of vasopressor choice on renal outcome in septic shock : a systematic review of randomised trial a a guide for future research .	McDonald R, Burns M, Wong A, Smith C, Ostermann M, Hutchings S	patient with septic shock be high risk for develop acute kidney injury ( aki ) , with it associated morbidity . this systematic review assess the evidence for an effect on renal outcome from choice of vasopressor . search be conduct on medline , embase , cochrane central , congress abstract and trial registry . the search strategy include septic shock , vasopressor agent and renal impairment . inclusion criterion be non-crossover randomise control trial of adult septic shock compare individual or combination of vasopressor and placebo control trial . primary outcome be the incidence of aki in study participant . secondary outcome be aki duration , renal replacement therapy ( rrt ) rate , rrt duration , renal failure free day , requirement for long term rrt and major adverse kidney event ( make ) at 30 and 90 day . a total of 4259 patient , from 17 study , be include . vasopressin and terlipressin study predominate . in 8 study report aki rate , no effect be see relate to vasopressor choice . rrt rate be the most reported secondary outcome . of five study that investigate the role of vasopressin , only one show significant benefit . alongside limited reporting , no conclusive benefit be demonstrate in other secondary outcome . no study report requirement for long term rrt , make 30 or 90. this be the first systematic review focussed on renal outcome with differential vasopressor therapy in septic shock . it illustrate the paucity of evidence support a particular vasopressor . also highlight be problem of population and study heterogeneity , as well a the focus on rrt a a proxy for renal outcome . standardise renal outcome reporting , large and appropriately powered trial and focussed sub-population study be require to far inform renal focussed vasopressor research and practice . this systematic review be prospectively register on prospero ( crd42023481778 ) .	Critical care (London, England)	02/10/2025
10.1002/ajh.70099	clinical characteristic , treatment response and outcome of light chain multiple myeloma .	Bolarinwa A, Zanwar S, Abdallah N, Buadi FK, Hayman SR, Gertz MA, Dispenzieri A, Muchtar E, Kapoor P, Gonsalves W, Kourelis T, Dingli D, Warsame R, Leung N, Cook J, Binder M, Lin Y, Hwa Y, Rogers MG, Hobbs M, Fonder A, Jevremovic D, Rajkumar SV, Kumar SK	light chain multiple myeloma ( lcmm ) be a subtype of multiple myeloma ( mm ) characterize by the exclusive production of immunoglobulin light chain and account for 15 % -20 % of newly diagnose mm . a comprehensive comparison of lcmm with mm produce intact immunoglobulin ( non-lcmm ) remain limited . in this retrospective study , we describe distinct clinical and cytogenetic feature and assess long-term outcome in 852 lcmm patient diagnose between 01/01/2004 and 12/31/2022 , compare with non-lcmm control match for age , sex , and year of diagnosis . on univariable analysis , lcmm patient be more likely to present with elevated creatinine ( > 2 mg/dl ) , beta-2-microglobulin ≥ 5.5 mg/l , elevate ldh , hypercalcemia , t ( 11 ; 14 ) , del ( 13q ) , and t ( 6 ; 14 ) . conversely , ims-imwg high-risk disease , hyperdiploidy , t ( 4 ; 14 ) , and serum albumin < 3.5 g/dl be less common . on multivariable analysis , elevate creatinine ( 5.1 , 95 % 1.2-27 , p = 0.04 ) , t ( 11 ; 14 ) ( 2.6 , 95 % 1.3-5.2 , p = 0.006 ) , and del ( 13q ) ( 4.1 , 95 % 2.1-8.2 , p < 0.001 ) be independently associate with lcmm , while ims-imwg high-risk disease ( 0.3 , 95 % 0.1-0.8 , p = 0.02 ) and hyperdiploidy ( 0.3 , 95 % 0.1-0.7 , p = 0.002 ) be less frequent . despite these difference , progression-free survival with frontline treatment ( 0.97 , 95 % 0.84-1.11 , p = 0.63 ) and overall survival ( 0.99 , 95 % 0.87-1.13 , p = 0.94 ) be similar between lcmm and non-lcmm patient . this study highlight the distinct clinical and cytogenetic feature of lcmm , mark by high rate of renal failure , t ( 11 ; 14 ) , and del ( 13q ) , low prevalence of ims-imwg high-risk disease , and comparable survival outcome .	American journal of hematology	04/10/2025
10.1016/j.bbadis.2025.168065	metabolic reprogramming represent a targetable mechanism to overcome acquire resistance to venetoclax in acute myeloid leukemia .	de Queiroz GN, Lima K, Cipelli M, Tomaz V, Cortez LGF, de Franca Basto Silva M, Guedes RLM, Campregher PV, Rego EM, Câmara NOS, Costa-Lotufo LV, Machado-Neto JA	acute myeloid leukemia ( aml ) often develop resistance to the bcl2 inhibitor venetoclax through metabolic reprogramming . this study establish acquire venetoclax-resistant aml model ( mv4-11vr and molm-13vr ) to explore resistance mechanism and therapeutic strategy . cell viability and apoptosis assay reveal robust acquire resistance to venetoclax upon intermittent drug exposure . metabolic profile revealed distinct adaptation : mv4-11vr cell favor glycolysis , while molm-13vr cell increase oxidative phosphorylation . proteomic analysis support these finding , show pathway enrichment for carbohydrate metabolism in mv4-11vr and aerobic energy production in molm-13vr . despite these difference , both model share hyperactivation of the pi3k/akt/mtor pathway , a show by rps6 hyperphosphorylation . apoptotic regulation also diverge between the cellular model in relation to modulate bcl2-related gene and activation of the mapk signal pathway . target these metabolic change with metformin ( a mitochondrial complex i inhibitor ) or kpt-9274 ( a nampt inhibitor ) re-sensitized resistant cell to venetoclax . combination treatment show strong synergy and near-complete cell elimination . these result highlight metabolic reprogramming a a heterogeneous but targetable resistance mechanism and support combine metabolic inhibitor with bcl2 blockade to treat refractory aml .	Biochimica et biophysica acta. Molecular basis of disease	01/10/2025
10.1186/s10194-025-02134-9	application of machine learning in migraine classification : a call for study design standardization and global collaboration .	Petrušić I, Messina R, Pellesi L, Azorin DG, Chiang CC, Pietra AD, Ha WS, Labastida-Ramirez A, Onan D, Ornello R, Raffaelli B, Rubio-Beltran E, Ruscheweyh R, Tana C, Vuralli D, Waliszewska-Prosół M, Wang W, Wells-Gatnik WD, Martelletti P, Raggi A	migraine be a complex neurological disorder with diverse clinical phenotype and a multifaceted pathophysiology , which pose substantial challenge for accurate diagnosis , subtype differentiation , and biomarker discovery . machine learning ( ml ) technique have emerge a promising tool for classify migraine patient and uncover the underlying neurobiological mechanism that differentiate migraine type and subtypes . this systematic review identifies current ml classification model for migraine type and subtypes , evaluate the quality , reproducibility , and clinical utility of publish study . the finding demonstrate that current ml model , particularly support vector machine and linear discriminant analysis , can accurately classify migraine patient base on structural and functional neuroimaging feature with accuracy range from 75 to 98 % . however , quality assessment reveal significant methodological heterogeneity across study , include inconsistent reporting of model performance , insufficient patient phenotyping , small and imbalanced datasets , and limit external validation . these limitation hinder the global generalizability and reproducibility of these study . we propose a roadmap for future research emphasize well-characterized clinical subgrouping , standardize data acquisition and feature engineering protocol , transparency in model development and reporting , and collaborative multicentric design to enable large-scale validation . furthermore , this review stress the importance of incorporate real-world phenotypic data , such a treatment response , comorbidities , and digital phenotyping metric , to enrich ml model and support the transition toward precision medicine in migraine care . ultimately , this review highlight the urgent need for methodological rigor in migraine ml classification study to bridge the gap between experimental success and clinical applicability .	The journal of headache and pain	02/10/2025
10.1016/j.esmoop.2025.105808	cyclin-dependent kinase 4/6 inhibitor beyond progression in hormone receptor-positive , her2-negative advance breast cancer : a systematic review and meta-analysis ( reignite study ) .	de Almeida LFC, Leite LF, Filho VOC, Noronha MM, Cappellaro AP, Gouveia M, da Silva JL, Ernst B, de Melo AC, Tarantino P, Batalini F	add cyclin-dependent kinase 4/6 inhibitor ( cdk4/6i ) to endocrine therapy ( et ) be consider the first-line treatment of advanced hr-positive/her2-negative breast cancer . however , with the recent approval of several additional target agent , the optimal treatment sequencing remain uncertain , and it be unclear whether the benefit of cdk4/6i extend beyond progression on first-line therapy . we conduct a systematic review and meta-analysis to evaluate the efficacy of cdk4/6i in the second-line setting after progression on cdk4/6i in the first line , with a particular focus on patient who have either pik3ca or esr1 mutation . we include randomized clinical trial ( rcts ) compare cdk4/6i combine with et to et alone in patient who experience tumor progression on cdk4/6i treatment in the first-line setting . the result be pool use a random-effects model with 95 % confidence interval ( ci ) . five rcts encompass 1184 patient be include . overall , cdk4/6i plus et significantly improve progression-free survival ( pfs ) versus et alone , yield a hazard ratio of 0.73 ( 95 % ci 0.56-0.94 , p < 0.05 ) , with a more prominent benefit in patient who switch the cdk4/6i ( hazard ratio 0.61 , 95 % ci 0.48-0.77 , p < 0.05 ) . the benefit be consistent in patient with somatic pik3ca mutation ( hazard ratio 0.71 , 95 % ci 0.52-0.98 , p < 0.05 ) , and esr1 mutation ( hazard ratio 0.66 , 95 % ci 0.49-0.89 , p < 0.05 ) . the toxicity profile be compatible with the known side effect from cdk4/6i . our result support the strategy of switch the cdk4/6i in the second-line setting and demonstrate persistent benefit even in patient with pik3ca or esr1 mutation .	ESMO open	01/10/2025
10.1038/s41467-025-63882-5	dual membrane receptor degradation via folate receptor target chimera .	Wang Z, Li Z, Högström J, Inuzuka H, Jing R, Yan P, Hou T, Qi Y, Huang D, Wang J, Wu T, Shi X, Liu B, Muranen T, Zhang D, Wei W	cancer drug resistance pose a significant challenge in oncology , often drive by intricate cross-talk among membrane-bound receptor that compromise mono-targeted therapy . we develop a dual membrane receptor degradation strategy leverage folate receptor α ( frα ) to address this issue . folate receptor α target chimeras-dual ( foltac-dual ) be engineer degrader design to selectively and simultaneously degrade distinct receptor pair : ( 1 ) egfr/her2 and ( 2 ) pd-l1/vista . through modular optimization of modality configuration and geometry , we identify the `` string '' format a the most effective construct . mechanistic study demonstrate an ~85 % increase in egfr-binding affinity compare to the conventional knob-into-hole design , likely contribute to the improved efficiency of dual-target degradation . proof-of-concept study reveal that egfr and her2 foltac-dual effectively counteract resistance in trastuzumab/lapatinib-resistant her2-positive breast cancer model , while pd-l1 and vista foltac-dual rejuvenates immune response in pd-l1 antibody-resistant syngeneic mouse model . these finding establish foltac-dual a a promising dual-degradation platform for clinical translation .	Nature communications	02/10/2025
10.1038/s41591-025-03944-9	prevention of type 2 diabetes through prediabetes remission without weight loss .	Sandforth A, Arreola EV, Hanson RL, Wewer Albrechtsen NJ, Holst JJ, Ahrends R, Coman C, Gerst F, Lorza-Gil E, Cheng Y, Sandforth L, Katzenstein S, Ganslmeier M, Seissler J, Hauner H, Perakakis N, Wagner R, Machann J, Schick F, Peter A, Lehmann R, Weigert C, Maurer J, Preissl H, Heni M, Szendrödi J, Kopf S, Solimena M, Schwarz P, Blüher M, Häring HU, Hrabé de Angelis M, Schürmann A, Kabisch S, Mai K, Pfeiffer AFH, Bornstein S, Stumvoll M, Roden M, Stefan N, Fritsche A, Birkenfeld AL, Jumpertz von Schwartzenberg R	clinical practice guideline recommend defined weight loss goal for the prevention of type 2 diabetes ( t2d ) in those individual with increase risk , such a prediabetes . however , achieve prediabetes remission , that be , reach normal glucose regulation accord to american diabetes association criterion , be more efficient in prevent t2d than solely reach weight loss goal . here we present a post hoc analysis of the large , multicenter , randomize , control prediabetes lifestyle intervention study ( plis ) , demonstrate that prediabetes remission be achievable without weight loss or even weight gain , and that it also protect against incident t2d . the underlying mechanism include improved insulin sensitivity , β-cell function and increment in β-cell-glp-1 sensitivity . weight gain be similar in those achieve prediabetes remission ( responder ) compare with nonresponders ; however , adipose tissue be differentially redistribute in responder and nonresponders when compare against each other-while nonresponders increase visceral adipose tissue mass , responder increase adipose tissue in subcutaneous depot . the finding be reproduce in the u diabetes prevention program . these data uncover essential pathway for prediabetes remission without weight loss and emphasize the need to include glycemic target in current clinical practice guideline to improve t2d prevention .	Nature medicine	29/09/2025
10.1186/s13148-025-01976-z	explore causal relationship between epigenetic age acceleration and alzheimer 's disease : a bidirectional mendelian randomization study .	Liu H, Yin Z, Chen X, Wang Z	alzheimer 's disease ( ad ) be identify by a distinct progression of aging-associated cognitive and functional impairment . recent advance recognize the dna methylation-based epigenetic clock a a precise predictor of age process and their related health outcome . however , observational study explore this link be often compromise by confound factor and reverse causality bias . to address the question , our study employ a bidirectional mendelian randomization ( mr ) analysis to explore the causal relationship between epigenetic age acceleration ( eaa ) and ad . genome-wide association study ( gwas ) statistic for epigenetic clock ( grimage , phenoage , horvathage , and hannumage ) be source from edinburgh datashare and the alzheimer disease genetics consortium ( adgc ) . the dataset comprise 63,926 participant , and among them , 21,982 case be ad patient and 41,944 be control . the primary analytical method for the mr be the inverse variance weight ( ivw ) . the potential pleiotropy and heterogeneity among the instrumental variable be evaluate by additional sensitivity analysis . employ the random-effects ivw approach , we find that , a indicate by grimage , eaa be associate with an increase risk of ad ( odds ratio [ or ] = 1.025 , 95 % confidence interval [ ci ] : 1.006-1.044 , p = 0.009 ) . quality control assessment confirm the reliability and robustness of our finding . however , the evidence do not support a causal relationship between ad and epigenetic aging in the reverse direction . our mr study indicate a positive causal relationship between eaa and ad . further research be necessary to explore the underlying physiological mechanism .	Clinical epigenetics	03/10/2025
10.1016/j.jvoice.2016.01.008	gardasil vaccination for recurrent laryngeal papillomatosis in adult men : first report : change in hpv antibody titer .	Makiyama K, Hirai R, Matsuzaki H	patient with human papillomavirus ( hpv ) dna-positive recurrent laryngeal papillomatosis commonly have repeat recurrence follow surgery . the reason be suspect to be a mechanism by which latent hpv infection in the surround healthy mucosa reinfects the surgical site . it may be that production of hpv antibody in the laryngeal mucosa with gardasil injection could inhibit postoperative recurrence . this be a case series study . the purpose of this study be to examine whether gardasil injection effectively inhibit recurrence . however , a a first report , we describe the antibody titer before and after vaccination . gardasil be inject in 12 men ( age 32-74 year ; mean age 47.9 year ) with hpv-positive laryngeal papillomatosis . serum antibody titer of hpv-6 , -11 , -16 , and -18 be measure by a competitive luminex-based immunoassay before the vaccination and 7 month after the start of the vaccination . each of the antibody titer be very low before vaccination , and they rise in all patient after the vaccination . this finding demonstrate that antibody titer increase with gardasil injection in post-adolescent male .	Journal of voice : official journal of the Voice Foundation	01/01/2016
10.4103/jisppd.jisppd_133_25	comparative evaluation of antimicrobial effectiveness of 2 % chlorhexidine , 25 % aqueous extract of propolis , and 2.4 % curcuma longa a intracanal irrigants : an ex vivo study .	Sengupta U, Sogi HPS, Shah SG, Bala R, Saini R, Garg N, Jain M	the primary teeth 's unique histological property and interaction with the oral cavity pose a challenge in treatment , unlike the permanent teeth . a repaired natural tooth maintain space well than an artificial one . these factor lead to a great emphasis on save the tooth by pulpectomy involve effective chemical cleaning and disinfection of canal than on meticulous mechanical canal shaping . a chemically available irrigants show cytotoxic effect , hence herbal-based irrigants be be consider viable option . the present study be undertake to compare and assess the antimicrobial effect of 2.4 % curcuma longa extract , 25 % aqueous propolis , and 2 % chlorhexidine in deciduous teeth . forty eight subject in age range of 4-7 year be allocate equally into four group - group i : saline ( negative control ) , group 2 % chlorhexidine ( positive control ) , group 2.4 % curcuma longa , and group 25 % aqueous propolis base on inclusion and exclusion criterion . isolation be achieve use a rubber dam . pre and postirrigation sample be collect use sterile absorbent paper point and transfer to a test tube contain brain heart infusion . the pre and postirrigation sample be send for microbial assay . streptococcus mutans and enterococcus faecalis be isolate use standard microbiological method , and serial dilution method be do to determine the pre and post irrigation colony count . the plate be duplicate and incubate at 37°c for 24 h. the preirrigation and post irrigation colony count sample with different irrigants be count and compare . for the saline pair t-test be use to compare the pre- and postirrigation value , and for 2 % chlorhexidine , 2.4 % curcuma longa , and 25 % aqueous extract of propolis group . the wilcoxon match sign rank test be use to compare pre- and post-irrigation bacterial count . to compare the mean change in bacterial colony count anova test be do . s. mutans and e. faecalis be the most commonly isolated microorganism . there be no statistical significant difference between saline , 2 % chlorhexidine , 2.4 % curcuma longa , and 25 % aqueous extract of propolis . the micro-organisms prevalent in primary teeth with necrosis include s. mutans and e. faecalis . antimicrobial sensitivity test do with the serial dilution method show that herbal irrigants such a 2.4 % curcuma longa extract and propolis be equally effective a 2 % chlorhexidine .	Journal of the Indian Society of Pedodontics and Preventive Dentistry	01/07/2025
10.1038/s41591-025-03956-5	a consensus immune dysregulation framework for sepsis and critical illness .	Moore AR, Zheng H, Ganesan A, Hasin-Brumshtein Y, Maddali MV, Levitt JE, van der Poll T, Lu J, Bouma HR, Scicluna BP, Giamarellos-Bourboulis EJ, Kotsaki A, Martin-Loeches I, Garduno A, Rothman RE, Sevransky J, Wright DW, Atreya MR, Moldawer LL, Efron PA, Kralovcova M, Karvunidis T, Giannini HM, Meyer NJ, Sweeney TE, Rogers AJ, Khatri P	critical care syndrome such a sepsis , acute respiratory distress syndrome ( ards ) and trauma continue to have unacceptably high morbidity and mortality , with progress limit by the inherent heterogeneity within syndromic illness . although numerous immune endotypes have be propose for sepsis and critical care , the similarity and difference between these endotypes remain unclear , hinder clinical translation . the subspace consortium be an international consortium that aim to advance precision medicine in critical care through the sharing of transcriptomic data . here , evaluate the overlap of exist immune endotypes in sepsis across > 7,074 sample from 37 independent cohort , we develop cell-type-specific gene expression signature to quantify dysregulation within immune compartment . myeloid and lymphoid dysregulation be associate with disease severity and mortality across all cohort . importantly , this dysregulation be also observe in patient with ards , trauma and burn , suggest a conserved mechanism across various critical illness syndrome . moreover , analysis of randomize control trial data reveal that myeloid and lymphoid dysregulation be associate with differential mortality in patient treat with anakinra in the save-more trial ( n = 452 ) and corticosteroid in the victas ( n = 89 ) and vanish ( n = 117 ) trial , underscore their prognostic and therapeutic implication . in conclusion , our propose immunology-based framework for quantify cellular compartment dysregulation offer a potentially valuable tool for understand immune dysregulation in critical illness with prognostic and therapeutic significance .	Nature medicine	30/09/2025
10.1038/s41598-025-11466-0	proteomic analysis of brain and spinal cord tissue reveals distinct immune and mitochondrial process between human and mouse al model .	Spiteri AG, Steele JR, Lee HC, Zhang H, Sun J, Schittenhelm RB, Yu CH, McLean C, Masters CL, Goudey B, Jin L, Pan Y	amyotrophic lateral sclerosis ( al ) be a fatal neurodegenerative disease result in the progressive loss of motor neuron in the brain and spine . more than 95 % of case be pathologically characterize by the cytoplasmic accumulation of hyperphosphorylated and ubiquitinated transactive response dna-binding protein 43 ( tdp-43 ) . multiple mouse model with tdp-43 accumulation have be develop , however , whether they recapitulate molecular feature of al pathology be unclear . give the lack of curative treatment for al , there be an urgent need to identify the precise biological process contribute to disease pathogenesis for the development of effective therapeutic treatment . thus , in this study we employ label-based untargeted proteomics to characterize the al proteome and related biological process in the spinal cord and brain of tdp-43 ( q331k ) mouse , a transgenic mouse model of al and the motor cortex and the cervical , thoracic , and lumbar spinal cord region from human . in human , we observe highly overlap response across the four tissue examine , primarily relate to the upregulation of immune process and the downregulation of mitochondrial function . in contrast , tdp-43 ( q331k ) mouse demonstrate a lack of enrichment for immune activation and the opposite regulation of mitochondrial process . a meta-analysis of previously publish mouse datasets identify the ubqln2 knock-out mouse model a show strong parallel with our late-stage human al . overall , this study provide in-depth analysis of the site-specific dysregulated proteome and their associated functional process across specie . thereby , identify potential therapeutic target while emphasize the limitation of specific mouse model at certain timepoints in recapitulate als-related process for future model development .	Scientific reports	30/09/2025
10.3389/fphar.2025.1641747	drug-induced agranulocytosis : a disproportionality analysis and umbrella review .	Lu Y, Wu B, Li K, Liu Z, Chen Y, Xu T	drug-induced agranulocytosis ( dia ) be a rare but life-threatening hematologic disorder that demand increased clinical and research attention . this study aim to provide the current overview of dia for clinical guidance . use real-world data from fda adverse event reporting system ( faers ) , we perform a disproportionality analysis to identify the drug associate with agranulocytosis , employ the information component and reporting odds ratio algorithms . logistic analysis be conduct to explore the confound factor of dia . time-to-onset analysis be implement to compare the adverse event onset time among different drug . to comprehensively supplement and corroborate our disproportionality finding , we far conduct an umbrella review of systematic review ( sr ) . five electronic database be search with srs address dia a an included adverse event . two independent reviewer perform literature screening , data extraction , and quality assessment accord to the preferred reporting item for systematic review and meta-analysis statement . the result of the included sr be synthesize use qualitative analysis . the disproportionality analysis reveal that most identified dia signal be for anticancer drug . the top-five drug with dia signal by case number be methotrexate ( 6,462 case ) , lenalidomide ( 5,722 case ) , rituximab ( 5,691 case ) , doxorubicin ( 4,391 case ) , and carboplatin ( 4,371 case ) . high-risk drug ( e.g. , deferiprone ) , old age , and abnormal weight be strongly associate with dia base on multivariate logistic regression . time-to-onset analysis show that clozapine have the long median of onset time ( 1,121.3 day ) , while azithromycin have the short time ( 8.1 day ) . the umbrella review include seven systematic review , with five focus on anticancer therapy . their finding on dia-associated drug , include protein kinase inhibitor and immune checkpoint inhibitor , be consistent with those from the disproportionality analysis . antibiotic , antithyroid drug , and psychotropic drug be also identify a causative drug of dia . this study systematically review the faers database and exist literature on dia to identify a spectrum of associated drug . anticancer drug be predominant , with targeted therapy comprise a large proportion , while non-chemotherapy drug be also identify a suspect drug . these finding underscore the need for heightened clinical vigilance toward suspect drug and highlight the importance of future effort to validate high-risk mechanism and explore dia monitoring strategy .	Frontiers in pharmacology	01/01/2025
10.1101/2025.08.14.670400	symptomatic treatment by a bbb-permeable aav engineer to restore tdp-43 function slow motor neuron disease and prevents paralysis .	Peethambaran Mallika A, Yu JG, Sitzman O, Baghel MS, Renganathan S, Sinha IR, Melnikova T, Ling JP, Wong PC	tar dna-binding protein 43kda ( tdp-43 ) dysfunction be an early pathogenic mechanism that underlie amyotrophic lateral sclerosis ( al ) , a devastate neurodegenerative disorder that lack disease modify therapy . we previously develop a mouse model in which tdp-43 be selectively delete from motor neuron ( chat-cre ; tardbp ( f/f ) ) that mimic the early stage of al . here , we demonstrate that intravenous delivery of a blood-brain-barrier ( bbb ) permeable aav capsid express our rationally design splice repressor ctr ( aav-php.eb-ctr ) in symptomatic chat-cre ; tardbp ( f/f ) mouse markedly slow disease progression and prevented paralysis . systemic delivery of aav-php.eb-ctr lead to transduction of ∼80 % of spinal motor neuron , repression of tdp-43-associated cryptic exon within motor neuron express ctr , and attenuation of motor neuron loss . notably , the addition of the tardbp 3'utr autoregulatory element to ctr maintain it expression within a physiological range . in control littermates that receive aav-php.eb-ctr and be monitor for > 20 month , grip strength and body weight remain normal , and no histopathological abnormality be observe , underscore a favorable safety profile for this gene therapy . these result provide preclinical proof-of-concept that bbb-crossing aav delivery of ctr can rescue motor neuron disease through the restoration of tdp-43 function , offer a promising mechanism-based therapeutic strategy for al .	bioRxiv : the preprint server for biology	20/08/2025
10.1186/s12933-025-02928-w	association of six insulin resistance-related index with the risk and progression of cardio-renal-metabolic multimorbidity : evidence from the uk biobank .	Liu L, Yu G, Ji X, Wang Y, He H	insulin resistance ( ir ) -related index be increasingly recognize a important contributor to cardio-renal-metabolic ( crm ) diseases . however , most prior study have focus on isolated outcome or cross-sectional disease status , lack dynamic insight into disease progression . this study aim to evaluate the predictive value of six ir-related index for crm onset and multistage progression use multistate modeling , and to explore potential biological mechanism through mediation analysis . we include 327,692 crm-free participant from the uk biobank in this prospective cohort study . six ir-related index include triglyceride-glucose ( tyg ) index , tyg-body mass index ( tyg-bmi ) , tyg-waist circumference ( tyg-wc ) , tyg-waist-to-height ratio ( tyg-whtr ) , triglyceride/high-density lipoprotein cholesterol ( tg/hdl-c ) ratio , and metabolic score for insulin resistance ( mets-ir ) , be calculate use establish formula . cox proportional hazard and multistate model be use to assess association with crm incidence and progression . predictive performance be evaluate use area under the curve ( auc ) , net reclassification improvement ( nri ) , and integrated discrimination improvement ( idi ) . mediation analysis be conduct for inflammatory , hepatic , and renal biomarkers . over a mean follow-up of 13.6 year , 17.3 % ( n = 58,563 ) of participant develop at least one crm disease . all six ir-related index be significantly associate with crm multimorbidity , both in term of incidence and progression . in predict the incidence of crm disease , tyg-wc , tyg-whtr , and mets-ir demonstrate superior performance . for each 1-standard deviation ( sd ) increase in tyg-wc , the risk of develop first , double , and triple crm disease increase by 51.4 % , 88.6 % , and 128.7 % , respectively ( all p < 0.001 ) , with similar gradient observe for tyg-whtr and mets-ir . multistate cox model far confirm consistent association between ir-related index and crm progression , particularly for tyg-whtr and tyg . specifically , a 1-sd increase in tyg-whtr be associate with a 65.3 % increase risk of transition from healthy to first crm disease , 34.6 % from first to double , and 26.7 % from double to triple crm disease ( all p < 0.001 ) . in predictive performance evaluation , tyg-wc , tyg-whtr , and mets-ir achieve the high auc , nri , and idi value . mediation analysis indicate that systemic inflammation , organ function , and especially kidney function partially mediate the observed association . in summary , ir-related index , particularly tyg-wc , tyg-whtr , and mets-ir , be observe to be associate with the presence and progression of crm disease . their potential incorporation into risk assessment and prevention strategy , together with consideration of inflammatory and organ function pathway , might help reduce the burden of crm multimorbidity ; however , far prospective study be need to confirm these finding and clarify their clinical relevance .	Cardiovascular diabetology	30/09/2025
10.1038/s41523-025-00814-y	association of potential biomarkers with clinical outcome in metastatic triple-negative breast cancer treat with pembrolizumab or chemotherapy .	Cortes J, Lipatov O, Im SA, Goncalves A, Lee KS, Schmid P, Tamura K, Testa L, Ohtani S, Harbeck N, Loi S, Salgado R, Karantza V, Mejia J, Cristescu R, Loboda A, Nebozhyn M, Jelinic P, Huang L, Winer EP	in the randomized , phase 3 keynote-119 study , overall survival ( o ) be not significantly improve with pembrolizumab 200 mg q3w versus investigator 's choice of chemotherapy in participant with previously treat metastatic tnbc . in this exploratory analysis , we evaluate association of tumor-infiltrating lymphocyte ( tils ) , t-cell‒inflamed gene expression profile ( tcell ( inf ) gep ) , brca1/brca2 mutation ( brcam ) status , homologous recombination deficiency ( hrd ) status , and tumor mutational burden ( tmb ) with clinical outcome . til level be associate with improved objective response rate ( orr ) , progression-free survival ( pfs ) , and o with pembrolizumab but not with chemotherapy or after adjust for tcell ( inf ) gep . association be also identify between tcell ( inf ) gep and improved orr , pfs , and o with pembrolizumab . participant with tmb ≥ 10 mut/mb show a trend toward increase benefit with pembrolizumab versus chemotherapy . no association be see between brcam/hrd status and treatment response . these finding suggest a positive association between tils , tcell ( inf ) gep , and tmb with clinical outcome in patient with metastatic tnbc receive pembrolizumab . clinicaltrials.gov identifier : nct02555657 ( date of registration : september 18 , 2015 ) .	NPJ breast cancer	02/10/2025
10.2967/jnumed.125.270190	multicentric matched-pair analysis of long-term hematotoxicity of peptide receptor radionuclide therapy in patient postsplenectomy .	Steinhelfer L, Jungmann F, Endroes L, Lanzafame H, Hermann K, Pfob CH, Lapa C, Hartrampf PE, Dörrler AL, Buck AK, Götze K, Wenzel P, Geisler F, Walter R, Haneder E, Lohöfer F, Haller B, Braren R, Eiber M	peptide receptor radionuclide therapy ( prrt ) with ( 177 ) lu-dotatate be an approved treatment for metastatic neuroendocrine tumor ( net ) . although the therapy be effective , hematologic toxicity , particularly leukopenia , remain a significant concern . the spleen , which accumulate radiolabeled somatostatin analog , may play a critical role in modulate this toxicity . this study investigate whether patient undergo prrt after splenectomy exhibit lower hematologic toxicity . method : this multicenter retrospective study include 68 patient with metastatic net treat with prrt between 2009 and 2022. splenectomized patient ( n = 34 ) be match to nonsplenectomized patient on the basis of age , sex , tumor location , grading , metastatic pattern , and treatment cycle . hematologic parameter ( leukocyte , lymphocyte , neutrophil , hemoglobin , and platelet ) be assess at baseline and 12 and 24 mo after prrt . hematotoxicity be grade use common terminology criterion for adverse event . statistical analysis include t test , mann-whitney u test , and fisher exact test , with an α of 0.05 and bonferroni adjustment apply . result : splenectomized patient have significantly low rate of leukopenia , with a mean decline of 12.8 % in leukocyte count at 24 mo versus 47.2 % in nonsplenectomized patient ( p < 0.001 ) , and a high median absolute leukocyte count ( 7.2 vs. 4.2 × 10³/mm³ , p < 0.001 ) . leukopenia occur in 2 splenectomized patient compare with 20 in the control group ( p < 0.001 ) . lymphocyte decline be also less pronounced , with high absolute count at 24 mo . platelet count be consistently high postsplenectomy , although relative change over time be not significant . neutrophil count and hemoglobin level remain comparable between group . conclusion : splenectomy appear to reduce leukopenia and improve hematologic tolerability in net patient undergo prrt , highlight the spleen 's role in leukocyte regulation . these patient may better tolerate intensified prrt regimen , include additional cycle or reinduction , with minimal toxicity . this be particularly relevant for patient with pancreatic net , who frequently undergo splenectomy and face a poor prognosis . prospective study be need to far clarify the spleen 's impact on prrt-related hematotoxicity and guide treatment optimization .	Journal of nuclear medicine : official publication, Society of Nuclear Medicine	03/10/2025
10.1007/s13577-025-01294-9	elucidate the risk factor and oncogene driver of acute myeloid leukemia .	Sanya DRA, Onésime D	the hematopoietic system be critical for maintain physiological homeostasis but be also implicate in various pathology . the magnitude of hematopoietic response to perturbation or diseases exhibit significant inter-individual variability , underscore the need to identify predictor and determinant of blood responsiveness in human . these reaction be shape not only by genetic factor but also by epigenetic modification and environmental effect . elucidate baseline predictor of hematopoietic response and their molecular underpinnings be of particular interest in acute myeloid leukemia ( aml ) , give their potential to inform malignancy immunotherapy . due to limited understanding of the cellular and molecular mechanism drive diverse aml subtypes in pediatric and adult patient , couple with an increase prevalence of refractory or relapsed hematological malignancy , this review highlight underexplored prognostic biomarkers , their molecular mechanism , and their potential clinical utility in optimize therapeutic strategy for improved patient survival . it examine recent advance in aml research and vaccine development , focus on effort to address highly aggressive and rare aml subtypes drive by aberrantly activate transcription factor . the review also address clinical implication for overall survival and treatment response , as well a promising vaccine candidate . additionally , it highlight newly identify mutation and high-risk molecular marker that could enhance risk stratification for early disease progression , identify patient who may benefit from allogeneic stem cell transplantation or enrollment in clinical trial .	Human cell	04/10/2025
10.1016/j.bioactmat.2025.09.016	remodeling of senescent macrophage in synovium alleviates trauma- and aging-induced osteoarthritis .	Liu Y, Duan J, Dang Y, Hao R, Wang H, Tan E, Wang R, Li Y, Zhang S, Wang Y, Lv J, Qi Y, Zhang X, Cheng Y	osteoarthritis ( oa ) be one of the most concerned aging-related disease in the worldwide , yet the investigation of immune senescence in joint and related therapy be still poorly identify . single-cell sequencing analysis and immunofluorescence of oa synovium reveal increase senescent macrophage in trauma-induced oa compare to control . importantly , senescent macrophage in oa synovium show enhanced m1 polarization , mitochondrial damage and impaired efferocytosis , which could lead to increase senescence-associated secretory phenotype ( sasps ) in the joint and further exacerbate oa . hence , a novel senotherapeutic nanoparticle be develop use chloroquine ( cq ) -bearing polymer ( pcq ) for targeted delivery of superoxide dismutase ( sod ) to synovial macrophage , term a pcq/sod . the nanoparticle achieve efficient intracellular delivery of sod to synovial macrophage . rna-seq result reveal that pcq/sod nanoparticle inhibit macrophage senescence via p53 and cellular senescence signal pathway , further reprograms m1-to-m2 repolarization . furthermore , the deliver sod inhibit bax-dependent mitochondrial outer membrane permeabilization ( momp ) which further reduces mitochondrial dna ( mtdna ) release and sasp secretion , while pcq promotes macrophage efferocytosis against apoptotic cell via stat3/adam17/mertk signal . a a result , intraarticular injection of pcq/sod nanoparticles in mouse successfully alleviate not only trauma-induced oa , but aging-induced oa a well . the developed senotherapeutic nanoparticle in this study offer an effective approach for remodel of senescent macrophage in synovium and a promising therapeutic strategy for oa treatment .	Bioactive materials	01/01/2025
10.1038/s41409-025-02729-5	comparison of single-unit umbilical cord blood transplantation and haploidentical transplantation use posttransplant cyclophosphamide during first complete remission of acute myeloid leukemia .	Yanada M, Yamasaki S, Mizuno S, Sugita J, Fujino T, Misaki Y, Tanaka M, Uchida N, Onizuka M, Doki N, Ota S, Sawa M, Kawakita T, Hasegawa Y, Nakamae H, Ishiwata K, Hiramoto N, Ishimaru F, Kanda J, Ohbiki M, Atsuta Y, Nakasone H, Konuma T	choose an optimal alternative donor be an important clinical concern in allogeneic hematopoietic cell transplantation ( hct ) . in japan , single-unit umbilical cord blood transplantation ( ucbt ) have be widely use in the last two decade , whereas hct from hla-haploidentical related donor ( haplo-hct ) have be increasingly use follow the advent of posttransplant cyclophosphamide ( ptcy ) for graft-versus-host disease ( gvhd ) prophylaxis . this registry-based study aim to compare outcome between single-unit ucbt ( n = 848 ) and ptcy-based haplo-hct ( n = 241 ) perform during first complete remission in patient with acute myeloid leukemia . ucbt be associate with a low likelihood of engraftment ( p < 0.001 ) , a high risk of grade 2-4 and grade 3-4 acute gvhd ( p = 0.003 each ) , and a low risk of extensive chronic gvhd ( p = 0.048 ) . the ucbt and haplo-hct group do not significantly differ in 3-year probability of overall survival ( 68 % versus 69 % , p = 0.686 ) , gvhd/relapse-free survival ( 55 % versus 54 % , p = 0.866 ) , relapse ( 14 % versus 16 % , p = 0.463 ) , and non-relapse mortality ( 21 % versus 19 % , p = 0.403 ) , respectively , which be confirm with multivariate analysis . these result indicate that both procedure should be consider viable option for patient lack a match donor .	Bone marrow transplantation	05/10/2025
10.1002/advs.202508576	cgas inhibits aldh2 to suppress lipid droplet function and regulate masld progression .	Wang Y, Deng Y, Chen J, Hahn Q, Umbaugh DS, Zhang Z, Zhang Y, Rowe SE, Li L, Herring LE, Conlon BP, Miao EA, Damania B, Diehl AM, Liu P	cyclic gmp-amp synthase ( cgas ) be a cytosolic dna sensor essential for host defense against microbial infection , but it role beyond innate immunity remain unclear . here , a non-canonical function of cgas in regulate aldehyde metabolism and lipid homeostasis be identify . this be demonstrate that cgas directly bind to and suppresses aldh2 ( aldehyde dehydrogenase 2 ) , a key enzyme in ethanol metabolism and lipid peroxidation . loss of cgas activates aldh2 , thereby enhance ethanol tolerance in mouse . elevate aldh2 activity upon cgas loss increase aldehyde conversion into acetyl-coa , promote histone acetylation and transcription of lipid synthesis gene , which drive lipid droplet accumulation in cell and in cgas ( -/- ) mouse liver . these lipid droplet confer resistance to ferroptosis but simultaneously induce er stress , impair sting ( stimulator of interferon gene ) activation . functionally , cgas ( -/- ) mouse feed with a modified high-fat diet develop exacerbate metabolic dysfunction-associated steatotic liver disease ( masld ) , characterize by excessive lipid droplet accumulation in liver compare to wild-type control . in human masld patient cohort , increase cgas but reduced aldh2 mrna expression be observe relative to healthy individual . together , this finding uncover a previously unrecognized role of cgas in metabolic regulation , independent of it innate immune function . by suppress aldh2 , cgas control lipid droplet biogenesis and stress response , with direct implication for masld pathogenesis .	Advanced science (Weinheim, Baden-Wurttemberg, Germany)	03/10/2025
10.1001/jamapediatrics.2025.4091	reevaluate nonoperative management for pediatric uncomplicated acute appendicitis : a systematic review and meta-analysis .	Faria I, Cintra ACG, de Oliveira LGAM, Squizzato F, Maia AS, Cunha AG, Radhakrishnan RS	nonoperative management ( nom ) have emerge a a potential alternative to surgery for acute uncomplicated appendicitis in child ; however , while short-term outcome be often favorable , concern remain about treatment durability , complication rate , and long-term failure . an updated meta-analysis of randomized clinical trial ( rcts ) may help clarify the comparative safety and effectiveness of nom vs appendectomy . to evaluate the safety and effectiveness of nom compare with appendectomy for uncomplicated appendicitis in child use the high level of available evidence . a systematic review of pubmed , embase , scopus , cochrane , and web of science be conduct from inception through march 2025 to identify randomized clinical trial compare nom with surgical management in pediatric patient . rcts compare nom vs surgical management in pediatric patient young than 18 year be include . nonrandomized and quasi-randomized study be exclude . data be extract follow preferred report item for systematic review and meta-analyses guideline . meta-analyses be conduct use random-effects model . risk of bias be assess independently by multiple reviewer . trial sequential analysis be perform to determine whether the evidence be sufficiently robust and conclusive . the primary outcome be treatment failure and treatment success in 1 year and major complication ( clavien-dindo grade ≥iiib ) . secondary outcome include time to return to school and time to return to normal activity . of 1246 study screen , 7 rcts , include 1480 pediatric patient , meet inclusion criterion . treatment failure be significantly high in the nom group than in the appendectomy group at 1 year ( risk ratio [ rr ] , 4.97 ; 95 % ci , 3.57-6.91 ; i2 = 0.0 % ) . treatment success be significantly low in the nom group at 1 year ( rr , 0.67 ; 95 % ci , 0.60-0.75 ; i2 = 31.1 % ) . major complication classify a clavien-dindo grade iiib or bad be more frequent in the nom group ( rr , 33.37 ; 95 % ci , 7.89-141.05 ; i2 = 9.5 % ) . appendicitis recur at a rate of 18.47 events/100 observation ( 95 % ci , 12.62-25.07 events/100 observation ; i2 = 48.5 % ) among patient who receive nom . nom , compare with appendectomy , be associate with a modestly faster return to school ( mean difference , -1.36 day ; 95 % ci , -2.64 to -0.08 day ; p = .04 ; i2 = 57.7 % ) and return to normal activity ( -4.93 day ; 95 % ci , -8.68 to -1.19 day ; p = .01 ; i2 = 87.2 % ) , although this may be offset by subsequent readmission or reintervention . trial sequential analysis demonstrate the robustness and conclusiveness of primary outcome . in contrast to early study , this meta-analysis find significantly high treatment failure and major complication rate within a year with nom among child and adolescent . the meta-analysis provide pediatrician and pediatric surgeon with up-to-date data to inform share decision-making with family and encourage individualize , patient-centered treatment .	JAMA pediatrics	05/10/2025
10.1016/j.ccell.2025.09.005	distinct t cell function enable efficient immunoediting and prevent tumor emergence of develop sarcoma .	Cheung JF, Hunt BG, Wahed S, Cheng E, Connolly KA, Venkatesan S, Loza JL, Bansal I, Fagerberg E, Kessler EA, Riffard C, Buck J, Attanasio J, Borr ER, Wei W, William I, Fitzgerald B, Joshi NS	t cell edit tumor by eliminate neoantigen-expressing tumor cell . yet , how and when this be achieve remains uncertain . use a murine sarcoma model with fluorescent neoantigens , we find that tumor develop later and in few t cell-sufficient mouse ( ∼53 % penetrance ) than t cell-deficient mouse ( ∼100 % ) . with t cell , all emergent tumor cell have silence neoantigens , but neoantigen-negative tumor cell be also present in every t cell-deficient mouse . this suggest silencing be necessary but not sufficient for outgrowth . genetic removal of neoantigens restore tumor penetrance if implement on day 5 post-tumor initiation , but not day 10 , because cd8 ( + ) and cd4 ( + ) t cell infiltrate the tissue and eliminate most neoantigen-positive and -negative tumor cell within 8 day . single-cell analysis on day-7 tumor show oncogenic change include increased proliferation and t cell-dependent upregulation of the ifnγ-response gene cd274 ( pd-l1 ) . t cell-depletion rescue both neoantigen-positive and -negative cell , while ifnγ blockade rescue only negative cell . this show that t cell efficiently edit sarcoma of neoantigens and prevent early tumor via ifnγ-independent and ifnγ-dependent ( bystander ) mechanism .	Cancer cell	02/10/2025
10.1093/femsre/fux005	chemical ecology of antibiotic production by actinomycete .	van der Meij A, Worsley SF, Hutchings MI, van Wezel GP	actinomycete be a diverse family of filamentous bacteria that produce a plethora of natural product relevant for agriculture , biotechnology and medicine , include the majority of the antibiotic we use in the clinic . rather than a free-living bacteria , many actinomycete have evolve to live in symbiosis with among others plant , fungi , insect and sponge . a a common theme , these organism profit from the natural product and enzyme produce by the actinomycete , for example , for protection against pathogenic microbe , for growth promotion or for the degradation of complex natural polymer such a lignocellulose . at the same time , the actinomycete benefit from the resource of the host they interact with . evidence be accumulate that these interaction control the expression of biosynthetic gene cluster and have play a major role in the evolution of the high chemical diversity of actinomycete-produced secondary metabolite . many of the biosynthetic gene cluster for antibiotic be poorly express under laboratory condition , but they be likely express in response to host-specific demand . here , we review the environmental trigger and cue that control natural product formation by actinomycete and provide pointer a to how these insight may be harness for drug discovery .	FEMS microbiology reviews	01/05/2017
10.1038/s41392-025-02427-0	transarterial chemoembolization plus atezolizumab and bevacizumab in patient with intermediate hepatocellular carcinoma : a single-arm , phase 2 trial .	Wang K, Feng J, Yu H, Cheng Y, Xiang Y, Liu Z, Qin Y, Liu E, Shan Y, Fan C, Zhai J, He D, Zhou H, Tang Y, Shi J, Guo W, Yan M, Yu L, Kudo M, Cheng S	transarterial chemoembolization ( tace ) be the standard treatment for intermediate-stage hepatocellular carcinoma ( hcc ) , yet it efficacy a a standalone therapy remain suboptimal . this phase 2 trial ( chictr2100049829 ) evaluate the feasibility and safety of tace combine with atezolizumab and bevacizumab in patient with intermediate-stage hcc . participant receive tace follow by atezolizumab and bevacizumab until disease progression , unacceptable toxicity , or death . the primary endpoint be objective response rate ( orr ) assess per response evaluation criterion in solid tumor ( recist ) v1.1 . secondary endpoint include progression-free survival ( pfs ) , overall survival ( o ) , orr by modified recist ( mrecist ) , disease control rate ( dcr ) , time to response ( ttr ) , duration of response ( dor ) , and adverse event ( aes ) . between august 21 , 2021 and april 10 , 2023 , 45 patient be enrol . a of the data cutoff on september 30 , 2024 , the median follow-up be 26.7 month . the orr be 47 % per recist v1.1 and 67 % per mrecist . median pfs be 17.9 month , and median o be 33.0 month . the dcr be 87 % ( recist v1.1 ) and 91 % ( mrecist ) . median ttr be 11.9 week ( recist v1.1 ) and 4.9 week ( mrecist ) , with median dor of 36.6 week ( recist v1.1 ) and 44.4 week ( mrecist ) . of the 45 patient , 44 experience aes of any grade , with 20 report grade 3-4 aes ; no grade 5 aes be observe . tace combine with atezolizumab and bevacizumab appear safe and feasible for intermediate-stage hcc , support further investigation in large study .	Signal transduction and targeted therapy	06/10/2025
10.1038/hgv.2015.60	genomic architecture of inflammatory bowel disease in five family with multiple affected individual .	Stittrich AB, Ashworth J, Shi M, Robinson M, Mauldin D, Brunkow ME, Biswas S, Kim JM, Kwon KS, Jung JU, Galas D, Serikawa K, Duerr RH, Guthery SL, Peschon J, Hood L, Roach JC, Glusman G	currently , the best clinical predictor for inflammatory bowel disease ( ibd ) be family history . over 163 sequence variant have be associate with ibd in genome-wide association study , but they have weak effect and explain only a fraction of the observed heritability . it be expect that additional variant contribute to the genomic architecture of ibd , possibly include rare variant with effect size large than the identified common variant . here we apply a family study design and sequence 38 individual from five family , under the hypothesis that family with multiple ibd-affected individual harbor one or more risk variant that ( i ) be share among affected family member , ( ii ) be rare and ( iii ) have substantial effect on disease development . our analysis reveal not only novel candidate risk variant but also high polygenic risk score for common know risk variant in four out of the five family . functional analysis of our top novel variant in the remain family , a rare missense mutation in the ubiquitin ligase trim11 , suggest that it lead to increase nuclear factor of kappa light chain enhancer in b-cells ( nf-κb ) signal . we conclude that an accumulation of common weak-effect variant account for the high incidence of ibd in most , but not all family we analyze and that a family study design can identify novel rare variant confer risk for ibd with potentially large effect size , such a the trim11 p.h414y mutation .	Human genome variation	01/01/2016
10.1038/s41386-025-02227-8	inflammatory mechanism contribute to long-term cognitive deficit induce by perinatal asphyxia via interleukin-1 .	Kelemen H, Balla GY, Demeter K, Sipos E, Buzás-Kaizler A, Biró L, Aliczki M, Orsolits B, Kerényi Á, Balogh Z, Pászthy-Szabó B, Pejtsik D, Hegyi L, Szigeti K, Máthé D, Padmanabhan P, Bödör C, Fekete A, Szabó M, Kaila K, Dénes Á, Mikics É	perinatal asphyxia remain a lead cause of neonatal mortality and a major contributor to permanent neurological deficit . even mild case can result in long-term neurodevelopmental , cognitive , behavioural and psychiatric disorder . however , the mechanism underlie asphyxia-induced hypoxic-ischaemic brain injury remain poorly understood , limit the development of targeted intervention during the critical early plastic period . to explore the behavioural and molecular outcome of perinatal asphyxia that may model important aspect of neuropsychiatric disorder observe in human , we utilise a translationally relevant , non-invasive oxygen deprivation model of asphyxia in postnatal day 7 rat . we conduct a comprehensive assessment of asphyxia-induced change , integrate neurobehavioural profiling ( evaluate cognitive , emotional , social and neuromotor function ) , microglial morphology analysis , neuroimaging , stress hormone measurement and whole-transcriptome sequencing technique to elucidate the acute and long-term functional consequence . consistent with clinical observation , the extensive functional assessment reveal distinct sex-dependent effect , include increase anxiety and impulsivity , attention deficit and impaired inhibitory control , which be observe exclusively in male , with no apparent sensorimotor deficit . this phenotype resemble attention deficit hyperactivity disorder ( adhd ) in adult rat be associate with a lasting increase in inhibitory bouton density in the medial prefrontal cortex . the development of an acute inflammatory response after perinatal asphyxia mark by phenotypic transformation of microglia , parallel brain perfusion and stress hormone change . notably , microglial change be mitigate by the blockade of proinflammatory interleukin-1 signalling via systemic il-1 receptor antagonist ( il-1ra ) administration in a therapeutically relevant time window . importantly , early blockade of proinflammatory response be able to prevent cognitive deficit in adulthood and normalise inhibitory bouton density . rna sequence analysis reveal asphyxia-induced dysregulation of molecular pathway target gabaergic signalling , potentially contribute to subsequent morphological and neuropsychiatric alteration . il-1ra treatment appear to engage distinct epigenetic regulatory mechanism , rather than merely reverse these disruption in the acute post-asphyxia period . collectively , these finding demonstrate that perinatal asphyxia induces mark behavioural deficit in attention and inhibitory control , parallel by last inhibitory and epigenetic dysregulation , precede by acute induction of microglia-driven inflammatory process in the medial prefrontal cortex . systemic il-1ra administration may represent a promising therapeutic opportunity to prevent long-term cognitive impairment cause by perinatal asphyxia .	Neuropsychopharmacology : official publication of the American College of	02/10/2025
10.1016/j.bcp.2025.117376	cancer-associated transporter : molecular driver and drug delivery gateway .	Khan A, Biswas S, Garg M, Sengupta S	membrane transporter be critical regulator of cellular homeostasis , mediate the uptake and efflux of nutrient , ion , and drug . in cancer , their expression be frequently reprogrammed to support enhanced growth , survival , metabolic rewiring , invasiveness , and therapy resistance . among these several solute carrier ( slc ) transporter such a glucose transporter ( glut ) , monocarboxylate transporter ( mcts ) , and the sodium/iodine symporter ( ni ) also facilitate selective delivery of radiopharmaceutical , make them attractive therapeutic target . the tumor suppressor p53 know for it central role in genome stability and apoptosis , also regulate a broad spectrum of membrane transporter . however , oncogenic mutation or structural conversion into amyloid can disrupt this regulatory network , lead to alter transporter expression and multidrug resistance . despite grow interest , the transcriptional and post-transcriptional control of transporter by wt , mutant , and amyloid form of p53 remains underexplored . in this review , we systematically characterize the p53-mediated regulation of diverse transporter class involve in the transport of sugar , amino acid , metal ion , lipid along with abc transporter function and multidrug resistance . we highlight how cancer cell exploit transporter such a p-glycoprotein ( p-gp ) , lat1 , glut1 , mcts , and ni for metabolic advantage and survival . we also examine therapeutic strategy aim at modulate transporter function use crispr/cas9 , small-molecule inhibitor , sirna , and nanoparticle-based co-delivery system . in particular , lat1 inhibition demonstrate potential to starve tumor of essential nutrient . ultimately , we propose that dual targeting of p53 aberration and membrane transporter through synthetic biology and precision delivery approach could restore chemosensitivity and suppress tumor progression , offer promise avenue for personalized cancer therapy .	Biochemical pharmacology	02/10/2025
10.1038/s44161-025-00725-y	antxr1 blockade enhances cardiac function in preclinical model of heart failure .	Boccella N, Yu G, Seaman S, Feng Y, Lee J, Tomassoni-Ardori F, Yang L, Hsu KS, Dunleavey JM, Becker J, Hilton MB, Morris K, Borchin N, So D, Bajgain P, Yanpallewar S, Gross RT, Dewan KC, Bowles DE, Yuen DA, Tessarollo L, St Croix B	heart disease , a lead cause of mortality worldwide , be in urgent need of improved therapy . fibrosis , an accumulation of collagen-rich extracellular matrix in response to injury , be a hallmark of heart disease , but clinical agent that can interfere with the fibrotic pathway do not yet exist . here we show that antxr1/tem8 , a pathology-induced transmembrane protein require for collagen removal , exacerbate injury in multiple model of heart failure . genetic disruption of antxr1 and treatment with human neutralize antibody prevent heart deterioration follow acute myocardial infarction . antxr1 pharmacological blockade also improve heart function in model of pressure overload and obesity-induced heart disease with preserved ejection fraction . improved heart function be accompany by enhanced exercise tolerance . mechanistic study reveal an antxr1-antibody-driven improvement in post-infarct scar formation follow by attenuation of late-stage , chronic tgfβ-mediated extracellular matrix remodel . thus , antxr1-mediated collagen turnover during heart failure be both maladaptive and druggable , provide avenue for therapeutic intervention .	Nature cardiovascular research	02/10/2025
10.1016/j.immuni.2025.09.008	the transcriptional repressor blimp1 enforce tcf-1-dependent and -independent restriction of the memory fate of cd8 ( + ) t cell .	Murphy MK, McCullen M, Deffenbaugh JL, Chen AY, Pai J, Daniel B, Yousif A, Raju S, Hsiung S, Wang Z, Ghoneim HE, Satpathy AT, Colonna M, Oltz EM, Egawa T	during differentiation of cd8 ( + ) t cell , the transcription factor tcf-1 and blimp1 control progenitor and terminally differentiate state , respectively . here , we examine the hierarchy and functional consequence of cross-regulation between these factor . we identify two blimp1-bound cis-regulatory element , tcf7 ( +22kb ) and tcf7 ( +17kb ) , that enforce tcf7 silence in a context-specific manner during both acute and chronic response . deletion of these element decouple tcf7 repression from effector differentiation but do not rewire effector t cell to a memory state or prevent the acquisition of phenotypic hallmark of exhaustion . however , combine ablation of prdm1 and tcf7 preserve a memory surface phenotype despite defect in secondary expansion . thus , the anti-proliferative and pro-differentiative effect of blimp1 in effector or exhaust cd8 ( + ) t cell represent mechanistically distinct module , wherein repression of tcf7 limit proliferative capacity but not memory or progenitor specification .	Immunity	02/10/2025
10.1186/s13054-025-05491-8	rethink post-sepsis syndrome : link cellular dysfunction to the clinical picture .	Gorecki GP, Bodor A, Novac MB, Costea DG, Costea DO, Costea AC, Grasa CN, Tomescu DR	post-sepsis syndrome ( ps ) encompass a range of long-term complication , include immune dysregulation , chronic inflammation , and neuromuscular impairment , that persist beyond the resolution of the acute septic episode . while these clinical phenotype be increasingly recognize , the underlie molecular mechanism remain incompletely define . mitochondrial dysfunction , particularly in the form of persistent mitochondrial senescence , be emerge a a potential unifying factor drive multiple ps trajectory . accumulate evidence suggest that damage mitochondrion not only lose their bioenergetic capacity but also actively contribute to chronic immune and inflammatory signalling . base on this , we propose a dual-intervention strategy ( `` mitochondrial flush '' ) which involve the coordinated elimination of senescent mitochondrion and stimulation of mitochondrial biogenesis . the regenerative component , support by establish preclinical research on peroxisome proliferator-activated receptor gamma coactivator 1-alpha ( pgc-1α ) activation , represent a partially develop therapeutic arm , while the selective clearance of dysfunctional mitochondrion remain an area of active investigation . this concept raise important question regard regenerative capacity , therapeutic timing , and cellular resilience follow critical illness . we further propose a working definition of ps a a state of persistent mitochondrial dysfunction , possibly drive by ongoing oxidative stress , which may underlie a broad range of clinical phenotype than currently recognize . a deep understanding of mitochondrial quality control may offer a new therapeutic framework for reverse the chronic physiological decline observe in sepsis survivor .	Critical care (London, England)	02/10/2025
10.1126/science.7624776	effect of the obese gene product on body weight regulation in ob/ob mouse .	Pelleymounter MA, Cullen MJ, Baker MB, Hecht R, Winters D, Boone T, Collins F	c57bl/6j mouse with a mutation in the obese ( ob ) gene be obese , diabetic , and exhibit reduced activity , metabolism , and body temperature . daily intraperitoneal injection of these mouse with recombinant ob protein lower their body weight , percent body fat , food intake , and serum concentration of glucose and insulin . in addition , metabolic rate , body temperature , and activity level be increase by this treatment . none of these parameter be alter beyond the level observe in lean control , suggest that the ob protein normalize the metabolic status of the ob/ob mouse . lean animal inject with ob protein maintain a small weight loss throughout the 28-day study and show no change in any of the metabolic parameter . these data suggest that the ob protein regulate body weight and fat deposition through effect on metabolism and appetite .	Science (New York, N.Y.)	28/07/1995
10.1111/j.1465-0691.2004.1007.x	antimicrobial drug development -- the past , the present , and the future .	Powers JH	antimicrobial resistance have be an issue since the introduction into clinical use of the first agent in the 1940s . although the discovery and development of new class of antimicrobial through the 1960s present an array of treatment option , these option for some serious and life-threatening infectious disease may now be more limited . this paper examine the history of antimicrobial development , show how the challenge in discover new class of drug have be with u for the last 40 year . the present state of antimicrobial discovery and development be shape by these challenge as well a by the economic reality of the pharmaceutical industry . this paper also discuss some of the regulatory consideration in antimicrobial drug development , and present some potential solution to the challenge inherent in antimicrobial drug development , include step take by the u food and drug administration to streamline the drug review process for antimicrobial agent while maintain the standard necessary to protect and promote the health of the public .	Clinical microbiology and infection : the official publication of the European	01/01/2004
10.3389/fimmu.2025.1629060	the role of the tuft cell-interleukin-25 axis in the pathogenesis of inflammatory bowel disease .	Tao Z, Li L, Zhang Y, Tang Y, Zhang S, Yang H, Jiang G, Zhang R, Wu Z, He M	emerge evidence highlight the tuft cell-interleukin-25 ( il-25 ) axis ( tuft/il-25 axis ) a a critical orchestrator bridge luminal stimulus and intestinal immunity in inflammatory bowel disease ( ibd ) , which encompass crohn 's disease ( cd ) and ulcerative colitis ( uc ) . this review synergises current understanding of how dysregulation within this axis contribute to ibd pathogenesis , arise from disrupt immune homeostasis involve aberrant microbiota response , genetic susceptibility , and immune pathway dysregulation . central to this axis , intestinal tuft cell act a chemosensory epithelial sentinel , differentiate in response to microbial and metabolic cue to become the primary source of il-25 . il-25 , signal via il-17rb , engage innate and adaptive immune cell , particularly group 2 innate lymphoid cell ( ilc2s ) . while il-33-responsive homeostatic ilc2s ( nilc2s ) promote mucosal repair , il-25-driven inflammatory ilc2s ( iilc2s ) amplify inflammation , position them a pivotal effector . critically , il-25 exhibit a context-dependent `` double-edged '' role : engagement with il-25r ( + ) t cell and modulation of downstream signaling can exert anti-inflammatory effect and enhance barrier integrity , yet dysregulation drive pro-inflammatory injury . the axis be dynamically regulate by diverse luminal factor : helminth infection activate the tuft-ilc2 circuit , induce protective type 2 immunity ; specific microbial metabolite ( e.g. , succinate , scfas ) modulate it activity ; and viral infection can disrupt homeostasis by remodel tuft cell function . dysregulation of the tuft/il-25 axis , drive by infection , microbial metabolite fluctuation , or environmental factor ( include regional variation in helminth exposure link to the hygiene hypothesis ) , be increasingly recognize a a significant contributor to ibd pathogenesis . consequently , precisely regulate this axis to harness it beneficial effect while mitigate it detrimental potential represent a promising therapeutic frontier . future strategy should integrate microbiota remodeling , target metabolite intervention , and potentially virus-directed therapy . furthermore , deep investigation into the impact of geographical environmental factor on this axis and ibd risk be warrant . ultimately , multi-pathway approach aim at restore the `` immune-microbiota-epithelial '' triad via reprogramming the tuft/il-25 axis hold significant promise for novel ibd management .	Frontiers in immunology	01/01/2025
10.7150/thno.120824	ezh2-mediated h3k27me3 link microbial inosine loss to depression : a gut-brain epigenetic switch .	Zhu S, Li X, Yu Y, Han X, Yang F, Lu M, Dai G, Guo L, Xu D	background : depression , the second most prevalent neurological disorder globally , affect over 300 million people and present an urgent public health challenge . while gut microbiota dysbiosis be increasingly recognize a a key contributor to depression , the molecular mechanism link microbial imbalance to brain dysfunction remain poorly define . method : we investigate the role of ezh2 in gut microbiota-induced depressive behavior in mouse use the chronic unpredictable mild stress ( cum ) , fecal microbiota transplantation , and conditional knockout of ezh2 . cut & tag sequencing be employ to analyze ezh2-mediated h3k27me3 epigenetic reprogramming . untargeted metabolomics and luciferase reporter assay be use to identify metabolite that upregulate ezh2 expression . 16 rrna sequence combine with metabolic tracing be conduct to trace the microbial origin of inosine . additionally , natural compound screen identify coumaric acid ( ca ) a a novel ezh2-targeting degrader . result : conditional knockout of neuronal ezh2 abolishes microbiota-induced depressive behavior and neuronal apoptosis . mechanistically , reduce abundance of specific microbiota ( f_lachnospiraceae , f_oscillospiraceae , and f_erysipelotricaceae ) lead to inosine depletion . this depletion subsequently elevate ezh2 transcriptional activity by increase h3k9ac modification at it locus , mediate through attenuation of the a2ar-camp-pka-creb-hdac3 signaling axis . subsequently , ezh2 silence serotonergic synapse-related gene ( e.g. , tph2 , htr2a , htr6 ) via h3k27me3 reprogramming , ultimately drive depressive behavior and neuronal apoptosis in mouse . importantly , ca be identify a a first-in-class ezh2 degrader that bind lysine residue k623/k646 and recruit ube3a for proteasomal degradation . ca treatment restores synaptic integrity and revers depressive behavior with minimal toxicity . conclusion : collectively , these finding define a novel `` microbiota-inosine-ezh2 '' axis in depression pathogenesis and highlight ezh2 degradation a a promising therapeutic strategy for microbiota-associated neuropsychiatric disorder .	Theranostics	01/01/2025
10.1093/braincomms/fcaf348	clinical and molecular characterization of slc31a1-related developmental and epileptic encephalopathy : insight from 13 new case .	Juliá-Palacios N, Muñoz-Pujol G, Maroofian R, Bertoli-Avella AM, Gómez-Chiari M, Muchart-López J, Paredes-Fuentes AJ, O'Callaghan M, Machado-Casas IS, Cristian I, Morrison J, Garcia-Cazorla A, Codina A, Miryounesi M, Zonic E, Bauer P, Cheema H, Anjum MN, Al-Sannaa N, Abd Elmaksoud M, Ababneh F, Alijanpour S, Tonekaboni SH, Fayazi A, Urbaniak M, Barba U, Hoenicka J, Palau F, Houlden H, Ortigoza-Escobar JD, Ribes A, Santos-Ocaña C, Tyler M, Gaffney P, Carroll CJ, Tort F, Wierenga KJ, Webb BD, Artuch R, Baide-Mairena H, Urreizti R	copper be indispensable for various metabolic process , notably mitochondrial respiration . in human , copper homeostasis hinge on transporter such a copper transporter 1 ( ctr1 ) , encode by the slc31a1 gene . recently , bi-allelic mutation in slc31a1 have be associate with a new neurodevelopmental disorder . this study present clinical , genetic , and biochemical finding from 13 new case across 10 family worldwide . rna sequence evaluated gene expression , and western blotting assess copper transporter 1 protein level . additionally , mitochondrial respiratory capacity be measure via high-resolution respirometry . affected individual exhibit a distinct clinical phenotype characterize by early-onset epileptic encephalopathy , severe neurodevelopmental delay and hypotonia , with high mortality . neuroimaging reveal significant brain atrophy and white matter abnormality . genetic analysis identify bi-allelic slc31a1 variant , predominantly p.his120gln in six case and p. ( arg102cys/his ) in three case . functional study in patient fibroblast demonstrate impaired mitochondrial respiration . this study significantly broaden the clinical spectrum of this recently describe syndrome , present a a severe developmental encephalopathy with high mortality risk , and suggest mitochondrial dysfunction a a potential pathomechanism . these finding contribute to the mount evidence link copper transporter 1 dysfunction to neurodegeneration , underscore the urgency for further therapeutic investigation .	Brain communications	01/01/2025
10.1038/s41556-025-01758-y	define heterogeneity in core regulatory circuitry reveals hoxb3 condensation a a potential target in glioblastoma .	Zhang C, He Y, Zhan X, Yu J, Xu S, Zhang Q, Qiu R, Wang X, Gao Z, Huang M, Long W, Liu Q, Zhao W	glioblastoma ( gbm ) exhibit mark heterogeneity , yet therapeutic strategy effectively target this variability remain inadequately develop . here we employ single-cell cut & tag analysis to investigate h3k27ac modification , uncover pronounced heterogeneity within the core regulatory circuitry ( crc ) of gbm . notably , we observe heterogeneous condensation state of crc factor , particularly hoxb3 , which be shape by it intrinsically disorder region and interaction with runx1 , drive the phenotypic manifestation . leverage these finding , we synthesize the peptide p621-r9 , which effectively disrupt hoxb3 condensation , alter chromatin structure and reduced transcription at super-enhancer-associated oncogenic site in gbm cell exhibit hoxb3 condensation . treatment with p621-r9 selectively diminish tumourigenic potential in gbm patient-derived xenograft model characterize by hoxb3 condensate , but show no efficacy in the model lack these condensate . these result highlight the critical role of crc condensation in gbm heterogeneity and suggest that peptide-based targeting of distinct gbm subpopulation could represent an avenue for therapeutic exploration .	Nature cell biology	30/09/2025
10.1002/14651858.CD016192.pub2	effectiveness of sars-cov-2 test strategy inreducing covid-19 case , hospitalisation , and death .	Saif-Ur-Rahman KM, Nurdin N, Movsisyan A, Kothari K, Gleeson C, Conway T, Tierney M, Taneri E, Mulholland D, Tricco AC, Dinnes J, Devane D	severe acute respiratory syndrome coronavirus 2 ( sars-cov-2 ) have substantially affect daily life . sustainable testing practice be essential to balance the resource demand of widespread test with the need to reduce the health impact of covid-19 . however , the effectiveness of specific test strategy for symptomatic and asymptomatic individual in reduce covid-19 case , hospitalisation , and death remain uncertain . to evaluate the effectiveness of different sars-cov-2 testing strategy in reduce covid-19 case , hospitalisation , and death amongst suspect case and asymptomatic individual . we search central , medline ( ovid ) , embase ( elsevier ) , europe pmc , clinicaltrials.gov , and the world health organization ( who ) international clinical trial registry platform . we also conduct reference check , citation search , and contact study author to identify eligible study . the most recent search be conduct on 07 october 2024. we include randomise control trial ( rcts ) , non-randomised study of intervention ( nrsis ) , control before-and-after study ( cba ) , match cohort study , and observational study with a comparison group involve suspect or asymptomatic individual . eligible study compare test strategy versus no testing or standard care or usual practice ; one test strategy with another , such a antigen-detecting rapid diagnostic test ( rdts ) versus nucleic acid amplification test ( naat ) , include reverse transcription polymerase chain reaction ( rt-pcr ) ; home-based versus provider-administered testing ; one-time test versus repeat test at different frequency ; and target test versus widespread testing . combination of these component be also consider . in this review , we define 'sars-cov-2 test strategy ' a a complex intervention comprise multiple varying component , include test type ( e.g . naat , antigen-detecting rdt ) , sample type ( e.g . nasopharyngeal swab , saliva ) , target population ( e.g . symptomatic , contact ) , set ( e.g . home , clinic , congregate ) , frequency of test ( e.g . one-time , weekly , daily ) , and response protocol ( e.g . isolation , confirmatory testing , treatment ) . we exclude single-arm study , review , thesis , editorial , letter , commentary , study report solely in abstract form , laboratory or animal study , mathematical modelling study , and diagnostic test accuracy study . our critical outcome be : covid-19 case avoid ( reduction in new case ) ; covid-19-related hospitalisation avoid ( reduction in hospital admission ) ; covid-19-related death avoid ( reduction in mortality ) ; and serious adverse event relate to test , include unnecessary intervention , employment impact , isolation effect , and psychological harm . we use the risk of bias 2 ( rob 2 ) tool to assess the risk of bias in rcts and the robins-i tool to assess the risk of bias in nrsis , cba study , and match cohort study . a a meta-analysis be not feasible due to the nature of the data , we apply synthesis without meta-analysis ( swim ) method . we assess the certainty of the evidence for each outcome use the grade approach . we include 21 study ( 10 rcts and 11 nrsis ) with 13,312,327 participant . among these , 13 studies-comprising eight rcts and five nrsis-either report one or more prespecified outcome ( four study ) , provide relevant information through proxy measurement ( five study ) , or supply information follow author correspondence ( four study ) . we present the prioritised comparison and critical outcome . for the comparison test strategy versus no testing or standard care or usual practice , one include study measure two critical outcome . the study do not measure the other critical outcome : covid-19 case avoid , and serious adverse event relate to test . no study measure any critical outcome for the other prioritised comparison : antigen-detecting rdt versus naat testing . benefit and harm of test strategy versus no testing or standard care or usual practice one observational study with a comparison group , conduct in a long-term care facility in israel , compare weekly sars-cov-2 rt-pcr test with no testing and measure two of our critical outcome . base on the analysis , the evidence be very uncertain about the effect of sars-cov-2 rt-pcr testing on reduce hospitalisation ( decrease in the hospitalisation rate from 13.59 % to 11.41 % ; 1 study , 162,205 participant , very low-certainty evidence ) and mortality ( 33.8 % decrease in expect mortality ; 1 study , 162,205 participant , very low-certainty evidence ) compare to no test . we downgrade the certainty of the evidence because of methodological limitation , indirectness , and imprecision . author ' the available data be of very low-certainty . only one of the 21 included study report hospitalisation or death ; therefore , we can not draw conclusion about the effect of test strategy versus no test on reduce hospitalisation and mortality . no study evaluate other critical outcome i.e . covid-19 case avoid , and serious adverse event relate to test . future research should aim for consistency and relevance by use clearly define outcome , preferably base on a standardise core outcome set . a qualitative evidence synthesis ( qes ) would help identify barrier and facilitator to routine sars-cov-2 testing in healthcare setting , which could help inform intervention development . the qes would explore factor affect the implementation of routine testing , draw on the perspective of healthcare provider , patient , and other interest holder . this cochrane review be partially fund by the world health organization ( who ) and the health research board of ireland . protocol ( 2025 ) 10.1002/14651858.cd016192 .	The Cochrane database of systematic reviews	02/10/2025
10.1080/14779072.2025.2570839	novel therapy for lower low-density lipoprotein level for atherosclerotic cardiovascular disease prevention : reach the target where others have fail .	Dziewierz A, Bobrowska B, Streb W, Pelliccia F, Bartuś S, Rajtar-Salwa R	atherosclerotic cardiovascular disease ( ascvd ) remain a lead cause of global morbidity and mortality , with elevate low-density lipoprotein cholesterol ( ldl-c ) establish a a primary causal factor . despite foundational therapy , many high-risk patient fail to achieve optimal ldl-c target . this review examine establish ldl-c lowering agent ( statin and ezetimibe ) , detail their mechanism and limitation , include statin intolerance and residual cardiovascular risk . we provide a comprehensive analysis of novel therapeutic option , include proprotein convertase subtilisin/kexin type 9 ( pcsk9 ) modulators ( monoclonal antibody , small interfering rna , and emerge oral agent ) , atp-citrate lyase inhibitor ( bempedoic acid ) , angiopoietin-like protein 3 ( angptl3 ) inhibitor , and pioneer gene-editing technology . we discuss mechanism of action , pivotal efficacy data ( ldl-c reduction and plaque modification ) , safety profile , and key finding from major cardiovascular outcome trial . novel ldl-c lowering therapy represent a paradigm shift , offer unprecedented efficacy in reduce ldl-c and mitigate ascvd risk . however , significant challenge remain , include cost-effectiveness concern , the need for long-term safety data , profound global disparity in access , and persistent clinical inertia that impede real-world implementation even in well-resourced healthcare system . future research should prioritize personalized lipid management , combination strategy , and development of durable , cost-effective solution to reduce the residual ascvd burden .	Expert review of cardiovascular therapy	02/10/2025
10.1016/S2213-2600(25)00239-5	taladegib for the treatment of idiopathic pulmonary fibrosis ( env-ipf-101 ) : a multicentre , randomise , double-blind , placebo-controlled , phase 2a trial .	Maher TM, Goldin JG, Hood J, Pitman J, de Los Rios M, Hobbs BP, Yu-Lin AB, Buendia-Roldan I, Thien F, Song JW, Perea PC, Ramírez-Rivera A, DiFrancesco A	the hedgehog ( hh ) signal pathway promotes fibrosis in idiopathic pulmonary fibrosis ( ipf ) , an interstitial lung disease with a high mortality rate . currently , there be no cure for ipf , and available anti-fibrotics only slow the rate of decline in lung function in ipf . we aim to assess the safety and efficacy of taladegib ( env-101 ) , an hh pathway inhibitor , in ipf in a phase 2a , proof-of-concept clinical trial . env-ipf-101 be a randomised , double-blind , placebo-controlled , phase 2a trial conduct at 16 clinical site in australia , canada , malaysia , mexico , and south korea for patient with ipf old than 40 year who be not treat with concurrent ipf therapy . patient be randomly assign to taladegib 200 mg or placebo equivalent once daily , orally for 12 week , with a 6-week follow-up . the primary outcome be safety in the intention-to-treat population and change from baseline in forced vital capacity ( fvc ) in the efficacy-evaluable population . exploratory outcome be measure of fibrosis on high-resolution ct ( hrct ) in the efficacy-evaluable population . this study be register with clinicaltrials.gov , nct04968574 . between aug 12 , 2021 , and july 28 , 2023 , 41 patient be randomly assign to the taladegib group ( n=21 ; three [ 14 % ] female and 18 [ 86 % ] male ) or the placebo group ( n=20 ; four [ 20 % ] female and 16 [ 80 % ] male ) . all treatment-emergent adverse event possibly or probably relate to the study drug be grade 1 or 2 , all except one be mild or moderate in severity , and none be serious adverse event . the most common treatment-emergent adverse event in the taladegib group be dysgeusia ( 12 [ 57 % ] of 21 ) , muscle spasm ( 12 [ 57 % ] of 21 ) , and alopecia ( 11 [ 52 % ] of 21 ) ; none of these event be report in the placebo group , for which the most common adverse event report be diarrhoea ( four [ 20 % ] of 20 ) , headache ( three [ 15 % ] of 20 ) , and dizziness ( one [ 5 % ] of 20 ) . patient treat with taladegib have an improvement from baseline in fvc and across multiple hrct-based measure of disease . between-group difference in change from baseline to week 12 favour taladegib for the efficacy measure of percent predict fvc ( 3·95 % [ 95 % ci 0·31-7·60 ] ; p=0·035 ; mean change from baseline of 1·9 % in the taladegib group vs -1·3 % for placebo ) , total lung capacity by hrct ( 257·0 ml [ 95 % ci 86·8-427·2 ] ; p=0·0040 ; mean change from baseline of 206·67 ml in the taladegib group vs -55·58 ml in the placebo group ) , and percent quantitative interstitial lung disease ( p=0·047 ; mean change from baseline of -9·4 % in the taladegib group vs 1·1 % in the placebo group ) . no death occur during the trial . the acceptable safety profile and efficacy analysis of taladegib support further investigation in a phase 2b trial in patient with ipf ( whistle-pf ) . endeavor biomedicine .	The Lancet. Respiratory medicine	30/09/2025
10.1016/j.ijrobp.2025.08.066	tumor treat field ( ttfields ) therapy after stereotactic radiosurgery for brain metastasis from non-small cell lung cancer : final result of the phase 3 metis study .	Mehta MP, Gondi V, Ahluwalia MS, Roberge D, Sio TTW, Trifiletti DM, Muanza T, Krpan AM, Zhu Z, Ramakrishna NR, Fiveash JB, Metellus P, Yu J, Wang CJ, Jacob J, Freyschlag CF, Csőszi T, Salmaggi A, Taliansky A, Lucas A, Debus J, Brown PD, Harat M	improved treatment for brain metastasis from non-small cell lung cancer ( nsclc bm ) be need to prolong time to intracranial progression without increase neurotoxicity . ttfields , be electric field deliver via skin-based array that disrupt cancer cell division , have demonstrate efficacy and safety in glioblastoma , nsclc , and pancreatic cancer . in the phase 3 metis trial ( nct02831959 ) adult with 1-10 newly-diagnosed nsclc bm suitable for sr receive optimal therapy for extracranial disease be randomize 1:1 to srs follow by ttfields ( 150 khz ) or srs alone . radiologic progression be assess by an independent radiology review committee . primary endpoint be time to intracranial progression ( ttip ; rano-bm ) . secondary endpoint include overall survival , neurocognitive function , quality of life ( qol ) , and safety . patient ( n=298 ) be follow for a median of 8.6 ( 0.07-85.2 ) month . ttfields significantly delay ttip ( hr 0.72 [ 95 % ci 0.53-0.98 ] ; fine-gray p=0.044 ) . intracranial progression rate at month 2 , 6 , 12 , and 24 be 13.6 % vs 22.1 % ( p=0.034 ) , 33.7 % vs 46.4 % ( p=0.018 ) , 46.9 % vs 59.4 % ( p=0.023 ) , and 53.6 % vs 65.2 % ( p=0.031 ; post hoc ) . time to distant intracranial progression ( ttdp ) favor ttfields therapy , although not statistically significantly ( hr 0.76 [ 0.51-1.12 ] ; log-rank p=0.165 ; post-hoc ) . in patient receive immune checkpoint inhibitor ( ici ; n=118 ) , the delay in both ttip ( hr 0.63 [ 0.39-1.0 ] ; cox p=0.049 ; fine-gray p=0.055 ) and ttdp ( hr 0.41 [ 0.21-0.81 ] ; log-rank p=0.0087 , post-hoc ) be more pronounced . device-related aes be mainly grade ≤2 skin event . ttfields do not cause qol deterioration , and improvement in deterioration-free survival and time to deterioration of the global health status , physical functioning and fatigue domain be observe ( post-hoc ) . by significantly prolong ttip , without worsen qol or cognitive function , ttfields after sr be a new treatment option for patient with nsclc bm , include those receive ici .	International journal of radiation oncology, biology, physics	29/09/2025
10.1186/s12943-025-02467-8	non-coding rna in gastric cancer : mechanism and therapeutic prospect .	Han Z, Liu W, Zhu Y, Sun Y, Sun D, Jia R, Yang Y, Qi H, Zhang L, Huo Y, Zhang N, Chai J, Yang M	gastric cancer be the fifth most common cancer and the third leading cause of cancer-related death worldwide . it be associate with high molecular and phenotypic heterogeneity . early-stage gastric cancer can be treat with endoscopic resection and surgery , whereas at it advanced stage , sequential chemotherapy present the only treatment option , which start with first-line platinum and fluoropyrimidine-based dual drug , support a median survival period of less than one year . target monoclonal antibody approve for the treatment of gastric cancer be effective for a limited subset of patient . furthermore , painless and precise marker for the early detection of gastric cancer and new target for it treatment be unavailable . interestingly , many non-coding rna ( ncrnas ) , such a micrornas ( mirnas ) , long non-coding rna ( lncrnas ) , and circular rna ( circrnas ) , play key role in the development of gastric cancer . multiple piece of evidence suggest that ncrnas play a crucial role in the treatment of gastric cancer use chemotherapy and targeted therapy drug . in this article , we systematically review the important role of ncrnas in chemotherapy resistance , immune escape , metabolism , and angiogenesis of gastric cancer , and systematically elucidate the relevant molecular mechanism . in addition , we also propose the potential clinical significance of ncrna a a new therapeutic target and prognostic biomarker for gastric cancer .	Molecular cancer	03/10/2025
10.1126/sciadv.adv2283	meiotic cohesin rad21l shape 3d genome structure and transcription in the male germline .	Marín-Gual L, Vara C, Sainz-Urruela R, Cuartero Y, Álvarez-González L, Felipe-Medina N, Garcia F, Llano E, Marti-Renom MA, Pendás AM, Ruiz-Herrera A	the distinctive three-dimensional ( 3d ) chromatin architecture adopt by chromosome during meiosis be essential for fertility , yet the functional implication of the fine-scale spatial organization remain poorly understood . here , we investigate the impact of rad21l deletion , a meiosis-specific cohesin subunit , on the 3d genome architecture and gene expression in the male germ line . use fluorescence-activated cell sorting , high-throughput chromosome conformation capture , and single-cell rna sequencing , we demonstrate that rad21l deficiency impair meiotic chromatin organization and inter/intrachromosomal interaction . this conspicuous 3d genome reorganization also disrupt bouquet formation , result in increase telomeric interaction between heterologous chromosome in primary spermatocyte . genome reorganization be accompany by detectable transcriptional dysregulation in spermatogonia and primary spermatocyte , mainly affect sex chromosome . collectively , our finding establish the cohesin rad21l a a germline-specific critical regulator of genome-wide 3d genome reorganization during spermatogenesis and a modulator of the male germline transcriptional landscape .	Science advances	03/10/2025
10.2967/jnumed.125.270952	initial multicenter experience with [ ( 161 ) tb ] tb-psma in [ ( 177 ) lu ] lu-psma-refractory metastatic castration-resistant prostate cancer : preliminary result .	Kucuk NO, Coskun N, Araz M, Alan Selcuk N, Berberoglu K, Ozdemir EC, Gumuser FG, Kuyumcu S, Sezgin C, Sanli O, Sanli Y, Sendur MAN, Urun Y	( 161 ) tb be a theranostic radionuclide that emit both β ( - ) particle and auger electron with high linear energy transfer , potentially enhance cytotoxicity in micrometastatic disease . we report the first multicenter clinical experience of [ ( 161 ) tb ] tb-psma in patient with metastatic castration-resistant prostate cancer ( mcrpc ) refractory to [ ( 177 ) lu ] lu-psma therapy . method : this prospective , multicenter study include 7 patient with mcrpc who have progress despite prior androgen receptor pathway inhibitor , taxane-based chemotherapy , and at least 2 cycle of [ ( 177 ) lu ] lu-psma . all patient have psma-positive disease without any [ ( 18 ) f ] fdg-discordant lesion . each receive 2 cycle of [ ( 161 ) tb ] tb-psma ( 7.4 gbq per cycle , 6-wk interval ) . response be assess with [ ( 68 ) ga ] ga-psma pet/ct per recip 1.0 and prostate-specific antigen kinetics . posttherapy dosimetry be perform use spect/ct imaging at 4 time point . result : of the 7 patient , 4 ( 57 % ) demonstrate objective imaging response and 4 ( 57 % ) show at least a 50 % decline in prostate-specific antigen level . treatment be well tolerate , with only mild adverse event ( grade 1-2 ) and no toxicity great than grade 3. organ dosimetry confirm favorable absorbed dose distribution . conclusion : [ ( 161 ) tb ] tb-psma demonstrate promising molecular and biochemical activity with a favorable safety profile in patient who have progress after [ ( 177 ) lu ] lu-psma therapy . these preliminary finding support further investigation of ( 161 ) tb-based radiopharmaceutical a next-generation therapeutic option for mcrpc .	Journal of nuclear medicine : official publication, Society of Nuclear Medicine	03/10/2025
10.1053/j.seminhematol.2025.08.003	the immunotherapy landscape in aml : defining knowledge gap toward rational combinatorial strategy .	Subklewe M, Rutella S, Curti A	immunotherapy have dramatically improve outcome in lymphoid malignancy . in b cell cancer , cd19-directed car t cell and t-cell engagers have produce high remission rate and durable response , now form the cornerstone of treatment in many relapse or refractory setting . in contrast , acute myeloid leukemia ( aml ) have not experience a comparable breakthrough . to date , only antibody-drug conjugate have reach regulatory approval , with gemtuzumab ozogamicin approve in combination with intensive induction and consolidation therapy for newly diagnose cd33-positive aml . this divergence be root in the biological and immunologic complexity of aml . unlike b-cell malignancy with lineage-restricted surface marker such a cd19 , aml lack leukemia-specific antigen . most target be share with normal hematopoietic progenitor , lead to on-target/off-leukemia toxicity . moreover , aml exerts local and systemic immunosuppression through both tumor-intrinsic and microenvironmental mechanism , limit t-cell persistence and function . this review will introduce the current immunotherapy platform under investigation in aml , start with antibody-based approach , follow by t-cell redirecting therapy , and culminate in an overview of immune resistance , the bone marrow microenvironment , and strategy toward personalize combinatorial immunotherapy . by synthesize recent clinical data and mechanistic insight , include those from early car and t-cell engager trial , we aim to provide a translational framework for how immunotherapy might still reshape aml care-through integration of immune contexture of the bone marrow environment aim for rational combinatorial approach .	Seminars in hematology	29/08/2025
10.1089/vim.2019.0055	effective neutralizing antibody produce in mouse directly immunize with integrated pichia pastoris express hpv16l1 protein .	Xv Z, Lv J, Jiang J, Wang W, Feng F, Zhang L, Xue X, Li W	the human papillomavirus ( hpv ) vaccine have not be widely use in develop country because of it high cost and multiple subtype restriction . the present study aim to develop an economical , convenient , and effective vaccine to produce neutralizing antibody . use late protein 1 ( l1 ) from the hpv16 subtype a the target antigen ( hpv16l1 ) and pichia pastoris a the antigen release system , integrate p. pastoris express hpv16l1 ( name yeast-hpv16l1 ) be prepare and vaccinate directly into mouse by subcutaneous multipoint injection . after immunization be perform thrice , high titer ( great than 1:40,960 ) of specific anti-hpv16l1 antibody be obtain in immune serum and be observe to continuously rise over time . the indirect hemagglutination test and indirect hemagglutination inhibition test be use to detect neutralize antibody activity in vitro , and the result demonstrate the hemagglutination ability of the immune serum and the reduction in or loss of the hemagglutination ability if preneutralized antigen be add to the immune serum . the protection confer by immune serum to tumor-bearing mouse at the early stage be confirm , but the neutralizing activity disappear when the tumor reach a size of 1 mm ( 3 ) . the neutralization activity of the immune serum be confirm both in vitro and in vivo .	Viral immunology	01/01/2019
10.1093/eurheartj/ehaf667	transthyretin amyloid cardiomyopathy : from cause to novel treatment .	Fontana M, Aimo A, Emdin M, Porcari A, Solomon SD, Hawkins PN, Gillmore JD	transthyretin amyloid cardiomyopathy ( attr-cm ) be a progressive disorder mark by amyloid deposition in the heart , ultimately impair cardiac function . recent treatment advance have parallel an evolve understanding of attr-cm pathophysiology . one emerge hypothesis suggest that an imbalance between in vivo amyloid production and natural clearance may drive disease progression , a conceptual framework that still require validation . transthyretin ( ttr ) stabilizer , such a tafamidis and acoramidis , mitigate amyloid formation by promote the native tetrameric conformation of circulate ttr , thereby slow functional decline and prolong survival . similarly , ttr gene silencer inhibit hepatic ttr synthesis , and gene-editing therapy with nexiguran ziclumeran offer an additional strategy to reduce amyloid production . however , these approach do not enhance the body 's limited capacity to clear exist amyloid deposit , underscore the need for novel agent that accelerate amyloid removal . promisingly , monoclonal antibody target ttr amyloid be under development , with early clinical trial suggest that this passive immunotherapy may reverse disease progression and improve heart function . ultimately , optimal management of attr-cm will require further elucidation of the complex interplay between amyloid formation , it structural and functional impact , it clearance mechanism , and the potential for myocardial reverse remodelling .	European heart journal	01/10/2025
10.1007/s40259-025-00744-y	biological therapy in chronic obstructive pulmonary disease : new direction in personalised respiratory medicine .	Mappin-Kasirer B, Pavord ID	chronic obstructive pulmonary disease ( copd ) , a lead cause of global morbidity and mortality , be a complex and heterogeneous respiratory condition characterise by incompletely reversible airflow obstruction on spirometry . the aetiology and pathological pattern of copd be vary , which have long be view a a hindrance to target treatment . yet inflammation be central to the diverse mechanism of copd pathogenesis , and type 2 inflammation have emerge a a measurable , modifiable and clinically meaningful therapeutic target in those patient in whom it be identify . the approval of first biological therapy against type 2 inflammation in copd build on our understanding of immunological mechanism in airways disease , be inform by a decade of randomised trial and make possible a fundamental shift in our approach to this common condition . this review will ( 1 ) assess aspect of pathological inflammation in copd , namely type 1 , 2 and 3 inflammation , and the role of epithelial alarmins ; ( 2 ) examine data from randomise trial on the efficacy and safety of monoclonal antibody against inflammatory mediator in copd ; and ( 3 ) discus future direction for biological therapy in copd , include new patient population , new agent and new approach that focus on high-risk disease and open the door to prevention .	BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy	04/10/2025
10.1038/s41598-025-17908-z	dynamic of detergent-resistant membrane of plasmodium falciparum during blood stage development .	Sferra G, Fratini F, Birago C, Megliorini L, Mochi S, Lalle M, Paone S, Olivieri A, Ferreri C, Sansone A, Ponzi M, Currà C, Pizzi E	membrane microdomains , also know a detergent-resistant membrane ( drms ) , be tightly pack assembly enrich in cholesterol and sphingolipids , where various membrane-associated process occur . many intracellular pathogen , include plasmodium , exploit these raft-like structure to recognize and invade host cell . in particular , plasmodium depend on host cholesterol to build it own membrane , a it be unable to perform sterol synthesis . use quantitative proteomics , lipid analysis , and bioinformatics , this study define the composition and dynamic of plasmodium falciparum drms from key developmental stage : schizonts , which give rise to invasive merozoite , and gametocyte , which be responsible for transmission to the mosquito vector . comparative analysis of the flotation property of drm-associated protein and lipid reveals both conserve and stage-specific feature in the structural organization of membrane microdomains . follow parasite invasion , host drms be also remodel with the internalization of component of the erythrocyte junctional complex and their repositioning in the newly generate parasitophorous vacuole membrane . prediction and analysis of the drm interactomes reveal a core of protein involve in fundamental biological process maintain between the schizont and gametocyte stage . this common core form a highly interconnected subnetwork that occupy a central position in the interactomes , while stage-specific function occupy a peripheral position in the network .	Scientific reports	03/10/2025
10.1001/jamanetworkopen.2025.34927	memantine to treat social impairment in youth with autism spectrum disorder : a randomized clinical trial .	Joshi G, Gönenc A, DiSalvo M, Faraone SV, Ceranoglu TA, Yule AM, Uchida M, McDougle CJ, Wozniak J	pharmacologic intervention for address social impairment in autism spectrum disorder ( asd ) be lack . proton magnetic resonance spectroscopy ( 1h-mrs ) study in individual with asd have document altered glutamate level in the pregenual anterior cingulate cortex ( pgacc ) . to evaluate the safety and efficacy of memantine for treat social impairment in youth with asd and to explore pgacc glutamate level a a potential biomarker for treatment response . design , set , this 12-week , placebo-controlled , double-blind , parallel-design randomized clinical trial be conduct between january 20 , 2015 , and july 11 , 2018. the study population comprise youth age 8 to 17 year with asd without intellectual disability ( iq≥85 ) recruit from ambulatory psychiatry clinic at an academic institution . age- and sex-matched healthy control participant provide reference data for pgacc glutamate level . data analysis be conduct between january 7 , 2020 , and december 19 , 2024. participant with asd be randomize to memantine or placebo , with dose titration up to 20 mg/d . 1h-mrs scan be acquire to assess pgacc glutamate level . response be define a priori a ( 1 ) a 25 % or great reduction in informant-rated social responsiveness scale-second edition total score and ( 2 ) a clinician-rated clinical global impression-improvement subscale ( anchor for asd ) score of 2 or less . the association between pgacc glutamate level and treatment response be explore use receiver operate characteristic ( roc ) curve analysis . this study include 42 youth with asd who initiate treatment ( mean [ sd ] age , 13.2 [ 2.6 ] year ; 32 male [ 76.2 % ] ) . of these youth , 35 be include in the intention-to-treat efficacy analysis ( n = 16 treat with memantine and 19 with placebo ) , and 33 complete the trial ( n = 16 treat with memantine and 17 with placebo ) . significantly more memantine-treated participant meet the response criterion compare with placebo-treated participant ( 9 of 16 [ 56.2 % ] vs 4 of 19 [ 21.0 % ] ; odds ratio , 4.8 [ 95 % ci , 1.1-21.2 ] ; p = .03 ) . memantine be well tolerate and do not have significantly more adverse event compare with placebo . mean ( sd ) pgacc glutamate level be significantly high in youth with asd v healthy control participant ( 95.5 [ 14.6 ] iu v 76.6 [ 17.7 ] iu ; standardize mean difference , -1.2 [ 95 % ci , -1.8 to -0.6 ] ; p < .001 ) . abnormally elevated pgacc glutamate level ( ≥1 sd above that of healthy control participant ) be observe in 20 of 37 participant ( 54.0 % ) with asd and be associate with more treatment responder to memantine than placebo ( 8 of 10 [ 80.0 % ] vs 2 of 10 [ 20.0 % ] ; odds ratio , 16.0 [ 95 % ci , 1.8-143.2 ] ; p = .007 ) . roc curve analysis indicate that pgacc glutamate level be highly efficient at identify treatment responder . in this trial , memantine be well tolerate and significantly improve social impairment in youth with asd . elevate pgacc glutamate level be associate with a favorable treatment response , support their potential a a biomarker for assess memantine efficacy in individual with asd . clinicaltrials.gov identifier : nct01972074 .	JAMA network open	01/10/2025
10.1186/s12967-025-07053-6	cbp/p300 , a promising therapeutic target for prostate cancer .	Xu H, Hou Y, Zhao Z, Zhang J, Li P, Cao Y, Nie X, Hou J	prostate cancer ( pca ) remain the most prevalent malignancy among men , with the inevitable emergence of castration-resistant prostate cancer ( crpc ) present the great challenge . accumulate evidence have confirm that the overexpression of camp response element-binding protein ( creb ) -binding protein ( cbp ) and e1a-binding protein ( p300 ) , two highly homologous transcriptional coactivators , play a crucial role in the development of pca and it progression to crpc , thereby make them prominent therapeutic target for all type of pca . in this review , we systematically discuss the structure and function of cbp/p300 and elucidate the detailed mechanism by which cbp/p300 promote prostate carcinogenesis and development . specifically , cbp/p300 facilitate prostate carcinogenesis by acetylate specific lysine residue on essential transcription factor involve in androgen receptor ( ar ) signaling , canonical wnt signaling , p53 signaling , as well a other pathway such a pi3k/akt and mapk signaling . additionally , they contribute to tumor immunosuppression and adaptive resistance to program death ligand 1 ( pd-l1 ) blockade treatment by induce the expression and secretion of the pd-l1 protein . furthermore , we explore the late advance in the use of various inhibitor target different domain of cbp/p300 and proteolysis-targeting chimera ( protac ) degrader in pca . we propose that comb cbp/p300 inhibitor or degrader with current anti-pca therapy , include androgen deprivation therapy ( adt ) , chemotherapy , and immunotherapy , hold potential to overcome the challenge in treat advanced pca and improve clinical outcome for all pca patient .	Journal of translational medicine	02/10/2025
10.1073/pnas.89.24.12180	papillomavirus l1 major capsid protein self-assembles into virus-like particle that be highly immunogenic .	Kirnbauer R, Booy F, Cheng N, Lowy DR, Schiller JT	infection by certain human papillomavirus type be regard a the major risk factor in the development of cervical cancer , one of the most common cancer of woman worldwide . analysis of the immunogenic and structural feature of papillomavirus virion have be hamper by the inability to efficiently propagate the virus in cultured cell . for instance , it have not be establish whether the major capsid protein l1 alone be sufficient for virus particle assembly . in addition , it be not know whether l1 , l2 ( the minor capsid protein ) , or both present the immunodominant epitope require for induction of high-titer neutralizing antibody . we have express the l1 major capsid protein of bovine papillomavirus type 1 and human papillomavirus type 16 in insect cell via a baculovirus vector and analyze their conformation and immunogenicity . the l1 protein be express at high level and assemble into structure that closely resemble papillomavirus virion . the self-assembled bovine papillomavirus l1 , in contrast to l1 extract from recombinant bacteria or denatured virion , also mimic intact bovine papillomavirus virion in be able to induce high-titer neutralizing rabbit antiserum . these result indicate that l1 protein have the intrinsic capacity to assemble into empty capsid-like structure whose immunogenicity be similar to infectious virion . this type of l1 preparation might be consider a a candidate for a serological test to measure antibody to conformational virion epitope and for a vaccine to prevent papillomavirus infection .	Proceedings of the National Academy of Sciences of the United States of America	15/12/1992
10.1002/cam4.71232	the association between the tyg index and the risk of cancer-a systematic review and meta-analysis .	Li H, Chen Z, Jiang G, Yu W, Luo J, Li S, Xie L, Bai X, Xu Y, Jiang Y, He M, Mao M, Wang X	the triglyceride glucose ( tyg ) index , a simple and reliable surrogate marker of insulin resistance ( ir ) , have garner increase attention in metabolic research . although ir be mechanistically link to carcinogenesis through multiple pathway , include chronic inflammation , hyperinsulinemia-driven pro-mitogenic signaling , and alter adipokine secretion , the specific utility of the tyg index for cancer risk assessment remain unclear . this systematic review examine whether the tyg index show consistent association across cancer type and hold value a an independent risk predictor beyond establish metabolic syndrome component . we systematically search pubmed , embase , and web of science database from 2008 ( the year the tyg index be establish a an ir marker ) to december 31 , 2024 , for study on the tyg index-cancer association . cohort , cross-sectional , and case-control study be include . use meta-analysis , we pool effect size and conduct subgroup analysis by gender , region , population source , and study design . trial sequential analysis ( tsa ) evaluate evidence reliability . this meta-analysis incorporate a total of 20 eligible study . our finding demonstrate that elevate tyg index level be significantly associate with increased risk of various malignancy , include digestive system cancer ( 1.22 , 95 % ci 1.13-1.31 ) , urogenital system cancer ( 2.04 , 95 % ci 1.53-2.71 ) , and breast cancer ( 1.64 , 95 % ci 1.49-1.80 ) when compare to low tyg index level . these association remain consistent across all pre-specified subgroup analysis stratify by study characteristic . furthermore , tsa confirm sufficient statistical power for definitive conclusion . the consistent observe association between elevate tyg index and increase cancer risk highlight it potential a a candidate biomarker for further investigation . while these finding support the biological plausibility of insulin resistance in oncogenesis , current evidence-partially derive from observational studies- can not establish causality or direct clinical utility . future research should prioritize : ( 1 ) prospective validation of tyg index threshold for cancer risk prediction , ( 2 ) mechanistic study elucidate it role in tumor biology , and ( 3 ) assessment of it incremental value to exist risk stratification tool .	Cancer medicine	01/01/2008
10.1016/j.bneo.2025.100152	ivosidenib or venetoclax combine with hypomethylating agent in idh1-mutated acute myeloid leukemia : a real-world study .	Lachowiez CA, Smith BD, Ambinder AJ, Binder G, Angiolillo A, Potluri R, Papademetriou E, LeBlanc TW	approximately 10 % of patient with newly diagnose acute myeloid leukemia ( nd-aml ) harbor the isocitrate dehydrogenase 1 gene mutation ( midh1 ) . in this real-world study evaluate ivosidenib ( ivo ) + hypomethylating agent ( hmas ; n = 181 ) v venetoclax ( ven ) + hmas ( n = 99 ) in patient with midh1 nd-aml , those treat with ivo+hma have high rate of complete remission ( cr ; 42.5 % vs 26.3 % ; p = .007 ) , high rate of composite cr + cr with incomplete platelet count recovery ( 63.0 % vs 48.5 % ; p = .019 ) , short median time to best response ( 3.3 vs 4.1 month ; p = .006 ) , and improve 6-month event-free survival ( 55.8 % vs 38.4 % ; p = .006 ) . most patient treat with ven receive well under 28 day of ven per cycle , likely due to anticipation of toxicity ; outcomes with this short-schedule ven be proportionately bad with few day of exposure per cycle . the between-group rate of grade ≥3 adverse event be similar within 30 day of treatment initiation , except for high rate of febrile neutropenia for ven+hma v ivo+hma ( 8.1 % vs 1.7 % ; p = .008 ) . these finding support result from the phase 3 agile trial demonstrate ivo+hma 's efficacy and favorable toxicity profile in patient with midh1 nd-aml . ivo + azacitidine should be consider a the preferred standard of care treatment regimen in this patient subgroup .	Blood neoplasia	01/01/2025
10.3324/haematol.2025.288553	long-term outcome in flt3-mutated acute myeloid leukemia after frontline hypomethylating agent , venetoclax and a flt3 inhibitor .	Short NJ, Loghavi S, Yilmaz M, Karrar O, Kim K, Dinardo CD, Kadia TM, Maroun M, Borthakur G, Issa GC, Jabbour J, Oran B, Shpall EJ, Popat U, Patel KP, Routbort M, Konopleva M, Ravandi F, Kantarjian H, Daver N	triplet regimens with a hypomethylating agent , venetoclax and a flt3 inhibitor yield high rate of response in newly diagnose flt3-mutated aml . however , the long-term outcome and pattern of relapse with these triplet regimen be not well-established . in this retrospective analysis , 73 patient with newly diagnose flt3-mutated aml receive a frontline flt3 inhibitor-containing triplet regimen . the composite complete remission ( cr ) and cr with incomplete hematologic recovery ( cri ) rate be 93 % . next-generation sequence flt3-itd mrd negativity ( sensitivity : 0.005 % ) be achieve in 60 % of patient after cycle 2 and 90 % after cycle 4. the estimate 3-year relapse-free survival ( rf ) for flt3-itd-mutated and flt3 tkd-mutated aml be 38 % and 76 % , respectively , and the 3-year overall survival ( o ) be 45 % and 76 % , respectively . neither age , npm1 co-mutation , eln 2022 risk , nor allogeneic stem cell transplantation in first remission significantly impact o . baseline ras pathway mutation be associate with poor long-term survival ( 3-year os 22 % versus 63 % without ras pathway mutation ) . flt3 wild type relapse account for 65 % of relapse , and new ra pathway mutation be observe in 24 % of relapse . outcome be poor after relapse ( median o of 6.1 month ) , particularly for those with persistently detectable flt3 mutation . triplet combination of an hma , venetoclax and a flt3 inhibitor result in durable remission and encouraging long-term o in old adult with newly diagnose flt3-mutated aml . however , good strategy to prevent flt3 wild type relapse and to overcome ras pathway-mediated resistance be still need .	Haematologica	02/10/2025
10.3389/fmed.2025.1638496	relative efficacy of minoxidil in combination with other treatment for androgenic alopecia : a network meta-analysis base on randomized control trial .	Xia Y, Chen H, Chen Y, Chen Z	androgenetic alopecia be the most prevalent form of progressive hair loss . minoxidil be widely regard a a standard treatment for this condition . consequently , we assess the effectiveness of minoxidil in combination with other pharmacological agent for the treatment of androgenetic alopecia . a comprehensive search be conduct across four databases-pubmed , embase , web of science , and cochrane library-on december 10 , 2024. eligible study be select base on the picos framework . data extraction and synthesis be carry out use a bayesian network meta-analysis , focus on mean difference and sample size data . league table and surface under the cumulative ranking ( sucra ) value be employ to evaluate the relative efficacy of the intervention . among the 20 study group analyze , the combination of platelet-rich plasma and basic fibroblast growth factor with minoxidil demonstrate the high overall efficacy ( sucra = 93.06 % ) . this combination result in a mean increase in hair density of 35.12 hairs/cm ( 2 ) compare to the group treat with minoxidil alone . in male subgroup , finasteride combine with minoxidil be the most effective treatment ( sucra = 80.18 % ) . among seven combination therapy for female , microneedle with minoxidil prove most effective ( sucra = 87.18 % ) . this study establish a clinically actionable hierarchy of minoxidil-based combination therapy , provide evidence-based guidance for dermatologist to optimize androgenetic alopecia management . http : //www.crd.york.ac.uk/prospero/view/crd42024623164 , identifier crd42024623164 .	Frontiers in medicine	01/01/2025
10.1001/jamanetworkopen.2025.35119	traumatic brain injury and risk of amyotrophic lateral sclerosis .	Zhu X, Russell ER, Lyall DM, Ho F, Mackay DF, Pell JP, Stewart W	history of traumatic brain injury ( tbi ) or repetitive head impact be associate with an increase risk of neurodegenerative disease . this association have attract attention in recent year through the relationship between contact sport participation and the increase risk of a number of neurodegenerative disease , include motor neuron disease or amyotrophic lateral sclerosis ( al ) . however , to date , the association between tbi in the community and al risk remain uncertain . to leverage population-level health record to explore the association between a history of tbi and subsequent al risk . design , set , this retrospective cohort study access uk-wide electronic health record ( ehr ) data from individual 18 year or old with tbi history and age- , sex- , and area deprivation-matched general population comparators . ehr data be available from january 1 , 2005 , to december 31 , 2020 , with database interrogation perform on february 11 , 2021 , and data analysis conduct between june 1 , 2023 , and october 3 , 2024. document history of tbi . outcome be obtain by individual-level linkage to ehr data available via clinical practice research datalink . risk of al be evaluate use cox proportional hazard regression model to investigate it association with tbi . overall , 85 690 adult with a history of tbi and 257 070 match adult with no history of tbi be include , for a total of 342 760 participant ( 50.1 % male ; mean [ sd ] age , 50.7 [ 17.6 ] year ) . during a median 5.72 ( iqr , 3.07-8.82 ) year of follow-up , provide 2.13 million person-years of follow-up , 150 incident al case be record , result in 7.05 case per 100 000 person-years . risk of al be high among individual with a history of tbi compare with individual without a tbi history ( hazard ratio [ hr ] , 2.61 ; 95 % ci , 1.88-3.63 ) . however , this association be time dependent , with risk confine to the 2 year follow tbi ( hr , 6.18 ; 95 % ci , 3.47-11.00 ) , but not thereafter . in this retrospective cohort study of 342 760 adult , an association between tbi and subsequent risk of al be identify . however , this association be confine to the 2 year immediately follow injury . a such , the association between tbi and high al risk may indicate reverse causality , with tbi in some individual perhaps reflect a consequence of early , subclinical al .	JAMA network open	01/10/2025
10.1186/s12888-025-07387-x	association between sleep duration , depression and cognitive decline trajectory : finding from a prospective cohort study in china .	Li C, Wu X, Li Y, Zhang M, Zhang L, Zhou C, Ma F	this study investigate the relationship between sleep duration and cognitive decline trajectory among chinese adult with age ≥ 45. additionally , it examine whether baseline depression symptom mediate the association between sleep duration and cognitive decline trajectory . data come from the china health and retirement longitudinal study ( charls ) , a nationally survey of chinese adult . total sleep duration be group into shorter ( ≤ 6 h ) , normal ( 6-9 h ) , and long ( > 9 h ) . nighttime sleep duration be categorize a shorter ( ≤ 6 h ) , normal ( 6-8 h ) , and long ( > 8 h ) . daytime nap duration be classify into no nap , shorter ( ≤ 0.5 h ) , normal ( 0.5-1.5 h ) , and long ( > 1.5 h ) . cognitive decline trajectory be identify use a group-based trajectory model ( gbtm ) . depression symptom , measure by baseline depression score , be include a a potential mediating variable . multinomial logistic regression model be apply to analyze the association between sleep duration and cognitive trajectory . a total of 4,094 respondent be include . participant be classify into three trajectory group : high-level stable ( n = 1,278 , 31.2 % ) , moderate-level slow-decline ( n = 2,089 , 51.0 % ) , and low-level rapid-decline ( n = 727 , 17.8 % ) . compare to the stable group , short total sleep duration be associate with both rapid-decline ( 1.510 ; 95 % 1.079,2.114 ) and slow-decline ( 1.466 ; 95 % 1.145,1.877 ) cognitive trajectory . similarly , short nighttime sleep duration be associate with both rapid-decline ( 1.572 ; 95 % 1.089,2.271 ) and slow-decline ( 1.480 ; 95 % 1.129,1.939 ) cognitive trajectory compare to the stable group . baseline depression symptom do not mediate these relationship ( p > 0.05 ) . short total sleep duration ( ≤ 6 h ) and short nighttime sleep duration ( ≤ 6 h ) be significantly associate with cognitive decline trajectory . however , baseline depression symptom do not mediate these relationship .	BMC psychiatry	01/10/2025
10.7150/thno.117202	hsa_circ_0058495-mediated igf2bp2 ubiquitination and m6a modification of mekk1 promote the progression of pdac .	Lv S, Zhang J, Peng X, Liu H, Chu T, Liu Z, Duan K, Guo J, Wang J, Liu Y, Wei F	background : pancreatic ductal adenocarcinoma ( pdac ) be a highly aggressive malignancy with dismal clinical outcome . we identify hsa_circ_0058495 a significantly upregulated in pdac tissue and pdac cell-derived exosomes , where it contribute to tumor proliferation and invasion . the molecular mechanism underlie it oncogenic function , however , remain incompletely understood . method : differential circrna expression be profile by rna sequencing . the functional role of hsa_circ_0058495 and it molecular interaction be interrogate through western blotting , rt-qpcr , co-immunoprecipitation , rna pull-down , and rna immunoprecipitation assay . confocal microscopy and pet/ct imaging be employ to delineate it biological effect in vitro and in vivo . result : hsa_circ_0058495 be enrich in pdac-derived exosomes and stabilize igf2bp2 by prevent trim25-mediated ubiquitination and attenuate autophagy-dependent degradation . stabilize igf2bp2 enhance the stability of mekk1 mrna , lead to sustain erk1/2 phosphorylation and consequent promotion of pdac cell proliferation and invasion . moreover , exosomal hsa_circ_0058495 facilitate m2 macrophage polarization , thereby foster an immunosuppressive tumor microenvironment . conclusion : hsa_circ_0058495 promote pdac progression by stabilize igf2bp2 and activate the mekk1-erk signaling cascade , while exosomal transfer of hsa_circ_0058495 drive m2 macrophage polarization to reinforce tumor-associated immunosuppression . these finding establish hsa_circ_0058495 a a pivotal regulator of pdac progression and underscore it potential utility a both a diagnostic biomarker and a therapeutic target .	Theranostics	01/01/2025
10.1186/s12885-025-14791-9	real-world management strategy and clinical outcome of metastatic her2-positive breast cancer in greece in the second-line setting and beyond ( the together study ) .	Korantzis I, Koumarianou A, Rapti V, Timotheadou E, Christodoulou C, Tryfonopoulos D, Karageorgopoulou S, Boukovinas I, Zagouri F, Nikolaidi A, Papazisis K, Razis E, Barbounis V, Christopoulou A, Mavroudis D, Georgoulias V, Kesisis G, Papadopoulos EI, Michalea R, Ardavanis A	in the realm of her2-positive ( her2+ ) metastatic breast cancer ( mbc ) , the advent of targeted therapy , notably trastuzumab and pertuzumab , represent a substantial advancement in enhance patient outcome . however , the intricacy of treatment escalate when patient encounter progression or resistance during first-line ( 1l ) therapy . the together study aim to elucidate real-world insight into the profile , management strategy , and outcome for her2+ mbc patient initiate second-line treatment ( 2lt ) in greece , predate recent international guideline change incorporate trastuzumab deruxtecan and tucatinib in the second line and beyond line of treatment . data from adult female patient with her2+ mbc who have initiate 2lt between 01-jan-2015 and 31-dec-2018 in 18 oncology department across greece be retrospectively abstract through medical chart review . the eligible population comprise 122 patient , 68.0 % of whom present with recurrent mbc . among the latter , 26.5 % be test for her2 both in early and metastatic setting with 27.3 % of them change her2 status from negative to positive . retesting of her2 expression follow 2lt initiation be record in 8 case . at 2lt initiation , patient ' median age be 57.0 year and 63.6 % be hormone receptor-positive . the most common metastatic site be bone ( 56.6 % ) , lung ( 44.3 % ) , liver ( 41.0 % ) , and brain ( 29.5 % ) . anti-her2 agent usage in 1l and 2l stood at 91.8 % and 92.6 % , respectively , with rate slightly diminish in third ( 3l ) ( 85.9 % ) and fourth line ( 4l ) ( 82.4 % ) . endocrine therapy administration be generally low across treatment line ( 12.3 % , 9.9 % , and 5.9 % , in 2l , 3l , and 4l respectively ) , while chemotherapy use increase from 30.3 % in 2l to 47.9 % and 47.1 % to 3l and 4l , correspondingly . median progression-free survival ( pfs ) for 2l , 3l , and 4l be 7.7 [ 95 % confidence interval ( ci ) 6.0-14.4 ] , 6.4 ( 95 % ci 5.4-7.1 ) , and 5.6 ( 95 % ci 2.6-9.0 ) month , respectively , while median overall survival be 25.0 ( 95 % ci 20.5-34.4 ) month . although the 2lt pattern in greece generally align with guideline , persistently poor treatment outcome underscore a significant unmet medical need for these patient .	BMC cancer	01/10/2025
10.1186/s40164-025-00710-y	phase ii study of zevorcabtagene autoleucel , a fully human bcma-targeting car t cell therapy , in patient with relapsed/refractory multiple myeloma .	Chen W, Fu C, Fang B, Liang A, Xia Z, He Y, Lu J, Liu H, Hou M, Cai Z, Yang W, Hao S, Jiang S, Jing H, Liu J, Du X, Fu R, Mei H, Zhu Z, Yang Y, Liu H, Meng X, Rajakumaraswamy N, Yuan D, Wang H, Li Z	zevorcabtagene autoleucel ( zevor-cel ) be a fully human autologous car t-cell therapy target b-cell maturation antigen approve in china since 2024 for patient with relapsed/refractory multiple myeloma ( rrmm ) . lummicar study 1 be a phase 2 , single-arm study conduct across 23 center in china . rrmm patient age ≥ 18 to ≤ 75 year with measurable disease who have receive ≥ 3 prior line of therapy , with adequate organ function and bone marrow reserve , with an eastern cooperative oncology group ( ecog ) score of 0-1 , be eligible . patient previously treat with any car t-cell therapy , or any bcma-directed therapy be ineligible . the primary endpoint be objective response rate ( orr ) determine by an independent review committee . the secondary endpoint include orr determine by investigator , additional efficacy outcome include complete response ( cr ) / stringent complete response ( scr ) rate , duration of response ( dor ) , minimal residual disease negativity , safety outcome include incidence and severity of adverse event , and pharmacokinetics of zevor-cel . overall , 125 patient underwent apheresis , 105 patient received lymphodepletion , 102 patient ( median age of 59.5 [ range : 38 , 75 ] year ; 53.9 % male and 46.1 % female ) receive zevor-cel . the orr be 92.2 % ( 95 % ci 85.13-96.55 ) with 70 patient ( 68.6 % ) achieve scr and 3 ( 2.9 % ) achieve cr . at a median follow-up of 20.3 ( interquartile range [ iqr ] 12.5 , 23.8 ) month , 45 ( 44.1 % ) progression-free survival ( pfs ) event and 20 ( 19.6 % ) overall survival ( o ) event be observe , the dor , pfs and o data be not mature . cytokine release syndrome be report in 92 ( 90.2 % ) patient , with grade 3 or 4 event in 7 ( 6.9 % ) patient . immune effector cell associate neurotoxicity syndrome be report in 2 patient at grade 1 ; no zevor-cel-related grade ≥ 3 neurotoxicity occur . zevor-cel induces deep and durable response in heavily pre-treated rrmm patient with a manageable safety profile .	Experimental hematology & oncology	30/09/2025
10.1136/jitc-2025-012423	transformer-based ai approach to unravel long-term , time-dependent prognostic complexity in patient with advanced nsclc and pd-l1 ≥50 % : insight from the pembrolizumab 5-year global registry .	Cortellini A, Santo V, Brunetti L, Garbo E, Pinato DJ, La Cava G, Naidoo J, Katz A, Loza M, Neal JW, Genova C, Gettinger S, Kim SY, Jayakrishnan R, El Zarif T, Russano M, Pecci F, Di Federico A, Alessi JV, Montrone M, Owen DH, Ramella S, Signorelli D, Fidler MJ, Li M, Camerini A, Halmos B, Vincenzi B, Metro G, Passiglia F, Yendamuri S, Guida A, Ghidini M, D'Alessio A, Banna GL, Fulgenzi CAM, Grisanti S, Grossi F, D'Incecco A, Josephides E, Van Hemelrijck M, Russo A, Gelibter A, Spinelli G, Verrico M, Tomasik B, Giusti R, Balachandran K, Bria E, Sebastian M, Rost M, Forster M, Mukherjee U, Landi L, Mazzoni F, Aujayeb A, Dupont M, Curioni-Fontecedro A, Chiari R, Sforza V, Tiseo M, Friedlaender A, Addeo A, Zoratto F, De Tursi M, Cantini L, Roca E, Mountzios G, Rocco D, Della Gravara L, Kalvapudi S, Inno A, Bironzo P, Di Marco Barros R, O'Reilly D, Fitzpatrick O, Karapanagiotou E, Monnet I, Baena J, Macerelli M, Piedra A, Agustoni F, Cortinovis DL, Tonini G, Minuti G, Bennati C, Mezquita L, Gorría T, Servetto A, Beninato T, Lo Russo G, Prelaj A, De Giglio A, Rogado J, Moliner L, Nadal E, Biello F, Nana FA, Dingemans AM, Aerts JGJV, Ferrara R, Abu Hejleh T, Takada K, Naqash AR, Garassino MC, Peters S, Wakelee HA, Nassar AH, Ricciuti B, Soda P, Caruso CM, Guarrasi V	with nearly one-third of patient with advanced non-small cell lung cancer ( nsclc ) and pd-l1 tumor proportion score≥50 % survive beyond 5 year follow first-line pembrolizumab , long-term outcome challenge traditional paradigm of cancer prognostication . the emergence of non-cancer-related factor and time-dependent trend underscore the need for advanced analytical framework to unravel their complex interplay . we analyze the pembro-real 5y registry , a global real-world dataset of 1050 patient treat across 61 institution in 14 country with a long-term follow-up and a large panel of baseline variable . two complementary approach be employ : ridge regression , choose for it ability to address multicollinearity while retain interpretability , and not another imputation method ( naim ) , a transformer-based artificial intelligence model design to handle miss data without imputation . endpoint include risk of death at 6 , 12 , 24 , 60 month and 5-year survival . the ridge regression model achieve a c-statistic of 0.66 ( 95 % 0.59 to 0.72 ) for the risk of death and an area under the curve ( auc ) of 0.72 ( 95 % 0.65 to 0.78 ) for 5-year survival , identify eastern cooperative oncology group performance status ( ecog-ps ) ≥2 , increase age , and metastatic burden a primary risk factor . however , wide ci for some predictor highlight statistical instability . naim demonstrate robust handling of miss data , with a c-index of 62.98±2.11 for risk of death and an auc of 60.52±3.71 for 5-year survival . the comprehensive shapley additive explanation analysis reveal dynamic , time-dependent pattern , with early mortality dominate by acute factor ( eg , ecog-ps , steroid ) and long-term outcome increasingly influence by systemic health marker ( eg , absence of hypertension , increase body mass index ) . unexpected insight include the protective role of dyslipidemia ( but not statin ) and the nuanced impact of smoke status , reflect evolve disease dynamic and host-tumor interplay . our integrative framework illuminate the complexity of long-term outcome in patient with nsclc treat with pembrolizumab , uncover dynamic , non-linear prognostication trend . this analysis provide insight into patient trajectory , emphasize the need for holistic , long-term management strategy .	Journal for immunotherapy of cancer	29/09/2025
10.1016/j.ejphar.2025.178206	statin activate temperature-gated transient receptor potential ion channel .	Oprita G, Domocos D, Selescu T, Paduraru A, Tunaru S, Leffler A, Babes A, Babes RM	statin be hmg-coa reductase inhibitor administer to decrease level of ldl cholesterol and to lower the risk of cardiovascular disease . although statin be relatively well tolerate , adverse effect such a myalgia and painful peripheral neuropathy have be report . while the underlie cause have not be fully elucidate , accumulate evidence show that statin have numerous pleiotropic effect include anti-inflammatory and analgesic action in several animal pain model . here we report that some of the most extensively used statin activate member of the temperature-gated transient receptor potential ( trp ) ion channel subfamily express in heterologous system . all test statin ( simvastatin , atorvastatin and rosuvastatin ) activate human trpa1 and , in addition , simvastatin activates human trpv1 and rosuvastatin activates human trpm8 . the activation of trpv1 by simvastatin be abolish in a capsaicin-insensitive mutant . furthermore , the sensitivity of both trpv1 and trpa1 to simvastatin be diminish in triple cysteine mutant know to exhibit a reduced sensitivity to reactive oxygen specie . rosuvastatin-induced activation of trpm8 seem to involve an aspartate residue which be essential for sensitivity to the synthetic trpm8-agonist icilin . in mouse dorsal root ganglion ( drg ) neuron , simvastatin activate a subpopulation of neuron which also respond to the trpv1-agonist capsaicin or the trpa1-agonist allyl isothiocyanate . in addition , trpm8 play an important role for the activation of a small population of drg neuron by rosuvastatin . take together , these result indicate that statin activate thermo-sensitive trp channel express in nociceptive sensory neuron . this property may explain some of the pleiotropic effect of these widely use drug .	European journal of pharmacology	01/10/2025
10.1016/j.yjmcc.2025.09.008	decode long covid-associated cardiovascular dysfunction : mechanism , model , and new approach methodology .	Thomas D, Yang PC, Wu JC, Sayed N	the covid-19 pandemic have reveal that the impact of sars-cov-2 infection extend well beyond the acute phase , with long-term sequela affect multiple organ system , most notably , the cardiovascular system . long covid , or post-acute sequela of sars-cov-2 infection ( pasc ) , be characterize by persistent symptom such a fatigue , dyspnea , chest pain , and palpitation , which can last for month or even year after initial recovery . increase evidence implicates immune dysregulation , endothelial dysfunction , persistent viral antigen , and coagulopathy a central driver of cardiovascular complication . mechanistic study demonstrate that direct viral infection of cardiac and vascular cell , along with autoantibody formation and cytokine-mediated injury , contribute to myocardial inflammation , fibrosis , and arrhythmias . sex-based immunological difference and underlie comorbidities far influence individual susceptibility and disease trajectory . large-scale epidemiological study have confirm significantly increased risk of pericarditis , cardiomyopathy , dysrhythmias , and heart failure among covid-19 survivor . in parallel , the emergence of advanced preclinical platform , include patient-derived induced pluripotent stem cell ( ipsc ) -based cardiac organoids , engineer heart tissue , and organ-on-a-chip system have enable mechanistic dissection of long covid pathophysiology . these human-relevant model , when integrate with clinical datasets and artificial intelligence ( ai ) -driven analytics , offer powerful tool for biomarker discovery , risk stratification , and precision therapeutic development . this review synthesize the current understanding of cardiovascular involvement in long covid , highlight key mechanistic insight from both clinical and preclinical study , and outline future direction for diagnostic and therapeutic innovation .	Journal of molecular and cellular cardiology	30/09/2025
10.1016/j.breast.2025.104588	investigate the prognostic role of citrullination-related gene in breast cancer by combine transcriptomics , single-cell analysis and verification .	He W, Fan S, Luo Y, Yi X, Liu Y, He G, Li Z, Li Y	citrullination , a process link to autoimmune disease , have be implicate in cancer , but it role in breast cancer ( brca ) remain unclear . this study aim to identify citrullination-related gene ( crgs ) associate with prognosis in brca . we utilized datasets from the cancer genome atlas ( tcga-brca ) and gene expression omnibus ( geo ) , pinpoint candidate gene by intersect differentially express gene ( degs ) from tcga-brca with known crgs . prognostic crgs be select use univariate cox regression and lasso regression analysis , and a predictive nomogram be create base on independent prognostic factor identify through multivariate cox regression . our finding reveal that sez6 , s100b , spib , and tff1 be key crgs use to construct a risk model . high-risk brca patient exhibit immune-suppressive tumor microenvironments ( tmes ) with low cd8 ( + ) t cell mutation and enrichment in c1/c4 immune subtypes . in contrast , low-risk patient display high immune infiltration and enrichment in c2/c3/c6 subtypes . high expression of s100b , spib , and tff1 be associate with increase immune infiltration by nk cell and t cell , while high sez6 expression be link to neutrophil mutation , pd-l1 upregulation , and low cd8 ( + ) t cell infiltration . molecular dock study explore the interaction of these crgs with entinostat . in conclusion , sez6 , s100b , spib , and tff1 be identify a significant prognostic gene in brca , provide insight into brca pathogenesis and potential personalized treatment strategy .	Breast (Edinburgh, Scotland)	25/09/2025
10.1002/1878-0261.70132	characterize epithelial-mesenchymal transition-linked heterogeneity in breast cancer circulate tumor cell at a single-cell level .	Topa J, Richert J, Stokowy T, Staśczak A, Szajewski M, Ciesielski M, Grešner PM, Tomasik B, Arcimowicz Ł, Stankiewicz A, Suchodolska G, Senkus E, Kruszewski W, Żaczek AJ, Markiewicz A	epithelial-mesenchymal transition ( emt ) generate heterogeneity in circulate tumor cell ( ctc ) , affect their biological property and hamper their detection . this limit our understanding of the mechanism underlie hematogenous dissemination , especially in early breast cancer ( bc ) , where ctc be rare . here , we aim to detect ctc with different emt status from bc patient . ctc in blood sample from 107 bc patient be evaluate use immunomagnetic depletion and multi-marker immunofluorescence ( epcam , e-cadherin , mcam , cell surface vimentin , cd31 , cd45 ) , follow by single-cell transcriptomics . ctc be detect in 51.9 % of therapy-naïve early bc case , with 3.8 % show only epithelial ctc ( ectcs ) , 5.8 % epithelial-mesenchymal ( emctcs ) , 26.0 % mesenchymal ( mctcs ) , and 16.3 % mixed phenotype . ctc heterogeneity be more frequent in triple-negative ( 86 % ) than in luminal bc ( 17 % , p = 0.008 ) . lymph node involvement strongly predict dissemination of all ctc phenotype , while tumor size correlate with mctc abundance . single-cell rna sequence revealed downregulation of ribosomal gene and translation inhibition in ctc with mesenchymal feature , link to mtorc1 signal . finding be also validate in an independent dataset , highlight vulnerability in ctc during dissemination .	Molecular oncology	05/10/2025
10.1186/s12967-025-07030-z	microrna signature of cancer risk in kidney transplant patient : insight from the cometa study .	Simeoni M, Tufano R, Grandinetti V, Cossu AM, Alfieri C, Pollastro R, Calcutta A, Scrima M, Bocchetti M, Zappavigna S, Simeone I, Grandaliano G, Capasso A, Messa P, Castellano G, Mella A, Biancone L, Ceccarelli M, Caraglia M, La Manna G, Capasso G, Citterio F	post-transplant malignancy be one of the leading cause of morbidity , mortality and graft failure in kidney transplant recipient ( ktrs ) . while viral infection and immunosuppressive drug have historically be consider primary cause , the mechanism underlie post-transplant cancer occurrence remain incompletely understood . furthermore , predictive cancer biomarkers have yet to be identify in ktrs . cometa study be an observational study involve 138 ktrs , and it aim to elucidate the interplay between the immune system and cancer by integrate comprehensive clinical data with high-throughput small-rna sequencing on the serum of patient with post-kidney transplant malignancy . our result identify three distinct serum mirna profile , respectively , associate with kidney transplantation , pro-oncogenic and onco-protective factor in this unique population . these profile be also use to create mirna classifier , which demonstrate promising predictive performance , especially for tumor-promoting signature . notably , mir-210-3p up-regulation , within the cancer-related profile be first find to be associate with non-melanoma skin cancer . these finding could serve a a basis for future research , pave the way for the development of advanced tool for early cancer diagnosis , precise prognosis formulation , and the creation of targeted therapy for ktrs with neoplastic complication .	Journal of translational medicine	03/10/2025
